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iv. Abstract 
 
Introduction: A complex two-way link between periodontitis and diabetes is widely 
accepted.  Although the mechanisms underlying this link have not been fully elucidated, 
disruption of host immunity (neutrophil function, cytokine release), tissue biochemistry, 
accumulation of advanced glycation end products (AGEs), matrix metalloproteases 
(MMPs) levels and the oral microbiota have been implicated.  
Aims and objectives: This project aims to investigate potential mechanisms through 
analysis of the impact of AGEs (a consequence of hyperglycaemia), on biofilm 
composition and telomerase immortalised gingival keratinocytes (TIGK). In addition, 
presented here is a preliminary feasibility study for comparison of oral biofilm 
composition and functionality, neutrophil function, and saliva and gingival crevicular fluid 
(GCF) cytokine and MMP profiles from healthy and periodontitis individuals.  
Methods: The study characterised receptor for AGE (RAGE) expression in TIGK cells 
and the consequent immune response initiated by AGE/RAGE interactions in these cells.  
Model oral biofilms (comprising five periodontal species) grown in the presence and 
absence of AGE were characterised using culture dependent methods. Complex 
biofilms, derived from combined saliva/tongue/plaque inocula, grown with AGE 
concentrations representative of hyperglycaemia or health were analysed using next 
generation sequencing.  In a preliminary study, biofilms were also co-cultured with TIGK 
cells in media supplemented with high AGE concentrations to determine changes in 
inflammatory responses.  
Individuals with periodontitis and healthy controls were recruited through DenTCRU for 
the preliminary clinical study.  Neutrophil migration, phagocytosis and respiratory burst 
in these individuals were analysed. Plaque, GCF and saliva were collected for analysis 
of cytokine and MMP expression and oral microbiome profiles.  
Results: The expression of RAGE by TIGK cells, at either the mRNA or protein level, 
did not change with varying concentrations of AGE. The addition of AGE to model five 
species biofilms encouraged the growth of A. naeslundii while reducing the proportion of 
P. gingivalis in the biofilms.  Analysis of complex biofilms indicated enrichment of genera 
including Prevotella, Streptococcus and Veillonella and decreases in Fusobacterium, 
Campylobacter and Bacteroides amongst others.   
The preliminary clinical study indicated feasibility of analysing neutrophil function and 
cytokine and MMP profiles from saliva and GCF. While impairment of neutrophil 
functions, increase in MMP8 and MMP9, changes in biofilm compositions and increases 
in cytokines in saliva (IL-8, IL-1β and MCP-1), plasma (IL-8 and IL-1β) and GCF (IL-8, 
 19 
 
IL-1β and MCP-1) were observed in periodontitis, further analysis using a larger cohort 
of individual’s ± periodontitis is required for these to reach significance. 
Conclusion: Together the results suggest AGEs can alter the composition of biofilms, 
appearing to encourage the growth of health associated genera. Preliminary co-culture 
experiments demonstrate co-culture of TIGK cells with complex biofilms decreases IL-8 
and IL-6 release.  
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1. Introduction
The oral cavity is in a delicate balance between the microorganisms that colonise it and 
the host immune response. The following, reviews the current understanding of 
microbiology and immunological processes involved in the maintenance of oral health 
and how dysregulations can lead to oral diseases. A particular interest is paid to 
periodontitis; understanding the aetiology of periodontitis can help our understanding of 
the mechanisms that link periodontitis to systemic diseases. This review and the 
research presented in this thesis examines the relationship between periodontitis and 
diabetes. The two diseases have long been considered interlinked, but the processes 
involved are relatively unknown.  
The research presented here focusses on the immune responses of periodontitis and 
how hyperglycaemic conditions in diabetes can influence both the bacterial composition 
of the oral cavity microbiota and the inflammatory responses of oral cells.  
1.1. The oral microbiome  
The multitude of microorganisms colonising the human body are commonly reported to 
outnumber human cells 10:1, providing functions which are essential for survival (Bryan 
et al., 2017). Although still quoted in the literature, this ratio was recently challenged in a 
study which re-evaluated both the number of bacterial cells and human cells in an 
average 70 kg body and concluded a 1:1 ratio was more accurate (Sender et al., 2016). 
The microorganisms of the body and microbial communities of various sites are referred 
to as the ‘microbiota’ (Lederberg and McCray, 2001). Colonisation of the body begins at 
birth through the exposure to microorganisms from the environment and other people. 
Factors, including tissue type, temperature, pH and nutrient availability as well as host 
age, sex and diet, influence microbial colonisation so that distinct sites within the human 
body have diverse and characteristic microbial communities. This colonisation leads to 
the generation of the ‘microbiome’ which is defined as the collective genomes of all the 
microbial species at a given site as well as the genomes of the environment they reside 
in (Marchesi and Ravel, 2015, Abdul-Aziz et al., 2016). The microbiota impact, both 
directly and indirectly, aspects of the body’s normal physiology, nutrition and defence. In 
health, the microbiota has a harmonious relationship with the host but a disturbance or 
imbalance in the normal composition of the microbiota which causes changes to the host 
responses (dysbiosis) can lead to a variety of diseases (Morgan et al., 2013, Petersen 
and Round, 2014, Abdul-Aziz et al., 2016).  
As early as the 1680s, studies into the diversity of the human microbiota have been 
carried out. Antonie van Leeuwenhoek in 1683 began the comparison of the species 
present in his oral cavity and faecal matter and comparisons between health and 
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disease, noting the difference between them (Porter, 1976, Ursell et al., 2012). 
Advancements in both culture dependent and culture-independent molecular techniques 
have vastly increased our understanding of the human microbiota. With the initial DNA 
sequencing methods of Sanger sequencing to the now commonly applied high-
throughput NGS, a vast amount of data have been collected and analysed, providing 
insight into the composition and functionality of the human microbiota (Curtis et al., 2011, 
Human Microbiome Project, 2012, Morgan et al., 2013, Abdul-Aziz et al., 2016).  
Although the majority of the 10-100 trillion symbiotic microbes that make up the human 
microbiota are found as bacteria in the gut, the oral cavity harbours the second largest 
microbiota within the human body (Lazarevic et al., 2010, Ursell et al., 2012, Wade, 
2013). The oral microbiota is considered to include microbes and biofilms (surface 
associated, structured microbial community enclosed in an extracellular polymeric 
substance matrix) originating from various sites within the mouth such as the mucosal 
surfaces of the tongue, cheeks, gingiva (gums) and tonsils and the harder supragingival 
or subgingival surfaces of the teeth (Curtis et al., 2011, Ursell et al., 2012, Proctor and 
Relman, 2017). The diversity in biofilm structure and composition across these various 
sites exists partially due to heterogeneity in the topographical anatomy which leads to 
variations in local chemistry, temperature, moisture, host physiology and immunity 
(Proctor and Relman, 2017). In line with this, a recent study using human microbiome 
data showed microbial communities on the exposed tooth surfaces are influenced by 
both tooth aspect and class of tooth as well as the physical distance separating the sites 
(Callahan et al., 2016).  
Furthermore, variations in tissue types and their associated structure also influence 
microbial communities. The oral cavity consists of both shedding (oral mucosa) and non-
shedding (dental enamel) tissue, as well as non-keratinized and keratinized cells (which 
can further be divided into parakeratinized or orthokeratinized cells), all of which 
contributes to the differences in microbial colonisation seen across sites in the oral cavity 
(Proctor and Relman, 2017).  
In addition to anatomical and structural differences in the oral cavity, proximity to salivary 
glands also impacts microbial communities (Proctor and Relman, 2017). For example, 
microbial differences seen between cheek facing surfaces of teeth and tongue facing 
surfaces of teeth is partially associated with the dense network of the minor salivary 
glands. They bathe the glands and surrounding tissues (labial, palatal and buccal 
mucosa) in viscous, highly proteinaceous secretions with low buffering capacity so that 
these tissues have distinct microbial communities (Sato et al., 2015, Simon-Soro et al., 
2013, Proctor and Relman, 2017). The major salivary glands have differing salivary 
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secretory rates and salivary composition, creating gradients in salivary film velocity, oral 
clearance and pH across teeth surfaces (Proctor and Relman, 2017).  
Bacterial communities of the mouth encompass over 1000 different species with 
individuals harbouring approximately 400 species at any given time (Dewhirst et al., 
2010, Wade, 2013, Samaranayake and Matsubara, 2017). The advancements in 
technologies and the completion of the Human Microbiome Project (HMP) have enabled 
the identification of the dominant phyla of the oral microbiome; Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria, Spirochaetes and Fusobacteria account for 96% of 
species present (Human Microbiome Project, 2012, Zhu and Kreth, 2012, Wade, 2013, 
Zaura et al., 2014). In addition to the bacterial population, the oral microbiome also 
includes viruses, archaea, fungi and protozoa (Wade, 2013). Given the high oral bacterial 
density, viral presence in the mouth is mostly associated with bacteriophages (Pride et 
al., 2012, Wade, 2013). A range of disease-associated viruses (such as upper respiratory 
infection causing viruses) can also be found in the mouth during acute phases of infection 
(Wade, 2013). A much smaller number of protozoa are associated with the oral 
microbiome, mainly Entamoeba gingivalis and Trichomonas tenax, with an increase in 
both seen in oral diseases and poor oral hygiene. Although initially this increase 
implicated the microorganisms as potential pathogens, it is now believed that the lack of 
oral hygiene causes an increase in food debris and bacteria providing a rich nutritional 
environment for the protozoa (Wade, 2013). The predominant fungal genera are 
Candida, Cladosporium, Aureobasidium, Saccharomycetales, Aspergillus, Fusarium 
and Cryptococcus. Candida species, although causing acute and chronic infections, are 
carried asymptomatically by many individuals (Arendorf and Walker, 1979, Wade, 2013). 
Archaea in the oral microbiota is limited to select species able to colonise/survive in the 
environment; Methanobrevibacter oralis and two Methanobrevibacter phylotypes 
(Methanobacterium curvum/congolense and Methanosarcina mazeii). These 
methanogens are detected in a healthy mouth in small proportions, but an increase is 
observed in oral diseases (Lepp et al., 2004, Matarazzo et al., 2011, Wade, 2013). 
1.1.1. Establishment of a healthy oral microbiota 
The oral cavity, being nutrient-rich and humid with a resting pH of between 6.75 and 
7.25, is an ideal environment for microbial colonisation (Rosier et al., 2014). The biofilms 
found in the oral cavity, particularly on the surface of the teeth, are referred to as dental 
plaque and although found in health, they are also associated with the most common 
oral diseases (Rosier et al., 2014, Samaranayake and Matsubara, 2017, Marsh et al., 
2015). Data from the HMP have indicated that the oral microbiome has the largest 
number of commonly shared microbes amongst unrelated individuals, more so than 
habitats such as the gut or the skin (Human Microbiome Project, 2012, Li et al., 2013). 
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Despite daily physical and chemical challenges the oral microbiome encounters through 
processes such as food intake and oral hygiene, a long-term stable microbiome is 
present in healthy mouths. The ability of the oral microbiota to adapt to changes in 
oxygen availability, temperature, pH, antimicrobials and dietary components and survive 
mechanical sheer forces (through mastication and brushing), helps establish and 
maintain health (Wright et al., 2013, Zaura et al., 2014). Although the processes that 
contribute to the development of diseases (particularly caries and periodontal diseases) 
are well documented, the mechanisms that maintain health are relatively poorly 
understood.  
1.1.1.1. Early colonisation 
Although the process of oral bacterial colonisation begins immediately following birth, 
tooth eruption creates novel microhabitats. These new potential colonisation sites can 
increase the diversity of the microbiota. In addition, complement, phagocytes and other 
components from the bloodstream begin to enter the oral cavity in minute amounts, 
providing novel growth substances and immune control of commensal and pathogenic 
bacteria (Proctor and Relman, 2017). This subsequently changes microbiota 
composition and is reflected in infants where species such as Streptococcus salivarius 
and Streptococcus mitis colonise within days of birth but species such as Streptococcus 
sanguinis are not seen until tooth eruption, due to the ability of S. sanguinis to colonise 
dental enamel but not mucosa (Carlsson et al., 1975, Proctor and Relman, 2017). 
Dental plaque formation is a continuous process which begins following the selective 
absorption of salivary glycoproteins to the surface enamel of teeth, forming a protein film 
called a pellicle (Figure 1.1). The pellicle contains both saliva and gingival crevicular fluid 
(CGF) proteins including glycoproteins, lysozymes, proline rich peptides, 
lactoperoxidases, lipids and phosphoproteins (Marsh et al., 2016). The acidic proline rich 
proteins contain binding sites for both hydroxyapatite and bacteria and may provide 
highly specific attachment sites for early colonising bacteria (Carlen et al., 1998, Dodds 
et al., 2005). If the supragingival plaque matures and extends down the tooth to develop 
into subgingival plaque, an inflammatory response may be initiated leading to the 
development of gingivitis (Figure 1.1). 
Streptococcus and Actinomyces species are the predominant early colonisers of tooth 
surfaces with evidence showing early colonisation by Actinomyces following tooth 
cleaning with relative proportions shifting to favour streptococci (particularly S. mitis and 
Streptococcus oralis) between 2 and 6 hours after tooth cleaning (Li et al., 2004). Early 
colonisers recognise molecules which allow adherence to tooth surfaces. For 
streptococci and Actinomyces species these include host derived receptors such as 
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statherin and proline rich proteins which have absorbed into the pellicle from saliva. Later 
colonisers are attracted to these via bacterial signals and metabolites and are able to 
adhere to the early colonisers (co-aggregate) leading to the generation of a more 
complex biofilm (Kolenbrander et al., 2010, Curtis et al., 2011). Certain species, such as 
Streptococcus gordonii, can interact with both salivary proteins (which would include 
those in the pellicle) and other bacteria, and as such make effective early colonisers 
(Nobbs et al., 2009). Other species, such as Fusobacterium nucleatum, are particularly 
strong co-aggregators, with the ability to interact with early and late colonisers and are 
considered important bridging bacteria in the processes of biofilm formation 
(Kolenbrander et al., 2010).  
 
 
Figure 1.1: Colonisation of oral biofilm leading to the establishment of gingivitis. 
During the formation of biofilms there is a selection of early, intermediate, and late-
colonizing species (Kolenbrander et al., 2010, Curtis et al., 2011). Gram-positive aerobic 
and facultative anaerobic early colonisers are able to adhere to the pellicle proteins, and 
then form binding sites themselves for the addition of more bacteria allowing the 
development of the biofilm (Murray et al., 1992, Ahn et al., 2002, Kolenbrander et al., 
2010, Curtis et al., 2011, Wade, 2013). Biofilm maturation can increase the presence of 
Gram-negative anaerobes which then activate host inflammatory responses. 
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1.1.1.2. Microbial community interaction and microbial regulation involved 
in maintaining oral health  
Microbial community interactions also play a role in preservation of healthy microbiota. 
Once formed, dental plaque is structurally highly organised with complex mature biofilms 
having more resilience than immature biofilms or planktonic bacteria to mechanical 
removal (through oral hygiene processes) and to host immunity (Wright et al., 2013, Xu 
and Gunsolley, 2014).   
In established biofilms, specific bacteria are often found near each other or as a mixed 
population to create specific structures which encourage growth or adherence 
(Kuramitsu et al., 2007, Xu and Gunsolley, 2014). For example, Actinomyces naeslundii 
and S. oralis cannot effectively colonise saliva coated surfaces alone but together can 
produce biofilms on these surfaces due to the combined utilisation of salivary metabolites 
(Palmer et al., 2001, Kuramitsu et al., 2007). Bacterial co-operation also exists in biofilms 
where multiple species are involved in the metabolism of complex host molecules (such 
as glycoproteins) which cannot be metabolised by one species alone (Marsh et al., 
2015). Indeed, as early as 1992 it was documented that Streptococcus mutans and 
Streptococcus sobrinus independently metabolise bovine serum albumin (BSA) with low 
efficiency but combined with S. oralis or F. nucleatum, higher BSA degradation was 
observed (Homer and Beighton, 1992).  
Commensal bacterial communities have established mechanisms to prevent pathogenic 
colonisation which include competition for nutrients, neutralization of virulence factors, 
production of antagonists to inhibit growth and interference in growth impacting signalling 
mechanisms (Kuramitsu et al., 2007, Zaura et al., 2014). An example of direct control of 
colonisation by pathogens is seen in S. salivarius K12, which has been shown to inhibit 
the growth of periodontitis- and halitosis- associated Gram-negative bacteria through the 
production of the bacteriocins; salivaricin A2 and salivaricin B (Burton et al., 2006, 
Masdea et al., 2012, Wade, 2013). S. gordonii, exemplifies the ability of some bacterial 
species to interfere with growth mechanisms of other bacteria. In biofilms and to a lesser 
effect in broth, S. gordonii has been demonstrated to antagonize several quorum 
sensing-dependent mechanisms (particularly the production of bacteriocins) of S. 
mutans. This process is reliant on the inactivation of the S. mutans competence-
stimulating peptide (a quorum sensing mediator) by S. gordonii (Wang and Kuramitsu, 
2005). 
Conversely, some bacteria aid colonisation and growth of other bacterial species (often 
commensals). For instance, A. naeslundii is able to cleave sialic acid residues found in 
oligosaccharide side chains on epithelial cells and in the enamel pellicle through the 
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action of a neuraminidase. This then exposes galactosyl sugar residues that can be 
utilised by bacteria expressing galactosyl-binding lectins for attachment (Gibbons et al., 
1990, Marsh et al., 2016).  
Community members of a commensal oral biofilm not only hinder pathogen colonisation 
but also influence other members of the community via synergistic mechanisms that 
stimulate the growth/survival of other members. Furthermore, inter-species bacterial 
communication is important to the integrity of the biofilm with inter-microbial adhesion, 
cell signalling through cell-cell contact, metabolic interactions and quorum sensing all 
playing crucial roles (Kuramitsu et al., 2007, Wright et al., 2013, Zaura et al., 2014).  
Commensal bacteria aid in preventing a heavily colonised site from entering a damaging 
state of inflammation by regulating host responses. Commensal bacteria from 
subgingival plaque can influence neutrophil deployment by regulating expression levels 
of intracellular adhesion molecule I (ICAM-1), E-selectin and cytokines (Dixon et al., 
2004, Devine et al., 2015). Cytokines such as interleukin-8 (IL-8, also known as CXCL8), 
CXCL1 and CXCL2 secreted from gingival cells and found in gingival tissues, saliva and 
gingival crevicular fluid (GCF) establish gradients for neutrophil recruitment (Devine et 
al., 2015). Neutrophils (as discussed in detail in section 1.1.1.3) are important in the 
maintenance of healthy microbiota. Neutrophil recruitment is regulated by 
cytokines/chemokines, expression of neutrophil cytokine/chemokine receptors and via 
their effects on expression of the adhesion molecules (detailed in section 1.1.1.3). Thus, 
altering neutrophil recruitment through cytokine release of gingival cells may be a method 
by which commensal bacteria establish a health-associated inflammatory status (Devine 
et al., 2015). In fact, a study has demonstrated that mouse colonisation by commensal 
bacteria increased CXCL2 expression and consequently increased neutrophil 
recruitment (Zenobia et al., 2013). While both CXCL1 and CXCL2 were expressed in 
periodontal tissues of germ-free mice, the CXCL2 up-regulation was only observed in 
mice with commensal colonisation.  
Control of cytokine levels by commensal bacteria is of much interest considering the role 
cytokines play in both innate and adaptive immunity in the oral cavity (discussed in more 
detail in section 1.2.4). In cases where changes in cytokines have been explored, 
commensal bacteria often demonstrate inhibition or down-regulation of cytokine release. 
Illustrating this is a study showing S. salivarius K12 inhibition of epithelial cell IL-8 
secretion. S. salivarius has also been shown to prevent normal IL-8 responses from 
epithelial cells stimulated by LL37, flagellin and Pseudomonas aeruginosa (Cosseau et 
al., 2008). In addition, K12 has been implicated in regulating immune responses through 
cytokine independent mechanisms, these include production of antimicrobial peptides 
(salivarin A2 and B), up-regulation of hepcidin (antimicrobial and iron regulating peptide) 
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and activation of type I and type II interferon responses (Hyink et al., 2007, Cosseau et 
al., 2008, Devine et al., 2015). Furthermore, a study using oral administration of the 
probiotic lactobacillus, Lactobacillus reuteri, to individuals with mild gingival inflammation 
was associated with a decrease in GCF IL-8 and tumour necrosis factor-α (TNF-α) 
concentrations (Twetman et al., 2009). This provides more evidence for the role of 
commensal bacteria in the regulation of immune responses in the oral cavity.  
There is also evidence suggesting that bacteria found in oral health can up-regulate 
cytokine production. A transcriptomic analysis of S. gordonii and F. nucleatum co-
cultured with gingival epithelial cells, demonstrated that while both bacteria altered the 
epithelial transcriptome to a lesser extent than pathogens, they did alter MAPK (mitogen-
activated protein kinase) and TLR (toll-like receptor) expression (Hasegawa et al., 2007); 
both MAPK and TLR can impact cytokine production, suggesting bacterial 
immunomodulatory roles. Indeed, S. gordonii was shown to inhibit IL-8 and IL-6 secretion 
while F. nucleatum caused an increase (Hasegawa et al., 2007). This suggested that a 
delicate balance in immune regulation is achieved by oral commensals to ensure the 
gingival tissues do not enter a detrimental inflammatory state. 
1.1.1.3. Microbial recognition and immune regulation by the oral mucosa  
Following colonisation and the establishment of the stable microbiota, a complex, bi-
directional interaction between host and microbiota maintains health. Site-specific and 
continual interactions between microbes and the host immune system mean microbiota 
of mucosal surfaces (including those in the oral cavity and gut) are influenced by both 
innate and adaptive immune responses (Zaura et al., 2014).  
The oral mucosa plays an important role in health through immune activation in response 
to the constant exposure to microbes, environmental antigens (diet derived and airborne) 
and damage through mastication and oral hygiene. In health, the oral cavity must 
maintain effective immune surveillance and clearance of pathogenic or excessive 
bacteria without mounting uncontrolled or disproportionate immune responses 
(Moutsopoulos and Konkel, 2017). To aid in this, the oral mucosa is composed of both 
oral epithelial cells and immune cells (including cells such as macrophages, dendritic 
cells (DCs), natural killer (NK) cells and polymorphonuclear neutrophils), which 
contribute to the plethora of immunomodulatory cytokines found in the oral cavity. Oral 
keratinocytes further contribute to immune regulation through the production of biological 
mediators such as antimicrobial peptides (Feller et al., 2013). 
The specifics involved in health and immune homeostasis maintenance, however, are 
not well understood. While immune tolerance to commensal bacteria at other barrier 
surfaces (such as skin) in the human body are relatively well explored, immune control 
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in oral health is not (Moutsopoulos and Konkel, 2017). Although specific local immunity 
in oral health initiated by commensal microbes is not fully understood, Dutzan et al (2016) 
has shown lymphocytes in healthy oral tissue have a high proportion of T-cells and a 
network of antigen presenting cells, suggesting priming of the immune cells to local 
antigens.  There is also evidence, however, to suggest that homeostasis is not only 
dependent on host-microbial interactions but also microbe independent regulation. For 
example, a study in germ-free mice showed no changes in gingival Th17 (T-helper 17) 
cell number compared with controls, indicating gingival Th17 cell accumulation was not 
dependent on commensal colonisation (Dutzan et al., 2017). The role of Th17 cells in 
the oral cavity is discussed in more detail in section 1.2.2.3. Contrastingly, a different 
study in germ-free mice demonstrated microbial colonisation may have distinct effect of 
innate immune cells by showing an increase in neutrophil recruitment in commensal 
colonised mice compared with the germ-free mice (Zenobia et al., 2013).  
Much like other barriers in the human body (skin/gut), the oral mucosa’s first line of 
defence is a physical barrier in the form of keratinized epithelia. The oral mucosa consists 
of a variety of epithelial cells of varying keratinization. The gingival crevice epithelium is 
a non-keratinized squamous epithelium lining the inside of the gingivae (gingival sulcus) 
and towards the base of the sulcus (where the gingiva meets the tooth) becomes 
incompletely differentiated epithelium, the junctional epithelium (JE). The JE and lack of 
keratinization makes the gingival crevice epithelium particularly vulnerable to bacterial 
and mechanical damage. These JE are attached to the tooth by hemi-desmosomes to 
provide a permeable connection for the movement of GCF. Furthermore, JE cells are 
important to the transmigration of neutrophils (Groeger and Meyle, 2015, Moutsopoulos 
and Konkel, 2017). Indeed, histological investigation showed an accumulation of 
inflammatory cells at a steady state in the gingival crevice (Moskow and Polson, 1991).  
In addition to the physical properties, gingival epithelial cells are also important in the 
recognition of bacterial products. Microorganism recognition by cells is mainly 
accomplished through members of the pattern recognition receptor (PRR) family and 
opsonins. While a variety of receptors are associated with PRRs to enable recognition 
of viral, fungal, protozoal and bacterial MAMPs (microbial-associated molecular 
patterns), TLRs and nucleotide oligomerization domain receptors (NODs) are the most 
prevalent and well-studied in oral cells (Ross and Herzberg, 2016, Feller et al., 2013). 
Oral and gingival epithelial cells have been shown to express TLRs 1 – 9 with variable 
and inducible expression and localisation (Sugawara et al., 2006, Beklen et al., 2007, 
McClure and Massari, 2014). 
Upon activation, TLRs initiate inflammatory responses via signalling cascades (NF-κB, 
MAPK and interferon regulatory factors) that lead to the transcription of cytokines. 
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Although many of the cytokines produced are pro-inflammatory and, as such, are 
involved in the recruitment of immune cells, immune cell-independent responses are also 
induced in oral keratinocytes. This includes production of antimicrobial peptides (LL-37 
and β-defensins) which are immunomodulatory molecules and can directly kill 
microorganisms (Ross and Herzberg, 2016). Epithelial release of IL-1α in response to 
microbial stimulation leading to the transcription of the antimicrobial protein calprotectin 
is an example of immune cell-independent responses (Sorenson et al., 2012). The study 
suggested this was achieved through IL-1 receptor interactions on adjacent or the same 
epithelial cell. Furthermore, increased resistance to bacterial invasion was also observed 
(Sorenson et al., 2012). The activation of anti-microbial mechanisms such as these, 
highlight potential roles of gingival epithelial cells in maintaining health and immune 
homeostasis.  
TLR activation in the gingival epithelium initiates the release of proinflammatory 
cytokines including IL-1α, IL-1β, IL-6, IL-8 and TNF-α, which are discussed in detail in 
section 1.2.4 (Meyle and Chapple, 2015, Groeger and Meyle, 2015). The release of 
these cytokines initiates inflammatory responses that are aimed at clearance of 
microorganisms. Regulation by negative feedback loops ensures resolution is achieved 
upon clearance of the stimulus, helping maintain the balance between effective microbial 
control and host damage (Figure 1.2). TLR specificity controls the magnitude and 
duration as well as type of adaptive immune response. For example, TLR2 recognises 
MAMPs associated with Gram-negative and Gram-positive bacteria (including 
lipoproteins and peptidoglycan) while TLR4 recognises bacterial components such as 
Gram-negative bacterial lipopolysaccharide: LPS. The clearance of pathogens is 
achieved through activation of phagocytosis by immune cells, release of antimicrobial 
peptides/inflammatory mediators and activation of inflammasomes (Feller et al., 2013, 
Kramer and Genco, 2017).  
In addition to release of cytokines, epithelial detection of microbes has also been linked 
to activation of the autophagosome and inflammasome as well as release of reactive 
oxygen species (ROS) and components of the complement system (Feller et al., 2013, 
Ross and Herzberg, 2016). The complement system is comprised of a cascade of 
interacting soluble and cell surface bound molecules including pattern recognition 
molecules, proteases, regulators and signalling receptors. Together these work to initiate 
and regulate the inflammatory response and are involved in direct microbe killing (Ricklin 
et al., 2010). For example, C3a and C5a recruit inflammatory cells while C3b functions 
as a microbial opsonin and C5b-C9 attacks membranes of susceptible microbes 
(Hajishengallis et al., 2013). Both complement and TLRs are involved in early defence 
mechanisms and responses against microbes, acting rapidly once activated to mediate 
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the link between innate and adaptive immunity (Hajishengallis and Lambris, 2016). 
Interestingly, microbial products typically associated with TLR activation (such as LPS, 
zymosan and CpG DNA) have also been demonstrated to initiate complement cascades 
(Zhang et al., 2007, Mangsbo et al., 2009). Recently, Hajishengallis and Lambris (2016) 
reviewed in depth, the studies linking TLR and complement activation and highlighted 
the importance of the interactions between the two systems, which can act synergistically 
(to enhance immune responses) or antagonistically (to regulate immune responses and 
maintain homeostasis).  
DCs are antigen presenting cells and are resident members of the oral mucosa. They 
act as regulators of immune tolerance and protection and play an important role in health. 
Antigen capture and presentation by DCs leads to the expression of cytokines and 
molecules required for presentation of antigens to B- and T-cells and the subsequent 
activation of adaptive immunity. In addition to mounting defences against pathogenic 
bacteria, DCs can also inhibit immune responses against commensal bacteria via 
complex mechanisms that involve deletions of T-cells through apoptosis and functional 
inactivation of T-cells (Santoro et al., 2005). Furthermore, they play a role in the 
development of antigen specific T-regulatory cells (T-regs). These multifactorial roles 
highlight their importance in homeostasis maintenance. In the gut, DCs can suppress 
inflammation and promote immunological tolerance of commensal bacteria (Iliev et al., 
2007). However, when pathogen load is high, non-immunosuppressive DCs are 
recruited to promote protective immune responses. This mechanism may also take place 
in the oral cavity (Santoro et al., 2005, Zaura et al., 2014). 
Polymorphonuclear neutrophils perhaps play the biggest role in maintaining oral health 
and immune homeostasis especially when considering they account for approximately 
95% of leukocytes in the oral mucosa and have been shown to be increased during 
inflammation (Dutzan et al., 2016). They are constantly extravasated from the circulation 
into the gingival tissue via the JE following chemokine gradients established by oral 
epithelial cells and other immune cells. Their exact role in oral health maintenance is not 
fully understood (Kinane et al., 2017). However, recently a cross-sectional clinical study 
looking at both oral and systemic polymorphonuclear neutrophils did demonstrate higher 
neutrophil activation in oral samples compared with systemic neutrophils even in the 
absence of periodontal disease indicating a role in oral health maintenance (Rijkschroeff 
et al., 2016). A more in-depth discussion of polymorphonuclear neutrophils and in 
particular their role in periodontitis progression is discussed in section 1.2.1. 
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1.1.1.4. Role of saliva and gingival crevicular fluid in establishing healthy 
microbiota 
Saliva, being protein rich and continuously bathing the surfaces of the oral cavity, is 
important in oral health. Components from both saliva and GCF contribute to health 
associated immunity. The GCF is a serum transudate which flows continuously into the 
gingival sulcus. It is composed of a variety of variable substances including 
immunoglobulins, albumin, immune modulators, antimicrobial peptides, tissue 
breakdown products and microbes from surrounding plaque. It resembles serum and in 
health is found in small quantities (Khurshid et al., 2017, Sonnenschein and Meyle, 
2015). Saliva, much like GCF, contains a variety of complex molecules including 
glycoproteins, inorganic ions, proline-rich peptides, host-defence peptides, mucins and 
amylase (Marsh et al., 2016).  
As described previously (section 1.1.1.1) salivary and GCF components play an 
important role in the generation of the pellicle and subsequent bacterial adherence. In 
addition, certain salivary proteins act only when in fluid saliva. For example, salivary 
agglutinin (also known as gp340) and the salivary mucin MUC7 are involved in 
aggregating planktonic bacteria, leading to their removal through swallowing and 
preventing their attachment to the surfaces of the oral cavity (Marsh et al., 2016, Madsen 
et al., 2010). While this is beneficial in situations where the bacteria could be detrimental 
to health, it could potentially hinder the establishment of a commensal microbiota. To 
overcome this, certain proteins found in saliva are equipped to select for particular 
bacteria. For example, proline rich peptides found in saliva contain bacterial attachment 
protein segments which are only exposed when the protein is absorbed into the pellicle 
and bound to the hydroxyapatite on the surface of teeth. This then allows commensal 
bacteria to avoid aggregation and removal but still bind to the pellicle (Marsh et al., 2015). 
Salivary agglutinins also have the additional function of activating the complement 
system via the classical pathway (Leito et al., 2011). An early study demonstrated 
interaction of salivary agglutinin with the C1q receptor of complement (the first 
component of the classical pathway) in freshly isolated human serum (Boackle et al., 
1993). Under normal conditions, these two proteins would not interact, but under 
inflammatory conditions where blood or GCF may leak into the saliva their potential for 
interaction increases (Madsen et al., 2010). More recent studies have demonstrated finer 
control of complement activation by salivary agglutinin, whereby activation of 
complement is achieved only when agglutinin is surface bound and inhibition is observed 
when it is in solution (Leito et al., 2011, Reichhardt et al., 2012). Together these findings 
suggest that agglutinins may be important in regulating immune responses as well as 
impacting the microbiota.  
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Other immunomodulatory molecules in saliva and GCF are the antibodies, secretory 
immunoglobulin A (sIgA) and to a lesser extent immunoglobulin G (IgG). The exact role 
of these in health, beyond antimicrobial immune response activities (such as 
neutralisation and aggregation), are not fully understood (Dawes et al., 2015). However, 
IgA proteases are well known virulence factors of pathogens such as Neisseria 
meningitidis and Streptococcus pneumoniae but are also produced by commensal 
bacteria such as S. mitis, S. oralis and S. sanguinis, all of which are primary colonisers 
of the oral cavity and are found as the major colonisers of oral mucosal sites of adults 
(Marsh et al., 2009, Zaura et al., 2014). This suggests a role in both prevention of 
colonisation and survival of particular species.  
Although the exact role of all the proteins in health are not fully understood, Table 1.1 
highlights important health maintenance roles of some of the many proteins found in 
saliva.  
1.1.2. Periodontal diseases  
The periodontal diseases gingivitis and periodontitis are two of the most common human 
diseases (Preshaw et al., 2012, Xu and Gunsolley, 2014). Periodontitis is a common 
condition that affects approximately 10-15% of adults in its severe form and 40-60% in 
the moderate form (Petersen and Ogawa, 2012, Preshaw et al., 2012, Kinane et al., 
2017). Although not fatal periodontal diseases can have a substantial impact on health 
services and a patient’s quality of life.  
Periodontitis predominantly falls into two categories – chronic and aggressive (American 
Academy of Periodontology, 2015). Chronic periodontitis progresses from untreated 
gingivitis and is associated with chronic inflammation leading to irreversible tissue 
damage (Kinane et al., 2017). Aggressive periodontitis is often more severe, has an 
earlier onset and faster progression rate (Armitage, 1999, Wade, 2013). More rare 
categories of periodontitis include necrotizing ulcerative periodontitis and syndromic 
chronic periodontitis. While necrotizing ulcerative periodontitis is an acute form of the 
disease with rapid progression, syndromic chronic periodontitis is associated with 
systemic diseases (such as Chediak-Higashi syndrome and Papillon-Lefѐvre syndrome) 
which impact host immune responses (Kinane et al., 2017).  The inflammatory responses 
associated with periodontitis can lead to the formation of the characteristic periodontal 
pocket and eventual loss of attachment between teeth and gingivae (Figure 1.2 and 
Figure 1.3). Periodontal tissue destruction, although slow to progress, is in the main 
irreversible (Darveau, 2010, Preshaw et al., 2012, Scannapieco, 2013, Wade, 2013). 
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Table 1.1: The role of some salivary components in oral health maintenance  
Component  Function in oral health maintenance 
α-amylase Inhibits growth of pathogenic bacteria Porphyromonas gingivalis 
(Ochiai et al., 2014). 
Histatins Inhibits growth of opportunistic oral fungus Candida albicans 
(Oppenheim et al., 1988). 
Statherin Inhibits growth on anaerobic bacteria (Gorr, 2009).  
Acts in a buffering capacity and limits damage associated with pH 
changes caused by bacterial metabolism (Zaura et al., 2014) 
Provides attachment sites in the pellicle for oral colonisers (Dodds 
et al., 2005). 
Glycans Acts as decoys to prevent adherence of C. albicans (Everest-Dass 
et al., 2012).  
Involved in toxin interaction and neutralization (Dawes et al., 2015). 
Lactoperoxidase Catalyses the conversion of the bacterial metabolite hydrogen 
peroxidase and saliva-secreted thiocynate into hypothiocyanite. 
Hypothiocyanite acts as an antimicrobial and inhibits bacterial 
glycolysis (Kilian et al., 2016).   
Lysozyme Cationic protein that causes bacterial cell wall damage (Dawes et 
al., 2015). 
Lactoferrin Acts as iron chelator. Removal of iron can interfere with metabolism 
of some pathogens (Dawes et al., 2015). 
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Figure 1.2: Host immune responses and the impact on periodontitis progression. 
Bacterial products are recognised by cells in the periodontal environment via toll like receptors 
(TLRs) and nucleotide oligomerization domain receptors (NODs) (1) causing intracellular 
signalling cascades which result in the release of inflammatory cytokines and chemokines by 
residential cells (epithelial cells/fibroblasts/dendritic cell) (2). These act on blood-vessels and 
circulating leukocytes to selectively recruit leukocytes to the periodontal space causing a 
further release of pro-inflammatory cytokines and chemokines (3). Recruited leukocytes, upon 
recognition of bacterial products (via TLRs and NODs) become activated to release 
antimicrobial compounds including myeloperoxidase (MPO) and nitric oxide (NO) and 
neutrophil extracellular traps (NETS) (4). Maintenance of periodontal health is also aided by 
the release of cytokines and antibodies that initiate phagocytosis (5). In periodontitis 
leukocytes also produce or induce production, by resident cells, of RANKL (receptor activator 
of nuclear factor-κB ligand) (6). An increase in RANKL and a disruption in levels of its inhibitor, 
OPG (osteoprotegerin) (7) increases bone resorption through activation of osteoclasts 
(OCLs). This causes a disruption in the bone formation (8) and bone resorption balance. 
Inflammatory mediators produced by the leukocytes also inhibit coupled bone formation (9) in 
an attempt to counteract the increased OCL activity. The local chronic inflammatory state 
results in an imbalance of MMP (matrix metalloproteases) and TIMP (tissue inhibitors of 
metalloproteinase) ratio leading to increase in extracellular matrix (ECM) destruction of 
periodontal tissues (10). Periodontal pathogens also activate antimicrobial compounds such 
as lactoferrin, - and - defensins and LL-37. Adapted from Garlet (2010). 
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Figure 1.3: Progression of gingivitis and periodontitis (adapted from 
Hajishengallis, 2015). The accumulation of bacteria at the gingival crevice leads to the 
initiation of gingivitis. A subsequent shift in bacterial composition from Gram-positive 
aerobes and facultative anaerobes to predominantly Gram-negative anaerobes disrupts 
inflammatory responses and activates the progression to periodontitis and the formation 
of a periodontal pocket. This leads to eventual destruction of the collagen fibres of the 
periodontal ligament, bone resorption and attachment loss (Preshaw et al., 2012, 
Scannapieco, 2013).  
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Our understanding of oral diseases has progressed substantially over the years. It is now 
understood that gingivitis and periodontitis are characterised by a combination of 
pathogenic bacterial accumulation and subsequent detrimental host inflammatory 
responses, but the exact cause of periodontal disease onset is continually under review 
(Preshaw et al., 2012, Ramamurthy et al., 2014, Xu and Gunsolley, 2014). Initially 
periodontitis was considered to be caused by an accumulation of microorganisms within 
the dental plaque and the subsequent host response (Schultz-Haudt et al., 1954, 
Macdonald et al., 1956). This hypothesis was followed, in 1986, by a theory based on 
studies utilising culture dependent methods to identify a complex biofilm of over 200 
species in the absence of brushing, with an increase in bacterial load and shifts in 
proportions in periodontitis but no identification of a single causative species. Thus, the 
theory of multiple responsible species was put forward (Theilade, 1986). In 1994 the 
ecological plaque hypothesis was put forward by Marsh, who postulated that shifts in 
microbial composition as a consequence of changes in the environment led to flourishing 
of bacterial species and development of  pathogenic bacterial consortia which could 
cause host infection (Marsh, 1994). A more recent theory based on the ecological plaque 
hypothesis is the polymicrobial synergy and dysbiosis hypothesis, which proposes that 
oral diseases are initiated and maintained by synergistic and dysbiotic microbial 
communities (rather than specific oral pathogens) so that they represent a specific 
genetic fingerprint to work together to stabilise and grow the disease provoking biofilm 
(Hajishengallis and Lamont, 2012, Hajishengallis et al., 2012).  
Dental plaque maturation contributes to the progression of gingivitis and periodontitis. If 
kept in check through regular tooth cleaning, the dental plaque remains present only in 
small amounts and the activation of detrimental inflammatory processes can be avoided 
(Socransky, 1977, Wade, 2013). When plaque matures however, there is an 
accumulation of bacteria and an increase in the presence of bacteria with pathogenic 
potential (including opportunistic pathogens which are damaging to the host under 
certain conditions). This accumulation of bacteria triggers the onset of gingivitis where 
the gingivae become inflamed through the activation of a defensive inflammatory 
response. It is now widely accepted that this accumulation of bacteria alone is not 
sufficient to trigger the advancement to periodontitis, but rather a series of complex 
interactions between the gingivitis associated biofilm and the host immune response is 
required for progression (Figure 1.1 and Figure 1.2) (Kilian et al., 2016, Zijnge et al., 
2010, Wade, 2013).  
In gingivitis, the GCF changes from a transudate to a microbial and host-derived 
substance rich exudate. The host derived components include pro-inflammatory 
cytokines, immune cells and enzymes such as proteases (Kilian et al., 2016, 
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Sonnenschein and Meyle, 2015, Lamster, 1997). This change in composition added to 
an increased flow of GCF and accompanied local gingival bleeding leads to disruption in 
the microenvironment. This then causes the main bacterial load in the gingival crevice to 
shift from predominantly Gram-positive aerobes and facultative anaerobes towards 
Gram-negative anaerobes (Figure 1.1). Increase in bacterial load and subsequent 
oxygen utilisation in addition to deepening of the periodontal pocket creates an 
increasingly anaerobic and reduced environment (Figure 1.2 and Figure 1.3), which 
further enhances the shift from health to dysbiosis by encouraging the growth of an 
obligate anaerobic community in the subgingival plaque (Hajishengallis, 2015).   
In addition to the formation of the periodontal pocket, inflammation can cause bleeding 
in the gingival crevice which increases the haemoglobin and transferrin content of the 
environment. This produces conditions ideal for the growth of the periodontitis associated 
pathogens such as Porphyromonas gingivalis (Kuramitsu et al., 2007, Meyle and 
Chapple, 2015, Kilian et al., 2016).The metabolic processes of the now favoured 
bacteria, increases pH but also contributes to making the environment more anaerobic 
further encouraging growth of the bacteria adapted to these environments such as P. 
gingivalis and Tannerella forsythia. These proteolytic bacteria not only directly damage 
host tissue, but also impact host immunity through degradation of immunoregulatory 
proteins (Marsh et al., 2015).  
The progression of gingivitis to periodontitis occurs in individuals when gingivitis-
associated inflammation is no longer proportionate or self-resolving but rather becomes 
exaggerated and ineffective, particularly in the connective tissue supporting the teeth. 
This can be perpetuated by external factors which increase susceptibility such as 
tobacco consumption and poorly-controlled diabetes (Kilian et al., 2016). The shift in the 
biofilm composition causes the destruction of periodontal tissue through exacerbated 
and dysregulated inflammation (Abdul-Sater et al., 2009, Garlet, 2010, Scannapieco, 
2013). 
The destruction of periodontal ligaments through the breakdown of collagen fibres can 
cause the deepening of the periodontal pocket (Figure 1.2 and Figure 1.3). Tissue 
breakdown also provides further nutrients for pathogenic bacterial growth, promoting 
further inflammation, tissue destruction and dysbiosis (Kilian et al., 2016). Colonisation 
of the periodontal pocket, a prime location for anaerobic bacteria, also triggers 
downstream alveolar bone resorption leading to attachment loss (Figure 1.2 and Figure 
1.3) (Preshaw et al., 2012).  
Unlike in gingivitis, there are several species of bacteria which are associated with 
periodontitis. Socransky et al in 1998 proposed a model which distinguished bacteria into 
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coloured complexes based on their involvement in periodontitis (Figure 1.4) (Socransky 
et al., 1998). Based on data from over 13,000 subgingival plaque samples, analysed for 
the presence of 40 culturable species (using DNA-DNA hybridization) it was concluded 
that the bacteria associated with the blue, green, purple and yellow complexes were 
involved in initial colonisation of tooth surfaces. The Orange complex bacteria showed 
increased prevalence in moderate disease and were described as being associated in 
the progression of periodontitis. Red complex bacteria  had increased prevalence in 
diseased sites and are associated with established and severe periodontitis (Figure 1.4) 
(Socransky and Haffajee, 2002). Although this nomenclature is still used today, the 
advancement in culture independent bacterial identification has improved microbial 
profiling so that bacteria associated with each of these colour complexes now includes 
non-culturable species not described in the original model (Hiranmayi et al., 2017).  
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Figure 1.4: Representation of the colour complexes defined using the checkerboard 
technique of culturable bacteria associated with periodontal health and disease. The 
base of the pyramid represents health associated bacteria which are early colonisers of tooth 
surfaces. Upon plaque maturation the orange complex bacteria increase in predominance and 
bridge the colonisation of red complex bacteria which are found to be more prevalent in 
periodontitis (adapted from Socransky and Haffajee, 2002).  
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Disease associated bacterial communities persist in the periodontal pocket without 
invading the periodontal tissue. The immune system is unable to effectively eliminate the 
microorganisms causing a chronic inflammatory state such that the prolonged host 
responses lead to tissue destruction (Okada and Murakami, 1998). Despite the 
association of these bacteria with periodontitis, it remains unclear if any particular 
species is involved in disease onset or if it is the shift in biofilm composition leading to 
the formation of the pocket and subsequent chronic inflammation which produces optimal 
conditions for these bacteria to flourish (Curtis et al., 2011, Wade, 2013).  
The role of viruses in periodontitis has also recently been investigated. In particular 
herpesviruses have been implicated in gingival infections, periodontal diseases and 
mucosal ulceration (Silva et al., 2015). Herpesviruses often have latent persistence in a 
variety of cells including immune cells and can modulate immune responses. Although 
little is known about the exact mechanisms linking viral load to progression of 
periodontitis, these viruses have been shown to have a higher prevalence in periodontal 
tissues in patients with periodontitis (Slots and Contreras, 2000, Silva et al., 2015). It is 
proposed that local immunomodulatory effects caused by herpesvirus infection could 
enable the increase in bacterial load and virulence in periodontitis. In addition, 
herpesvirus infection could induce the release of cytokines/chemokines contributing to 
the excessive immune response associated with periodontitis (Silva et al., 2015, Meyle 
and Chapple, 2015, Slots and Contreras, 2000, Wright et al., 2008). 
1.2. Molecular mechanisms involved in the progression of periodontitis  
With the advancement of technology, our understanding of the immune response 
associated with periodontitis has evolved. Since it was first suggested in 1976 by Page 
and Schroeder, the idea that bacterial presence is essential but not sufficient for the 
progression of periodontitis is still valid. Active periodontitis could be characterised by 
the changes in inflammatory cells (including polymorphonuclear neutrophils, DCs, T-
cells and macrophages) as well alterations in immunomodulatory molecules (including 
cytokines and complement) with alveolar bone resorption and gingival tissue damage as 
a consequence of prolonged immune responses. Below is a brief description of some 
aspects of both the innate and adaptive immune responses that have been shown to be 
involved in periodontitis. 
1.2.1. Polymorphonuclear neutrophils 
Polymorphonuclear neutrophils (referred to as neutrophils from this point) as previously 
alluded to (section 1.1.1.3) are significant players in the establishment and maintenance 
of a healthy periodontium. In the absence of inflammation, the number of leukocytes 
migrating through the JE amount to 3000 leukocytes/min into the periodontal pocket 
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(Schiott and Loe, 1970). These are predominantly neutrophils and an increase in 
numbers has been observed in periodontitis. Interestingly an increase in systemic 
numbers of neutrophils is also observed in both localised and generalised periodontitis 
(Loos et al., 2000), suggesting an exacerbated systemic innate immune response 
stemming from the increased inflammation in the oral cavity associated with periodontitis. 
Furthermore, treatment of patients with generalised periodontitis led to a decrease in 
systemic neutrophil numbers (Christan et al., 2002). These studies suggest a mechanism 
by which local infection controls neutrophil generation.  
Once in the periodontal pocket, neutrophils form a barrier between microorganisms and 
the host cells, providing early lines of immune defence (Nicu and Loos, 2016). 
Neutrophils function following a two-step processes. The first step, priming, results from 
the initial exposure to activating factors (cytokines and bacterial products) (Summers et 
al., 2010). Priming ensures maximal neutrophil degranulation and oxidative burst by 
making neutrophils more responsive to activating agents and able to survive longer 
through delayed apoptosis (Guthrie et al., 1984, Colotta et al., 1992, Nicu and Loos, 
2016). Priming is followed by activation and subsequent removal of activating agent 
(Summers et al., 2010). Following is a brief overview of neutrophil activation, the 
mechanisms employed by neutrophils for bacterial control and the roles played by 
neutrophils in periodontitis progression and associated tissue damage.  
Prior to activation, neutrophils act in a searching capacity, circulating in blood to find 
potential targets or areas of inflammation to which they may be recruited. These targets 
include the cytokines produced by epithelial cells in response to microorganisms or 
tissue damage (section 1.2.4), which signal the presence of pathogens (Nicu and Loos, 
2016). In addition to release of chemokines (such as IL-8, C5a and prostaglandin E2: 
PGE2) by DCs, macrophages, mast cells, endothelial and epithelial cells, response to 
local infection also includes an up-regulation of adhesion molecules on local blood vessel 
endothelium. Together these changes direct and aid the migration of neutrophils from 
the blood into the infected tissue (Delima and Van Dyke, 2003, Phillipson and Kubes, 
2011, Amulic et al., 2012, Hajishengallis and Chavakis, 2013). In the JE, IL-8 production 
is paramount to the generation of a chemotactic gradient for recruitment of neutrophils 
into the periodontal pocket (Curtis et al., 2011, Uriarte et al., 2016). The role of IL-8 in 
periodontitis is discussed in more detail in section 1.2.4.1.  
Upon reaching a site of infection, neutrophils undergo a series of processes to 
transmigrate through the blood vessels into the tissue. Chemokines produced by host 
cells and microbial components (LPS, lipoteichoic acid or N-formyl-methionyl-leucyl-
phenylalanine: fMLP) initiate this process (Nicu and Loos, 2016). The release of 
histamine and complement components (C3a and C5a) cause vasodilation, slowing of 
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blood flow and increased vascular permeability thus allowing the neutrophils to 
successfully undergo the tethering process (Meyle and Chapple, 2015). The increase in 
vascular permeability also increases serum release into the periodontal pocket. In health, 
serum, being rich in inflammatory mediators (such as antibodies and complement 
components), aids the clearance of pathogenic bacteria (Meyle and Chapple, 2015). In 
periodontitis, however, the increase in the GCF serum content can provide nutrients to 
enhance the growth of pathogenic communities. Indeed, P. gingivalis has been shown 
to activate C5a through cysteine protease (gingipain) associated conversion of C5. This 
potentially causes an increase in migration and retention of neutrophils into tissues and 
activates macrophages to prolong inflammation, leading to an increase in potential 
growth substances (Wingrove et al., 1992, Meyle and Chapple, 2015). The increase in 
local C5a levels induced by P. gingivalis also interferes with the interactions between 
TLR2 and C5a such that IL-12p70 is inhibited and pro-inflammatory cytokines (IL-1β, IL-
6 and TNF-α) are increased. In an in vivo mouse model, this mechanism presents as 
evasion of immune clearance and inflammatory bone loss which is not found in either 
C5a receptor or TLR2 deficient mice (Liang et al., 2011). Furthermore, C5a receptor-
TLR cross talk has also been shown to be exploited by P. gingivalis to evade 
macrophage associated killing which could be recovered by addition of a C5a receptor 
antagonist (Wang et al., 2010). Complement associated manipulations by P. gingivalis 
are associated with a host of other mechanisms including impairment of iNOS (inducible 
nitric oxide synthase) dependent killing of pathogens, gingipain proteolytic cleavage of 
C3 thus prevention of complement activation, activation of TLR2 and subsequent IL-12 
down-regulation and cleavage of complement regulatory protein (CD46) from host cell 
surfaces (Hajishengallis, 2010, Olsen et al., 2017). 
The up-regulation of adhesion molecules on local blood vessels further aid the initial 
tethering of neutrophils to endothelial cells and slows their movement to allow rolling. 
Rolling is dependent on interactions between neutrophil cell surface molecules such as 
L-selectin (neutrophil cell surface), P-selectin (endothelium), E-selectin (endothelium) 
and endothelial cell receptor P-selectin glycoprotein ligand-1 (endothelium and 
neutrophils) (Ley et al., 2007). Platelets also express a high level of P-selectin and, given 
decreases observed in neutrophil rolling and adhesion in response to anti-platelet 
antibodies, it has been proposed platelets act as bridges between neutrophils and 
endothelial cells to aid adherence of neutrophils (Carvalho-Tavares et al., 2000). 
Interestingly, untreated periodontitis has been associated with increased platelet P-
selectin expression and adhesion of platelets to neutrophils in response to bacterial 
challenge and increased systemic platelet activation (Nicu et al., 2009, Papapanagiotou 
et al., 2009). Furthermore, greater phagocytosis responses have been observed with 
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neutrophil-platelet complexes compared with neutrophils alone in both periodontitis and 
periodontally healthy patients (Nicu et al., 2009).   
The process of rolling allows binding between integrins on neutrophil cell surfaces (such 
as lymphocyte function-associated antigen and macrophage-1 antigen) to their receptors 
on activated endothelium (including intercellular adhesion molecule 1 and 2) for firm 
adhesion. Adhesion requires the binding of chemokines to their neutrophil receptors 
(achieved during neutrophil rolling) to activate neutrophils and lead to the integrin 
confirmation changes needed for receptor binding (Nicu and Loos, 2016). In addition, 
binding of chemokines to neutrophils initiates cytosolic actin reorganisation and 
development of cellular polarity, both of which aid in contact between neutrophils and 
the endothelial cells (Meyle and Chapple, 2015). Once adhered to the endothelial 
surface, neutrophils begin the process of transmigration after crawling along the 
endothelial lining to find an appropriate place. Transmigration is a complicated process 
reliant on a host of molecules including; junctional adhesion molecules, platelet 
endothelial cell adhesion molecule-1, integrins and vascular endothelial cadherin 
(reviewed in detail in Schmidt et al., 2011 and Muller, 2013).  
Neutrophils are characterised by both their lobed nuclei and the high granulation of their 
cytoplasm. These granules contain a large variety of antimicrobial peptides and enzymes 
and are divided into four categories; azurophilic, specific, gelatinase and secretory 
vesicles (Uriarte et al., 2016). A brief description of some of the contents of the 
azurophilic, specific and gelatinases is outlined in Table 1.2 (Faurschou and Borregaard, 
2003) with the addition of lysozyme which is found in all three types of granules and 
functions by cleaving peptidoglycan polymers of bacterial cell walls and bind LPS to 
reduce associated cytokine release (Faurschou and Borregaard, 2003, Wiesner and 
Vilcinskas, 2010). 
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Table 1.2: Neutrophil granular content and function. Predominant antimicrobial 
protein functions within each granule (Faurschou and Borregaard, 2003). 
 
Granule  Antimicrobial protein Main function 
Azurophilic 
(primary) 
 
Myeloperoxidase Lead to the formation of microbicidal 
molecules (hydrochlorous acid, N-
chloramines, tyrosine radicals and 
reactive nitrogen intermediates) 
which attack the surface membrane 
of microorganisms. Formed via 
interactions with hydrogen peroxide.  
Serine proteases  Involved in hydrolysis of extracellular 
matrix. Includes elastases, cathepsin 
G, azurocidin and proteinase 3. 
Defensins  Forms multimeric transmembrane 
pores. Small cationic antimicrobial 
and cytotoxic peptides. 
Bactericidal/permeability-
increasing protein (BP1) 
Cationic protein which binds to 
lipopolysaccharide of Gram-negative 
bacteria leading to the rearrangement 
of outer membrane lipids, growth 
inhibition and inner membrane 
damage.  
Promotes bacterial attachment to 
neutrophils and monocytes. 
Specific 
(secondary) 
Lactoferrin  Sequesters iron to inhibit bacterial 
growth.  
Binds to bacteria cell membranes 
causing irreversible damage and cell 
lysis 
Human cathelicidin  Antimicrobial protein whose C-
terminal (LL-37) has antimicrobial 
activity against Gram-negative and 
Gram-positive bacteria and acts as a 
chemoattractant for neutrophils, T 
cells and monocytes.  
Lipocalin neutrophil gelatinase-
associated lipocalin (NGAL) 
Bacteriostatic through sequestering 
of ferric-siderophore complexes.  
Matrix metalloproteinase 8 
(MMP-8) 
Collagenase 
Gelatinase 
(tertiary)  
Matrix metalloproteinase 9 
(MMP-9) 
Gelatinases 
Macrophage-1 antigen  Firm adhesion of neutrophils to 
endothelial cells  
Nicotinamide adenine 
dinucleotide phosphate oxidase 
component (cytochrome b558) 
Involved in the generation of ROS.  
Natural resistance-associated 
macrophage protein 1 
Deprives microorganism in the 
phagosome of essential metals such 
as iron, magnesium and zinc.  
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Mobilisation and degranulation in neutrophils is hierarchical, such that neutrophil 
activation favours mobilisation and degranulation of gelatinase granules over specific 
granules which are favoured over azurophilic granules (Nauseef and Borregaard, 2014). 
This process allows the neutrophil to transform from a sentinel cell into a potent active 
innate immune cell (Faurschou and Borregaard, 2003). Secretory vesicles are mobilised 
during the initial activation of neutrophils (during rolling) and function via their 
membranes to provide neutrophils with additional receptors (including integrins, 
macrophage-1 antigen, LPS/lipoteichoic acid-receptor, CD14, immunoglobulin 
receptors, formylated bacteria peptide receptors and matrix metalloproteinase (MMP)/ 
/leukolysin receptors). This mobilisation aids in priming neutrophils for transmigration, 
making them integrin presenting cells which are highly responsive (Nicu and Loos, 2016).  
Once neutrophils transmigrate through the endothelial cells, they move through the 
vascular basement membrane to exit the vessel and enter the infected tissue. This 
process requires the release of proteases such as MMPs, elastases and proteinase-3 
(Nussbaum and Shapira, 2011, Kuckleburg et al., 2012). Neutrophils contain three main 
MMPs types: collagenases, gelatinases and leukolysin. Prior to degranulation these are 
stored as inactive pro-forms mainly in gelatinase and specific granules (Faurschou and 
Borregaard, 2003). 
Neutrophil activation occurs through binding of TLRs of which neutrophils express most, 
excluding TLR3 and TLR7. Once these bind their ligands, neutrophils are activated and 
phagocytosis, superoxide generation and production of cytokines/chemokines is initiated 
(Prince et al., 2011). Phagocytosis is the most characteristic mechanism by which 
neutrophils clear activating agents. The process is facilitated by opsonization through 
which activating agents are coated in host derived molecules such as complement 
factors, antibodies and mannose-binding lectin. These opsonins have receptors on the 
surface of neutrophils (including C3b receptors and antibody/immunoglobulin receptors) 
which, once bound, lead to the invagination of the neutrophil membrane and 
internalisation of the activating agent into a phagosome (Nicu and Loos, 2016). Killing 
within the phagosome is achieved through two main mechanisms: ROS generation and 
release of granular proteases (Roos et al., 2003). Furthermore, hydrogen peroxide (one 
of the ROS generated) is also a substrate for myeloperoxidase (MPO) for the formation 
of a chlorinated derivative which is toxic to many microbes (Table 1.2, Faurschou and 
Borregaard, 2003). 
In addition to phagocytosis, neutrophil extracellular traps (NETs) have more recently 
been indicated as important in neutrophil killing (Brinkmann et al., 2004). These 
structures are assembled intracellularly following the loss of nuclear integrity and the 
combining of double stranded DNA, histones, cathelicidin (LL-37), elastases and MPO. 
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Release of NETs is achieved following plasma membrane perforation or cell lysis in a 
ROS release-dependent process known as NETosis (Fuchs et al., 2007). In chronic 
periodontitis NETs have been observed in periodontal pockets and GCF (Vitkov et al., 
2009). Interestingly, P. gingivalis, T. forsythia, F. nucleatum and Prevotella intermedia, 
have been shown to have DNAse activity and can degrade NETs under certain growth 
conditions, thus, avoiding NET-associated killing (Palmer et al., 2012).  
Following removal of the neutrophil activating agent, resolution is achieved through 
apoptosis of neutrophils (Nussbaum and Shapira, 2011). Achieving this requires 
suppression of pro-inflammatory cytokine production and induction of anti-inflammatory 
cytokine (such as IL-10 and TGF-β) production by phagocytic macrophages (Kennedy 
and DeLeo, 2009). Disposal of unused neutrophil granules is carried out following anti-
inflammatory cytokine-associated recruitment of anti-inflammatory macrophages. This 
minimises the risk of excessive tissue damage (Savill et al., 1989). A distortion in the 
apoptosis and clearance of neutrophil products can prolong tissue damage and 
inflammation. Apoptosis resistant neutrophils have been found in the GCF of patients 
with periodontitis. These patients showed a decrease in granulocyte monocyte-colony 
stimulating factor (GM-CSF) which can increase mitochondrial stability and reduce 
caspase 3 activity to reduce neutrophil apoptosis (Gamonal et al., 2003). Furthermore, 
there is evidence for inhibition of apoptosis in periodontal neutrophils by LPS and a 
consequent increase in necrosis (Turina et al., 2005). This in turn may cause the release 
of neutrophil enzymes and ROS into the periodontium thus exacerbating the tissue 
damage associated with periodontitis.   
Although neutrophils are generally effective at clearing bacteria that pass through the 
oral epithelial barrier, some periodontal pathogens (Aggregatibacter 
actinomycetemcomitans and P. gingivalis being two of the most well studied) have 
developed methods to diminish or avoid neutrophil clearance. A. 
actinomycetemcomitans has been shown to produce a leukotoxin which can lead to loss 
of effectiveness in neutrophils (Berthold et al., 1992, Kolodrubetz, 1996, Lally et al., 1996, 
Dennison and Van Dyke, 1997, Delima and Van Dyke, 2003). P. gingivalis, on the other 
hand, secretes a serine protease which has been shown to inhibit the synthesis of IL-8 
by epithelial cells and thus interferes with recruitment of neutrophils (Darveau et al., 
1998, Bainbridge et al., 2010). As well as IL-8 secretion inhibition, the decrease of 
intracellular adhesion molecule-1 has also been demonstrated, further suggesting P. 
gingivalis interferes with neutrophil recruitment (Madianos et al., 1997). In addition, P. 
gingivalis has a dense capsule which can hinder phagocytosis (Delima and Van Dyke, 
2003).   
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While neutrophils are imperative to control of microbial growth in the oral cavity, their 
function may also contribute to the pathogenesis of periodontitis. The release of ROS 
and MMPs required for neutrophil transmigration and killing can diffuse through the JE 
into supporting tissues (such as the periodontal ligament) causing damage and potential 
attachment loss (Nicu and Loos, 2016).    
1.2.2. Adaptive immune cells  
Alongside the innate immune system, a profile of adaptive immune cells and cytokines 
has also been described in association with periodontitis pathogenesis.  This aspect of 
the immune response in periodontitis is controlled by T-cells and B-cells. T-cells mediate 
the activation of polyclonal B-cells and subsequent production of specific antibodies 
(Gonzales, 2015). In periodontitis, B-cells are associated with pathogenesis due to their 
RANKL (receptor activator for nuclear factor κB ligand) positive status (Kawai et al., 
2006). As discussed in detail below (section 1.2.4.4), RANKL plays an important role in 
periodontitis associated bone resorption.  
Of the adaptive immune cells, T-cells predominate over others in gingival tissues with 
the majority being accounted for by CD4+ T-cells (Dutzan et al., 2016). They are 
subdivided based on their cytokine production, specific functions and gene-expression 
patterns.  Of these subsets T-helper 1 (Th1), T-helper 2 (Th2), Th17 and T-regs are 
those mostly associated with the progression of periodontitis (Silva et al., 2015). The 
process of naïve T-cell differentiation is initiated by T-cell receptor-mediated activation 
followed by the activation of specific transcription factors for each lineage. The presence 
of specific patterns of cytokines polarises cell differentiation towards that of a particular 
subset, where upon cells will express a specific set of chemokine receptors to aid in the 
leukocyte migration towards infection sites (Gonzales et al., 2012, Gonzales, 2015, 
Meyle and Chapple, 2015). 
In the 1990s, Baker et al carried out multiple studies which implicated the adaptive 
immune response in the destructive pathogenesis of periodontitis. Using a P. gingivalis 
induced periodontitis mouse model these studies demonstrated that mice lacking both 
T- and B-cells had decreased periodontitis-associate bone loss compared with control 
mice (Baker et al., 1999, Baker et al., 2002). The group also demonstrated a specific role 
for CD4+ cells, showing a decrease in periodontitis bone loss in CD4+ cell deficient mice 
compared with CD8+ deficient mice and controls (Baker et al., 1994). A more recent study 
also demonstrated that in transplant patients receiving cyclosporin A treatment (prevents 
T-cell activation) and in animal studies using cyclosporin A treatment, there was no 
periodontal disease progression or periodontitis associated bone loss despite loss of T-
cells (Pejcic et al., 2014, da Silva Peralta et al., 2015). A brief description of the most 
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studied subsets of CD4+ cells, their activation profile and subsequent impact on 
periodontitis follows below. 
1.2.2.1. T-helper 1 cells 
Th1 cell differentiation is predominantly activated through the action of IL-12 sourced 
from innate immune cells such as antigen presenting DCs (Hajishengallis and Korostoff, 
2017). Binding of IL-12 to its CD4+ cell receptor initiates signalling through janus kinase 
2 (JAK2) and tyrosine kinase 2 (TYK2). This leads to the subsequent phosphorylation of 
signal transduce and activation of transcription (STAT) 4 which promotes the expression 
of the T-bet transcription factor. These IL-12 activated signalling cascades initiate the 
transcription of cytokines characteristic of Th1 cells (Oestreich and Weinmann, 2012). 
Interferon γ (IFN-γ) also activates T-bet and has been shown to increase IL-12 receptor 
activation, further encouraging Th1 differentiation (Murphy and Reiner, 2002, Appay et 
al., 2008). Combined STAT4 and T-bet activity have been shown to be crucial to the 
regulation of IFN-γ in Th1 cells where T-bet alone was unable to activate transcription 
required for the Th1 linage (Thieu et al., 2008). Th1 cells are characterised by expression 
of IFN-γ, IL-2 and TNF-α (Campbell et al., 2016). In addition, they are involved in 
production of IgG2 opsonising and complement-fixing antibodies, activation of 
macrophages and antibody-dependent cell cytotoxicity (Gonzales, 2015). As such their 
role can be considered as one which aids phagocytic host responses.  
The role for Th1 in periodontitis progression is not entirely clear. While in some cases T-
cells in periodontitis were associated with the Th1 subsets based on their chemokine 
receptor profiles and associated increases in Th1 chemokines (such as IL-5), other 
studies indicated a predominance of Th2 cells in patients with early onset or advance 
periodontitis (Manhart et al., 1994, Gamonal et al., 2001, Lappin et al., 2001, Taubman 
and Kawai, 2001). More recently, an increased expression of T-bet has been shown in 
active lesions of periodontitis compared with inactive lesions, with the increase 
correlating with increases in IL-1β and IFN-γ (Dutzan et al., 2009a). This suggests that 
CD4+ differentiation in periodontitis is shifted towards Th1, correlating with early studies 
where Th2 was found less frequently than Th1 in periodontitis gingival tissues (Seymour 
et al., 1993). 
The cytokine release profiles of Th1 cells have been associated with infectious 
inflammatory bone destruction, indicating a role in alveolar bone resorption in 
periodontitis (Silva et al., 2015). In addition, studies have demonstrated upregulations in 
RANKL expression through the action of IFN-γ and subsequent increase in TNF-α and 
IL-1β, as well as chemoattraction of RANKL positive cells to increase osteoclast (OCL) 
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activation and bone resorption initiation (Figure 1.3) (Honda et al., 2006, Gao et al., 2007, 
Garlet et al., 2008, Repeke et al., 2010).  
1.2.2.2. T-helper 2 cells 
Opposing the bone destruction associated with Th1, Th2 cell cytokine release is 
associated with decreasing bone loss. Th2 differentiation is dependent on IL-4 (from B-
cells and naïve CD4+ T-cells) which leads to the downstream phosphorylation and 
activation of STAT3 and subsequent induction of the GATA3 transcription factor (Gilmour 
and Lavender, 2008, Hosoya et al., 2010). Activation of GATA3 promotes increased 
transcription of IL-4 and additional anti-inflammatory cytokines (including IL-5 and IL-13) 
(Mjosberg et al., 2012). Th2 differentiation also inhibits the expression of the IL-12 
receptor β2 subunit, thus, further preventing Th1 differentiation (Ouyang et al., 1998). 
Th2 cells have also been shown to undergo histone modifications which inhibit the 
transcription IFN-γ and encourage commitment to the Th2 linage (Chang and Aune, 
2007). In addition to the production of IL-4, IL-5 and IL-13, Th2 cells have been 
demonstrated to produce IL-10. Knockout mice studies have shown that the production 
of IL-10 by Th2 was enhanced by an additional transcription factor – Etv5 (Koh et al., 
2017). Evidence suggests that both IL-4 and IL-10 impair macrophage killing activity 
through inhibition of NO synthesis (Cenci et al., 1993). In addition, Th2 cells have been 
associated with IgE and IgG1 switching, mucosal immunity through mast cell production, 
growth and differentiation induction of eosinophils (Hajishengallis and Korostoff, 2017). 
Together these functions suggest Th2 aid in phagocytosis-independent host responses.   
IL-4 could potentially inhibit the function of MMPs and an upregulation of TIMP2 (tissue 
inhibitor of metalloproteinase 2) has been demonstrated as a response to IL-4 (Ihn et al., 
2002). In periodontitis this could provide protection from MMP-associated tissue 
destruction. Indeed, increased concentrations of IL-4 have been observed in GCF in 
periodontal health compared with periodontitis (Pradeep et al., 2008). Furthermore, Th2 
cells have been implicated in inhibition of osteoclastogenesis by acting on precursor cells 
through the action of secreted IL-4. This is highlighted in mouse P. gingivalis periodontitis 
models where Th1 predominant mice showed higher infiltrations of OCLs compared with 
Th2 predominant and control mice which showed almost none (Stashenko et al., 2007).  
1.2.2.3. T-helper 17 cells 
Although originally T-cells were divided into the Th1 and Th2 subsets, it is now 
understood additional subsets also exist with an amount of plasticity between them 
(Cosmi et al., 2014). In periodontal health and disease, Th17 have been implicated in 
addition to Th1 and Th2 cells. Th17 cells are characterised, as the name suggests, by 
their production of IL-17 and undergo differentiation in a manner distinct from that of Th1 
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and Th2 cells (Harrington et al., 2005, Park et al., 2005, Wilson et al., 2007). Their 
polarisation down this cell lineage is initiated by a complex cytokine profile involving IL-
6, IL-1β, IL-23 and TGF-β which, upon receptor binding, initiate phosphorylation of 
STAT3 leading to the activation of the transcription factor ROR-γ (Ivanov et al., 2006, 
Annunziato et al., 2012). The importance of STAT3 was highlighted in a mouse study 
where deletion of the STAT3 inhibited Th17 differentiation, which could be recovered 
following retroviral introduction of STAT3 (Yang et al., 2007). 
Th-17 cells mediate a variety of immune response through secretion of IL-17A, IL-17F 
and IL-23. Interesting, Th17 cells have also been shown to secrete IL-8, thereby showing 
neutrophil chemo-attractive properties, as well as production of TNF-α and GM-CSF 
which could contribute to activation and survival of neutrophils (Pelletier et al., 2010). 
Furthermore, Th17 cells have also been demonstrated to produce IL-10 in an antigen-
dependent matter, such that Th17 cells produced IL-10 and IL-17 when stimulated with 
S. aureus but produced IL-17 and IFN-γ in response to Candida albicans (Zielinski et al., 
2012).  
Activation of ROR-γ leads to induction of pro-inflammatory cytokines (TNFα, IL-6 and IL-
1β) so that increased Th17 and the subsequent release of cytokines could be part of the 
non-resolving inflammatory response seen in periodontitis. Exemplifying this, an 
increase in pro-inflammatory cytokines such as IL-17, TGF-β, IL-1β, IL-6 and IL-23 was 
observed in gingival tissues of periodontitis patients (Takahashi et al., 2005, Cardoso et 
al., 2009, Ohyama et al., 2009).  
Furthermore, IL-17, IL-1β and TNF-α were observed in periodontitis with an increased 
production of MMP1 and MMP3. The same study showed that while IL-17 did not induce 
MMPs to the same extent as IL-1β and TNF-α, it induced further IL-1β and TNF-α 
production by macrophages as well as IL-6 and IL-8 from gingival fibroblasts (Beklen et 
al., 2007). There is also evidence suggesting that the Th17 associated cytokine release 
is important in neutrophil recruitment; mice lacking the IL-17 receptor (IL-17RA-dificient 
mice) showed increased periodontal bone resorption in response to P. gingivalis, 
reduced chemokine levels and reduced neutrophil migration (Yu et al., 2007). Like Th1 
cells, Th17 cells have also been associated with bone resorption. Using primary OCLs, 
it has been demonstrated that IL-17 induced the expression of OCL differentiation factor, 
encouraging the formation of OCLs (Kotake et al., 1999). Together these studies indicate 
Th17 cells play a role in the progression of periodontitis and the associated alveolar bone 
reabsorption.  
The role of Th cells in periodontitis is evident but controversy still exists regarding the 
responses associated with progression. Adding to this controversy is the difficulty in 
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determining which of the T-cell subsets are found in periodontal lesions as well as 
distinguishing roles of their cytokine profiles in destructive and protective processes. The 
presence of T-regulatory cells, the associated release of anti-inflammatory cytokines (IL-
10 and TGF-β) and their potential role in RANKL regulation and subsequent periodontitis 
protection further complicates the role of T-cells in periodontitis pathogenesis (Steinsvoll 
et al., 1999, Dutzan et al., 2009b). 
1.2.3. Matrix metalloproteinases  
Another important aspect of periodontitis progression, is the extracellular matrix (ECM) 
and collagen breakdown associated with MMPs, which leads to destruction of 
periodontal tissues leading to eventual permanent attachment loss (Silva et al., 2015).To 
date 23 human MMPs have been identified and are zinc-dependent endopeptidases 
(Franco et al., 2017). Given the destructive potential of MMPs, regulation of activity is 
tightly controlled. This is achieved through gene activation, proenzyme activation, and 
inhibition. In humans, MMPs are inhibited by four TIMPs with differing specificity (Arpino 
et al., 2015).  
Periodontal inflammation and the persistence of pathogens, as described in previous 
sections, is associated with pro-inflammatory mediators (such as pro-inflammatory 
cytokines), generation of ROS, increased numbers of neutrophils and an increase in 
bacterial proteases; many of which can lead to the increase in prevalence and activity of 
MMPs. Classically, MMPs are linked to the degradation of ECM components and 
basement membranes, characteristics that are associated with periodontal tissue 
destruction in periodontitis (Silva et al., 2015). They, however, are also involved in 
regulatory functions which include: chemokine processing and the subsequent neutrophil 
regulation, proteolysis of receptors and their ligands, enzyme modulation and release of 
bioactive molecules from the ECM (Franco et al., 2017).   
Due to the high levels of collagen I in the ECM of soft and hard periodontal tissues, 
studies to date have predominately concentrated on the functions of collagenases 
(MMP8 and MMP13) and gelatinases (MMP2 and MMP9) in periodontitis (Sorsa et al., 
2010). Of the MMPs with collagenase activities found in the GCF and gingival tissues, 
MMP8 is the most predominant. In the case of gelatinases, two are detected in the oral 
cavity and of these MMP9 is the most prevalent (Sorsa et al., 2016). When considering 
the high prevalence of neutrophils in periodontal tissues in both health and disease, and 
the presence of MMP8 and MMP9 in neutrophil granules (section 1.2.1) it is unsurprising 
that these MMPs predominate in gingival tissues and GCF. Given this, a brief description 
of the association of MMP8 and MMP9 with periodontitis follows. Smaller amounts of 
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other MMPs (including 1, 2, 3, 7, 12, 13, 14, 25 and 26), TIMP1 and TIMP2 have also 
been demonstrated to be present in GCF and saliva (Buduneli and Kinane, 2011). 
Production of MMP8 takes place in a range of cells (resident and inflammatory) but it is 
found mainly to be produced by neutrophils in periodontal tissues. On the other hand, 
MMP9 is produced by a limited number of cells types and is found mainly to be produced 
by immune cells (Silva et al., 2015). 
As discussed in previous sections, MPO release as a result of neutrophil activation can 
lead to the production of oxidant hypochlorous acid (section 1.2.1) which has 
antimicrobial activity and is also involved in the oxidative, non-proteolytic activation of 
MMPs (Alfakry et al., 2016). ROS are key mediators of tissue degradation of MMPs 
through their ability to directly oxidise the enzymes and hypochlorous acid has been 
shown to activate both MMP8 and MMP9 (Weiss et al., 1985, Peppin and Weiss, 1986, 
Saari et al., 1990). This suggests that the increase in neutrophils in periodontitis can also 
lead to an increase in MMP activation and, thereby, an exacerbation of periodontitis 
pathogenesis. Indeed, a longitudinal study of GCF samples from periodontitis patients 
showed high levels of both MMP8 and MPO prior to periodontal treatment in both active 
and inactive sites, with decreases in MPO levels in active sites following treatment 
(Hernandez et al., 2010). An increase in glutathione peroxidase, lactoferrin, MPO and 
IL-1β in periodontitis has also been observed, which could contribute to the activation of 
MMPs (Wei et al., 2004). Furthermore, concentrations/levels of MMP8, TIMP2, MPO and 
MMP9 were found to be higher in GCF of patients with periodontitis compared with 
controls but no differences were observed in TIMP1. A decrease in MMP8, TIMP2, MPO 
and MMP9 was observed following periodontal treatment (Marcaccini et al., 2010). There 
is also evidence for ROS-dependent MMP9 activation in periodontal fibroblast cells 
(Osorio et al., 2015). 
Many cytokines/chemokines are targets for MMP cleavage, including periodontitis 
upregulated Th1 pro-inflammatory cytokines (such as TNF-α, IL-1β and IL-6), anti-
inflammatory cytokines (such as TGF-β1 and IL-10) and chemokines (such as IL-8) 
(Franco et al., 2017). This suggests that MMPs may regulate cytokine/chemokine 
expression and consequently impact periodontal health. For example, upregulation of IL-
6 and MMP9 (levels and activity) in periodontal ligament fibroblasts stimulated with ROS 
was observed, while inhibition of MMP activity led to higher IL-6 levels suggesting MMP 
degradation of IL-6 (Cavalla et al., 2015).  
Emerging evidence also suggests that MMP13 plays a role in the tissue damage 
associated with periodontitis. In addition to MMP8 and MPO, MMP13 was also higher in 
the GCF of patients with periodontitis compared with those with gingivitis and controls 
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(Leppilahti et al., 2014). MMP13 has also been implicated in activation of MMPs through 
a proteolytic cascade in which MMP13 has been shown to induce MMP9 in gingival cells 
from periodontitis patients (Hernandez Rios et al., 2009, Franco et al., 2017). MMP13 
dependent regulation of OCL activation has also been reported whereby MMP13 
activated MMP9 cleaves the osteoclastogenesis inhibitor galectin-3 (Pivetta et al., 2011). 
Furthermore, MMP13 can regulate the RANKL/OPG (osteoprotegerin) (discussed in 
section 1.2.4.4) axis to favour RANKL and as such encourage bone reabsorption 
(Nannuru et al., 2010). 
In addition to changes in MMP levels, there have also been studies indicating changes 
in TIMP levels suggesting, perhaps, periodontitis progression is dependent on shifts in 
the ratios of MMPs and their inhibitors, particularly when considering MMPs are present 
even in the healthy oral cavity (Makela et al., 1994, Hernandez et al., 2007, Meschiari et 
al., 2013, Reddy et al., 2014, Sapna et al., 2014, Noack et al., 2017). In GCF of 
periodontitis patients, periodontitis progression correlated with an increase in MMP1 
concentration and a decrease in TIMP1 concentration which was reversed following 
treatment (Ghodpage et al., 2014, Popat et al., 2014). 
1.2.4. Cytokine/chemokines  
As indicated above, cytokines play a crucial role in the modulation of the immune system 
in the oral cavity and are involved in the progression of periodontitis. Many cytokine 
concentrations and activities have been shown to be dysregulated in periodontitis. There 
is evidence for cross-regulation of cytokine/chemokine release by gingival cells. For 
example, gingival fibroblasts (which are highly responsive to LPS that can induce the 
production of pro-inflammatory cytokines) have an exacerbated IL-8 response to LPS 
following prior exposure to IFN-γ (Tamai, 2002). IL-1β is not only able to induce IL-6, IL-
8 and TNF-α expression in gingival fibroblasts but can also encourage the expression of 
more IL-1β in an autocrine manner (Agarwal et al., 1995, Chae et al., 2005). A synergistic 
activation of IL-8 and IL-6 secretion by IL-1β and TNF-α was also observed in gingival 
fibroblasts which was supressed by IFN-γ (Takigawa et al., 1994, Kida et al., 2005).  
Below is a brief description of selected cytokines and their involvement in periodontitis. 
Particular interest is paid to IL-8 (due to its potent neutrophil chemotactic ability and the 
high numbers of neutrophils in gingival tissue and GCF), IL-1β (due to its pivotal role in 
cytokine/chemokine regulation and initiation of inflammatory response) and IL-6 (due to 
its impact on T-cells and central role in immune regulation). The importance of IL-1β and 
IL-6 is highlighted by Kinane and Preshaw, who described these cytokines as being 
involved in first responses in both innate and adaptive immune responses (Kinane et al., 
2011).  
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1.2.4.1. IL-8  
IL-8, a chemotactic factor for leukocytes and neutrophils, has been demonstrated to be 
vital in oral health (section 1.1.1.3 and 1.2.1) and has been implicated in the progression 
of periodontitis. IL-8 was the first chemokine of the CXC chemokine family to be 
described. In 1987 Yoshimura identified a protein called monocyte-derived neutrophil 
chemotactic factor or neutrophil activating peptide as a chemoattractant for neutrophils 
but not monocytes. Shortly after, this protein was also shown to attract T-cells and was 
renamed IL-8 (Larsen et al., 1989). Since then our understanding of IL-8 has vastly 
increased and its importance in immune responses has been highlighted.  
IL-8 is a member of the CXC chemokine family and in humans is initially produced as a 
99-amino acid peptide (Palomino and Marti, 2015). Secretion of IL-8 is induced in many 
cell types including monocytes, fibroblasts, lymphocytes, mesenchymal cells and 
endothelial cells following stimulation by inflammatory mediators such as IL-1β and  
TNF-α (Okada and Murakami, 1998, Sonnenschein and Meyle, 2015). As discussed 
previously (section 1.2.1), in the periodontium, IL-8 acts as a chemoattractant for 
neutrophils. Neutrophils express receptors (CXCR1 and CXCR2) which are able to bind 
IL-8 (Holmes et al., 1991, Murphy and Tiffany, 1991, Zeilhofer and Schorr, 2000). 
Activation of these G-coupled receptors can initiate an increase in free intracellular Ca2+ 
which leads to the subsequent activation of β2 integrins, cytoskeletal rearrangement, 
phagosome-lysosome fusion and exocytosis of granule proteins (Jaconi et al., 1990, 
Kernen et al., 1991, Lawson and Maxfield, 1995, Van Kooyk et al., 2009, Palomino and 
Marti, 2015). In addition, IL-8 may regulate ROS generation by neutrophils through the 
upregulation of complement receptor 1 and, consequently, an upregulation of 
complement-dependent responses (Paccaud et al., 1990).  In addition to having 
chemotactic functions, IL-8 has also been shown to initiate monocyte differentiation into 
OCLs, indicating IL-8 may regulate osteoclastgenosis (Bendre et al., 2003). 
Furthermore, osteoblasts (OBLs) have been shown to express CXCR1, suggesting a 
role for IL-8 in modulation of OBL activity and subsequently a role in bone resorption 
(Silva et al., 2007). 
Given these chemoattractive and regulatory roles, it is unsurprising that IL-8 is found in 
healthy periodontal tissues and is associated with periodontitis progression. Indeed, an 
increase in neutrophils associated with an increase in IL-8, ICAM-1, IL-1β and TNF-α 
has been observed in the gingival tissues of periodontitis patients (Liu et al., 2001). 
Evidence suggests that the periodontal pathogen P. gingivalis increases IL-8 (in addition 
to IL-1α, IL-1β, IL-6 and IL-12) secretion by oral epithelial cells via TLR2 activation 
(Sandros et al., 2000, Kusumoto et al., 2004). In contrast, there is also evidence to 
suggest that while the bacteria, F. nucleatum, Neisseria flavescens and Haemophilus 
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parainfluenzae initiated IL-8 secretion by oral epithelial cells, their co-inoculation with P. 
gingivalis prevented this. Furthermore, P. gingivalis was also shown to degrade IL-8 
accumulated in gingival epithelial cells in response to the other bacteria (Darveau et al., 
1998, Huang et al., 2001). This proteolytic activity of P. gingivalis on IL-8 is associated 
with gingipains. Interestingly, gingipains have been shown to stimulate IL-8 and IL-6 
secretion in monocytes through protease-activated receptor signalling (Uehara et al., 
2008). Although gingipains can penetrate gingival epithelial and fibroblast cells and 
stimulate IL-8 secretion, higher concentrations have been shown to cause a decrease in 
IL-8 (O'Brien-Simpson et al., 2009). 
It appears different bacteria initiate different IL-8 responses in gingival cells. T. denticola 
(a periodontal pathogen), for example, did not induce IL-8 or IL-6 secretion by gingival 
epithelial cells (Brissette et al., 2008). A. actinomycetemocomitans and F. nucleatum, on 
the other hand, increased IL-8 (and IL-1β with A. actinomycetemocomitans) in gingival 
epithelial cells while a commensal bacterium (S. gordonii) produced no significant 
differences in cytokine production (Uchida et al., 2001, Stathopoulou et al., 2010). 
Furthermore, BspA (Bacteroides surface protein A) from T. forsythia stimulated IL-8 
secretion from gingival epithelial cells (Onishi et al., 2008). Decreases in IL-8 secretion 
could perhaps aid in increasing periodontal colonisation by decreasing neutrophil 
recruitment while increases in IL-8 could initiate exacerbated neutrophil recruitment, 
which could in-turn initiate the periodontal tissue damage observed in periodontitis.   
In addition to chemotactic roles of IL-8 in periodontitis there is also evidence for its 
potential role as an immunomodulator. For instance, IL-8 has been demonstrated to 
prevent apoptosis of CXCR1 and CXCR2 expressing endothelial cells, enhancing their 
survival, in addition to enhancing the production of MMP2 and MMP9 (Li et al., 2003). 
These roles in the periodontium could enhance periodontal tissue damage and prolong 
inflammation.  
While studies investigating the responses of cells to individual bacteria or simple mixed 
cultures are informative, they do not take into account the complexities of a biofilm and 
its interaction with the host. To get a better understanding of changes in IL-8 associated 
with periodontitis clinical studies are required. To date, such studies looking at IL-8 levels 
in gingival tissues, GCF and saliva are contradictory. In GCF, IL-8 analysis was 
predominantly carried out by ELISAs with results indicating both an increase in IL-8 
(Gamonal et al., 2001, Giannopoulou et al., 2003, Holzhausen et al., 2010, Konopka et 
al., 2012, Ertugrul et al., 2013, Khalaf et al., 2014, Lutfioglu et al., 2016) and a decrease 
(Jin et al., 2000, Luo et al., 2011) in periodontitis. In addition, checkerboard 
immunoblotting and Luminex immunoassays have also been applied to measure IL-8 in 
GCF and in both cases increased IL-8 was observed in periodontitis (Teles et al., 2009, 
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Tymkiw et al., 2011). In gingival tissues and saliva, results were more consistent and IL-
8 was observed at higher concentrations in periodontitis conditions (Cesar-Neto et al., 
2007, Michiels et al., 2009, Venza et al., 2010, Lisa Cheng et al., 2014, Khalaf et al., 
2014, Souto et al., 2014). 
1.2.4.2. IL-1 
IL-1 was first described in 1972 and has been widely researched in variety of 
inflammatory disorders (Horton et al., 1972). Although originally classified as an OCL 
activating factor, it is understood to exist in two isoforms (Dewhirst et al., 1985, March et 
al., 1985). These isoforms, IL-1α and IL-1β, only share 27% homology at the amino acid 
level but have similar biological activities. IL-1α remains cell bound whereas IL-1β is 
secreted, but both bind to the same receptors (IL-1 receptor 1 and IL-1 receptor 2) found 
on nearly all cell types (Weber et al., 2010). While both play a role in the periodontium, 
IL-1β has been shown to be consistently detected at higher levels in GCF of patients 
with periodontal diseases with decreases observed following treatment and as such has 
been the target of many studies (Preshaw and Taylor, 2011). As described in previous 
sections, IL-1β impacts periodontal colonisation, host immunity in the periodontium, 
neutrophils, Th cells, tissue breakdown and tissue homeostasis and is thought to play an 
important role in the pathogenesis of periodontitis. Indeed, some studies discussed in 
the previous section observed not only increases in IL-8 in gingival tissues in response 
to periodontal bacteria but also increases in IL-1α and/or IL-1β (section 1.2.4.1).  
Once stimulated, many cell types in the periodontium produce IL-1 including 
macrophages, monocytes, lymphocytes, epithelial cells, endothelial cells and fibroblasts 
(Preshaw and Taylor, 2011, Garlanda et al., 2013). In periodontitis, IL-1 is mainly 
produced by macrophages but production can be induced in monocytes by LPS, 
lipoteichoic acid and fimbriae, potentially accounting for the increase seen in periodontitis 
(Okada and Murakami, 1998, Sonnenschein and Meyle, 2015). 
Cellular secretion of IL-1β requires the activation of TLR-4 to initiate the transcription of 
the pro-IL-1β. Further processing of pro-IL-1β is dependent on an additional signal to the 
activated cell (such as extracellular ATP, extracellular DNA or ROS) and the activation 
of the inflammasome. This leads to caspase-1 mediated activation of IL-1β (Latz, 2010, 
Yilmaz and Lee, 2015). IL-1β processing is associated with the NALP3 (nacht domain-, 
leucine-rich repeat-, and pyrin domain (PYD)-containing protein 3) inflammasome 
complex. NALP3 is regulated by an effector molecule (apoptosis associated speck-like 
protein) and antagonised by NLRP2, both of which have been shown to be down-
regulated in monocytes in response to P. gingivalis with an associated increase in 
NALP3 (Bostanci et al., 2009). The same study also demonstrated an increase in NALP3 
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in chronic and aggressive periodontitis patients, with an associated increase in IL-1β and 
IL-18. Activation of the TLR4 in gingival cells is often shown to induce release of IL-1β, 
as well as IL-6 and TNF-α (Jotwani and Cutler, 2004, Diya et al., 2008, Hajishengallis et 
al., 2009, Sahingur et al., 2010). In addition, there is evidence suggesting gingival 
fibroblasts from patients with periodontitis not only produce more IL-1 but are more 
responsive to P. gingivalis and as such produce more IL-1 compared with healthy tissues 
stimulated with P. gingivalis (Kent et al., 1999). 
Although P. gingivalis and A. actinomycetemcomitans growth was not impacted when 
cultured with IL-1β and IL-6, P. gingivalis does appear to degrade IL-1β, IL-6 and IL-1Ra 
(the IL-1 receptor antagonists). When considering the role IL-1β has on modulating 
immune responses, this suggests P. gingivalis can alter IL-1β and potentially dampen 
immune responses (Fletcher et al., 1997). Despite this, there is evidence that IL-1β is 
found at higher concentration in gingival tissues and GCF of patients with periodontitis 
compared with healthy controls (Giannopoulou et al., 2003, Holzhausen et al., 2010, Luo 
et al., 2011, Tymkiw et al., 2011, Konopka et al., 2012, Ertugrul et al., 2013). Similarly, 
salivary levels of IL-1β are also increased in patients with periodontitis (Miller et al., 2006, 
Tobon-Arroyave et al., 2008, Gursoy et al., 2009, Mirrielees et al., 2010, Kaushik et al., 
2011, Ebersole et al., 2013, Rathnayake et al., 2013). These levels of IL-1β in saliva 
correlated with disease severity and decreased with treatment (Ng et al., 2007, 
Scannapieco et al., 2007, Kaushik et al., 2011, Kinney et al., 2011, Sexton et al., 2011, 
Rathnayake et al., 2013). 
IL-1 promotes increases in type 1 procollagen, collagenase, hylauronate, PGE2 and 
fibronectin, and is therefore important for periodontal tissue homeostasis (Okada and 
Murakami, 1998, Sonnenschein and Meyle, 2015). Studies have shown an increase in 
levels in GCF and gingival tissue from periodontitis diseased sites compared with healthy 
sites, with a decrease in levels following periodontitis treatment (Masada et al., 1990, 
Irwin and Myrillas, 1998, Sonnenschein and Meyle, 2015). Furthermore, IL-1β has been 
linked to OCL activity, with activation of OCLs achieved through the IL-1R1 and 
subsequent NF-κB activation, thus, suggesting a role for IL-1β in periodontitis-associated 
bone resorption (Kim et al., 2009). Indeed, local and systemic inhibition of IL-1β in animal 
models of periodontitis have led to decreases in alveolar bone loss (Assuma et al., 1998, 
Graves et al., 1998, Delima et al., 2001).  
In human gingival fibroblasts, IL-1β with TNF-α has been shown to increase PGE2 which 
resulted in an increase in IL-6 (Czuszak et al., 1996, Palmqvist et al., 2008). The IL-1β-
associated increase in IL-6 was associated with the activation of p38, MAPK and NF-κB 
signalling pathways (Chae et al., 2005). In addition, IL-1 is a potent inducer of bone 
resorption and an inhibitor of bone formation. Although both isoforms mediate effects on 
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bone, studies have shown that IL-1β is more potent than IL-1α (and TNF-α) with higher 
levels of IL-1β in GCF from periodontitis sites (Gowen and Mundy, 1986, Irwin and 
Myrillas, 1998, Okada and Murakami, 1998). The diverse roles of IL-1β have been 
highlighted by Steinberg et al (2006), who showed an upregulation in genes in human 
gingival fibrocytes related to inflammatory cytokines (such as IL-6 and TNF-α), the NF-
κB pathway, chemokines (such as IL-8, CXCL1, CXCL2 and CCL2), MMPs (such MMP3 
and MMP12) and adhesion molecules (such as ICAM-1, CD44 and vascular cell 
adhesion moleculre-1) in response to IL-1β treatment (Steinberg et al., 2006b, Vardar-
Sengul et al., 2009). 
1.2.4.3. IL-6 
IL-6 is a multifunctional cytokine produced by many different cell types (including  
B-cells, T-cells, monocytes, macrophages, keratinocytes, endothelial cells and 
fibroblasts) with secretion dependent on stimulation by bacterial LPS or other cytokines 
such as IL-1 and TNF-α (Tanaka et al., 2014, Sonnenschein and Meyle, 2015). 
Many of the immunomodulatory roles of IL-6 have been discussed in previous sections. 
In a protective capacity, IL-6 can play an important role on the maintenance of oral health. 
For instance, IL-6 (in combination with TGF-β) is required for differentiation of Th17 cells 
and can also inhibit T-reg differentiation (Bettelli et al., 2006, Korn et al., 2009). As 
discussed previously, differentiation of Th cells down the Th17 lineage, while playing a 
role in health, can also be damaging to the periodontium so that an increase in IL-6 could 
cause an exacerbation of periodontitis through dysregulation of the Th cell differentiation.  
In addition to T-cell differentiation modulation, IL-6 has also been implicated in B-cell 
differentiation into antibody-producing plasma cells which in the oral cavity can play a 
regulatory role in controlling bacterial colonisation but when found in excess can lead to 
destructive hypergammaglobulinemia and autoantibody production (Tanaka et al., 
2014). 
In health, IL-6 acts as a pro-inflammatory mediator in an attempt to control infection and 
therefore can act in a protective capacity. In disease this role becomes dysregulated and 
there is evidence to suggest oral pathogens can initiate this dysregulation and potentially 
prolong the inflammatory response. For example, P. gingivalis gingipains have been 
shown to stimulate IL-6 secretion in epithelial cells, monocytes and fibroblast cells 
(Lourbakos et al., 2001, Uehara et al., 2008, O'Brien-Simpson et al., 2009). Furthermore, 
gingival fibroblasts increased IL-8 and IL-6 secretion in response to A. 
actinomycetemcomitans and Campylobacter rectus (Dongari-Bagtzoglou and Ebersole, 
1996). Periodontal ligaments displayed a similar trend, with increases in IL-6, IL-1β, IL-
8 and TNF-α in response to P. gingivalis and P. intermedia (Yamamoto et al., 2006). 
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Furthering the destructive capability of IL-6 is the ability to impact MMP levels. Co-culture 
of fibroblasts with macrophages led to an increase in MMP1 and was enhanced by 
fibroblast released IL-6 (Sundararaj et al., 2009). In gingival fibroblasts, an IL-6 dose 
dependent increase was observed in MMP1 (Irwin et al, 2002). Contrastingly, IL-6 has a 
protective role, highlighted by the ability of L-6 to induce antagonistic effects against IL-
1 receptors and TNF-α soluble receptors. Given that both IL-1 and TNF-α induce 
production of IL-6, these antagonistic effects suggest a role in balancing pro-
inflammatory effects (Irwin and Myrillas, 1998).  
Furthermore, in response to bone resorbing agents such as IL-1 and TNF-α, OBLs 
secrete IL-6, further enhancing cell differentiation into OCLs and indicating the potential 
role of IL-6 in promoting bone resorption (Teng, 2006, Preshaw and Taylor, 2011). IL-6 
has also been demonstrated to initiate bone resorption in mouse models in response to 
pro-inflammatory cytokines which initiate an increase in RANKL and decrease in OPG 
(Nakashima et al., 2000). IL-6 concentrations and resulting bone remodelling activities 
in periodontal tissues differ across studies; some studies have shown no resorptive 
activity induced by IL-6 while others suggest high concentrations of IL-6 (>100 ng ml-1) 
act against IL-1- and TNF-α-induced OCL bone resorption (Poli et al., 1994, Flanagan et 
al., 1995, Irwin and Myrillas, 1998, Okada and Murakami, 1998, Sonnenschein and 
Meyle, 2015). 
Although there is a significant amount of IL-6 detected in healthy GCF and saliva, studies 
regarding expression levels in periodontitis have been contradictory. The majority of 
studies indicate an increase in the concentration of IL-6 from periodontitis patients 
compared with healthy controls, with increased levels correlating with the severity of the 
disease (Cesar-Neto et al., 2007, Costa et al., 2010, Holzhausen et al., 2010, Venza et 
al., 2010, Tymkiw et al., 2011, Prakasam and Srinivasan, 2014). In other cases, no 
significant differences were observed (Rathnayake et al., 2013, Gursoy et al., 2009). In 
some clinical studies no correlation between IL-6 and alveolar bone reabsorption in 
periodontitis was observed (Ng et al., 2007, Scannapieco et al., 2007). Gingival 
mononuclear cells from periodontitis patients have also been shown to have in increase 
in expression of IL-6 (mRNA and protein) which was not seen in peripheral blood 
mononuclear cells, suggesting local IL-6 production (Fujihashi et al., 1993, Irwin and 
Myrillas, 1998). Other studies, however, have shown an increase in serum levels of IL-6 
in people with periodontitis indicating a more systemic response (Loos, 2005, 
Paraskevas et al., 2008).  
1.2.4.4. RANKL 
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As indicated above, RANKL plays an important role in the bone resorption associated 
with periodontitis. RANKL belongs to the tumour necrosis factor and ligand superfamily 
along-side its receptor (receptor activator for nuclear factor κ, RANK) and its inhibitor, 
the soluble decoy receptor, OPG. RANK binding of RANKL is able to induce 
osteoclastogenesis, while OPG binding of RANKL prevents this activation (Simonet et 
al., 1997, Lacey et al., 1998, Nakagawa et al., 1998). RANKL/RANK interactions initiate 
NF-κB and MAPK signalling cascades to trigger cellular cytoskeletal reorganisation and 
cellular polarization (Yavropoulou and Yovos, 2008). Maintaining a balance between 
bone forming OBLs and bone-resorbing OCLs is important in ensuring excessive bone 
resorption (osteoporosis) or excessive gain in bone mass (osteopetrosis) is avoided 
(Nagy and Penninger, 2015). The balance of OBLs and OCLs is in a tightly regulated 
homeostatic state, and with the observation of T-cells expressing RANKL, connections 
between chronic inflammation, dysregulation of the RANKL/OPG axis and bone loss 
were established (Anderson et al., 1997, Wong et al., 1997, Kong et al., 1999a, Kong et 
al., 1999b). 
As described above, activation of Th cells and their subsequent cytokine release profiles 
are important in maintaining homeostatic levels of RANKL and modulating their action. 
The release of Th1 and Th17 associated cytokines (including IL-1β, IL-17 and TNF-α) 
can stimulate the expression of RANKL on the surfaces of periodontal OBLs as well as 
Th17 cells (Chabaud et al., 1999, Dong, 2008). Furthermore, patients with active 
periodontitis had higher levels of GCF RANKL compared with patients without 
periodontitis. This was associated with an increase in IL-17 production by gingival Th17 
cells alongside a down regulation of IL-10 and TGF-β (Vernal et al., 2004, Takahashi et 
al., 2005, Vernal et al., 2005, Silva et al., 2008, Dutzan et al., 2009a). Although exact 
concentrations of RANKL in GCF appear to vary between studies, a general trend is 
seen with higher concentrations of RANKL observed in periodontitis patients compared 
with healthy controls (Silva et al., 2015).  
1.3. The oral microbiome and its impact on general health  
The relationship between the oral microbiome and systemic health is complex but 
evidence suggests both positive impacts of a healthy microbiota and negative impacts 
of dysbiotic microbiota to systemic health. Changes associated with periodontitis have 
been linked to systemic diseases such as diabetes, rheumatoid arthritis and 
cardiovascular disease (Bartold and Mariotti, 2017). Altered oral microbiomes are 
observed not only during systemic disease but also when body homeostasis is altered, 
such as during pregnancy and lactation (Scannapieco, 2005, Scannapieco, 2013). Our 
understanding of the potential impact of the oral microbiome on systemic diseases is 
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expanding. Its role in systemic health, however, is still not fully defined beyond the role 
of pathogen colonisation prevention (section 1.1.1.2).  
An example of health associated consequences of the oral microbiome is the impact on 
nitrate metabolism. Although the majority of ingested nitrate is excreted in urine, a portion 
is actively taken up by salivary glands, where it is concentrated (20-fold) and reduced 
(Lundberg and Govoni, 2004, Bryan et al., 2017). Mammals lack an effective method for 
reduction of nitrate and so a complex bacterial community interaction is relied upon for 
the reduction to nitrite, with commensal facultative anaerobic bacteria undertaking this 
task via nitrate reductases (Bryan et al., 2017). The nitrite can then be taken up by the 
blood stream via gastric absorption and converted to NO. NO is essential for vascular 
health (impacting suppleness and pliancy) as well as providing anti-hypertensive effects 
via vasodilation (Wade, 2013, Bryan et al., 2017). This is illustrated in a study which 
demonstrated a decrease in salivary nitrite when antibacterial mouthwash was used prior 
to sodium nitrate consumption. Furthermore, there was no difference in nitrate 
accumulation in saliva, suggesting reduction in commensal bacteria impacted the 
conversion of nitrate to nitrite (Govoni et al., 2008).   
Periodontitis progression can lead to an increase in the gingival wound surface 
(deepening of periodontal pocket) which increases the likelihood of bacterial 
translocation from the wound area into the bloodstream resulting in bacteraemia. Dental 
treatments such as tooth extractions and subgingival scaling in periodontitis patients also 
has the potential to lead to bacteraemia (Larsen and Fiehn, 2017). Bacteria translocation 
from the periodontal pocket often results in an infected root canal, from where the 
bacteria can enter the blood stream and spread into surrounding tissues. Once in blood, 
oral bacteria can spread and infect a variety of organs and have been associated with 
infectious endocarditis as well as brain and liver abscesses (Mylonakis and Calderwood, 
2001, Marques da Silva et al., 2004, Wade, 2013). Oral bacteria have also been shown 
in atherosclerotic plaques. P. gingivalis and S. sanguinis have both been shown to 
aggregate platelets causing the formation of atherosclerotic plaques (Herzberg and 
Meyer, 1996, Herzberg and Weyer, 1998). Evidence also suggests a link between P. 
gingivalis translocation and rheumatoid arthritis, with higher prevalence of P. gingivalis 
DNA in synovial tissues and synovial fluid of patients with rheumatoid arthritis 
(Farquharson et al., 2012, Totaro et al., 2013). 
Since the establishment of the HMP, studies have shown a decrease in species diversity 
at particular sites (alpha diversity) in diseased states when compared with health 
(Kramer and Genco, 2017). Such changes have been observed in oral squamous cell 
carcinoma where Streptococcus species dominate in tumour site microbiota compared 
with non-tumour sites in the same individuals (Pushalkar et al., 2012). In other cancers, 
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a dysbiosis of the oral microbiota is observed; for example, in saliva samples of patients 
with squamous cell carcinoma and adenocarcinoma, a higher abundance of 
Capnocytophaga, Selenomonas and Veillonella and a lower abundance of the 
commensal Neisseria was observed (Yan et al., 2015).  
In addition to bacterial changes, the increased inflammatory burden associated with 
periodontitis and the potential increase in systemic inflammation is thought to play a 
central role in linking periodontitis to chronic inflammatory diseases such as rheumatoid 
arthritis, osteoporosis and diabetes (Bartold and Mariotti, 2017). Inflammatory mediators 
associated with periodontitis, including IL-6, endotoxins, LPS and neutrophils are 
increased systemically in patients with periodontitis (Loos, 2005, Pussinen et al., 2007, 
Shaddox et al., 2011). In addition, an increase in C-reactive protein (CRP), an indicator 
of acute phase response, has also been observed at increased systemic levels in 
periodontitis (Slade et al., 2000, Noack et al., 2001). While periodontitis was initially 
considered a consequence of risk factors such as diabetes and smoking, in 1998 Page 
suggested a bidirectional relationship between oral health and systemic health, whereby 
periodontitis could exacerbate systemic disease in addition to systemic disease 
impacting on periodontal health (Page, 1998, Mark Bartold and Mariotti, 2017). One of 
the diseases believed to have a two-way relationship with periodontitis is diabetes which 
is explored in detail below.  
1.4. Periodontitis and diabetes   
Diabetes mellitus (a group of metabolic disorders) are common chronic diseases which 
according to the World Health Organization are increasing in prevalence worldwide. Two 
main types of diabetes exist: type 1 and type 2. Although both are associated with 
hyperglycaemia (elevated blood sugar) the mechanisms leading to the hyperglycaemic 
state differ. Type 1 diabetes is considered an autoimmune disease accounting for 5 – 
10% of diabetics. This form of diabetes is caused by the immune destruction of 
pancreatic β cells (Kharroubi and Darwish, 2015). Type 2 diabetes, on the other hand, is 
caused by insulin resistance in peripheral tissues as well as eventual defects in β cell 
functions, leading to their inability to meet increased insulin demand (Kharroubi and 
Darwish, 2015). The characteristic hyperglycaemia of diabetics has been implicated in 
activation of pathways that lead to an increase in inflammation, oxidative stress and 
apoptosis (Preshaw et al., 2012).   
Initially periodontitis was thought to be a commonly occurring consequence of diabetes 
(Loe, 1993, Wilson, 1989). Epidemiological studies demonstrated susceptibility to 
periodontitis increases in diabetics and a positive correlation between the degree of 
hyperglycaemia and severity of periodontitis (increased bone loss and attachment loss) 
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has been observed (Emrich et al., 1991, Shlossman et al., 1990, Taylor et al., 1998).  
Furthermore, there is evidence to suggest hyperglycaemia plays a significant role in 
increased susceptibility to periodontitis, as patients with poorly controlled diabetes had 
a higher prevalence of periodontitis compared with healthy people but those with well 
controlled diabetes showed no significant differences in periodontitis prevalence (Tsai et 
al., 2002). Now it is understood that a more complex and two-way relationship exists 
between the two diseases, so that not only is diabetes a risk factor for periodontitis but 
that periodontitis has negative impacts on glycaemic control (Preshaw et al., 2012, 
Scannapieco, 2013, Casanova et al., 2014). Although the majority of studies regarding 
diabetes and periodontitis have concentrated on type 2 diabetes, it is important to note 
that type 1 diabetes also has an increased risk of periodontitis due to the hyperglycaemia 
associated with both forms of diabetes (Cianciola et al., 1982, Lalla et al., 2007). 
The systemic pro-inflammatory cytokine increase in diabetes can influence local host 
responses in periodontal tissues (Lalla and Papapanou, 2011, Sonnenschein and Meyle, 
2015). This leads to the hypothesis that diabetes effects the host responses to bacteria 
so that immune and tissue biochemistry modulators (for example cytokines and MMPs) 
in diabetic GCF, saliva and gingival tissues are different to those in systemically healthy 
individuals (Lalla and Papapanou, 2011, Sonnenschein and Meyle, 2015). Thus, 
hyperglycaemia-induced exacerbation of periodontal immune response and tissue 
degradation could contribute to periodontal disease and attachment loss (Iwamoto and 
Hioki, 2001, Kiran et al., 2005, Scannapieco, 2013). This increased immune response to 
bacterial stimulation was indicated in a study that identified an up-regulation of adhesion 
molecules, cytokines and chemokines in cardiovascular tissue of mice following 
subcutaneous inoculation of LPS. The up-regulation was seen to be more rapid and 
pronounced in the diabetic mouse compared with the non-diabetic mouse (Graves et al., 
2006). Furthermore, diabetes can increase immune responses in periodontal tissues, 
thus, exacerbating periodontitis. This is highlighted by the observation of higher levels of 
IL-1β in the GCF of diabetic patients with periodontitis compared with patients with the 
same extent of periodontitis but no diabetes (Salvi et al., 1997b). In addition, poor 
glycaemic control appears to be the driving force behind this increase, with the increase 
being observed in diabetics with poor glycaemic control but not those with good 
glycaemic control (Engebretson et al., 2004). 
On the other hand, an increase in systemic pro-inflammatory cytokines as a 
consequence of periodontitis could impair intracellular insulin signalling leading to an 
exacerbation of diabetes and potentially linking the two diseases (Iwamoto and Hioki, 
2001, Rotter et al., 2003, Paraskevas et al., 2008, Lalla and Papapanou, 2011, Preshaw 
et al., 2012, Sonnenschein and Meyle, 2015). The potential for periodontitis-associated 
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increases in systemic inflammation is supported by studies which show that therapeutic 
approaches against periodontitis reduce systemic inflammation (as seen by a reduction 
in mediators such as TNF-α, CRP and IL-6) and potentially improve glycaemic control 
(as indicated by a reduced haemoglobin A1c: HbA1c) (Iwamoto et al., 2001, D'Aiuto et 
al., 2004, Kiran et al., 2005, Marcaccini et al., 2009). Epidemiological studies suggest 
periodontitis is associated with poor glycaemic control (regardless of diabetic state) 
(Taylor et al., 1996, Saito et al., 2004, Demmer et al., 2010, Morita et al., 2010). This 
indicates the increase in insulin resistance associated with periodontitis can exacerbate 
diabetes and suggests a higher risk of developing diabetes-associated complications 
(Borgnakke et al., 2013, Scannapieco, 2013). This is exemplified by increases in 
incidence of neuropathy and end-stage renal disease in diabetics with positive 
correlations to severity of periodontitis (Shultis et al., 2007).  
The triggering of an acute phase response by the liver, thought to be a consequence of 
bacteraemia caused by periodontitis, can cause a release in acute-phase proteins (the 
majority of which are CRP, serum amyloid P component and serum amyloid A protein) 
(Steel and Whitehead, 1994). Pro-inflammatory cytokines (including IL-1, IL-6 and TNF-
α) have been implicated in stimulation of hepatocytes to initiate the release of CRP 
(Gruys et al., 2005, Polepalle et al., 2015). As described previously, pro-inflammatory 
cytokines are key in the progression of periodontitis and have also been observed at 
increased systemic levels in periodontitis (sections 1.2 and 1.4). Given this, it is 
unsurprising that increased systemic and GCF levels of CRP have been observed in 
periodontitis with periodontitis therapy leading to a decrease (Slade et al., 2000, 
Fitzsimmons et al., 2010, Megson et al., 2010, Leite et al., 2014). Increased CRP has 
also been associated with increased insulin resistance (Nesto, 2004). Although the exact 
mechanism by which CRP impacts insulin resistance is unclear, a study in Fcγ receptor 
IIB knockout mice demonstrated a protection to CRP associated insulin resistance. The 
Fcγ receptor IIB is involved in glucose delivery and, thus, the study proposes a role for 
CRP in inhibiting Fcγ receptor IIB associated glucose delivery (Tanigaki et al., 2013). 
Another study, indicated a role for ERK1/2 by demonstrating that inhibition of the 
MAPK/ERK1/2 pathway reversed CRP induced insulin resistance in rat hepatocytes (Xi 
et al., 2011). The increased potential for bacteraemia in periodontitis patients and the 
subsequent increases in pro-inflammatory cytokines and acute-phase proteins could be 
a potential linking mechanism between diabetes and periodontitis (Hasturk and Kantarci, 
2015, Meyle and Chapple, 2015). 
As technology advances, our understanding of microbial involvement in linking diabetes 
and periodontitis has increased. Culture dependent methods for periodontal bacterial 
recovery in an early study indicated that the levels of periodontal pathogens (including 
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A. actinomycetemcomitans, F. nucleatum and P. intermedia) were similar in diabetics 
and non-diabetics but P. gingivalis was higher in diabetics (Thorstensson et al., 1995). 
Later culture dependent studies demonstrated changes in oral microbial composition in 
the supragingival plaque of diabetics with increased prevalence of periodontitis 
associated pathogens (Figure 1.4) such as T. denticola, and P. nigrescens (Hintao et al., 
2007). An increase in the periodontitis associated bacteria Eubacterium nodatum in the 
subgingival plaque of diabetics was also demonstrated (Lalla et al., 2006). Studies 
utilising DNA checkerboard hybridization demonstrated increased abundances of P. 
gingivalis, A. actinomycetemcomitans and Campylobacter spp. in periodontitis sites of 
diabetics compared with periodontitis sites of those without diabetes (Ebersole et al., 
2008). A recent study utilising culture independent methods (16s rRNA sequencing)  
contradicts these previous studies and demonstrated periodontitis subgingival plaque of 
diabetic patients with poor glycaemic control had higher abundances of some genera 
(such as Neisseria, Actinomyces, Capnocytophaga, Fusobacterium, Veillonella, 
Aggregatibacter, Selenomonas and Streptococcus) and lower abundances of others 
(including Synergistetes, Tannerella, Porphorymonas and Eubacterium) (Casarin et al., 
2013). Furthermore, Xiao et al (2017) used a diabetic mouse model to demonstrate a 
shift in bacterial composition as a consequence of diabetes, with an increase in 
Enterobacteriaceae, Aerococcus, Enterococcus and Staphylococcus as well as a 
decrease microbial alpha diversity in diabetic mice but did not describe any differences 
in bacteria typically associated with periodontitis. The study, did however, demonstrate 
pathogen- and periodontitis- associated bone loss could be initiated following microbial 
transfer of microbiota from diabetic mice to germ free mice. Transfer from diabetic mice 
showed a significantly higher level of bone loss compared with transfer from non-diabetic 
mice. These inconclusive results highlight the necessity for further study in relationships 
between the oral microbiota and diabetes, particularly considering the changes in gut 
microbiota associated with diabetes (as reviewed in Tilg and Moschen , 2017).  
Diabetes mellitus and periodontitis are both associated with increased levels of 
inflammation. The most promising immune response-associated linking mechanisms are 
discussed in more detail below and outlined in Figure 1.5.  
  
 
Figure 1.5: Potential mechanistic links between diabetes and periodontitis. Schematic highlighting some of the immune responses implicated in 
the complex relationships between periodontitis and diabetes. Red indicates aspects of the immune response which impact periodontitis and/or 
diabetes. Yellow indicates host responses which trigger downstream cascades that can exacerbate periodontitis and/or diabetes. Purple boxes indicate 
consequences of diabetes. AGE: advanced glycation end product, RAGE: receptor for advanced glycation end products, LPS: lipopolysaccharide, IL-
6: interleukin-6, TNF-α; tumour necrosis factor-α.
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1.4.1. Cytokine/chemokine networks linking diabetes and periodontitis  
As eluded to in the above section (1.4), changes in local (saliva, GFC and gingival 
tissues) cytokine profiles play a crucial role in periodontitis progression and can lead to 
changes in systemic cytokine/chemokine levels. As such, these changes have been 
implicated in linking diabetes to periodontitis. A few of these potential 
cytokines/chemokines and their roles in both diseases are briefly described below.  
Diabetes is characterised by an abnormal metabolism and impaired transport of glucose, 
which is associated with defects in insulin production and increases in tissue insulin 
resistance. As a consequence hyperglycaemia is observed which can lead to increases 
in free fatty-acids (FFAs) and pro-inflammatory cytokines (Boni-Schnetzler et al., 2009). 
Pro-inflammatory cytokines have been reported to negatively affect pancreatic β-cells. 
For example, IL-1β has been demonstrated to cause β-cell decreases in docking and 
fusion of insulin granules to β-cell membrane which cause a decrease in β-cell response 
to glucose (Ohara-Imaizumi et al., 2004). Prolonged exposure to IL-1β and IL-1β in 
combination with IFN-γ, and the associated β-cell functional impairment, have been 
reported to initiate apoptosis of β-cells via NF-κB or STAT1 activation (Giannoukakis et 
al., 2000, Eizirik and Mandrup-Poulsen, 2001, Heimberg et al., 2001). IL-1β has also 
been demonstrated to induce NO production dependent on iNOS as demonstrated by a 
lack of NO in iNOS negative β-cells (Andersson et al., 2001). In the same study IL1-β 
and IL-1β/IFN-γ were also reported to impair glucose-stimulated insulin release, 
decrease the overall insulin in the β-cell, decrease IL-1β/IFN-γ oxidation rates and 
increase cell death. Contrastingly, while IL1-β impaired insulin release in iNOS negative 
cells, IL-1β/IFN-γ in combination did not impact cell viability or oxidation rates. Together 
these findings suggest a role for IL1-β and IL-1β/IFN-γ in impairment of insulin release 
independent of NO and cell death. Moreover, the results suggest that combined IL-
1β/IFN-γ-associated cell death was dependent on NO (Andersson et al., 2001). 
Furthermore, FFAs release associated with hyperglycaemia can also induce release of 
IL-1β, IL-6 and IL-8, thus, exacerbating the diabetic condition (Boni-Schnetzler et al., 
2009). TNF-α has also been detected at higher concentrations in diabetics (Pickup et al., 
2000, Chen et al., 2007). TNF-α is associated with an increase in insulin resistance via 
activation of protein phosphatase 2C which leads to inhibition of 5’AMP-activated protein 
kinase and subsequently causes a decrease in glucose uptake and an increase in insulin 
resistance (Steinberg et al., 2006a). As discussed previously (section 1.2.4), systemic 
pro-inflammatory cytokines are increased in periodontitis and it is possible these 
increases can exacerbate the immune disruption of function and destruction of β-cells 
via these mechanisms. On the other side of the two-way relationship, it is possible that 
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these systemic increases associated with diabetes can increase cytokine-mediated 
pathogenesis of periodontitis.  
Elevation in systemic IL-6 has also been observed in patients with diabetes (Kado et al., 
1999, Pickup et al., 2000, Mirza et al., 2012, Ryba-Stanislawowska et al., 2013). As 
described previously (section 1.2.4.3) IL-6 plays an important role in T-cell differentiation 
and in diabetes the increase in IL-6 has been associated with an increase in peripheral 
Th17 cells and a decrease in T-reg cells compared with healthy individuals (Ryba-
Stanislawowska et al., 2013). The increase in Th17 is associated with an increase in pro-
inflammatory cytokines (section 1.2.2.3) which in turn can cause the progression of 
diabetes. Given the Th17 role in periodontitis, a diabetes-associated systemic increase 
could potentially exacerbate periodontitis.  
When determining impact of diabetes on cytokine/chemokine associated periodontitis 
progression, the GCF has been the main focus of investigations. While some studies 
have demonstrated an increase in IL-1β concentrations in GCF of patients with 
periodontitis and diabetes compared with those without diabetes or healthy controls 
(Bulut et al., 2001, Duarte et al., 2007b, Duarte et al., 2007a, Salvi et al., 2010, Bastos 
et al., 2012), others have indicated no differences in GCF IL-1β levels associated with 
diabetes (Navarro-Sanchez et al., 2007, Correa et al., 2008, Kardesler et al., 2008). 
Although some studies showed no differences in IL-1β concentrations between diabetics 
with periodontitis and systemically healthy participants with periodontitis, Navarro-
Sanchez et al (2007) demonstrated lower HbA1C in diabetics following non-surgical 
periodontitis treatment, thus, suggesting improvement of periodontitis (and the 
subsequent decrease in inflammatory mediators such as IL-1β and TNF-α) impacts 
metabolic control.  
An increased concentration of TNF-α in the GCF of diabetic individuals with periodontitis 
has been shown compared with systemically healthy individuals but no significant 
differences were observed in periodontal/gingival tissue (Duarte et al., 2014). In a similar 
manner to IL-1β, other studies have shown no significant differences in TNF-α 
concentrations between periodontitis patients with and without diabetes (Takeda et al., 
2006, Navarro-Sanchez et al., 2007, Cole et al., 2008, Santos et al., 2010). Interestingly, 
one study demonstrated a difference in IL-1β and TNF-α GCF levels between type 1 and 
type 2 diabetics with periodontitis, with higher concentrations observed in type 1. This 
suggests type 1 diabetes is more detrimental to periodontal health than type 2 diabetes 
(Aspriello et al., 2011). 
Differences in IL-6 concentrations between patients with periodontitis and diabetes and 
those with periodontitis alone are also contradictory. Some studies have shown an 
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increase in IL-6 CGF levels (Duarte et al., 2007b, Cole et al., 2008, Ross et al., 2010, 
Kardesler et al., 2011, Bastos et al., 2012, Duarte et al., 2014) and others demonstrated 
no significant differences (Cutler et al., 1999, Camargo et al., 2013). IL-6 was also 
reported to be decreased in GCF of diabetic patients with periodontitis following 
treatment (Kardesler et al., 2011).  
Studies into the changes in IL-8 concentration are comparably sparse. While some 
studies indicated no differences in IL-8 concentrations between periodontitis patients 
with and without diabetes (Engebretson et al., 2004, Duarte et al., 2007a) others 
demonstrated a decrease in IL-8 in gingival tissues and GCF (Duarte et al., 2007b, 
Engebretson et al., 2006). 
In addition to cytokine analysis in patients, mice models have also provided an insight 
into the relationship between diabetes and periodontitis. For example, Pacios et al (2012) 
demonstrated prolonged inflammation in a diabetic mouse model with ligature-induced 
periodontitis, which was inhibited by the treatment of mice with a TNF-α inhibitor. 
Furthermore, inhibition of TNF-α in the model also reduced mRNA levels of cytokines, 
including IL-1β and IFN-γ (Pacios et al., 2012). Takano et al (2010) also demonstrated 
reversal of P. gingivalis induced increases in serum cytokines (IL-6 and TNF-α) in 
diabetic mice treated with a TNF-α inhibitor. Nishihara et al (2009) demonstrated 
increased serum levels of TNF-α and IL-6 in diabetic mice in response to P. gingivalis 
with a corresponding increase in mRNA of these cytokines in liver and visceral adipose 
tissue.   
1.4.2. Polymorphonuclear neutrophils in diabetes and periodontitis  
Neutrophils are also an important factor influencing the relationship between diabetes 
and periodontitis. Diabetic patients have been shown to have impaired neutrophil 
phagocytosis, apoptosis, chemotaxis and anti-microbial functions due to the metabolic 
changes associated with diabetes (Manouchehr-Pour et al., 1981, Salvi et al., 1997b, 
Alba-Loureiro et al., 2006, Graves et al., 2006, Alba-Loureiro et al., 2007, Preshaw et al., 
2012). 
A study investigating peripheral blood neutrophil apoptosis demonstrated a delayed 
apoptosis response in diabetics. A significant decrease in apoptosis, caspase-3 and 
caspase-8 was observed in neutrophils from patients with diabetes and diabetes with 
periodontitis (Manosudprasit et al., 2017). In addition to changes in apoptosis, 
neutrophils in diabetes have also been reported to have altered metabolism. In a diabetic 
rat model, phagocytosis, measured as phorbol myristate acetate (PMA)-stimulated H2O2 
production, was decreased in diabetic rats compared with healthy controls. A decrease 
in glucose-6-phosphate dehydrogenase and glutaminase (enzymes involved in 
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glucose/glutamine metabolism) and increases in phosphofructokinase were observed in 
neutrophils from diabetic rats. Following treatment with insulin, neutrophil changes were 
abolished. These results indicate an alteration in neutrophil metabolism in diabetics may 
lead to changing in functions such as phagocytosis and oxidative burst (Alba-Loureiro et 
al., 2006). In addition to changes in apoptosis and metabolism, studies have also 
demonstrated impaired chemotaxis, phagocytosis and bactericidal activity in diabetes 
(Cutler et al., 1991, Lecube et al., 2011). Despite these decreases, other aspects of 
neutrophils in diabetes appear to be exacerbated. This is highlighted in a recent study 
which reported a higher basal level of ROS in diabetic neutrophils which, following 
neutrophil stimulation with PMA, remained consistently high,  in contrast with healthy 
neutrophils in which ROS levels decreased over time (Ridzuan et al., 2016). 
Furthermore, increased pro-inflammatory cytokines/chemokines (IL-1β, IL-8 and TNF-α) 
were released from neutrophils of diabetics both under unstimulated and LPS-stimulated 
conditions (Hatanaka et al., 2006). In contrast, Gupta et al (2017) saw no differences in 
cytokine levels (including IL-6, IL-8, IL-1β and TNF-α) in neutrophils from diabetics with 
both poor and good glycaemic control and with and without complications. They did, 
however, report increase mRNA of IL-6, IFN-γ and TNF-α in neutrophils of patients with 
good and poor glycaemic control but with no complications compared with systemically 
healthy participants (Gupta et al., 2017). As described previously (section 1.2.1) NETs 
are important aspects of neutrophil associated protection and are involved in neutrophil-
associated periodontal destruction. Recently, a study reported basal levels of NETs in 
diabetics were higher compared with healthy controls both in vitro and in vivo (using 
blood nucleosomes and HNE-DNA complexes as an indirect measurement of NET 
formation) (Carestia et al., 2016). Together these alterations in neutrophils as a 
consequence of diabetes have the potential to exacerbate periodontitis. Impaired 
apoptosis in diabetics could increase neutrophil retention in the periodontium thus 
prolonging their destructive properties (for example MMP release), with increases in 
ROS and pro-inflammatory cytokines in response to stimuli (hyper-responsive 
neutrophils) adding to tissue destruction.  
The study of neutrophils in diabetics has predominantly concentrated on peripheral cells 
and ex vivo assay with limited studies examining the GCF neutrophils in patients with 
periodontitis and diabetes (Sonnenschein and Meyle, 2015). Peripheral neutrophil 
studies have demonstrated changes in neutrophils as a consequence of diabetes. For 
example, Gursoy et al. (2008) indicated a decrease in neutrophil chemotaxis in diabetics 
with an increase in periodontal pocket depth. However, they observed no difference in 
phagocytosis or intracellular killing between periodontitis patients with and without 
diabetes. Shetty et al. (2008), on the other hand, did detect significant decreases in 
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phagocytosis and P. gingivalis killing by neutrophils from diabetics with periodontitis in 
addition to decrease in chemotaxis. Furthermore, peripheral neutrophils from patients 
with periodontitis were more reactive to periodontal pathogen extracts (P. gingivalis and 
A. actinomycetemcomitans) compared with healthy individuals. This hyper-reactivity 
could indicate the role of periodontitis in the tissue destruction associated with diabetes 
complications such as neuropathy (Restaino et al., 2007, Silva et al., 2015). 
While studies in human GCF neutrophils are limited, animal model studies have provided 
an insight into local changes associated with diabetes in periodontitis. For example, 
diabetic mice were shown to have increased gingival vessel permeability, increased 
numbers of rolling leukocytes and increased leukocyte expression of P-selectin 
glycoprotein ligand-1. These results indicate a higher potential for neutrophil migration 
and translocation into gingival tissues in diabetes compared with health (Sima et al., 
2010). A similar observation was made by Gyurko et al. (2006) who also showed 
enhanced leukocyte rolling and attachment to gingival vessels in diabetic mice in addition 
to decreased chemotaxis and increased ROS release by neutrophils from diabetic mice.  
The role of MMPs in periodontitis has been discussed previously and as mentioned their 
regulation is dependent on neutrophils. Given the dysregulation of neutrophils in both 
diabetes and periodontitis, a consequential dysregulation in MMP levels can also be 
suggested which could contribute to the attachment loss. Indeed, evidence suggests 
increased MMP8 and MMP9 levels in periodontal tissues, GCF and saliva from 
periodontitis patients with diabetes (Kumar et al., 2006, Correa et al., 2008, Costa et al., 
2010, Hardy et al., 2012). Furthermore, increases in TIMP2 and TIMP4 have also been 
observed in gingival tissues of diabetics with periodontitis compared with systemically 
healthy participants (Shin et al., 2010, Kim et al., 2011, Jung et al., 2013). This perhaps 
suggests a role for both MMPs and their inhibitors in the progression of periodontitis in 
diabetics.  
1.4.3. Advanced glycation end products  
Another major inflammation-associated element playing a role in increased periodontal 
inflammation in diabetic individuals is the increased prevalence of advanced glycation 
end product (AGEs) and their 35 kDA transmembrane receptor RAGE (receptor for 
advanced glycation end products).   
The formation of AGEs is a non-enzymatic protein modification which results in protein 
structure change. The post-translational modification occurs when amino groups on 
proteins (particularly lysine, arginine and histidine) condense with the carbonyl group of 
reducing sugars. Generation of AGEs occurs mainly through the Maillard reaction which 
transitions from reversible Schiff base adducts to protein bound Amadori products that 
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undergo a series of irreversible oxidation and dehydration reactions to form a broad 
range of heterogeneous products (Figure 1.6) (Ahmad et al., 2017). The resulting AGEs 
are mostly fluorescent nitrogen- and oxygen- containing heterocyclic compounds 
(Younessi and Yoonessi, 2011, Tsutsui et al., 2016, Ott et al., 2014). During the 
conversion of the Schiff base into Amadori products, superoxides are formed while 
during later stages (conversion of Amadori products to AGEs) hydroxyls are formed 
(Ahmad et al., 2017). This generation of ROS during the production of AGEs could 
contribute to complications associated with diabetes (microvascular complications) and 
potentially exacerbate local tissue damage in periodontitis (Brownlee, 2005, Chilelli et 
al., 2013). Structural protein changes associated with the glycation process have been 
implicated in diseases such as Alzheimer’s, atherosclerosis, nephropathy, retinopathy 
and diabetes (Zheng et al., 2002, Lin et al., 2003, Semba et al., 2010, Wang et al., 2012). 
In particular, proteins with longer half-lives that are directly exposed to high extracellular 
glucose levels for prolonged periods of time (such as albumin, haemoglobin, collagen 
and alkaline phosphatases) are susceptible to glycation (Singh et al., 2001). 
Although the full extent of AGE involvement in diabetes is not known, studies have 
implicated AGEs in cellular insensitivities to insulin in diabetes as a consequence of AGE 
associated overproduction of ROS, impairment in proteasomal activities and 
dysregulation of inflammatory responses (Berbaum et al., 2008, Younessi and Yoonessi, 
2011). Glycated proteins often form aggregates and so are more resistant to degradation 
and proteasomal activity. This causes a retention of cross-linked and AGE modified 
proteins in cells and body tissues impacting their normal function. For example, AGE 
modified collagen aggregates are responsible for ECM stiffening which can lead to organ 
and vessel dysfunction, both of which can exacerbate diabetic complications 
(Badenhorst et al., 2003). Furthermore, a recent study showed that although AGE 
modified albumins were rapidly captured by scavenger cells, the proteins and protein 
fragments accumulated in the liver and showed hindered excretion. This increase in AGE 
proteins in the liver can affect normal liver excretion pathways and may play an important 
role in liver complications associated with diabetes (Tsutsui et al., 2016).   
In addition to structural changes caused by the formation of AGEs, interaction of AGEs 
with RAGE have been shown to cause inflammation and oxidative stress both of which 
are important in the progression of periodontitis and diabetes. RAGE is constitutively or 
inducibly expressed in a variety of cell types, including neurones, immune cells 
(neutrophils, monocytes, macrophages, lymphocytes and dendritic cells), smooth 
muscle cells and vascular endothelial cells (Younessi and Yoonessi, 2011, Chuah et al., 
2013). It contains a short cytoplasmic domain, a single transmembrane domain and an 
extracellular domain, composed of a variable domain and two constant domains. The 
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protein belongs to the immunoglobulin super family and has the rare characteristic of 
having the potential to bind multiple ligands from different families. RAGE is thus 
considered a PRR (Younessi and Yoonessi, 2011, Ott et al., 2014). 
Given the high prevalence of neutrophils in periodontitis and indeed the dysregulation of 
neutrophil recruitment and function associated with both diabetes and periodontitis (as 
discussed previously; 1.2.1 and 1.4), AGE/RAGE interactions on these cells have the 
potential to cause increased local inflammatory responses. Upon AGE binding to RAGE, 
expression of inflammatory mediators (such as IL-1β, TNF-α and IL-6) are upregulated 
(Lalla et al., 2000, Graves et al., 2006). Furthermore, AGE is associated with increased 
levels of ROS and oxidative stress (causing endothelial cell changes and vascular injury), 
impairment of bone formation and repair (potentially impacting bone resorption in 
periodontitis), a decrease in ECM production and decrease in collagen strength and 
turnover, all of which may impact periodontal health and the progression of diabetic 
complications (Lalla et al., 2001, Vlassara, 2001, Cortizo et al., 2003, Santana et al., 
2003, Wong et al., 2003, Preshaw et al., 2012). 
Linking diabetes to periodontitis, increased serum AGE in diabetics with a positive 
correlation to increased periodontitis-associated attachment loss has been 
demonstrated (Takeda et al., 2006). Furthermore, immunohistochemical analysis of 
gingival tissues from diabetics indicated a higher percentage of AGE on cells (epithelium, 
blood vessels and fibroblasts) in diabetes with periodontitis compared with healthy 
tissues (Zizzi et al., 2013). On the other hand, studies have also demonstrated increased 
RAGE expression in gingival tissues of diabetics with periodontitis in both human (Katz 
et al., 2005) and animal studies (Chang et al., 2013). Ren et al. (2009) showed gingival 
fibroblasts exposed to AGE modified human serum albumin had decreased cell viability 
and impairment of intracellular collagen I and collagen III synthesis and expression. This 
suggests AGE dysregulates collagen turnover which may exacerbate periodontitis tissue 
destruction.  
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Figure 1.6: Formation of advanced glycation end products through various 
pathways. In addition to the Maillard reaction (red), various other pathways lead to the 
formation of AGEs. These include lipid and amino acid degradation and cleavage of 
dicarbonyl compounds from glycolytic intermediates as well as the formation of carbonyl 
compounds following auto-oxidation of monosaccharides such as glucose, ribose, 
fructose and glyceraldehyde. AGE: advanced glycation end product, HOCl: 
hypochlorous acid, NADPH: nicotinamide adenine dinucleotide phosphate.  
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1.4.4. Other potential linking mechanisms  
As discussed previously (section 1.1.1.4), saliva is important in the maintenance of a 
healthy oral microbiome. In diabetes, salivary flow rate and composition have been 
shown to be altered (Harrison and Bowen, 1987, Thorstensson et al., 1989, Dodds et al., 
2005). Dodds et al. (2005) showed a reduction in stimulated and unstimulated 
submandibular/sublingual saliva outputs. Diabetic salivary proteins were also 
demonstrated to have increases in lactoferrin, MPO and salivary peroxidase in 
stimulated parotid and increased levels of secretory IgA, albumin and lactoferrin in 
stimulated submandibular/sublingual saliva. Although the significance of these changes 
is yet to be fully understood, upregulated salivary proteins in diabetes could encourage 
dysbiosis of the oral microbiota. For instance, changes in IgA levels could potential 
effecting colonisation. Furthermore, increases in salivary albumin could cause an 
increase in AGE modified albumin in diabetics with hyperglycaemia, thus an increase in 
AGE associated immune responses which could contribute to the progression of 
periodontitis (Dodds et al., 2005).  
Impairment of apoptosis has also been suggested as a potential link between diabetes 
and destruction of tissue in periodontitis. In diabetic mice, a higher incidence of fibroblast 
apoptosis was observed when compared with non-diabetic mice upon induction of tissue 
injury through P. gingivalis inoculation (Liu et al., 2004). An increase in apoptosis of these 
matrix-producing cells could indicate an impairment in inflamed tissue repair which in 
periodontitis could contribute to attachment loss (Dodds et al., 2005). 
1.5. Conclusions  
Periodontitis is a complex disease involving both the oral microbiome and the host 
responses. Periodontitis is considered an inflammatory disease, with the innate immune 
response playing crucial roles in periodontal tissue destruction. Diabetes is similarly 
associated with dysregulated immune responses. While the two diseases have been 
shown through epidemiological studies to be linked in a two-way relationship the exact 
mechanisms are unclear. Some potential links have been discussed above but others 
(such as OPG/RANKL levels, TLR expression, T-cells and B-cells) have also been 
suggested as potential links and have been reviewed in detail elsewhere (Sonnenschein 
and Meyle, 2015).  
In addition to host responses, the microbiome of the oral cavity has also been implicated 
in the progression of periodontitis. While studies regarding the differences in the oral 
microbiome between systemically healthy and diabetic individuals with periodontitis are 
contradictory and sparse, it is well established that changes are observed in microbiota 
composition in periodontitis so that periodontitis bacteria (for example P. gingivalis and 
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T. forsythia) are favoured. With advances in technology, the role of the microbiota in 
linking diabetes and periodontitis can be better understood.  
Although many potential linking mechanisms have been postulated for the two-way 
relationship between periodontitis and diabetes, current evidence is unclear and often 
contradictory indicating a need for further investigations. 
1.6. Aims and objectives 
It is now widely accepted that a two-way relationship exists between periodontitis and 
diabetes. To date, studies comparing the changes associated with the two diseases have 
produced contradictory results. The aim of this study is to provide evidence for potential 
linking mechanisms between diabetes and periodontitis.  
 It is the objectives of this project to determine if increased AGEs (a consequence of 
hyperglycaemia) increase AGE-RAGE interactions to change inflammatory responses 
(measured as changes in IL-8, IL-1β and IL-6) in gingival keratinocytes. Furthermore, 
this study utilises an in-house developed biofilm model to ascertain if AGEs influence 
biofilm bacterial composition (using both culturing methods and NGS) as well as how 
biofilms grown with concentration of AGEs that are commensurate with diabetes and 
health impact inflammatory responses (IL-1β, IL-8, IL-6 and ROS changes) when co-
cultured with gingival keratinocytes.  
In addition to in vitro studies, a preliminary clinical study was undertaken to uncover 
differences in biofilm composition and functionality in systemically healthy individuals 
with and without periodontitis. This was achieved through next generation sequencing 
(NGS). In addition to this it is important to determine the local and systemic levels of pro-
inflammatory mediators (cytokines/chemokines and MMPs) in these individuals to 
establish molecular mechanisms involved in periodontitis. The study also looked at 
systemic neutrophil functions (migration, phagocytosis and respiratory burst) as 
defective neutrophils have been associated with periodontitis progression. By 
understanding the systemic changes involved in periodontitis, one could understand the 
potential effect multiple diseases with distinct pathogenesis, indeed this preliminary 
clinical study will set the basis for a more complex study involving diabetics with and 
without periodontitis. 
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2. Material and Methods 
2.1. Solutions and Buffers 
Table 2.1: Table of buffers and solutions used 
Artificial Saliva 2.5 g/L mucin, 6.52 mM NaCl, 14.94 mM KCl, 
5.42 mM KH2PO4, 11.35 µM ascorbic acid. Added 
post sterilisation: 9 mM Urea and 5 mM arginine 
Basal medium 10 g/L Proteose-peptone, 5 g/L Trypticase-
peptone, 5 g/L yeast extract, 33.53 mM KCl, 4.13 
mM cysteine. pH 7.4 
Blocking Buffer 5% semi skimmed milk powder dissolved Tris 
Buffered Saline (Bio-Rad Laboratories Ltd) with 1% 
(v/v) Tween-20 (TBS-T) 
ELISA coating buffer 51.1 mM NaHCO3, 50 mM Na2CO3, pH 9.4 
ELISA stop buffer 1.8N H2SO4 
ELISA wash buffer 1.46mM KH2PO4, 9.9 mM KH2PO4 – 3H2O, 1.36 
mM EDTA, 5%(v/v) Tween 20, pH 7.4 
Reduced transport fluid (RTF) 
(Rundell et al., 1973) 
68.11 mM (NH4)2SO4, 154 mM NaCl, 28.70 mM 
K2HPO4, 33.07 mM KH2PO4, 37.74 mM Na2CO3, 
13 mM EDTA, 12.97 mM Dithiothreitol, 7.30 mM 
MgSO4, 0.1% (v/v) Resazurin 
RIPA buffer 
(Radioimmunoprecipitation 
assay buffer) 
150 mM NaCl, 1% (v/v) Triton X, 0.5% (v/v) sodium 
deoxycholate, 0.1% (v/v) SDS, 50 mM Tris 
Serum medium Basal medium supplemented with 20% (v/v) heat 
inactivated foetal bovine serum (FBS), 1.45 mM 
haemin and 1.1 µM menadione 
TGS buffer 
(Bio-Rad Laboratories Ltd) 
Tris/Glycine/SDS buffer 
Diluted to 1x working solution in dH2O prior to use 
Tris EDTA (ethylene diamine 
tetra acetic acid buffer) 
(TE Buffer) 
10 mM Tris, 1 mM EDTA, pH 8.0 
ELISA assay buffer 136.89 mM NaCl, 7.96 mM Na2HPO4, 1.47 mM 
KH2PO4, 2.68 mM KCl, 0.5% (w/v) Bovine Serum 
Albumin (BSA), 0.1% (v/v) Tween 20, pH 7.4 
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2.2. Tissue culture  
Cells were cultured using standard aseptic techniques. Human telomerase immortalized 
gingival keratinocytes (TIGK: Moffatt-Jauregui et al., 2003) were kindly gifted from Dr 
Richard Lamont (School of Dentistry, University of Louisville). The TIGK cells were grown 
in Basal Medium Dermalike K complete kit with supplements (LifeLine® cell technology, 
USA) and incubated at 37°C, in 5% CO2. Medium was changed every 2-3 days and cells 
were passaged when confluency reached 70-80% and used between passages 5 and 
15. To passage, the monolayer of cells was washed with phosphate buffered saline 
(PBS) prior to incubation with 0.25% (v/v) Trypsin-EDTA solution (Sigma-Aldrich, UK), 
for 5 min or until cells detached at 37°C, 5% CO2. Upon cell detachment, trypsin was 
neutralised by the addition of fresh medium at a 1:1 ratio and the suspension centrifuged 
at 300 g for 5 min. The supernatant was discarded, and the resulting cell pellet was re-
suspended in an appropriate volume of medium to enable counting using a 
haemocytometer and seeding of tissue culture flasks or plates at the desired density. All 
tissue culture was carried out in sterile tissue-culture-treated flat bottom plates or tissue 
culture flasks (Corning® Costar®). 
2.3. Western blot analysis 
Cell lysates were generated using standard RIPA (Radioimmunoprecipitation assay 
buffer) lysis buffer protocols. Briefly, monolayer cells were washed with ice-cold PBS and 
the cells detached, using a cell scraper, directly into ice-cold RIPA buffer with added 
protease inhibitor cocktail (1 tablet/10 mL, cOmplete™, Mini protease inhibitor cocktail 
tablets, Roche, UK). The cell suspension was then incubated on ice for 15 min with 
agitation and centrifuged at 17000 g, 4°C for 20 min. Cell medium supernatant was also 
harvested and centrifuged at 17000 g, 4ºC for 20 min. Resulting supernatants were 
freeze dried and stored at -20°C for later analysis. 
Protein concentrations were quantified prior to Western blot analysis using the Bradford 
assay (Pierce™ Coomassie (Bradford) Protein Assay Kit, ThermoFisher Scientific, UK) 
as per manufacturer’s instructions for microplate procedures. Briefly, 5 µL of BSA 
standards (100-1500 µg/mL) or 5 µL sample was mixed with 250 µL Coomassie in a 96 
well plate. Following a 10 min incubation at room temperature (RT), the absorbance was 
read at 595 nm in a microplate reader (Varioskan Flash, Thermo scientific) and a four-
parameter standard curve generated to extrapolate sample protein concentrations.  
Mini-PROTEAN TGX Stain Free Gels (4-15%, Bio-Rad Laboratories Ltd, UK) were used 
for western blotting. 10 µg total protein, with a 1:1 ratio of 2x Laemmli sample buffer (Bio-
Rad Laboratories Ltd, UK) and supplemented with 100 mM β-mercaptoethanol was 
boiled for 5 min at 95°C prior to gel loading and the gel run for approximately 75 min at 
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120 V in TGS buffer. In addition to samples, Precision Plus Protein WesternC standards 
(Bio-Rad Laboratories Ltd, UK) were also loaded onto gels (10 – 250 kDa). Gels were 
then transferred to a PVDF (polyvinylidene difluoride) membrane (Trans-Blot Turbo 
transfer pack, 7 x8.5 cm, Bio-Rad Laboratories Ltd, UK) using a Trans-Blot ® Turbo™ 
transfer system (Bio-Rad Laboratories Ltd). Following transfer, membranes were rocked 
at RT in blocking buffer for a minimum of 1 h to reduce background binding of primary 
antibodies. Blocking buffer was discarded and membranes incubated with primary 
antibody diluted in 0.25% (w/v) milk in TBS-T, overnight at 4°C on a rocking platform 
(Table 2.2). This was followed by 3x 5 min washes in TBS-T with rocking at RT. 
Membranes were then blocked again to reduce non-specific secondary antibody binding 
followed by 3x 5 min washes in TBS-T with rocking at RT and incubation for 1 h at RT 
with the secondary antibody and a Precision Protein ™ StrepTactin-horseradish 
peroxidase (HRP) conjugate (Bio-Rad Laboratories Ltd) in 0.25% (w/v) milk in TBS-T 
(Table 2.2). The StrepTactin-HRP was added to enhance visualisation of standards. 
Unbound antibody was removed with 3x 5 min washes and the antibody staining 
revealed by 5 min incubation of membranes in SuperSignal™ WestFemto Maximum 
Sensitivity Substrate (Fisher Scientific Ltd, UK) for chemiluminescence exposure and 
visualised using the ChemiDoc™ MP imaging system (Bio-Rad).   
For multiple antibody probing, membranes were rocked in Restore PLUS Western Blot 
Stripping buffer (Thermo Fisher Scientific, Life Technologies, UK) for 30 min at RT 
followed by 3x 5 min washes in TBS-T with rocking at RT and the process above 
repeated from the first blocking step. 
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Primary Antibody Secondary Antibody  
Antibody: Mouse monoclonal to human 
RAGE 
Dilution: 1:1000 dilution  
Final concentration: 0.5 µg/mL  
Abcam (MM0520-8D11) 
Antibody: Rabbit polyclonal antibody to 
mouse IgG (HRP) 
Dilution: 1:10000 dilution 
Final concentration: 2 µg/mL 
Abcam  
Antibody: Rabbit polyclonal to human β-
Actin 
Dilution: 1:1000 dilution 
Final concentration: 0.5 µg/mL 
Abcam  
Antibody: Goat polyclonal antibody to 
rabbit IgG (HRP) 
Dilution: 1:20000 dilution 
Final concentration: 1 µg/mL 
Abcam  
Table 2.2: Antibody details for Western Blotting. HRP; Horseradish peroxidase, 
RAGE; receptor for advanced glycation end products, IgG; Immunoglobulin G. 
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2.4. Enzyme-linked immunoassay  
Enzyme linked immunoassays (ELISAs) were carried out with the antibodies 
reconstituted according to manufacturer’s instructions. Briefly a 96 well flat bottomed 
plate (Greiner bio-one) was coated with monoclonal capture antibody (Table 2.3) and 
incubated at RT overnight. The plate was then washed (x3) in wash buffer and dried prior 
to blocking with assay buffer at RT for 1 to 2 h. The wash step was repeated before 
samples and standards were added to the plate and incubated at RT for 2 h. Standards 
were added to each assay plate (with ranges as indicated Table 2.3) in addition to a 
negative control of assay buffer alone. The wash step was repeated and assay buffer 
containing biotinylated detection antibody (Table 2.3) was added to each well and the 
plate incubated at RT for 2 h. Plates were washed again prior to the addition of 
Streptavidin horseradish peroxidase (Strep-HRP) (Table 2.3) and then incubated at RT 
for 20 min. Following a final wash, 200 µL of 3,3’,5,5’ - tetramethylbenzidine (stabilized 
chromogen TMB, Invitrogen, UK) was added as a substrate. Plates with TMB added 
were incubated at RT with protection from light for approximately 20 min. Once the 
appropriate amount of colour development was achieved a stop solution was added 
producing a yellow colour which was detectable at 450 nm. The absorbance of the wells 
were read and recorded, within 15 min of adding the stop solution, using a plate reader 
(Varioskan Flash, Thermo scientific) set to measure photometric absorbance at a 
wavelength of 450 nm. 
Sample absorbance readings were converted to analyte concentrations (pg/mL) using 
the curve of the line equation generated from the standard curve produced for each plate. 
Analyte concentrations were calculated with correction for background levels of 
absorbance.   
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 Table 2.3: Antibody details used for ELISAs. IgG: Immunoglobulin G, IL: Interleukin. 
 
  
Analyte 
Antibody 
Manufacturer 
Capture 
antibody 
concentration 
(Host/Clone/ 
Diluent) 
Detection 
antibody 
concentration 
(Host/ 
Clone) 
Standards 
range 
(pg/mL) 
Strep HRP 
concentration 
IL-8 R&D systems 
1 µg/mL 
(Mouse IgG/ 
6217/ 
Coating buffer) 
1 µg/mL 
(Goat IgG/ 
polyclonal) 
15.625 – 
1000 
1:5000 
dilution,  
R&D systems 
IL-6 
BD 
Pharmingen 
1 µg/ml 
(Rat IgG/ 
MQ2-13A5/ 
Coating buffer) 
2 µg/ml 
(Rat IgG2a/ 
MQ2-39C3) 
15.625 – 
1000 
1:5000 
dilution,  
R&D systems 
IL-1β 
R&D systems 
– Duoset 
4 µg/ml  
(-/-/PBS) 
12 µg/mL  
(n/a) 
3.91 – 250 
1:40 dilution, 
R&D Duoset 
RAGE 
R&D systems 
– Duoset 
1 µg/ml  
(-/-/PBS) 
100 ng/mL 
(n/a) 
62.5 – 4000 
1:200 dilution, 
R&D Duoset 
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2.5. Next generation sequencing  
2.5.1. Bacterial DNA extraction and quantification  
DNA was extracted from samples using a DNA extraction kit (UltraClean® Microbial DNA 
Isolation kit, MoBio Laboratories, Inc., UK) following the manufacturer’s instructions. 
Briefly, microbial cell pellets were re-suspended in MicroBead solution, gently vortexed 
and transferred to a MicroBead tube followed by heating at 65°C for 10 min and the 
addition of lysis solution. The MicroBead tubes were then vortexed for 10 min on a 
horizontal vortex. The specialised beads and bead beating tube in combination with the 
heating and addition of lysing solution uses chemical and mechanical mechanisms for 
microbial lysis. Following microbial lysis, released DNA was bound to spin filters, washed 
and eluted in DNA-free Tris buffer. Extracted DNA was stored at -20°C for further 
analysis.  
DNA concentration was determined using a Quant-iT™ PicoGreen™ double stranded 
(ds) DNA assay (ThermoFisher Scientific, UK) according to manufacturer’s instruction. 
Briefly, 1 µL of extracted DNA was added to wells of a 96 well plate containing 99 µL of 
TE (Tris EDTA) buffer. DNA standards were run in conjunction with samples with a range 
of 1000 ng/mL to 10 ng/mL (high range quantitation) or 50 ng/mL to 1 ng/mL (low range 
quantitation). PicoGreen (Quant-iT™ PicoGreen™ ds DNA assay, ThermoFisher 
Scientific, UK) was added to each well (100 µL) and the plate incubated, protected from 
light, for 2 to 5 min at RT. Fluorescence was read at 480 nm excitation, 520 nm emission 
and DNA concentration of samples calculated using the curve of the line equation 
generated from the standards.   
2.5.2. DNA shearing and size distribution electrophoresis  
Extracted bacterial DNA was sheared using Covaris microTUBEs (Covaris, Inc.) to 200 
base pairs (bp) fragments using the pre-set ‘Microtubes 200 bp’ program on the sonicator 
(Covaris s220 high performance ultrasonicator, Covaris, Inc.). The fragment size of the 
sheared DNA was immediately checked using the Agilent 2200 TapeStation system 
(Agilent). Briefly, 2 µL of DNA sample was added to the well of a V-bottom 96 well plate 
(Agilent, UK) with an equal volume of loading buffer (High sensitivity D1000 sample 
buffer, Agilent, UK). Samples were run along-side a High sensitivity D1000 ladder 
(Agilent, UK) and loaded onto High sensitivity D1000 ScreenTapes (Agilent, UK). 
Following size verification (Figure 2.1) sheared DNA was immediately used for library 
preparation or stored at -20ºC for later processing.  
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Figure 2.1: Example of tape station results post DNA shearing. (A) Example of 
electrophoresis tape image. Lane 1 shows ladder while lane 2 & 3 show sheared DNA 
extracted from saliva. (B) Example of size distribution of sheared samples. Sheared 
samples show a bell curve with a peak at approximately 200 bp indicating successful 
shearing.  
  
A B 
1 2 3 
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2.5.3. Next generation sequencing library preps  
Libraries for Next Generation Sequencing (NGS) were prepared using the NEBNext Ultra 
(for samples with extracted DNA 5 ng – 1 µg) or NEBNext Ultra II (for DNA <5ng) library 
preparation kit for Illumina (New England BioLabs, USA). Libraries were prepared 
following the manufacturer’s instructions as outlined in Figure 2.2 . NEBNext Multiplex 
adaptors (set 1 (E7335) and set 2 (E7500), New England Biolabs, USA) were used for 
multiplexing library preparations.     
Resulting libraries were then checked for quality using an Agilent TapeStation as 
described above. In cases where starting DNA concentrations were low, adaptor 
contamination could occur (Figure 2.3A). To remove adapter contamination a clean-up 
step using 0.8x beads was carried out. DNA concentrations of resulting libraries was 
established using Quant-iT™ PicoGreen™ ds DNA assay (section 2.5.1) and an 
equimolar concentration of each sample was added to a pool (24 samples with different 
index primers per pool maximum) and the samples sequenced on one lane of  the 
Illumina HiSeq3000 available at the NGS facility at the University of Leeds 
(http://dna.leeds.ac.uk/genomics/). 
2.6. Next generation sequencing data analysis 
Sequencing data was received de-multiplexed from the NGS facility and analysed using 
the high performance computing (HPC) system. These data were processed as outlined 
in Figure 2.4 utilising QIIME (Caporaso et al., 2010b), SortMeRNA (Kopylova et al., 
2012), DIAMOND (Buchfink et al., 2015) and MEGAN (Huson et al., 2007) for filtering, 
mapping, operational taxonomic unit (OTU) picking and functional analysis. SortMeRNA 
allows the sorting of reads into rDNA reads and non-rDNA reads using a reference 
database. During this analysis the HOMD was utilised for rDNA sorting 
(http://www.homd.org/index.php?name=seqDownload&file&type=R). The rDNA and 
DNA sorted reads were mapped to reference databases using QIIME and 
DIAMOND/MEGAN, respectively.  
OTU count tables were loaded in R (https://www.R-project.org/) through the phyloseq 
package (McMurdie and Holmes, 2013). For clinical sample analysis, the OTU count 
table, metadata mapping file and phylogenetic tree were loaded into phyloseq to 
generate a phyloseq object for analysis of sample bacterial composition. Graphs were 
generated using the ggplot package in R (Wickham, 2009). For analysis of complex 
biofilm NGS data, phyloseq objects of OTU counts and functional counts were used in 
DESeq2 for statistical analysis of bacterial composition. Differential abundance was 
determined using the Wald test to determine significance (p < 0.1).  
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Figure 2.2: Schematic outlining the process for next generation sequencing library preparation using NEBNex library prep kits 
for Illumina.  
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Figure 2.3: TapeStation analysis of next generation sequencing library 
preparations. (A) Example of library preparation with adapter contamination. Adapters 
at 120 bp (top) were removed using 0.8x bead clean-up so that the library peak (at 
approximately 319 bp) was larger than any remaining adapter contamination (bottom). 
(B) Example of library preparation without any adaptor contamination 
  
A B 
  
 
 
 
 
 
 
 
Table 2.4: Example of a metadata file used in analysis pipeline. 
#SampleID BarcodeSequence linkerPrimerSequence InputFileName SampleType SampleSite Description 
p001p ATCACG p001plaque p001pinterleaved.fna Periodontitis Plaque p001pperio 
p002p CGATGT p002plaque p002pinterleaved.fna Periodontitis Plaque p002pperio 
p003p TTAGGC p003plaque p003pinterleaved.fna Healthy Plaque p003phealth 
p004p TGACCA p004plaque p004pinterleaved.fna Periodontitis Plaque p004pperio 
p005p ACAGTG p005plaque p005pinterleaved.fna Periodontitis Plaque p005pperio 
p006p GCCAAT p006plaque p006pinterleaved.fna Periodontitis Plaque p006pperio 
p007p CAGATC p007plaque p007pinterleaved.fna Healthy Plaque p007phealth 
p008p ACTTGA p008plaque p008pinterleaved.fna Healthy Plaque p008phealth 
p009p GATCAG p009plaque p009pinterleaved.fna Healthy Plaque p009phealth 
p010p TAGCTT p010plaque p010pinterleaved.fna Healthy Plaque p010phealth 
p011p GGCTAC p011plaque p011pinterleaved.fna Healthy Plaque p011phealth 
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2.6.1. Taxonomic analysis based on rDNA reads 
As outlined in Figure 2.4 raw read files (as .fastq files) were first processed for the 
removal of adaptors using Cutadapt (Martin, 2011) and trimmed for removal of low quality 
reads using Sickle (Joshi and Fass, 2011). The paired end reads were then interleaved 
using SortMeRNA so that forward and reverse reads for each sample were in one file. 
Interleaved read files were converted to fasta for use with QIIME. The interleaved files 
for each sample were combined into a single file containing all sample reads with labels 
corresponding to sample identity using a metadata mapping file which provides 
information on each file (see Figure 2.4 for example). These reads were then sorted into 
rDNA and non-rDNA following comparison to the HOMD database (reads provided as 
.fastq file).  
Representative sequences for each OTU were then picked from rDNA reads for 
taxonomic assignment. Although achieved through QIIME scripts, taxonomic assignment 
used an uclust algorithm to cluster nucleotides based on sequence similarities, via the 
RDP Classifier 2.2. (Wang et al., 2007, Edgar, 2010).   
Taxonomic classification was followed by generation of OTU count tables for 
downstream analysis. In addition to OTU count table generation, representative OTU 
sequences were used for phylogenetic tree building using QIIME, PyNast (Caporaso et 
al., 2010a) and FastTree 2.1.3. (Price et al., 2010) to align representative sequences to 
existing alignments, Greengenes core reference alignment, (DeSantis et al., 2006) and 
tree generation. 
Principle coordinate analysis (PCoA) with Bray Curtis dissimilarity plots were generated 
using MEGAN to visualise sample relationships based on taxonomy. OTU tables were 
loaded into MEGAN (as .biom files) with NCBI taxonomy assignments and PCoA 
analysis carried out based on absolute counts.  
2.6.2. Taxonomic and functional analysis based on DNA contigs 
Raw reads were processed as outline in Figure 2.5. Following sorting of quality trimmed 
reads using SortMeRNA (Figure 2.5 – steps 1-4), non-rDNA short reads in each sample 
were assembled de novo using MEGAHIT (Li et al., 2015). The resulting contigs were 
aligned to the non-redundant (nr) NCBI protein database using DIAMOND. DIAMOND 
generated files, containing DNA contig based counts for each alignment labelled 
according to NCBI accession numbers, were imported into MEGAN.  
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MEGAN allows interactive visualisation of metagenomics data. DIAMOND files were 
collectively loaded into MEGAN for assignment of accession numbers to taxonomy and 
function (as described in Figure 2.5). Taxonomical assignment was based on the NCBI 
protein database. Functional assignment was based on EggNOG (evolutionary 
genealogy of genes: non-supervised orthologous groups, Huerta-cepas  et al, 2015) and 
SEED (Overbeek et al., 2005). Both databases are used to assign protein functions to 
genes. EggNOG is EMBL (European molecular biology laboratory) hosted database 
which provides information about orthologous groups of proteins at various taxonomical 
levels. SEED, contrastingly, assigns gene functions using homologous genes from 
complete genomes and presents them in functional categories.  
Taxonomy OTU counts and functional counts were exported from MEGAN and important 
into the phyloseq package of R with corresponding mapping files for further analysis 
(section 2.6). 
2.7. Preliminary study of clinical samples 
2.7.1. Sample Collection  
Saliva, blood, plaque and GCF was collected from participants with periodontitis 
(diseased) and healthy controls. Participants were recruited and samples collected at the 
Leeds Dental Translational and Clinical Research Unit, following ethical approval (Leeds 
East Research Ethics Committee) and informed consent (14/YH/0010). For all 
participants, samples from periodontally diseased sites were taken from participants with 
periodontitis, and samples from periodontally healthy sites only were taken from healthy 
participants. The periodontitis group were identified by research dental practitioners as 
having periodontal pockets with a probing depth of 5 mm or greater with bleeding on 
probing. For the periodontally healthy groups, sites were identified as having sulcus 
depths of 3 mm or less with no bleeding on probing and no clinical signs of inflammation. 
2.7.1.1. Saliva collection  
Participants were asked to provide a minimum of 2 mL of stimulated saliva (by chewing 
on sterile wax). Samples were kept on ice and centrifuged at 1500 g and 4°C for 15 min. 
The supernatant and resulting pellet were frozen at -80°C for future analysis.  
2.7.1.2. Blood collection and plasma separation 
Blood was collected from participants by venepuncture into both EDTA and lithium 
heparin coated anti-coagulant tubes. Whole blood (with lithium heparin anti-coagulant) 
was used immediately for neutrophil analysis (2.7.2, 0 and 2.7.4 for methodology). To 
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separate cell free plasma, samples were centrifuged at 1500 g at RT for 10 min with the 
brake disabled. Resulting plasma was stored at -80°C for future analysis.  
2.7.1.3. GCF collection and processing 
GCF was collected from 5 sites from each participant using Perio Paper strips (Oraflow 
Inc, New York). In all cases accessible sites were selected where moisture contamination 
could be controlled, with sites where bleeding on probing was extensive being rejected. 
Prior to collection, supragingival plaque was removed using a sterile cotton wool pledget. 
A strip was then inserted into the gingival crevice for 10 sec, with two strips being used 
per site. The strips from each site were placed into a single polypropylene tube before 
freezing at -80°C for later analysis.  
For analysis, immediately prior to assay, GCF was processed as previously described 
(Awang et al., 2014). Briefly each strip was thawed on ice before the addition of 200 µl 
ice cold phosphate buffered saline (PBS) supplemented with 1% (w/v) BSA and rotated 
for 60 min at 4°C. Following removal of the strips, the eluted GCF was centrifuged at 350 
g for 60 min at 4°C and then at 13,000 g for 3 min at 4°C and the resultant supernatant 
from the 10 strips from each patient pooled and used immediately for analysis.  
2.7.1.4. Plaque collection and processing  
Subgingival plaque was collected using sterile paper points (Maillefer Pro Taper Paper 
Points F3, BF Mullholland Ltd., UK). Prior to insertion of paper points into the gingival 
sulcus, collection sites were isolated and dried using sterile gauze and supragingival 
plaque removed with a sterile cotton pledget. A total of 5 sites were sampled with 3 paper 
points used for each site. Following collection paper points were stored at -80°C for 
further analysis.  
For plaque extraction a sterile glass bead was added to each tube containing 3 paper 
points from a single site. The tubes were vortexed vigorously for a minimum of 5 mins. 
Bacterial DNA was extracted (section 2.5.1) with the following adaptation: 300 µL of the 
microbead solution was added directly to a tube containing paper points from one site 
and a sterile glass bead. The tube was then vortexed and the solution transferred to a 
tube containing paper points from a different site from the same participant and a sterile 
glass bead. The process was repeated and in this manner plaque from the 5 sites from 
each participant was pooled prior to DNA extraction.  
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Figure 2.4: Pipeline for analysis of rDNA reads from metagenomics data. Blue text 
represents code.  
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Figure 2.5: Pipeline for analysis of rDNA reads from metagenomics data. Blue text 
represents code. 
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2.7.2. Quantifying migration of leukocytes  
The Migratest assay (Glycotope Biotechnology) allows the quantitative analysis of 
leukocyte chemotaxis. The numbers of cells migrating through cell culture inserts (3 µm 
pore size) towards a concentration gradient of the chemo-attractant N-formylmethionine-
leucyl-phenylalanine (fMLP) were quantitated against counting beads whilst changes in 
cell shape and the down regulation of the cell adhesion molecule L-selectin, were 
determined to monitor cell activation. The Migratest assay was performed as per 
manufacturer’s instructions with blood samples assayed within the recommended 24 h 
of collection, typically within 6 to 14 h. 
Leukocyte-rich-plasma (LRP) was generated by overlaying 1 mL of whole blood on top 
of the supplied leukocyte separation medium for 40 min at RT. The upper phase was 
collected and placed in cell culture inserts pre-positioned in wells (24 well plate) 
containing 350 µL fMLP (0.05 µM) in the supplied incubation buffer (Reagent B) or buffer 
alone for negative controls (Figure 2.6). Each sample was carried out in triplicate 
(referred to hereafter as technical repeats). Plates with inserts within wells were 
incubated in a 37 °C water bath for 30 mins.  Cell suspensions were then removed from 
the wells and transferred to polystyrene FACS (fluorescence-activated cell sorting) tubes 
(BD Biosciences) and placed on ice. Cell suspensions remaining within the control 
inserts (20 µL) were also removed to provide comparison with un-migrated cells. 20 µL 
of Reagent D (containing counting bead suspension and monoclonal anti-L-selectin-
FITC (fluorescein isothiocyanate)) was added to each sample, vortexed and incubated 
on ice for 10 min protected from light. Finally, 20 µL of 1x Reagent E (DNA stain) was 
added to each tube, the samples mixed and incubated on ice in the dark for 5 min.  
The data were acquired using a LSRII flow cytometer equipped with a 488 nm argon-ion 
laser (BD Bioscience) and BD Diva software within 120 min of protocol completion. The 
fluorescence from the counting beads and DNA stain were detected at 488 nm (within 
PerCP-Cy5-5-A labelled channel) and used to set an initial gate which identified 
leukocytes and counting beads (Figure 2.7A). A second gate was then set around the 
counting beads using a SSC (side scatter) vs FSC (forward scatter) contour plot to 
distinguish between the counting beads and leukocytes (Figure 2.7B). Data were 
acquired until 2000 events were recorded in the counting bead gate. This method 
standardised the volume analysed per data file and therefore ensured the amount of 
leukocytes within each sample was comparable. Leukocytes were quantitated and also 
analysed for surface L-selectin expression (FITC mean fluorescence intensity; MFI), a 
reduction in which indicates cellular activation by fMLP (Figure 2.7C).  In addition, the 
median FSC was used as an indication of changes in cell size.  The sample of cells taken 
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from the remainder within the insert were used as a comparison for these indicators of 
activation.   
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Figure 2.6: Schematic of sample stimulation for analysis of leukocyte chemotaxis. Sample leukocyte-rich-plasma was loaded onto cell culture inserts and 
placed in 24 well plates above wells containing either incubation buffer or fMLP (N-formylmethionine-leucyl-phenylalanine) as a chemoattractant. Following 30 
min incubation, inserts were removed and samples taken from each well for fluorescence-activated cell sorting. 
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Figure 2.7: Gating strategy for FACs acquisition and downstream analysis of 
neutrophil migration. (A) Initial acquisition gate was used to identify counting bead and 
leukocyte population. (B) Gates were drawn to distinguish between counting beads and 
leukocytes and 2000 events were collected within the counting bead region. (C) Gates 
set on FITC histogram were used to distinguish between low and high L-selectin 
expression. The unstimulated histogram shows samples with high-L-selectin-FITC 
indicating non-migrated cells. The stimulated histogram show samples with low-L-
selectin-FITC indicating migrated cells. (D) Population hierarchy and colour key for 
contour plots. 
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2.7.3. Quantifying phagocytosis by neutrophils  
The Phagotest (Glycotope Biotechnology) assay allows the quantitative analysis of 
phagocytosis. The assay detects and quantitates the ingestion of opsonised fluorescent 
(FITC-labelled) E. coli, allowing for the calculation of both the percentage of 
phagocytically active neutrophils and the extent of that activity (amount of bacteria per 
cell).  
The Phagotest protocol was carried out with adaptations to the manufacturer’s 
instructions. Briefly, 100 µL of heparinized whole blood (per test) was cooled on ice for 
10 min prior to the addition of either 20 µL (2 x 107 – 4 x 107 ), 5 µL (5 x 106 –1 x 107 ) or 
2 µL (2 x 106 – 4 x 106 ) of the supplied and pre-cooled E. coli preparation (Reagent B). 
The control samples remained on ice to prevent phagocytosis, while test samples were 
incubated in a 37°C water bath for 10 min. Samples were immediately placed on ice to 
prevent further phagocytosis. 100 µL of quenching solution (Reagent C) was added to 
each sample to eliminate fluorescence from E. coli adhering to external cell surfaces 
(fluorescence from internalised E. coli remains unaltered). Each sample was washed 
twice with 3 mL of the wash solution (Reagent A) and centrifuged at 250 g at 4°C for 5 
min. The resulting cell pellet was resuspended in 200 µL of pre-warmed (RT) lysing 
solution (1 x Reagent D) and incubated for 20 min in the dark at RT. Following lysis, the 
samples were centrifuged for 5 min at 250 g and 4°C and the wash process repeated 
prior to resuspension of the pellet in 200 µL DNA stain (Reagent E). 
Samples remained on ice until data acquisition (minimum of 10 min). Data were acquired 
using a LSRII flow cytometer equipped with 488 nm argon-ion laser (BD Bioscience, UK) 
and BD Diva software within 120 min of protocol completion. The fluorescence from the 
DNA stain (detected at 488 nm - within PE labelled channel) was used to set an initial 
gate to distinguish between bacterial aggregates and leukocytes (Figure 2.8A). 10000 
events per data file were collected within this gate.  
Analysis was carried out using the Diva software (BD Bioscience). An initial analysis gate 
was set on the population representing neutrophils (Figure 2.8B) as defined by FSC vs 
SSC. The FITC fluorescence of this gated population was analysed to calculate the 
percentage of cells that had performed phagocytosis (percentage of cells within the FITC 
positive gate in Figure 2.8C) and the amount of ingested bacteria (where mean 
fluorescence correlated to bacteria per leukocyte). For this purpose the negative controls 
were used to set the background level of FITC fluorescence shown as ‘FITC negative’ in 
Figure 2.8C. Any fluorescence above this marker was considered ‘FITC positive’ and 
indicated phagocytically active cells. 
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Figure 2.8: Gating strategy for FACs acquisition and downstream analysis of 
neutrophil phagocytosis. (A) DNA staining was used to distinguish between bacterial 
cells and Leukocytes. 10000 events were collected within the leukocyte gate. (B) The 
neutrophil gate was set to distinguish neutrophil populations of interest during analysis. 
(C) FITC histograms were gated to identify FITC positive and FITC negative cells within 
in the neutrophil population. Unstimulated cells remained within the FITC negative region 
while stimulated cells shifted into the FITC positive region. The FITC shift can also been 
seen in FITC vs SSC contour plots. (D) Population hierarchy and colour key for contour 
plots.  
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2.7.4. Quantifying respiratory burst of neutrophils 
Phagoburst (Glycotope Biotechnology) allows the quantitative analysis of neutrophil 
oxidative burst. The assay utilizes opsonised E. coli, phorbol 12-myristate 13-acetate 
(PMA) and fMLP as phagocytosis stimulants with dihydrochodamine (DHR) 123 as the 
fluorogenic substrate. The production of reactive oxidants following phagocytosis, 
oxidises DHR 123 to R 123 (rhodamine 123), the fluorescence of the latter can be 
measured to determine the percentage of cells which have produced ROS and their 
enzymatic activity (mean fluorescence intensity correlates to amount of converted DHR 
123).  
The Phagoburst assay was carried out with adaptations to the manufacturer’s 
instructions. Heparinised whole blood (100 µL per test) was cooled on ice for 10 mins 
prior to the addition of either the wash solution (negative control), fMLP (weak stimulant), 
PMA (strong stimulant) or the supplied pre-cooled E. coli (Table 2.5). The samples were 
then mixed and incubated for 10 min in a 37°C water bath. Following incubation, 20 µL 
of the DHR 123 substrate (Reagent E) was added to each sample, the sample vortexed 
and incubated for a further 10 min in a 37°C water bath. Red blood cells were then lysed 
through the addition of 2 mL pre-warmed (RT) lysing solution (1 x Reagent F), vortexing 
and incubation at RT for 20 min with protection from light. Lysed blood was centrifuged 
for 5 min at 250 g and 4°C and the supernatant discarded. Resulting pellets were washed 
with 3 mL of the wash solution (1 x Reagent A) and centrifuged again for 5 min at 250 g 
and 4°C. The final pellet was re-suspended in 200 µL of DNA staining solution (Reagent 
G), the tubes mixed and incubated for a minimum of 10 min on ice prior to acquisition.  
Data were acquired using an LSRII flow cytometer (equipped with 488 nm argon-ion 
laser) (BD Bioscience) and BD Diva software within 30 mins of final incubation. The 
fluorescence from the DNA stain (detected at 488 nm - within the PE fluorescence 
channel) was used to set an initial gate to distinguish between bacterial aggregates and 
leukocytes (Figure 2.9A). 10000 events per data file were collected within this gate.  
Analysis was carried out using BD Diva software. An initial analysis gate was set around 
the population of cells representing neutrophils (Figure 2.9B) using a FSC vs SSC 
contour plot. FITC histograms of this gated population were then used to calculate the 
percentage of cells which had undergone respiratory burst and their amount of ROS 
generated (where mean fluorescence correlated to the amount of R 123 product 
generated). For this purpose the negative controls were utilised to identify and gate the 
population considered ‘FITC negative’ (Figure 2.9C). Anything above this marker was 
considered ‘FITC positive’ and indicated cells which had undergone respiratory burst.  
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Table 2.5: Concentration of stimulants used in Phagoburst assay to initiate 
respiratory burst in neutrophils. PMA; Phorbol 12-myristate 13-acetate, fMLP; N-
formylmethionine-leucyl-phenylalanine. 
 
 
 
 
 
 
 
 
 
Test Reagent Volume 
Final 
concentration 
Control 
Wash buffer 
Reagent A 
20 µL N/A 
Test 1 
E. coli 
Reagent B 
20 µL 2 x 107 – 4 x 107 
Test 2 
E. coli 
Reagent B 
5 µL 5 x 106 –1 x 107 
Test 3 
E. coli 
Reagent B 
2 µL 2 x 106 – 4 x 106 
Weak stimulant 
fMLP 
Reagent C 
20 µL 0.834 µM 
Strong stimulant 
PMA 
Reagent D 
20 µL 1.35 µM 
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Figure 2.9: Gating strategy for FACs acquisition and downstream analysis of 
neutrophil respiratory burst. (A) DNA staining was used to distinguish between 
bacterial cells and leukocytes. 10000 events were collected within the leukocyte gate. 
(B) A gate was set to identify neutrophil populations of interest during analysis. (C) FITC 
histograms were gated to identify FITC positive and FITC negative cells within the 
neutrophil population. Unstimulated cells show cells within the FITC negative region 
while stimulated cells shift into the FITC positive region. (D) Population hierarchy and 
colour key for contour plots.  
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2.7.5. Analysis of inflammatory mediators  
The inflammatory profile of clinical samples (saliva, GCF and plasma) was investigated 
using the multiplex LEGENDplex™ Multi-Analyte Flow Assay kit (Biolegend). The 
custom panel of human inflammatory mediators and markers included IL-8, IL-1β, IL-6, 
MCP-1, MIP-1α, TNF-α, IL-17A, IL-17F and IL-23. The LEGENplex™ system allows 
detection and quantitation of multiple analytes in a single sample through use of beads 
conjugated with antibodies raised to analytes of interest. Sample exposure to capture 
beads is followed by the addition of biotinylated detection antibodies which can then be 
detected using the fluorescence generated by the addition and binding of Streptavidin-
phycoerythrin (Strep-PE), where the fluorescent signal intensity is proportional to the 
amount of bound analyte. The assay utilises two sets of beads with unique sizes and 
analyte specific APC (allophycocyanin) fluorescence to allow the distinction between 
different analytes.  
Prior to data acquisition, parameters were set using the provided set-up beads. FSC and 
SSC parameters were adjusted to distinguish between the two bead populations which 
were of different sizes (Figure 2.10) and the setting for APC and FITC adjusted until the 
bead signals were visible within the expected range (Figure 2.10B). In addition, PMT 
(photomultiplier tube) voltage of the classification channel APC reporter channel PE and 
the FITC channel were adjusted for ideal separation of bead populations. The APC 
channel enables distinguishing between beads associated with different analytes.  These 
settings were then applied for data acquisition.  
Plasma, saliva and eluted GFC samples were all diluted 2-fold in assay buffer prior to 
analysis and the assay carried out according to the manufacturer’s assay instructions for 
analysis of plasma samples in a V-bottom 96 well plate (provided, Biolegend). Briefly, 25 
µL of standards were mixed with 25 µL of matrix buffer while diluted samples were mixed 
with assay buffer. Solutions were then mixed with an equal volume of capture beads 
prior to incubation for 2 h at RT, protected from light with shaking at 800 rotations per 
min (rpm) (plate shaker). Following incubation, the plate was centrifuged at 250 g, RT 
for 5 min in a swing out rotor equipped with plate adaptor. The supernatant was 
discarded, and wash step carried out with 200 µL wash buffer, followed by shaking at 
800 rpm, RT for 1 min and centrifugation at 250 g, RT for 5 min. After removal of 
supernatant 25 µL of the detection antibody was added and the samples incubated for 1 
h at RT, protected from light with shaking at 800 rpm. Immediately after incubation 25 µL 
Strep-PE was added and samples incubated for a further 30 min at RT, protected from 
light with shaking at 800 rpm. Following a final wash, resulting bead pellets were re-
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suspended in 150 µL wash buffer for analysis. All standards and samples were run in 
duplicate. 
Data were acquired using a LSRII flow cytometer equipped with 488 nm argon-ion laser 
(BD Bioscience) and BD Diva software. 3000 events were collected per well using a high 
throughput 96 well plate autosampler (Figure 2.10). Analysis was carried out using the 
LEGENDplex™ Data Analysis Software. Initial gates were set to differentiate between 
the two bead populations, followed by assignment of the multiple APC intensities to their 
appropriate analyte (Figure 2.10C and D). The APC fluorescence of the standards were 
then used to generate a standard curve for each analyte, which was used to calculate 
analyte concentrations in the samples.  
2.7.6. Quantification of MMP8, MMP9 and TIMP1 in saliva, plasma and GCF 
Saliva, plasma and GCF samples were analysed for MMP8, MMP9 and TIMP1 
concentrations using Quantikine® ELISA kits (R&D systems). Saliva and plasma assays 
were performed following the recommended manufacturer’s instructions and dilutions, 
while GCF was analysed undiluted. Briefly, assay diluent (100 µL for MMP9 and TIMP1, 
150 µL for MMP8) was added to the wells of the supplied capture antibody pre-coated 
plate. Samples and standards (100 µL for MMP9 and TIMP1, 50 µL for MMP8) were 
added to the appropriate wells prior to 2 h incubation at RT on a horizontal orbital 
microplate shaker at 500 ± 50 rpm. Wells were aspirated, and washed by addition of 400 
µL wash buffer followed by complete removal of wash buffer. The wash was repeated a 
total of 4 times and the plate blotted to ensure complete removal of liquid. 200 µL of 
conjugate was then added to each well, the plates incubated for 1 h (MMP9, TIMP1) or 
2 h (MMP8) at RT with shaking followed by a wash step.  TMB substrate solution (200 
µL) was then added to each well and the plates incubated protected from light, at RT, for 
30 min. A stop solution was added (50 µL) to prevent further colour development and the 
optical density read within 30 min using a plate reader (Varioskan Flash, Thermo 
scientific) set to measure photometric absorbance at a wavelength of 450 nm. Sample 
absorbance readings were converted to analyte concentrations (pg/mL) using the curve 
of the line equation generated from the standard curve produced for each plate.  
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Figure 2.10: Gating strategy for LEGENDplex™ bead array. (A) Gates around the 
two bead populations were generated using set-up beads. (B) Dot plot indicating ranges 
of FITC and APC for set-up beads. (C) Assignment of APC intensities to analytes for 
generation of standard curves during experiments. (D) Example dotplot (top) of FITC 
intensities in test samples and example histograms of samples for the two bead 
populations (middle and bottom). 
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2.8. Generation of Advanced Glycation End product modified Human Serum 
Albumin (HSA-AGE) 
Human serum albumin (HSA) was modified as previously described (Liu et al., 2009). 
Briefly, a sterile solution of 1.75 g/L HSA (A5843, Sigma-Aldrich, UK) and 0.1M D-
glucose (G8769, Sigma-Aldrich, UK) in PBS was made and incubated at 37 ºC for 8 
weeks. Every 2 weeks, the pH of the solution was checked and adjusted to 7.4 and 
aliquots of solution removed to track progress of AGE generation. Generation of a control 
HSA solution (HSA-C) followed the procedure as above but without the addition of D-
glucose. 
Following 8 weeks incubation, samples were dialysed for removal of excess glucose 
(Slide-A-Lyzer dialysis cassettes, molecular weight cut off 2 kDa, ThermoFisher 
Scientific). Solutions were dialysed against sterile PBS for 5 days at RT with stirring. PBS 
was changed daily under sterile conditions. Resulting solutions were aliquoted and 
stored at -80ºC for later use.  
Presence of AGE was confirmed through fluorescence reading (Munch et al, 1997). 
Protein concentrations were determined using the Pierce™ Coomassie (Bradford) 
Protein Assay Kit as described previously (2.3) and fluorescence of 1 mg/mL total protein 
at Excitation/Emission 360/430 nm was determined (Varioskan Flash, Thermo scientific).  
Solution endotoxin levels were also tested using the Limulus Amebocyte Lysate (LAL) 
chromogenic Endotoxin quantitation kit (Pierce™, ThermoFisher Scientific, UK) as per 
manufacturer’s instructions. Briefly, a sterile endotoxin free 96 well plate (Corning® 
Costar®) was heated to 37ºC for 10 min, following which 50 µL of samples or standards 
were added to wells while the plate remained at 37ºC. The plate was covered and 
incubated for a further 5 min, prior to addition of 50 µL LAL reagent. Following further 
covered incubation for 10 min, 100 µL of substrate solution was added to each well, the 
plate vortexed and incubated at 37ºC for 6 min. The reaction was stopped by addition of 
50 µL of 25% acetic acid to each well and the photometric absorbance at 405 nm 
measured (Varioskan Flash, Thermo scientific). Endotoxin levels were calculated from 
the standard curve and samples were considered endotoxin free as defined by the 
manufacturer (< 0.1 EU/mL).  
2.9. TIGK viability in the presence of HSA-AGE 
TIGK cell viability was determined in the presence of HSA-AGE using the cell 
proliferation reagent WST-1 (Roche) as per manufacturer’s instructions. The WST-1 
tetrazolium salt is cleaved to soluble formazan through the glycolytic production of 
NADPH (nicotinamide adenine dinucleotide phosphate) in viable cells. The conversion 
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initiates a colour change which can be measured photometrically. Briefly, TIGK cells 
were seeded in 96 well plates to a density of 1 x 104 as previously described (section 
2.2). Following a 48 h incubation at 37°C, 5% CO2 medium was removed and fresh 
medium supplemented with HSA-AGE or HSA-C was added to the wells. Cells were then 
incubated for a further 8, 24 or 36 h. At each time point WST-1 was added to the wells 
at a 1:10 dilution, the plates incubated at 37°C, 5% CO2 for 1 h and the photometric 
absorbance at 420 nm read using a microplate reader (Varioskan Flash, Thermo 
scientific). For the 0 h time point, analysis was carried out immediately following the 
medium change.  
2.10. Characterisation of RAGE expression on TIGK cells 
2.10.1.  Cell culture and exposure to AGE  
TIGK cells were seeded in 6 well plates at a density of 3 x 105 or in 24 well plates at a 
density of 1 x 105 and cell growth was maintained for 48 h until cells reached 
approximately 80% confluency (section 2.2). Medium was replaced supplemented with 
HSA-AGE or HSA-C. Cells were incubated at 37°C, in 5% CO2 and harvested at 0 
(immediately) 8, 24 and 36 h.  
For Western blot and ELISA analysis, cell lysates and supernatants were generated and 
immediately analysed as previously described (section 2.3) or frozen at -80ºC prior to 
analysis.  For RNA extraction or for assessment of gene expression using quantitative 
real time polymerase chain reaction (qRT-PCR), cells were detached using trypsin 
(section 2.2) and RNA extracted as described below (section 2.11).  
2.11. Real time PCR 
2.11.1. RNA Extraction and cDNA synthesis  
Total RNA was isolated from detached cells using the RNeasy kit (Qiagen, UK) as per 
manufacturer’s instructions. Briefly, 600 µL buffer RLT was added to the harvested cell 
pellets in addition to 600 µL of 70% (v/v) ethanol. Samples were mixed and transferred 
to an RNeasy Mini spin column prior to centrifuging for 15 sec at 10,000 g. The flow-
through was discarded and buffer RW1 (700 µL) was added to the column, the column 
centrifuged again for 15 sec at 10,000 g and the flow-through discarded. Columns were 
then washed by addition of 500 µL of buffer RPE to the columns. The column was 
centrifuged for 15 sec at 10,000 g and the flow-through discarded. Columns were 
washed again and a drying step was carried out (columns centrifuged for 2 min at 10,000 
g). RNA was eluted by addition of 30 µL RNase-free water to the membrane followed by 
centrifuging for 1 min at 10,000 g.  
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Prior to cDNA synthesis, 1 µg RNA was treated with Amplification Grade DNAse I 
(Invitrogen) as per manufacturer’s instructions. Briefly, 1 µg RNA was incubated for 15 
min at RT with 1 µL 10X DNAse I reaction buffer and 1 U/µL DNase I. Following 
incubation, DNase was inactivated through addition of 1 µL of 25 mM EDTA and heating 
for 10 min at 65ºC. The resulting RNA was used immediately for cDNA synthesis or 
stored at -20ºC for downstream analysis.  
Reversed transcribed cDNA was synthesised using the High Capacity RNA-to-cDNA 
Master Mix (Applied Biosystems) as per manufacturer’s instructions. Briefly, 1 µg of 
DNase treated RNA was mixed with 2 x RT buffer, 20 x RT enzyme mix and a sufficient 
volume of RNase free water for a final reaction volume of 20 µl. Samples were then 
loaded into a thermocycler with conditions outlined in Table 2.6. Resulting cDNA was 
stored at -20ºC for downstream analysis. 
2.11.2.  Analysis of RNA expression in cells  
Following cDNA synthesis, gene expression was analysed using TaqMan Gene 
Expression assays (Applied Bioscience, UK) as per manufacturer’s instructions. Briefly, 
1 µL synthesised cDNA was mixed with 2x TaqMan Gene Expression Master Mix, 20 x 
TaqMan Gene expression Assay (Table 2.7) and RNase-free water to a final volume of 
20 µL in a 96 well plate (V-bottom LightCycler® 96 well plates, Roche). Plates were 
processed in a LightCycler (LightCycler 480, Roche) using a software pre-loaded 
protocol (Mono Color Hydrolysis Probe – UPL probe 96-II). The LightCycler 480 software 
was also used to automatically set thresholds for each plate and calculate CT values for 
each sample. 
Gene expression was determined as described by Schmittgen and Livak (2008). 
Technical replicates of 3 for each cDNA sample were averaged for use with the 
equations below. Final results were obtained by averaging biological replicate results 
obtained from four individual experiments.  
Absolute expression: 2-CT  
Expression relative to internal control: 2-ΔCT  
Where ΔCT = CT gene of interest – CT internal control  
Expression relative to control samples and normalised to internal control: 2-ΔΔCT 
Where ΔΔCT = (CT gene of interest - CT internal control) test sample – (CT gene of interest 
- CT internal control) control sample 
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Table 2.6: High capacity RNA to cDNA thermocycler conditions. 
 Step 1 Step 2 Step 3 
Temperature (ºC) 37 95 4 
Time 60 min 5 min Final hold 
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Table 2.7: Assay identifications for genes analysed using TaqMan based 
quantitative real time polymerase chain reaction. AGER: advanced glycation end 
product receptor gene, HPRT1: hypoxyanthine phosphoribosyltransferase gene, ACTB:  
β-actin.  
 
 
  
Gene Assay ID 
AGER Hs00542584_g1 
HPRT1 Hs02800695_m1 
ACTB Hs01060665_g1 
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2.12. Generation of five species biofilm model   
2.12.1. Solutions, growth media and buffers  
All solutions, media and buffers were made using Milli-Q water, under sterile conditions, 
using aseptic techniques. Sterilisation was accomplished through standard autoclaving 
procedures (121 °C for 15 min) unless otherwise stated and resulting solutions stored at 
4°C until required.  
All solid growth media were made as described in Table 2.8. Solutions were sterilised 
through autoclaving (unless otherwise stated), allowed to cool to approximately 50°C, 
blood/antibodies added (if required) and distributed into 5 mL petri dishes/plates. 
Antibiotics were sterilised by filtering using 0.2 µm-pore-size syringe filters (Sigma-
Aldrich, UK) prior to addition to media. Once set, plates were stored at 4°C and used 
within 2 weeks.  
Sterilized saliva was generated as previously described (Palmer et al, 2001; Sanchez et 
al, 2011). Briefly, stimulated saliva (stimulated by chewing on sterile parafilm) was 
collected 1.5 hours after drinking, eating, or brushing teeth. Saliva was collected over 
several days, held on ice during collection and processing and stored at -20°C. Pooled 
saliva was treated with 2.5 mM DL-Dithiothreitol, stirred for 10 min and clarified by 
centrifuging at 27, 000 g for 20 min, 4°C. The resulting supernatant was diluted 1:1 in 
sterile PBS, filtered through 0.22 µm-pore-size low-protein binding filter (Corning Inc., 
UK), aliquoted and stored at -20°C for later use. Sterility was ensured though plating onto 
CBA plates and incubation both anaerobically and in 10 % CO2 at 37°C (Table 2.8). 
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Table 2.8: Composition, selectivity and incubation conditions for growth on 
various solid growth media 
 
   
Media Composition Selective for 
Incubation 
conditions 
Columbia Blood 
agar (CBA) 
39 g/L CBA base (Oxoid), 5% (v/v) 
horse blood (Oxoid). Standard 
autoclaving sterilisation. 
Facultative 
anaerobes 
and aerobes 
10 % CO2, 37 °C 
2-5 days 
Facultative 
anaerobes 
10 % H2, 10% CO2, 
80% N2, 37 °C 
5-7 days 
Columbia Blood 
agar (CBA) + 
Vancomycin 
39 g/L CBA base (Oxoid), 5% (v/v) 
horse blood (Oxoid), 7.5 mg/L 
vancomycin.  
Standard autoclaving sterilisation. 
Gram 
negative 
anaerobes 
10 % H2, 10% CO2, 
80% N2, 37 °C 
5-7 days 
Cadmium 
sulphate 
fluoride acridine 
trypticase agar 
(CFAT) 
30 g/L trypticase soy broth 
(Sigma-Aldrich), 5 g/L glucose, 15 
g/L agar, 13 mg/L cadmium 
sulphate, 80 mg/L sodium fluoride, 
1.2 mg/L neutral acriflavin, 2.5 
mg/L potassium tellurite, 0.25 
mg/L basic fuchsine, 5% (v/v) 
horse blood, pH 7.3.  
Standard autoclaving sterilisation. 
Actinomyces 
10 % H2, 10% CO2, 
80% N2, 37 °C 
5-7 days 
Rogosa agar 
82 g/L Rogosa agar (Oxoid), 
dissolve by boiling before addition 
of 1.32 ml/L glacial acetic acid. 
Sterilised by heating to 90-100 °C 
with stirring until fully dissolved. 
Lactobacilli 
10 % CO2, 37 °C 
2-5 days 
Mitis Salivarius 
agar 
90 g/L Mitis Salivarius Agar 
(Sigma-Aldrich, Uk), 1% (v/v) 
potassium tellurite solution 
(Sigma-Aldrich, UK) added post 
sterilisation. Standard autoclaving 
sterilisation. 
Streptococci 
10 % CO2, 37 °C 
2-5 days 
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2.12.2. Growth of five species periodontitis biofilm model for determination of 
HSA-AGE impact on biofilm composition  
5 species biofilms, modelling the composition of biofilms associated with periodontitis 
(Figure 2.11), were grown on hydroxyapatite (HA) coated pegs in a Calgary device 
(MBEC Assays, Innovotech) following a sequential inoculation method of S. salivarius 
(clinical isolate ULCP97), A. naeslundii (clinical isolate), P. intermedia (OMZ 248), F. 
nucleatum (ATCC 10953) and P. gingivalis (W83) as established in-house by Naginyté 
(2017, unpublished). All biofilm growth was carried out in an anaerobic cabinet at 37°C 
(Don Whitley Scientific) with all growth media, solutions and buffers being pre-reduced 
by introduction to the anaerobic cabinet a minimum of 24 hours prior to use. All facultative 
aerobic bacteria were grown at 37°C, in air with 10% CO2.  
Prior to initial inoculation of HA-pegs, bacteria for biofilm growth were revived from 
glycerol stocks (stored at -80 °C) onto solid growth media (Table 2.9 and Figure 2.11). 
All five species were then subcultured into brain heart infusion (BHI) broth and grown 
under anaerobic conditions. Biofilms were grown as outlined in Figure 2.11. HA-pegs 
were pre-conditioned with 200 µL/peg of sterilised saliva by incubation for a minimum of 
5 h at 37 °C with shaking at 65 rmp.  
Early coloniser inoculation was accomplished by addition of 1.58 µL/mL (OD600 0.2) S. 
salivarius (ULCP97) and 4.375 µL/mL (OD600 0.2) A. naeslundii (clinical isolate) to serum 
medium. This inoculated serum medium was added to a 96 well plate (175 µL/well); the 
plastic lid containing the HA coated pegs was replaced and the plate incubated for a 
minimum of 12 h under anaerobic conditions. Following the 12 h incubation, the HA-peg 
lid was transferred to a 96 well plate containing pre-reduced, uninoculated serum 
medium and incubated overnight under anaerobic conditions.  
HA-pegs were then inoculated with late colonisers by the addition of 12.5 µL/mL (OD600 
0.2) F. nucleatum (ATCC 10953), 25 µL/mL (OD600 0.2) P. intermedia (OMZ 248) and 25 
µL/mL (OD600 0.2) P. gingivalis (W83) to pre-reduced serum medium, the inoculated 
serum medium added to a 96 well plate (175 µL/well) and the lid transferred to the fully 
inoculated plate. The plates were incubated under anaerobic conditions overnight, 
following which the late coloniser inoculation was repeated as described above. 
Subsequent to the second late coloniser inoculation, the lid was transferred to a 96 well 
plate containing fresh, sterile pre-reduced serum medium every day for the duration of 
the experiment. The impact of HSA-AGE or HSA-C on biofilms was tested by the 
introduction of serum medium supplemented with HSA-AGE or HSA-C at day 7 until day 
10 after which the medium was replaced daily (without HSA-AGE or HSA-C) for a 
recovery period of 3 days (Figure 2.11).  
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A total of 4-6 biofilms for each condition were harvested at day 10 and again at day 14. 
Each HA-peg was removed from the plastic lid using sterile pliers to snap the peg at the 
base, washed to remove loosely bound bacteria by dipping the entire peg 3 times 
consecutively into PBS. Biofilms were harvested in the anaerobic cabinet, by scraping 
the biofilm into 500 µL PBS, followed by vortex mixing for 1 min. 100 µL of the resulting 
suspension was serially diluted in PBS to a final dilution of 1:106 with various dilutions 
plated on CBA vancomycin plates for anaerobic growth and CBA plates for aerobic 
growth. Anaerobic plates were incubated for a minimum of 7 days, while aerobic plates 
were incubated for a minimum of 3 days. Following incubation, colonies on plates from 
each biofilm were counted. 
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Table 2.9: Species, strains and growth conditions of the five species used in the 
generation of a biofilm modelling periodontitis. CBA; Columbia blood agar. 
Bacteria Strain details 
Growth 
conditions 
Solid growth 
medium 
Streptococcus 
salivarius 
ULCP97 
Clinical isolate 
Aerobic (10 % CO2) 
and anaerobic 
37°C 
CBA 
Actinomyces 
naeslundii 
Clinical isolate 
Aerobic (10 % CO2) 
and anaerobic 
37°C 
CBA 
Fusobacterium 
nucleatum 
ATCC 10953 
Anaerobic 
37°C 
CBA + Vancomycin 
Prevotella 
intermedia 
OMZ 248 
Anaerobic 
37°C 
CBA + Vancomycin 
Porphyromonas 
gingivalis 
W83 
Anaerobic 
37°C 
CBA + Vancomycin 
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Figure 2.11: Timeline for growth and harvesting of the five species periodontitis 
model. Ss; S. salivarius, An; A. naeslundii¸ Fn; F. nucleatum, Pi; P. intermedia,  
Pg; P. gingivalis, HSA-AGE; human serum albumin-advanced glycation end product, 
HSA-C; human serum albumin-control. Dotted red lines represent biofilm harvests. 
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2.13. Generation of complex inoculum biofilms for determining the 
consequences of HSA-AGE addition to colonisation and composition 
2.13.1.  Sample collection and preparation of inocula  
Saliva, tongue scraping and supragingival plaque samples were collected from eight 
volunteers following ethical approval by University of Leeds Dental Research Ethics 
Committee (DREC: 020915/MN/175). Volunteers were asked to refrain from brushing 
their teeth eating or drinking on the day of collection until collection was complete. For 
saliva collection, volunteers were asked to produce a minimum of 5 mL parafilm wax 
stimulated saliva. Sterile tongue depressors were used to collect tongue scrapings, with 
volunteers asked to scrape all aspects of the tongue and place the tongue depressor 
directly into 6 mL ice-cold serum medium. Volunteers were also asked to use sterile 
toothpicks to scrape plaque from as close to the gum as possible from all tooth surfaces 
and place the toothpicks directly into 6 ml serum medium. All samples were held on ice 
until processing.  
Salivary bacteria were pelleted by centrifuging pooled saliva samples at 27, 000 g for 20 
min at 4°C. The resulting supernatant was discarded, and the bacterial pellet 
resuspended in serum medium. Tongue scrapings and supragingival plaque were 
harvested into serum medium by vigorous vortexing and the toothpicks/tongue 
depressors discarded. The resulting tongue scrapings, supragingival plaque and saliva 
were used as the inoculum for the production of biofilms for co-culture experiments 
(section 2.14) under conditions outlined in Table 2.10. For bacterial composition analysis, 
these pooled samples were separated into 3 and used as 3 individual inocula. 
For analysis of inoculum composition, each suspension used as the inoculum was 
serially diluted (final dilution 1x106) and several dilutions plated on solid selective media 
and incubated as indicated in Table 2.8. Following HA-peg inoculation, the remaining 
inoculum was propidium monoazide treated to select for DNA only from viable organisms 
prior to DNA extraction as described previously (section 2.5.1). Briefly, suspensions of 
bacteria were treated with 50 µM of propidium monoazide, incubated in the dark for 5 
min with mixing followed by light exposure for 2 min. Following photo-induced cross 
linking, samples were centrifuged at 5000 g for 5 min. The resulting supernatants were 
used for DNA extraction (section 2.5.1). 
2.13.2.  Complex biofilm growth 
Complex biofilms were grown on HA coated pegs on a Calgary device in the anaerobic 
cabinet at 37 °C. HA-pegs were first pre-conditioned as described previously (section 
2.13) with sterile saliva supplemented with various concentrations of HSA-AGE/HSA-C 
to represent health and disease (Table 2.10). Following pre-conditioning HA-peg lids 
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were transferred to 96 well plates containing 175 µL/well complex inoculum and 
incubated for 24 h under anaerobic conditions. After 24 h lids were transferred to fresh 
serum medium supplemented as described in Table 2.10. HA-pegs were transferred to 
fresh medium every 2-3 days. At day 2, day 7 and day 14, 4-6 biofilms for each condition 
were harvested. Biofilms were harvested in the anaerobic cabinet, by scraping the HA-
peg into 500 µL reduced transport fluid (RTF), followed by vortex mixing. Harvested 
biofilms from HA-pegs for each condition were pooled, and 100 µL of the resulting 
bacterial suspension was serially diluted in RTF to a final dilution of 1x106. Various 
dilutions were plated on selective media and incubated as described in Table 2.8. The 
remainder of the harvested biofilm was propidium monoazide treated (section 2.13.2) 
and DNA harvested (section 2.5.1). DNA from biofilms harvested at day 2 and day 14 as 
well as inoculum DNA were used to generate NGS libraries and sequenced as described 
previously (section 2.5). Individual plates were set up for different harvest time points to 
minimise biofilm disturbance and minimise contamination during harvests.  
2.14. Immune responses of TIGK cells in response to co-culture with complex 
biofilms with HSA-AGE co-stimulation 
2.14.1. Cytokine profiles of TIGK cells following co-culture with complex biofilms 
and HSA-AGE 
TIGK cells were seeded in 96 well plates, as described previously (section 2.2) to a 
density of 1x104 cells/well. Cells were grown for 48 hours to approximately 80% 
confluency and culture medium replaced immediately prior to co-culture. Following 
complex inoculum biofilm growth, mature biofilms (at day 15) grown under various 
conditions (Table 2.10) were co-cultured with TIGK cells and co-stimulated with 100 
µg/mL HSA-AGE or 100 µg/mL HSA-C. Biofilms were first washed in PBS (3 times) and 
introduced to the cells either by transferring the HA-peg containing lids directly into the 
96 well plate, or by detaching the HA-pegs from the lid and placing them into the wells 
on top of the cells. Co-cultures were incubated for 8 hours in 10% CO2 at 37 °C. 
After 8 hours, culture medium was harvested. Media from the same conditions (8 
biofilm/cell co-culture wells) were pooled and stored at -20°C until analysed for levels of 
cytokines IL-6, IL-8 and IL-1β via ELISA (section 2.4).  
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Figure 2.12: Timeline for growth and harvesting of the complex inoculum biofilms. 
HSA-AGE; human serum albumin-advanced glycation end product, HSA-C; human 
serum albumin-control. 
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Table 2.10: Hydroxyapatite peg pre-conditioning and complex inocula biofilm 
growth conditions for next generation sequencing and analysis of cytokine 
release following co-culture with TIGK cells. HSA-AGE; Human serum albumin-
advanced glycation end product. HSA-C; human serum albumin-control. HA; 
hydroxyapatite. 
HA peg pre-conditioning Growth medium 
Modelling systemic health 
or disease 
Sterile saliva + 1 µg/mL 
HSA-AGE and 99 µg/mL 
HSA-C 
Serum medium 
Health pre-conditioning – 
medium control growth 
Serum medium + 1 µg/mL 
HSA-AGE and 99 µg/mL 
HSA-C 
Health 
Serum medium + 100 
µg/mL HSA-C 
Health pre-conditioning –  
HSA control growth 
Sterile saliva + 100 µg/ml 
HSA-AGE 
Serum medium 
Disease pre-conditioning – 
medium control growth 
Serum medium + 100 
µg/mL HSA-AGE 
Disease 
Serum medium + 100 
µg/mL HSA-C 
Disease pre-conditioning –  
HSA control growth 
Sterile saliva + 100 µg/ml 
HSA-C 
Serum medium HSA control 
Serum medium + 1 µg/mL 
HSA-AGE and 99 µg/mL 
HSA-C 
HSA control 
Serum medium + 100 
µg/mL HSA-AGE 
HSA control 
Serum medium + 100 
µg/mL HSA-C 
HSA control 
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2.14.2. Reactive oxygen species generation by TIGK cells following co-culture with 
complex biofilms and HSA-AGE 
Saliva, tongue scrapings and supragingival plaque were collected from three volunteers 
(DREC: 020915/MN/175) and processed to generate a single complex inoculum for 
growth of complex biofilms modelling systemic health, systemic disease or a HSA-C 
control (Table 2.10) (section 2.13.1) and subsequently co-cultured with TIGK cells 
(section 2.14.1.).  
The impact of co-culture on cellular generation of ROS was determined using the cell-
permeant 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA, Life technologies, 
ThermoFisher Scientific, UK). Upon entering the cells, intercellular esterase cleaves the 
acetate group to form an intermediate, which is converted to the fluorescent compound 
2’,7’-dichlorofluorescein (DCF) on exposure to ROS and can be detected at Ex/Em 
485/535 nm.  
Immediately prior to use, the H2DCFDA was reconstituted in 100% (v/v) ethanol as per 
manufacturer’s instructions. Prior to introduction of biofilms to cells, cells were washed 
with PBS, 10 µM of H2DCFDA in culture media added to each well and the cells 
incubated at 37°C in 5% CO2 for 30 min. Following the 30 min incubation, medium was 
aspirated and replaced by fresh medium or medium supplemented with 100 µg/mL HSA-
AGE or HSA-C. Complex biofilms were then introduced to the cells and the co-cultures 
incubated for 7 hours at 37°C (section 2.14.1, Figure 2.13). ROS release was measured 
directly in the cell culture plates using a microplate reader (Varioskan Flash, Thermo 
scientific) set to measure fluorescence at Ex/Em 485/535. Prior to fluorescence readings, 
pegs that had been in direct contact with TIGK cells were removed and discarded.  
In parallel to cellular ROS generation, cellular death was also measured by determining 
LDH release using CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, UK). 
After the 7 h initial incubation, 10x lysis solution (CytoTox 96 assay kit) was added to the 
control wells to generate 100% LDH release (positive control) and the co-cultures 
incubated for a further 1 h. Following this, 100 µL medium was removed from each well, 
clarified by centrifuging at 17,000 g for 5 min at 4°C (to remove bacteria and cell debris) 
and the resulting supernatant immediately analysed for LDH release, as per 
manufacturer’s instructions. Briefly, 50 µL sample was mixed with 50 µL of CytoTox 96 
reagent in a 96 well plate (Corning® Costar®) and incubated at RT for 30 min before 50 
µL stop solution was added. LDH release was measured using a microplate reader 
(Varioskan Flash, Thermo scientific) at photometric absorbance 490 nm. LDH release 
from each sample was calculated as a percentage of maximum LDH release.  
Chapter 2 – Materials and Methods 
 
122 
 
 
Figure 2.13: Schematic for biofilm-TIGK cell co-culture. TIGK cells were co-cultured 
with complex inoculum biofilms in the presence of HSA-AGE or HSA-C. Biofilms (3 
biofilms for each condition) were either placed into wells while still attached to the lid to 
prevent direct contact (left) or removed from lid and placed directly on top of TIGK 
monolayer (right) for direct biofilm-cell contact. 
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Table 2.11: Hydroxyapatite peg pre-conditioning and complex inocula biofilm 
growth conditions for analysis of reactive oxygen species release and cell viability 
following co-cultures with TIGK cells. HSA-AGE; Human serum albumin-advanced 
glycation end product. HSA-C; human serum albumin-control. HA; hydroxyapatite. 
HA peg pre-conditioning Growth medium 
Modelling systemic 
health or disease 
Sterile saliva + 1 µg/mL 
HSA-AGE and 99 µg/mL 
HSA-C 
Serum medium + 1 µg/mL 
HSA-AGE and 99 µg/mL 
HSA-C 
Health 
Sterile saliva + 100 µg/ml 
HSA-AGE 
Serum medium + 100 
µg/mL HSA-AGE 
Disease 
Sterile saliva + 100 µg/ml 
HSA-C 
Serum medium + 100 
µg/mL HSA-AGE 
HSA control 
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3. Evaluation of telomerase immortalised gingival keratinocyte expression of 
RAGE for use as a model system to examine the potential of AGE-RAGE 
interactions in linking diabetes to periodontitis 
3.1. Introduction  
The presence of AGEs has been linked to the progression of diabetes and its 
complications. Indeed, measurement of blood haemoglobin A1c or glycated 
haemoglobin is used as an indication of diabetic control and glucose regulation (Wautier 
et al., 2017). As described previously (section 1.4.3), diabetes-associated 
hyperglycaemia can lead to the accumulation of AGEs and subsequent chronic 
inflammatory responses, which have been suggested to play an important role in the 
progression of diabetic complications (Hiroshima et al., 2018). Of these complications, 
increased periodontitis severity has been correlated to hyperglycaemia (Shlossman et 
al., 1990, Emrich et al., 1991, Taylor et al., 1998, Tsai et al., 2002). As described in more 
detail in section 1.4.3, this suggests the hyperglycaemic accumulation of AGE in diabetes 
could impact the progression of periodontitis.  
Previous studies have shown that the increase in serum levels of AGEs from diabetic 
patients correlated with an increase in periodontitis-linked attachment loss as well as 
increased immunoreactivity of AGEs in gingival tissues (Takeda et al., 2006, Zizzi et al., 
2013, Hiroshima et al., 2018). Furthermore, the receptor for AGE, RAGE, has been 
shown to be highly expressed in gingival tissue of patients with periodontitis and diabetic 
periodontitis patients. In particular, high expression was shown in gingival epithelial cells 
and circulating leukocytes. This contrasted with healthy gingiva, where RAGE 
expression was limited (Abbass et al., 2012).  
RAGE, a 45-50 kDa molecule, is encoded by a gene found on locus 6p21.3, next to the 
major histocompatibility complex (MHC) class III protein family (Wautier et al., 2017, Ott 
et al., 2014). Although it is now understood that AGE associated downstream signalling 
cascades are mediated by a variety of cell surface receptors (including AGE-R1/OST-
48, AGE-R2/80K-H, AGE-R3/galectin-3), RAGE is the most well studied (Araki et al., 
1995, Vlassara et al., 1995, Li et al., 1996, Ohgami et al., 2001a, Ohgami et al., 2001b, 
Ohgami et al., 2001c, Jono et al., 2002, Tamura et al., 2003). The multiple ligand receptor 
(pattern recognition receptor) belongs to the immunoglobulin superfamily and consists 
of a large extracellular domain (variable or V domain and two constant, C1 and C2, 
domains), a single transmembrane domain-spanning helix and a short cytoplasmic 
domain in its full length form (Ott et al., 2014, Wautier et al., 2017). To date 20 major 
splicing variants have been identified including full-length RAGE, N-truncated RAGE 
(lacking the ligand binding V-domain) and soluble RAGE (lacking the C-terminal domain). 
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In addition to the mRNA encoded soluble RAGE, which is secreted, proteolytic cleavage 
of full-length RAGE (by metalloproteinases ADAM10 and MMP9) also forms soluble 
RAGE (Yonekura et al., 2003, Hudson et al., 2008, Kalea et al., 2009). Soluble RAGE is 
considered a decoy receptor to prevent excessive RAGE activated immune responses 
(Ott et al., 2014, Wautier et al., 2017, Leung et al., 2016) .  
As discussed in detail previously (section 1.4.3), interactions between AGE and RAGE 
are linked to generation of ROS and initiation of pro-inflammatory responses (Younessi 
and Yoonessi, 2011). The binding of AGE to RAGE is thought to induce the activation of 
downstream NFκB, MAPK and other signalling pathways (Figure 3.1) (Schmidt et al., 
2000, Ishihara et al., 2003, Kokkola et al., 2005, Mallidis et al., 2007).  
This study aimed to determine if TIGK cells were appropriate for use as a model system 
to examine the impact of AGE/RAGE interactions of oral epithelial cells. The objectives 
of the following experiments were to determine if TIGK cells expressed RAGE and 
whether expression was inducible or increased following addition of AGE to the cell 
culture media. Following characterisation of TIGK cell RAGE expression, we investigated 
cytokine release (IL-1β, IL-6 and IL-8) as a consequence of AGE/RAGE interactions.  
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Figure 3.1: AGE related signalling and processing. The non-enzymatic modification 
of proteins following condensation of carbonyl groups of reducing sugars (such as 
glucose) and amino groups on proteins leads to the generation of an advance glycation 
end product (AGE). AGEs impact protein structure through cross linking or interact with 
a variety of receptors such as RAGE (receptor for advanced glycation end product). 
AGE/RAGE interactions initiate downstream signalling cascades leading to transcription 
of various inflammatory genes and growth factors. AGEs are processed and cleared 
following CD36 receptor mediated endocytosis (adapted from Ott et al. (2014)). 
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3.2. Results 
3.2.1. Generation of AGE modified human serum albumin for characterisation of 
TIGK cell RAGE expression and AGE/RAGE interactions  
Considering the increase in GCF volume in periodontitis patients compared with healthy 
and the associated increase in GCF albumin concentrations, human serum albumin 
(HSA) was deemed an appropriate choice for the generation of AGE modified HSA 
(HSA-AGE) for use in a periodontitis-diabetes model (Carneiro et al., 2014). HSA was 
incubated with or without glucose as previously described (section 2.8) to generate HSA-
AGE and HSA-C (HSA-control) respectively.  
As described previously (section 1.4.3) AGEs are fluorescent proteins and so 
fluorescence was measured (section 2.8) over the incubation period to track 
accumulation of AGE modified HSA (Figure 3.2). After an 8 week incubation period, HSA 
and glucose solutions had a higher fluorescence (Ex/Em 360/430 nm) in comparison 
with HSA solutions (11.44 nm ± 0.75 and 0.94 nm ± 0.43 respectively).  
After 8 weeks incubations, dialysis was carried out for removal of excess glucose and 
samples stored at -80°C for later use (section 2.8). Prior to use, protein concentrations 
of dialysed samples were quantified (as described in section 2.3) and fluorescence 
measured to ensure preservation of AGE modified proteins following dialyses and 
thawing of frozen samples.  
3.2.2. Viability of TIGK cells grown with HSA-AGE or HSA-C 
TIGK cells were treated with varying concentrations of the HSA-AGE preparation in cell 
culture and any impact on cell viability was assessed using a WST-1 assay as described 
previously (section 2.9). Conversion of the WST-1 tetrazolium salt to formazan and the 
resulting colour change is measured photometrically, so that absorbance correlates 
directly with the number of metabolically active cells. 
As indicated in Figure 3.3, the viability of TIGK cells appeared to be enhanced following 
incubation with all three concentrations of HSA-C compared with untreated cells and 
cells incubated with HSA-AGE. However, these differences were not significant (n=3, 
Two-way ANOVA, Tukey post-hoc, p > 0.05) and could be a consequence of cell 
proliferation. This indicates no markedly detrimental effects on cell viability over the time 
frame needed for further experiments with TIGK cells.  
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Figure 3.2: Fluorescence of HSA solutions during the incubation period for AGE 
modification. HSA was incubated with glucose for 8 weeks at 37ºC for the non-
enzymatic modification of HSA with AGE. In parallel HSA was incubated under the same 
conditions without glucose for use as a control. Fluorescence (± standard deviation, SD) 
was measured as an indication of AGE modification throughout the 8 week incubation 
period. AGE; advanced glycation end products, HSA; human serum albumin. 
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Figure 3.3: TIGK cell viability following exposure to HSA-AGE or HSA-C for 36 
hours. TIGK cells were grown with varying concentrations of HSA-AGE or HSA-C for 0, 
8, 24 and 36 hours prior to analysis of cell viability using a WST-1 assay. Conversion of 
WST-1 and the resulting colour change was measured as absorbance to indicate cell 
viability. Results are presented as means ± SD, n=3. HSA-AGE; Human serum albumin-
advanced glycation end products, HSA-C; Human serum albumin-control. 
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3.2.3. Characterisation of RAGE expression of TIGK cells  
3.2.3.1. RAGE protein expression  
Prior to analysis of RAGE expression by TIGK cells, anti-RAGE antibody (Abcam, 
MM0520-8D11) was tested against recombinant RAGE (rRAGE) (Abcam, ab63271). In 
addition, rRAGE was incubated at 37°C with 100 µg/mL HSA-AGE or HSA-C for 8 hours 
to determine if interactions between AGE and RAGE interfere with anti-RAGE antibody 
binding (Figure 3.4). Western blot protein analysis showed the detection of a band at 
approximately 45 kDa following probing of the membrane with an anti-RAGE antibody, 
and intensity increased with increasing amounts of loaded rRAGE. This correlates with 
the expected size of rRAGE which is stated to be 45 kDa. Additionally, no difference in 
size was observed in samples incubated with either HSA-AGE or HSA-C, indicating 
addition of receptor ligands does not impact size of band correlating to RAGE during 
protein detection using western blotting methods.  
Following confirmation that HSA-AGE and HSA-C are non-toxic to TIGK cells and 
detection of rRAGE through western blotting, RAGE expression on TIGK cells was 
characterised. TIGK cells were grown with various concentrations of HSA-AGE for 8, 24 
and 36 hours to determine if RAGE was constitutively expressed and if presence of AGE 
induced RAGE expression (as described previously in section 2.10). TIGK cells were 
treated with 200 µg/mL, 100 µg/mL or 50 µg/mL HSA-AGE or HSA-C prior to western 
blot protein analysis of both cell surface bound RAGE and secreted RAGE. Experiments 
were repeated 3 times and representative blots presented (Figure 3.5). 
Western blot analysis of RAGE resulted in bands of approximately 52 - 55 kDa (Figure 
3.5). While this was higher than the predicted molecular weight of RAGE (48 kDa), the 
previous detection of rRAGE with the anti-RAGE antibody suggests bands visualised 
were RAGE. The differences in size could be a consequence of post-translational 
modification of RAGE. Equal amounts of whole cell lysate (WCL) protein were loaded 
into each well with visualisation of β-actin as confirmation. Although no appropriate 
protein loading control is available for cell culture supernatant and analyses of secreted 
proteins, RAGE protein levels were normalised through loading of equal amounts of total 
protein.  
In WCL generated from untreated cells, RAGE was detected with maximum protein 
expression following 8 hours of cell culture (Figure 3.5A). Cell culture supernatant was 
freeze dried and reconstituted and loaded onto SDS-PAGE gels (10 µg total protein per 
well) for analyses of secreted RAGE (section 2.3). In culture supernatant of untreated 
cells, secreted RAGE levels were consistent over the 36 hours. Together the results 
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suggest RAGE secretion was unaltered over time while WCL RAGE levels were at their 
highest following 8 hours of cell culture with decreased levels after 24 and 36 hours.  
When cells were treated with 50 µg/mL of HSA-AGE the expression of RAGE in WCL 
and culture supernatant appeared to remain consistent over 36 hours (Figure 3.5B). A 
similar pattern was observed when cells were treated with 50 µg/mL HSA-C, thus, 
indicating 50 µg/mL HSA-AGE does not impact TIGK RAGE protein expression (Figure 
3.5C).  
Upon TIGK cell treatment with 100 µg/mL HSA-AGE there appeared to be maximum 
WCL protein expression of RAGE following 8 hour of cell culture, with a decrease after 
24 and 36 hours (Figure 3.5D). In addition, a lower expression of secreted RAGE in 
culture supernatant following 8 hours of culture with an increase after 24 and 36 hours 
was observed (Figure 3.5E). There appeared to be an increase in secreted RAGE 
expression at the later time points with 100 µg/mL HSA-AGE (Figure 3.5D) compared 
with 50 µg/mL HSA-AGE (Figure 3.5B) or untreated cells (Figure 3.5A) . When TIGK 
cells were treated with 100 µg/mL HSA-C, levels of secreted RAGE and WCL RAGE 
appeared to remain relatively consistent over time (Figure 3.5E).  
Finally, when cells were treated with 200 µg/ml HSA-AGE RAGE, protein levels remained 
relatively consistent over time in WCL (Figure 3.5F). Following cell treatment with 200 
µg/mL HSA-AGE, levels of secreted RAGE were similar to the those observed with 100 
µg/mL HSA-AGE (Figure 3.5G). Treatment of TIGK cells with 200 µg/mL HSA-C resulted 
in no discernible differences in WCL RAGE or secreted RAGE levels.  
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Figure 3.4: Representative western blot analysis of recombinant RAGE in the 
presence of absence of HSA-AGE or HSA-C. Recombinant RAGE (rRAGE) was 
detected via western blot using an anti-RAGE antibody. Recombinant RAGE was also 
incubated with advanced glycation end product modified human serum albumin (HSA-
AGE) or control HSA (HSA-C) to determine if AGE-RAGE interactions interfered with 
detection of RAGE (n=3). HSA-AGE; Human serum albumin-advanced glycation end 
products, HSA-C; Human serum albumin-control, RAGE; receptor for advanced 
glycation end products.  
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Figure 3.5: Representative western blot analysis of RAGE expression in TIGK 
cells. Cells were treated with various concentrations of HSA-AGE or HSA-C, whole cell 
lysate (WCL) and cell culture supernatant were harvested, and 10 µg total protein loaded 
onto each well. WCL RAGE was used as an indication of cell surface bound RAGE and 
supernatant RAGE was an indication of secreted RAGE (n=3). HSA-AGE; Human serum 
albumin-advanced glycation end products, HSA-C; Human serum albumin-control, 
RAGE; receptor for advanced glycation end products. 
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3.2.3.2. RAGE mRNA expression  
The impact of AGE on the expression of the advanced glycation end product receptor 
(AGER) gene in TIGK cells was analysed using qRT-PCR (section 2.10 and section 
2.11). Prior to qRT-PCR analysis for AGER, housekeeping genes were screened to 
ensure no changes in mRNA expression occurred over the duration of the experiment in 
all conditions tested. Both β-actin (ACTB) and hypoxanthine phosphoribosyltransferase 
1 (HPRT1) mRNA expression were analysed in TIGK cells over 36 hours under treatment 
with 100 µg/mL HSA-AGE or HSA-C as described previously (section 2.10 and section 
2.11). There was a significant difference (n=4, two-way ANOVA, Tukey, p < 0.05) in 
ACTB mRNA expression following treatment of cells for 36 hours with both HSA-AGE 
and HSA-C (Figure 3.6A) whereas no significant difference (n=4, two-way-way ANOVA, 
Tukey, p > 0.05) was observed in mRNA expression of HPRT1 over 36 hours. 
Furthermore, qRT-PCR analysis indicated no significant difference in HPRT1 mRNA 
expression in untreated cells compared with cells treated with 100 µg/mL HSA-AGE or 
HSA-C (Figure 3.6B). HPRT1 was confirmed as an appropriate choice for use as a 
housekeeping gene for analysis of AGER expression.  
The impact of AGE on expression of the AGER in TIGK cells was analysed by the 
quantification of AGER mRNA following exposure to 100 µg/mL HSA-AGE and 100 
µg/mL HSA-C over 36 hours (section 2.10 and 2.11).  There was no significant difference 
in the fold change of AGER mRNA expression (Figure 3.7) relative to untreated cells 
over time regardless of treatment with HSA-AGE or HSA-C (n=4, two-way ANOVA, 
Tukey, p > 0.05).  
Considering AGER expression did not increase beyond the 8 hour timepoint, dose 
dependent AGE induced changes in HPRT1 and AGER expression were analysed 
following culture of TIGK cells with 50, 100 or 200 µg/mL HSA-AGE or HSA-C for 8 hours 
(Figure 3.8). In a similar manner to AGER fold changes in TIGK cells treated with 100 
µg/ml HSA-AGE or HSA-C, no significant differences were observed in fold changes of 
AGER expression relative to untreated cells regardless of treatment (Figure 3.8B – n=4, 
one-way ANOVA, Tukey, p > 0.05).  
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Figure 3.6: Housekeeping gene screening for downstream qRT-PCR analysis. (A) 
screening of ACTB and HPRT1 housekeeping genes for qRT-PCR in TIGK cells cultured 
with 100 µg/mL HSA-AGE or HSA-C for 8, 24 or 36 hours. (B) Expression of HPRT1 in 
TIGK cells cultured untreated or treated with 100 µg/mL HSA-AGE or HSA-C. Results 
are presented as means ± SD, n=4. Symbol (*) indicates significant differences in gene 
expression (two-way ANOVA, Tukey, p < 0.05). HSA-AGE; Human serum albumin-
advanced glycation end products, HSA-C; Human serum albumin-control.  
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Figure 3.7: AGER gene expression of TIGK cells in response to HSA-AGE/HSA-C 
treatment. Expression of AGER in TIGK cells in response to treatment with 100 µg/mL 
HSA-AGE or HSA-C, analysed using qRT-PCR with expression normalised to HPRT1 
and relative to untreated cells. Results are presented as means ± SD, n=4. HSA-AGE; 
Human serum albumin-advanced glycation end products, HSA-C; Human serum 
albumin-control, AGER; advanced glycation end products receptor gene. 
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Figure 3.8: HPRT1 and AGER gene expression of TIGK cells following treatment with 
various concentrations of HSA-AGE/HSA-C. (A) Expression of the housekeeping gene 
HPRT1 following treatment with 50, 100 or 200 µg/mL HSA-AGE or HSA-C for 8 hours 
(n=4). (B) Fold change of AGER in TIGK cells in response to treatment with 50, 100 or 200 
µg/mL HSA-AGE or HSA-C, analysed using qRT-PCR with expression normalised to 
HPRT1 and relative to untreated cells. Results are presented as means ± SD, n=4. HSA-
AGE; Human serum albumin-advanced glycation end products, HSA-C; Human serum 
albumin-control, AGER; advanced glycation end products receptor gene. 
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3.2.4. Inflammatory response of TIGK cells to HSA-AGE and HSA-C 
Following confirmation of the expression of AGER by TIGK cells, inflammatory 
responses of cells were analysed after treatment with varying concentrations of HSA-
AGE or HSA-C. TIGK cells were cultured and treated with 50, 100 or 200 µg/mL  
HSA-AGE or HSA-C for 8 hours, the supernatant harvested and analysed for cytokine 
release using ELISAs as previously described (section 2.4).  
Of the three cytokines analysed, IL-8 was expressed at the highest concentrations. 
Despite an apparent trend whereby concentrations appeared to be lower in untreated 
cells (105.7 ± 85 pg/mL), compared with cells treated with either HSA-AGE or HSA-C 
(maximum mean of 359 ± 273.5 pg/mL) no significant differences were observed when 
comparing untreated with treated. This is possibly due to the variations observed 
between biological replicates across all treatment groups. Furthermore, no significant 
differences were seen between TIGK treatment with HSA-AGE or HSA-C (Figure 3.9A 
– n=3, one-way ANOVA, Tukey, p > 0.05).  
In a similar manner, IL-6 concentrations on average stayed consistent across the 
different treatment groups. In addition, IL-6 concentrations in untreated TIGK cells (2.43 
± 1.75 pg/ml) were lower than average concentrations of the different treatment groups 
(maximum mean of 16.6 ± 8.62 pg/mL) but still no significant difference was observed 
(Figure 3.9B – n=3, one-way ANOVA, Tukey, p > 0.05). IL-6 concentrations, in contrast 
to IL-8 concentrations, were generally lower and had less variation in concentrations 
comparing different biological replicates across the different treatment groups (0.62 – 
24.73 pg/mL).  
Out of the three cytokines analysed, IL-1β had the lowest detectable concentrations 
ranging from 0.04 to 7.6 pg/mL. Similar to IL-8 and IL-6, IL-1β concentrations were not 
significantly different across the different treatment groups, although this is possibly due 
to the concentrations observed being below or at the lower end of the detectable range 
of the assay and as such are less reliable (Figure 3.9C – n=3, one-way ANOVA, Tukey, 
p > 0.05). 
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Figure 3.9: Immune responses initiated by TIGK cells in response to treatment with HSA-AGE or HSA-C. (A) IL-8 cytokine, (B) IL-6 cytokine 
and (C) IL-1β cytokine release measured in cell culture supernatant following 8 hour treatment of TIGK cells with 50, 100 or 200 µg/mL HSA-
AGE or HSA-C. Concentrations were measured using ELISAs. Significance was calculated using a one-way ANOVA followed by a Tukey post-
hoc (*, p < 0.05, n=3). HSA-AGE; human serum albumin-advanced glycation end products, HSA-C; Human serum albumin-control,  
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3.3. Discussion  
Periodontitis has long been associated with diabetes, but the underlying mechanism 
linking the two diseases is still uncertain. The interactions between AGE and RAGE and 
the subsequent immune responses have been marked as a potential linking mechanism 
(Preshaw et al., 2012). Studies have previously shown an increased prevalence of RAGE 
in gingival tissues of individuals with periodontitis and more so in individuals with both 
periodontitis and diabetes (Abbass et al., 2012).  
Previous studies have shown an upregulation of RAGE in response to AGE in a variety 
of different cell types including immune cells, endothelial cells and epithelial cells, 
although the majority of studies concentrated on bronchial epithelial cells and immune 
cells (such as macrophages) (Schmidt et al., 2000, Ott et al., 2014, Wautier et al., 2017, 
Xu et al., 2016). However, recently, Hiroshima et al. (2018) characterised RAGE 
expression of OBA-9 (Simian virus-40 antigen immortalized human gingival epithelial 
cells) and showed an increase in AGER (mRNA) and RAGE protein in response to AGE 
(500 µg/mL AGE). Interestingly, our results did not correlate with this, and although they 
showed the expression of AGER and RAGE by TIGKs, mRNA expression of AGER was 
unaffected by AGE regardless of concentration or exposure time. These observed 
differences in AGE response are potentially due to differences in cell types. Hiroshima 
et al. (2018) also demonstrated a significant increase in RAGE expression following co-
stimulation with AGE and P. gingivalis LPS compared with unstimulated and stimulation 
with AGE alone. This perhaps suggests that co-stimulation is required for alterations in 
RAGE expression.  
It is possible that the lack of significant differences in AGER mRNA expression observed 
here was a consequence of the choice of AGER primer. The qRT-PCR carried out would 
most likely amplify all variants of AGER. To elucidate whether the lack of significant 
differences in AGER mRNA expression is indeed accurate or if it is rather a shift in the 
ratio of isoforms expressed, mRNA analysis for specific isoforms is required, especially 
considering our results do suggest a difference in protein expression of secreted AGER 
in response to AGE. A study demonstrating a positive correlation between secreted 
RAGE and MCP-1 and TNF-α in type 2 diabetics, further highlights the necessity to 
analyse isoforms independently (Nakamura et al., 2008).  
Recent studies have shown that different in vivo AGE products (of which methylglyoxal 
HSA (HSA-MG) and N-carboxymethyl lysine HSA (HSA-CML) are the most predominant) 
differentially regulate AGER isoform expression despite binding to the same receptor. 
While HSA-MG stimulates the expression of full-length, N-truncated and secreted 
isoforms in endothelial cells, HSA-CML upregulates only full-length and N-truncated 
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(Grossin et al., 2009, Wautier et al., 2017). In addition, due to the various methods for 
protein modification with AGE, and the heterogeneous nature of AGEs produced, it is 
difficult to ascertain what proportion (if any) of the generated HSA-AGE is HSA-MG and 
what proportion is HSA-CML, and indeed how that compares to previous studies. To fully 
understand the impact of the various HSA-AGEs on AGER expression in TIGK cells, the 
HSA-AGE composition generated needs to be established through methods such as 
mass-spectrometry. Alternatively, more defined and commercially available ligands 
(such as CML, S100 proteins and HMGB1) could be utilised for clarification of RAGE 
expression and activation in TIGK cells.  
However, our results also indicate high levels of secreted RAGE as a response to 200 
µg/mL HSA-C. This perhaps indicates that RAGE secretion is a consequence of the 
addition of exogenous proteins as opposed to a direct consequence of HSA-AGE, 
particularly when considering under normal conditions TIGK cells are cultured using 
serum free media.  Presence of AGE in the HSA-C preparation was determined through 
analysis of fluorescence. Although fluorescence in HSA-C preparations were lower than 
that seen in HSA-AGE preparations there is potential that the HSA used (indicated as ≥ 
96% pure by manufacturers) contained low amounts of AGE modified protein prior to 
HSA-C generation. This could explain why higher levels of secreted RAGE were 
observed with higher concentrations of HSA-C.  
The western blot analysis, however, is semi quantitative and to more accurately 
understand changes at a protein level quantitation of RAGE is required. To do this 
ELISAs were carried out (as described previously in section 2.4 and according to 
manufacturer’s instructions) but concentrations were below  the detectable range by this 
method, despite attempts to concentrate samples (data not shown). Due to time 
limitations, however, this analysis could not be optimised. 
Interaction of AGE with RAGE is known to lead to the activation of signalling cascades 
and downstream activation of inflammatory responses (Ott et al., 2014, Wautier et al., 
2017). In gingival epithelial cells specifically, an increase in IL-6 mRNA expression was 
observed in response to AGE (Hiroshima et al., 2018). Our results, however, showed no 
induction in IL-6, IL-8 or IL-1β expression by AGE. This is potentially due to the lack of 
increase in RAGE expression (as described above) such that no associated increase in 
cytokines is observed. There is also the possibility that the consistent level of cytokine 
expression is a consequence of sequestering of AGE by secreted RAGE, thus, 
preventing activation of membrane bound RAGE and downstream signalling cascades. 
This can be associated with the potential increase in secreted RAGE observed.  
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Although RAGE is the most studied receptor for AGE, various others have also been 
identified; AGE clearance receptor complex (AGE-R1/OST-48, AGE-R2/80K-H, AGE-
R3/galectin-3) and members of the scavenger receptor family (SR-A, SR-B, CD36, SR-
B1, SR-E, LOX-1, FEEL-1, FEEL-2). Prior to the elimination of AGE modified proteins, 
an intracellular processing of AGE proteins into AGE modified peptides must occur. 
These alternative receptors are thought to be involved in this first step of the removal 
process by binding extracellular AGEs to allow the uptake via receptor mediated 
endocytosis. Given their high affinity for AGEs, it is possible that these receptors 
compete against RAGE, inhibiting AGE-RAGE interactions and, thus, preventing 
downstream signalling (Sourris et al., 2009, Ott et al., 2014). However, to determine if 
these cells express these receptors and if AGE interacts with these receptors in TIGK 
cells requires further analysis.  
Finally, due to the complex immunoregulatory mechanisms employed by cells in an 
attempt to prevent excessive immune responses (particularly in the densely colonised 
oral cavity) it is possible that TIGK cellular responses to AGE require co-stimulation of 
other receptors with pathogens. Indeed, a recent study has shown increased RAGE and 
IL-6 expression in gingival epithelial cells in response to AGEs and P. gingivalis LPS 
compared with AGE alone (Hiroshima et al., 2018). The study also demonstrated AGE 
alone did not change IL-8 mRNA expression but co-stimulation of RAGE with AGE and 
P. gingivallis LPS decreased IL-8 mRNA and protein levels (Hiroshima et al., 2018). In 
addition, as mentioned previously, studies in patients with periodontitis alone and 
periodontitis as well as diabetes, showed higher RAGE expression in tissues of the latter 
(Abbass et al., 2012).   
To fully understand RAGE expression and immune responses in TIGK cells further 
analysis is required. Studies including higher concentrations of AGEs to overcome 
competition by other receptors, use of alternative, better defined AGE products, co-
stimulation of cells and analysis of RAGE isoforms in TIGK cells would increase our 
understanding of AGE-RAGE interactions in oral epithelial cells.  
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4. Changes in a five species biofilm model for periodontitis in response to HSA-
AGE  
4.1. Introduction  
In mammalian cells and tissues, AGEs are relatively well studied, with investigations into 
aspects of AGE generation, metabolism and impact during disease. We now understand 
AGEs accumulate, both intracellularly and extracellularly, over time and more so in 
certain diseases (such as diabetes and Alzheimer’s) (Cohen-Or et al., 2013). Given this 
accumulation it is possible AGEs could affect bacterial cells, particularly in densely 
colonised areas of the host such as the gut and oral cavity.  
To date, few studies have investigated the role of AGEs or AGE associated cross-linked 
proteins in bacterial adherence. Furthermore, studies examining the bacterial 
metabolism of AGEs and consequences of AGE breakdown products in terms of effects 
on the microbiota are sparse and generally limited to single species experiments. A 
series of studies have demonstrated AGEs produced by E. coli K12 are metabolised 
intracellularly by metalloproteases and secreted as low-molecular weight AGE peptides 
into the growth media (Katz et al., 2010, Cohen-Or et al., 2011, Cohen-Or et al., 2013). 
While this group demonstrated the potential for bacterial metabolism of AGEs, their 
studies are limited to intracellular bacterial AGEs and did not investigate bacterial uptake 
of extracellular/mammalian AGEs and subsequent metabolism.  
Studies examining the relationship between AGEs and bacteria are, to date, limited to 
the gut, with evidence suggesting potential AGE metabolism and utilisation: human and 
rat studies have indicated only partial recovery of AGEs in faecal matter or urine following 
oral administration (Delgado-Andrade et al., 2012, Alamir et al., 2013, Hellwig et al., 
2015). Hellwig et al. (2015), showed the ability of human colonic microbiota to metabolise 
three different AGE proteins (the early Amadori product N-ε-fructodyllysine and the 
irreversible final AGE products Nε-carboxymethyl lysine (CML) and Pyrraline (PYR). The 
different AGE proteins were incubated with faecal suspensions and the resulting 
metabolites measured using high performance liquid chromatography (HPLC) (Hellwig 
et al., 2015).  
In addition to studies examining bacterial AGE metabolism, there is evidence of AGE 
modified proteins passing through the colon in individuals with ulcerative colitis changing 
the composition of the gut microbiota (Mills et al., 2008). Using faecal inoculations from 
ulcerative colitis patients in a continuous flow culture model, bacterial composition in 
medium containing AGE-modified BSA as a growth substrate was shown to have higher 
abundances of Clostridium, Bacteroides and sulphate-reducing bacteria and decreases 
in the prevalence of Eubacterium and Bifidobacterium, when compared with bacterial 
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compositions of cultures in un-modified BSA. However, these changes as a response to 
AGE modified BSA were not observed when using faecal samples from healthy 
individuals (Mills et al., 2008). Other studies have shown consumption of diets high in 
AGEs inhibit the growth of lactobacilli in the colonic microbiota (Hernandez-Hernandez 
et al., 2011, Corzo-Martínez et al., 2013, Seiquer et al., 2014, Hellwig et al., 2015). These 
studies suggest that AGE associated changes in the microbiota are a consequence of 
both presence of AGE and host disease state, highlighting the complex relationship 
between AGEs and the microbiota.  
While the above described studies have demonstrated changes in gut microbiota as a 
consequence of AGEs, to date no studies have linked AGEs to changes in the oral 
microbiota. Investigating the role of AGEs on the oral microbiota is important when 
considering the present organisms are likely the first to encounter ingested dietary AGEs. 
Furthermore, there is evidence of an increased prevalence of HSA-AGE in the GCF of 
individuals with diabetes and periodontitis compared with those with periodontitis or 
diabetes alone (Kajiura et al., 2014). The evidence from studies of the gut microbiota 
and the increased prevalence of HSA-AGE in the GCF of individuals with both diabetes 
and periodontitis could suggest that the association between periodontitis and diabetes 
may be, in part, the result of changes induced in the oral microbiota by the increased 
abundance of AGEs in the subgingival environment. 
Given the evidence of AGE associated changes in gut microbiota, the following study 
utilises a five species biofilm (to model periodontitis) which was developed in our 
laboratory by Naginyté (2017, unpublished) to investigate the effect of HSA-AGE on 
biofilm composition. The model was developed to use HA coated pegs, pre-conditioned 
with salivary proteins, to represent tooth surfaces. The pegs are inoculated sequentially 
with early (A. naeslundii and S. salivarius) and late (F. nucleatum, P. intermedia and P. 
gingivalis) colonisers to generate a stable biofilm. In the study presented here, the 
bacterial growth protein rich medium is supplemented with 20% (v/v) FBS (serum 
medium; SM) to select for pathogenic/late colonisers and produce a biofilm 
representative of periodontitis. The effect of HSA-AGE addition to the SM of a 6 day old 
biofilm was investigated to determine if AGEs (as a representative of diabetic 
hyperglycaemia) alter biofilm composition. I hypothesise that the addition of HSA-AGE 
selects for the growth of periodontitis associated pathogens and could provide evidence 
for linking diabetes and periodontitis.   
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4.2. Results 
4.2.1. HSA-AGE associated changes in species composition of five species 
biofilms  
4.2.1.1. Composition of day 6 biofilms grown in serum medium to select for 
periodontitis associated pathogens 
Five species model biofilms were grown on HA coated pegs to model periodontitis (as 
described previously in section 2.12). Biofilms harvested at day 6 were analysed for 
relative abundance of each species based on selective media CFU counts (section 
2.12.2) (Figure 4.1). Six to eight pegs each from three individual experiments (minimum 
18 pegs) were harvested, CFUs counted and used to calculate the percentage 
abundance of each species in individual biofilms relative to total biofilm CFU. 
Both A. naeslundi and S. salivarius accounted for the majority of the biofilm mass and 
were significantly more prevalent than F.nucleatum, P. intermedia, P. gingivalis (black 
lines, Figure 4.1). However, significantly less A. naeslundi was observed compared with 
S. salivarius (*,Figure 4.1).  This difference is unsurprising given the later HA peg 
inoculation with F. nucleatum, P. intermedia and P. gingivalis (section 2.12) and the 
slower growth rate of these species. Importantly, the results indicated that all five species 
were present in the day 6 biofilm, such that any changes in biofilm composition upon 
addition of HSA-AGE or HSA-C reflect the impact of the addition as opposed to absence 
of particular species in the day 6 biofilm. 
4.2.1.2. Impact on day 6 biofilms following HSA-AGE addition to growth medium 
After 6 days, varying concentrations of HSA-AGE or HSA-C were added to the biofilm 
growth SM which was changed daily until day 10 (section 2.12). Day 10 biofilms were 
harvested and subsequent biofilm compositions analysed (Figure 4.2 and Table 4.1). In 
biofilms grown in SM without the addition of any HSA-AGE or HSA-C (baseline biofilms), 
P. gingivalis accounted for the bulk of the biofilm (mean abundance of 49.00 ± 21.19% 
of total viable counts) followed by S. salivarius (mean abundance of 22.55 ± 11.32%) 
and P. intermedia (mean abundance of 12.97 ± 9.94%) (Table 4.1). A. naeslundii and F. 
nucleatum accounted for similar percentages of the bacteria in the biofilm (mean 
abundance of 8.29 ± 8.93% and 7.00 ± 4.54% respectively), although more variability 
was observed in the percentage of A. naeslundii compared with F. nucleatum. Given the 
predominance of P. gingivalis and P. intermedia (periodontitis associated bacteria) in 
biofilms grown with SM for 10 days, the results confirm the periodontitis associated 
pathogens behave in the model biofilm in a manner that reflect their increased 
prevalence in periodontitis (Figure 4.1 and Table 4.1).  
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Figure 4.1: Bacterial composition of day 6 biofilms. Biofilms were grown following 
sequential inoculation of hydroxyapatite pegs with S. salivarius, A. naeslundii, F. 
nucleatum, P. intermedia and P. gingivalis. Following growth for 6 days under anaerobic 
conditions at 37°C in protein rich medium supplemented with 20% FBS (serum medium), 
6-8 biofilms were harvested for determining CFU (colony forming unit) counts on 
selective media and calculation of percentage abundances of total viable counts. Lines 
and * indicate significant differences (One-way ANOVA, Tukey, p < 0.05, n=3).  
 
 
 
 
 
 
 
 Chapter 4 – Five species biofilm model  
 
147 
 
Significant decreases in mean relative abundance of A. naeslundii and S. salivarius were 
observed when comparing HSA-AGE biofilms with their corresponding HSA-C biofilms 
(Table 4.1). Although no significant differences (two way ANOVA, Tukey,  
p > 0.05) in the early coloniser abundances were observed between the different HSA-
C biofilms, a significantly higher average percentages of A. naeslundii were observed in 
all HSA-C biofilms compared with baseline biofilms. This potentially indicates HSA is 
partially responsible for the increase in A. naeslundii growth in HSA-AGE biofilms. This 
increase in A. naeslundii corresponded with a decrease in mean P. gingivalis abundance 
(such that mean percentages were significantly lower in all HSA-C biofilms compared 
with baseline biofilms but not completely abolished as seen in HSA-AGE biofilms). In 
addition, no significant difference (two-way ANOVA, Tukey, p > 0.05) in mean 
abundances were observed in the different concentrations of HSA-C (Table 4.1). 
Growth media supplemented with HSA-AGE appeared to inhibit all three late colonisers. 
While these decreases are significant in P. gingivalis and P. intermedia, changes in mean 
abundance of F. nucleatum were not significant (two-way ANOVA, Tukey, p > 0.05), 
potentially due to the low percentages observed in baseline and HSA-C biofilms. P. 
intermedia abundances did not appear to be significantly different when comparing HSA-
AGE biofilms to their matched HSA-C biofilms (two-way ANOVA, Tukey, p > 0.05) but 
the decrease in HSA-AGE biofilms was significant compared with baseline biofilms 
(Table 4.1).  
 
 
 
 Chapter 4 – Five species biofilm model  
 
148 
 
 
 Figure 4.2: Bacterial composition of day 10 biofilms.  Biofilms were cultivated 
for 6 days in SM prior to the introduction of HSA-AGE/HSA-C to the SM until day 
10. On day 10 biofilms were harvested and the relative abundances of each species 
in individual biofilms were calculated and presented as medians with maximum and 
minimum percentages. Results represent 3 experiments with 6-8 biofilms harvested 
per experiment. HSA-AGE: human serum albumin-advanced glycation end product, 
HSA-C: human serum albumin-control, SM: serum medium. 
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 Percentage of total viable counts of biofilms grown in: 
 
Basal  
(SM only) 
SM + 50 µg/mL 
HSA-AGE 
SM + 50 µg/mL 
HSA-C 
SM + 100 µg/mL 
HSA-AGE 
SM + 100 µg/mL 
HSA-C 
SM + 200 µg/mL 
HSA-AGE 
SM + 200 µg/mL 
HSA-C 
  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
S. salivarius 22.55 11.32 1.44 2.55 32.87 23.66 0.29 0.68 21.64 12.65 1.11 3.03 33.64 25.00 
A. naeslundii 8.29 8.93 98.56 2.55 39.69 25.44 99.67 0.67 31.14 24.15 98.89 3.03 39.09 15.13 
F. nucleatum 7.00 4.54 0.00 0.00 4.81 1.83 0.01 0.03 10.43 7.26 0.00 0.00 5.75 3.06 
P. intermedia  12.97 9.94 0.00 0.00 6.66 4.94 0.00 0.00 7.92 6.33 0.00 0.00 4.37 2.93 
P. gingivalis 49.18 21.19 0.00 0.00 15.96 7.01 0.02 0.08 28.86 16.39 0.00 0.00 17.15 13.51 
Table 4.1: Bacterial composition of day 10 biofilms. Biofilms were cultivated for 6 days in SM prior to the introduction of HSA-AGE/HSA-C to the 
SM until day 10. On day 10 biofilms were harvested and the relative abundances of each species in individual biofilms were calculated and presented 
as mean % ± SD. Results represent 3 experiments with 6-8 biofilms harvested per experiment. Bold indicates significant differences compared with 
basal biofilms. Underlined indicates significant differences when comparing different concentrations of HSA-AGE or HSA-C. Colours indicate significant 
differences between HSA-AGE and HSA-C. All significance was calculated using a two-way ANOVA followed by a Tukey post-hoc (p < 0.05). HSA-
AGE: human serum albumin-advanced glycation end product, HSA-C: human serum albumin-control, SM: serum medium 
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4.2.1.3. Analysis of biofilms following change of medium from HSA-AGE/HSA-
C supplemented to non-supplemented serum medium   
Following growth of biofilms in HSA-AGE or HSA-C supplemented medium (from day 6 
to 10), growth medium was replaced with unsupplemented SM until day 14. At day 14, 
biofilms were harvested and subsequent percentage abundances calculated. The results 
indicated that at day 14, baseline biofilms maintained the higher prevalence of 
periodontitis associated bacteria (Figure 4.3 and Table 4.2). These biofilms favoured the 
growth of P. gingivalis and P. intermedia with abundances of S. salivarius, A. naeslundii 
and F. nucleatum only accounting for a small percentage of the total biofilm. 
Furthermore, the relatively high percentage abundance of S. salivarius observed at day 
10 (Table 4.1) decreased significantly at day 14 (Table 4.2), in addition to significant 
decreases in A. naeslundii and F. nucleatum (two-way ANOVA, Tukey, p  < 0.05). 
Together this suggests the maturation and preservation, over 14 days, of a biofilm that 
represents the increased prevalence of bacteria generally associated with periodontitis, 
which in this model is seen as higher percentage abundances of P. gingivalis and P. 
intermedia.   
Biofilms exposed to HSA-AGE supplemented growth medium prior to changing to SM 
showed significant recovery in the abundance of S. salivarius but no significant recovery 
in any of the late colonisers (two-way ANOVA, Tukey, P > 0.05), regardless of the HSA-
AGE concentration. Interestingly, the inability to recover late coloniser growth allowed 
the S. salivarius to grow to significantly higher abundances on average than in baseline 
and HSA-C biofilms. The recovery of S. salivarius was not significantly different across 
the different HSA-AGE concentrations (two-way ANOVA, Tukey, p > 0.05). In HSA-C 
exposed biofilms, no significant differences were observed in abundance of S. salivarius 
at day 14 in comparison with day 14 baseline biofilms (two-way ANOVA, Tukey, p > 0.05, 
Table 4.1).  
In HSA-AGE recovery biofilms, S. salivarius abundance increases correlate with a 
significant decrease in A. naeslundii. Despite the A. naeslundii decrease, the abundance 
in HSA-AGE biofilms was significantly higher when compared with baseline biofilms and 
correlating HSA-C biofilms. The higher abundance of A. naeslundii was consistent 
across all concentrations of HSA-AGE that biofilms were exposed to prior to the recovery 
period. In addition, A. naeslundii abundances in HSA-C recovery biofilms showed no 
significant difference compared with baseline biofilms (two-way ANOVA, Tukey, p > 
0.05), indicating changes observed in A. naeslundii in recovery HSA-AGE biofilms were 
a direct consequence of the AGE supplemented growth medium as opposed to changes 
associated with the addition of HSA (Figure 4.3 and Table 4.1) 
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Figure 4.3: Bacterial composition of day 14 biofilms.  Biofilms were cultured for 6 
days in SM prior to introduction of HSA-AGE or HSA-C to growth media until day 10 
after which media were changed to SM (day 10 to day 14). Relative abundances of 
each species in individual biofilms were calculated and presented as medians with 
maximum and minimum percentages. Results represent 3 experiments with 6-8 
biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced 
glycation end product, HSA-C: human serum albumin-control, SM: serum medium. 
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 Percentage of total viable counts of biofilms grown in: 
 
Basal  
(SM only) 
SM + 50 µg/mL 
HSA-AGE 
SM + 50 µg/mL 
HSA-C 
SM + 100 µg/mL 
HSA-AGE 
SM + 100 µg/mL 
HSA-C 
SM + 200 µg/mL 
HSA-AGE 
SM + 200 µg/mL 
HSA-C 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
S. salivarius 10.00 8.16 34.38 19.00 15.67 9.90 32.03 17.54 12.61 4.92 40.78 14.61 24.64 12.60 
A. naeslundii 2.27 1.72 65.62 19.00 10.56 6.46 67.87 17.62 7.45 4.17 59.18 14.60 8.35 2.84 
F. nucleatum 1.92 1.16 0.03 0.03 15.70 4.72 0.08 0.21 20.65 26.28 0.01 0.02 35.40 16.15 
P. intermedia  13.28 16.68 0.04 0.05 3.36 2.22 0.02 0.10 11.96 15.32 0.03 0.08 19.89 14.25 
P. gingivalis 72.52 19.14 0.06 0.09 54.70 19.08 0.01 0.02 47.33 20.74 0.00 0.01 11.72 4.25 
Table 4.2: Bacterial composition of day 14 biofilms. Biofilms were cultured for 6 days in SM prior to introduction of HSA-AGE or HSA-C to growth media until 
day 10 after which media were changed to SM (day 10 to day 14). On day 14 biofilms were harvested and the relative abundances of each species in individual 
biofilms were calculated and presented as mean ± SD. Results represent 3 experiments with 6-8 biofilms harvested per experiment. Bold indicates significant 
differences compared with basal biofilms Bold indicates significant differences compared with basal biofilms. Underlined indicates significant differences when 
comparing different concentrations of HSA-AGE or HSA-C. In the case of P. gingivalis, double underlined specifies 50 µg/mL and 100 µg/mL HSA-C are 
significantly different to 200 µg/mL. Colours indicate significant differences between HSA-AGE and HSA-C. All significance was calculated using a two-way 
ANOVA followed by a Tukey post-hoc (p < 0.05). HSA-AGE: human serum albumin-advanced glycation end product, HSA-C: human serum albumin-control, SM: 
serum medium. 
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In contrast to day 10, day 14 HSA-C biofilm A. naeslundii abundances were not 
significantly different to baseline biofilms (two-way ANOVA, Tukey, p > 0.05). The 
decrease in A. naeslundii abundance at day 14 in HSA-C recovery biofilms correlated 
with a significant increase in F. nucleatum (Figure 4.3 and Table 4.2). Thus it appeared 
that the presence of HSA-C encouraged the growth of A. naeslundii, which is outgrown 
by F. nucleatum following withdrawal of HSA-C. The significant decrease in F. nucleatum 
of baseline biofilms over time and the significant, dose dependent increase in F. 
nucleatum abundance in HSA-C recovery biofilms could suggest that the addition of 
HSA-C and subsequent increase in A. naeslundii abundances produces metabolic by-
products, which upon withdrawal of HSA-C encourages F. nucleatum growth to a point 
where its growth surpasses A. naeslundii.   
In addition, a significant dose dependent decrease in P. gingivalis mean abundance in 
all HSA-C recovery biofilms compared with baseline biofilms was observed. Similarly, 
average P. intermedia prevalence in recovery biofilms was lower than in baseline 
biofilms, however this was not significant (two-way ANOVA, Tukey, p > 0.05). P. 
intermedia average abundances in HSA-C biofilms also demonstrate a dose dependent 
increase, reaching significance between 100 and 200 µg/mL HSA-C (Table 4.2).  
4.2.1.4. Analysis of pH changes in biofilm growth media 
To evaluate changes in pH as a consequence of bacterial metabolism, pH of the biofilm 
growth medium was recorded every 24 hours for 14 days. This was achieved through 
use of a pH probe capable of measuring pH directly in wells of 96 well plates. I 
hypothesised changes in pH as a result of the metabolism of AGEs by A, naeslundii 
could be indicative of changes in pH causing late coloniser death.  
There was a daily drop in pH to approximately 6 over the first 6 days, prior to addition of 
HSA-AGE/HSA-C. In baseline and HSA-C biofilms pH changes remained relatively 
consistent over the course of the experiment, with pH not decreasing below 6 (Figure 
4.4). However, upon addition of various concentrations of HSA-AGE to growth media, a 
pH of approximately 4.5 was observed. Despite correction of pH by media replacement 
every 24 hours, the acidic environment created following the addition of HSA-AGE could 
account for the complete inhibition of late colonisers and the inability to revive them 
following a recovery period. Following removal of HSA-AGE, the pH of the environment 
reverted to pH 6 – 7 within 24 hours. The changes in pH were consistent across all HSA-
AGE concentrations which reflects the limited differences observed in biofilm 
composition between HSA-AGE biofilms (Figure 4.4). 
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 Figure 4.4: pH measurements of culture media following 24 hour incubation of biofilms with 
daily media changes accounting for pH correction to 7. Changes in pH measurements in 
biofilm growth with 50 (A), 100 (B) and 200 (C) µg/ml HSA-AGE or HSA-C. Solid arrow indicates 
introduction of medium supplemented with HSA-AGE or HSA-C, with daily changes until day 10. 
Dotted arrow indicates start of recovery period where medium was reverted to SM until day 14. 
Results represent 3 experiments with pH measured for 6-8 biofilms per experiment (mean ± SD). 
HSA-AGE: human serum albumin-advanced glycation end product, HSA-C: human serum albumin-
control, SM: serum medium. 
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4.2.2. Single species growth analysis to determine species responsible for 
changes observed in biofilms 
In addition to analysis of pH changes during the course of the five species biofilm growth, 
the bacteria were grown individually in SM and SM supplemented with 100 µg/mL HSA-
AGE or 100 µg/mL HSA-C. Media were inoculated with each species at the same 
proportion as used for HA peg inoculation and incubated anaerobically for 24 hours. The 
resulting bacterial suspension was diluted and plated as previously described for 
calculation of CFU. The pH of each suspension was also measured.   
In unsupplemented SM, CFU counts of P. gingivalis and P. intermedia were significantly 
lower than those of S. salivarius, A. naeslundii and F. nucleatum (Figure 4.5A). This 
suggests a slower growth rate of P. gingivalis and P. intermedia in SM compared with 
the other species. Contrastingly, in medium supplemented with HSA-AGE, P. intermedia 
and A. naeslundii both had significantly higher CFU counts compared with SM and HSA-
C. The increase in A. naeslundii grown with medium supplemented with HSA-AGE 
reflects the increase in growth observed in the five species HSA-AGE biofilms (Figure 
4.5A). 
F. nucleatum CFU counts in HSA-AGE media were significantly lower compared with 
SM but higher compared with HSA-C. P. gingivalis growth, on the other hand, was 
significantly higher in HSA-C media compared with both HSA-AGE and SM. 
Furthermore, no significant difference in P. gingivalis CFUs following growth in HSA-AGE 
medium and SM was observed (one-way ANOVA, Tukey, p > 0.05), perhaps suggesting 
HSA encourages P. gingivalis growth but modified HSA does not.   
After a 24 hour incubation, S. salivarius CFUs were significantly lower in HSA-AGE 
supplemented growth medium compared with SM but significantly higher in  
HSA-C supplemented medium. This is partially reflected in the biofilm model where 
growth of S. salivarius is decreased in the presence of HSA-AGE.  
Comparison of different bacterial suspensions under different growth conditions 
indicated a significantly lower pH following A. naeslundii growth in SM compared with 
both S. salivarius and P. gingivalis but no significant differences when comparing to F. 
nucleatum and P. intermedia (one-way ANOVA, Tukey, p > 0.05). This indicates that in 
SM, A. naeslundii and to a lesser extent F. nucleatum and P. intermedia reduced the pH 
of the media while S. salivarius and P. gingivalis maintain a neutral pH (Figure 4.5B). 
In contrast, growth of S. salivarius and A. naeslundii in HSA-AGE supplemented SM 
caused a decrease in the pH of the culture. For S. salivarius this decrease was significant 
compared with growth in HSA-C and SM. In general the pH profiles of  bacteria grown in 
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HSA-C and SM are the same and only S. salivarius growth in HSA-AGE caused a 
significant decrease in the pH compared with the two control groups. 
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Figure 4.5: Growth and pH changes associated with S. salivarius¸ A. naeslundii, F. nucleatum, P. intermedia and P. gingivalis 
grown as single species cultures in SM supplemented with HSA-AGE or HSA-C. (A) CFU counts and (B) pH changes of bacteria 
cultured for 24 hours in SM or SM supplemented with 100 µg/mL HSA-AGE or 100 µg/mL HSA-C. Matching symbols indicate significant 
differences in CFU counts (*, **) or pH (•, ••) of each species when grown in different media (One-way ANOVA, Tukey, p < 0.05 n=3). 
HSA-AGE: human serum albumin-advanced glycation end product, HSA-C: human serum albumin-control, SM: serum medium. 
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4.3. Discussion  
The roles of AGEs in mammalian cells and tissues are relatively well studied, with 
particular attention paid to the effects of AGEs on inflammation and diseases such as 
diabetes and Alzheimer’s. The presence of AGEs has been shown to initiate 
inflammatory responses and alter protein structures and functions. However, to date, 
little is known about the influence of AGEs in determining the composition of the human 
microbiome.  
The aim of this study was to determine if HSA-AGE can cause changes in biofilm 
composition when using a five species model. The results demonstrated that in the 
presence of HSA-AGE, within the concentration range tested, the composition of the 
biofilm altered so that A. naeslundii outgrew S. salivarius, F. nucleatum, P. intermedia 
and P. gingivalis. This increased abundance of A. naeslundii was accompanied by the 
inhibition of P. gingivalis, P. intermedia and F nucleatum growth which could not be 
revived following withdrawal of HSA-AGE. Analysis of the growth medium every 24 hours 
prior to medium change and resulting pH correction, demonstrated the development of 
an acidic environment when a 6 day biofilm was incubated in HSA-AGE supplemented 
medium. This drop in pH over the HSA-AGE growth period could account for the lack of 
P. gingivalis, P. intermedia and F. nucleatum growth. The prolonged exposure to the 
acidic environment may have caused bacterial death of these species and could explain 
the inability to revive them following withdrawal of HSA-AGE. The detrimental effects of 
acid environments on P. gingivalis, P. intermedia and F. nucleatum has been 
demonstrated in previous studies which indicate intolerance of these species to low pH. 
P. gingivalis has the lowest tolerance and cannot survive below a pH of 6, while P. 
intermedia and F. nucleatum can tolerate pH 5 and pH 5.5, respectively (Takahashi et 
al., 1997).  
Results from the single species experiments further supports the effect of pH on bacterial 
growth. When cultured in SM or SM supplemented with HSA-AGE/HSA-C, A. naeslundii 
lowered the pH of the environment. S. salivarius, on the other hand, only caused a 
significant decrease in pH when cultured with HSA-AGE. This suggests that the pH 
lowering ability of S. salivarius is based on its ability to metabolise AGEs resulting in 
acidic by-products. Given that the pH decrease associated with A. naeslundii was seen 
across all single species growth conditions but a S. salivarius associated decrease was 
only observed in HSA-AGE growth conditions, it is possible that in the five species model 
the decrease in pH which shifts the composition is a consequence of S. salivarius 
metabolism of HSA-AGE. To confirm this hypothesis further analysis is required. This 
can be achieved through NGS of S. salivarius cultures and investigation of metabolic 
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pathways, validated using culture dependent methods which utilise gene knockouts of 
identified proteins potentially involved in HSA-AGE metabolism. Furthermore, protein 
analysis (western blot, HPLC etc) of culture medium could help elucidate extent of HSA-
AGE metabolism. 
Interestingly, in the presence of HSA-C, an increase in P. gingivalis growth was 
observed. This could be indicative of the ability of P. gingivalis to utilise HSA as a carbon 
and nitrogen source through gingipain activity (Grenier et al., 2001). This was however 
not reflected in the model biofilm and could indicate that S. salivarius outcompete P. 
gingivalis for utilisation of HSA. The increase in S. salivarius growth in HSA-C cultures 
further validates this possibility. However, given the decrease in growth of A. naeslundii 
in HSA-C growth conditions compared with SM in single species experiments but an 
increase in abundance in the five species model it is evident that a more complex 
relationship exists. S. salivarius potentially metabolises HSA, producing products that A. 
naeslundii can utilise for growth when part of a biofilm.  
It is clear that analysis of AGE metabolism  by these bacterial species is required to fully 
understand their growth under the conditions of these experiments and elucidate the 
complex relationships in biofilms. This is particularly important when considering the 
potential changes in biofilm composition are a consequence of HSA-AGE metabolism. 
To date, few studies have investigated bacterial AGE metabolism and of these none 
have examined bacterial response to external AGE. Katz et al. (2010), identified a 
glycopeptidase (Gcp) involved in the prevention of AGE accumulation in E. coli. Using a 
Gcp depleted E. coli phenotype, they demonstrated a 60% increase in AGE 
accumulation through fluorescence analysis of the bacterial lysate. Although Gcp was 
demonstrated to be involved in AGE metabolism, the group also detected an increase in 
Amadori products (an intermediate of the Maillard reaction) and therefore suggested Gcp 
is involved directly in the metabolism of Amadori products. They proposed that the 
accumulation of Amadori products following Gcp depletion increases the potential for 
AGE development (Katz et al., 2010). A search of E. coli homologues and potential Gcp 
proteins (using the NCBI database) did identify the presence of Gcp in S. salivarius, 
however in silico protein analysis (using SignalP) showed lack of a signal peptide 
indicating the inability of Gcp to metabolise extracellular proteins. Further analysis is 
required in the organisms used in this study to determine if AGEs are transported into 
the cells and if the intracellular Gcp is involved in AGE metabolism. It is also possible 
that proteins with similar functions to Gcp which are secreted into the environment are 
present in the five species investigated in this study.    
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There is also the potential for AGEs to interact with specific receptors on the surface of 
bacteria to initiate endocytosis (such as CD36) or toxic responses (RAGE), similar to 
those seen in mammalian cells (Ott et al., 2014, section 3.1). However, an in silico protein 
search (using the NCBI database) for bacterial equivalents of RAGE and CD36 yielded 
no results. This suggests that if AGE metabolism is initiated following receptor activation, 
the bacterial receptors are distinct from those found on mammalian cells.   
I propose that in the five species biofilm model, when HSA-AGE is introduced to the 
growth medium, both early colonisers (A. naeslundii and S. salivarius) metabolise the 
AGE lowering the pH to such an extent that the environment becomes too acidic for the 
growth of P. ginigivalis, P. intermedia and F. nucleatum (which have a pH tolerance of 6, 
5.5 and 5, respectively). In SM and HSA-C conditions, the pH changes associated with 
A. naeslundii alone can potentially be negated by the action of P. gingivalis, P. intermedia 
and F. nucleatum (as all three have previously been shown to neutralise acids during 
growth) (Takahashi et al., 1997). However, in the presence of HSA-AGE the pH is 
lowered (through the combined action of A. naeslundii and S. salivarius) at a rate or to a 
pH where acid neutralisation is no longer effective and the late colonisers are killed. The 
acidic environment allows the A. naeslundii to flourish and outgrow but not entirely kill S. 
salivarius. Or perhaps the acidic pH as a direct consequence of AGE metabolism inhibits 
S. salivarius growth as indicated by a decrease or inhibition of growth in the single 
species experiments.   
This simple model highlights the potential of HSA-AGE in influencing bacterial growth 
and provides an insight into how HSA-AGE metabolism may change pH and, as a 
consequence, biofilm composition. Further work is required to elucidate the pathways 
through which HSA-AGE is metabolised (perhaps through NGS) and the by-products of 
this metabolism (through methods such as mass spectrometry analysis). To fully 
understand the role of HSA-AGE in influencing the composition of the oral microbiota a 
more complex model is required, as not only does this model not entirely represent the 
complex dense microbiota of the mouth but also lacks representation of host-microbiota 
interactions and complex biochemical and immune changes associated with diabetes 
and periodontitis.  
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5. Complex biofilm 
5.1. Introduction  
Periodontitis and diabetes have long been understood to have a two-way relationship 
but the mechanisms linking these two diseases are complex and not fully understood. 
Of the many potential links (Figure 1.5 and section 1.4), the increased presence of AGEs 
in diabetes have been postulated to be involved in increased periodontal inflammation 
leading to increased infection susceptibility and the periodontitis immune associated 
tissue destruction (section 1.4.3). Although the effect of AGEs on mammalian cells is 
reasonably well studied (section 1.4.3 and 3.1), their influence on the colonisation and 
maturation of biofilms in the oral cavity is unknown. There are, however, studies 
demonstrating changes in the gut microbiota as a consequence of excessive AGEs and 
microbial metabolism of AGEs in the gut (Mills et al., 2008, Seiquer et al., 2014, Hellwig 
et al., 2015) or metabolism of AGEs in single species cultures (Chalova et al., 2012).  
Considering the increased prevalence of HSA-AGE in the GCF of diabetics with 
periodontitis (Kajiura et al., 2014) and the results from the five species biofilm model 
(described in section 4) indicating a change in biofilm composition as a consequence of 
HSA-AGE addition to growth medium, it was hypothesised that HSA-AGE will also 
change the composition of a complex oral biofilm generated on a Calgary device using 
a physiological inoculum. This was tested in experiments described in this chapter. A 
proof of principle study was carried out to determine the use of this model as a method 
to investigate the role of HSA-AGE on the colonisation of HA coated pegs by pre-
conditioning the pegs with various concentrations of HSA-AGE. This was based on the 
possibility of AGE adsorption onto the HA peg alongside other salivary proteins (section 
1.1.1) thus potentially altering bacterial adherence and colonisation of the pegs. In 
addition, these preliminary experiments also aimed to establish the validity of the model 
to examine the changes in biofilm composition in response to HSA-AGE.  
In addition to analysis of bacterial composition, inflammatory responses of TIGK cells 
initiated by the complex biofilms were also assessed. Previous studies have implicated 
excessive AGE concentrations in increased inflammatory responses of a variety of cell 
types (including oral epithelial and immune cells). In the oral cavity, the high AGE 
concentration conditions can potentially lead to uncontrolled inflammatory responses 
(including cytokine/chemokine release and ROS generation) which are implicated in  
exacerbation of periodontitis (Lalla et al., 2001, Vlassara, 2001, Wong et al., 2003, 
Santana et al., 2003, Cortizo et al., 2003, Preshaw and Taylor, 2011, Preshaw et al., 
2012). 
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Although TIGK cells were shown to express RAGE (section 3), the previous experiments 
demonstrated no change in RAGE expression as a consequence of AGE and no 
changes in concentration of cytokines released following TIGK culture with varying 
concentrations of AGE (section 3.2.3). The presence of AGE has been correlated with 
increased cytokine release (section 1.4.3 and 3.1). These increases in cytokine 
concentrations have also recently been demonstrated to be further increased when 
coupled with bacterial co-stimulation (Hiroshima et al., 2018).Considering this, the 
generated biofilms were also assessed as a model to test the hypothesis that co-
stimulation of TIGK cells with HSA-AGE and complex oral biofilms could lead to a rise in 
cytokine release and an increase in cellular ROS generation. As a preliminary measure 
in this study the biofilm-TIGK co-cultures were carried out in HSA-AGE supplemented 
cell culture media, at concentrations representing those found in the GCF of diabetics by 
Kajiura et al (2014).   
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5.2. Results  
5.2.1. HSA-AGE associated changes on colonisation and mature biofilm 
composition using a complex biofilm model, analysed using selective 
media  
5.2.1.1. Bacterial composition of inocula and colonisation (day 2) biofilms 
Complex biofilms were grown on HA coated pegs using pooled saliva, plaque and tongue 
scraping inocula as described previously (section 2.13). Prior to inoculation of HA pegs, 
pooled inoculum was analysed on various selective media to determine its bacterial 
composition. The results indicated the physiological inoculum contained Actinomyces, 
Streptococcus, facultative anaerobes, anaerobes and Gram-negative anaerobes at 
approximately same abundances while counts of lactobacilli were observed to be 104 
fold lower (Figure 5.1).  
Prior to inoculation, HA pegs were pre-conditioned with artificial saliva containing 
concentrations of HSA-AGE to represent the consequence of diabetes-associated 
hyperglycaemia and health. Artificial saliva was supplemented with 100 µg/mL HSA-AGE 
to model the higher concentrations associated with diabetes and shown to be present in 
the GCF of diabetics (Kajiura et al., 2014). To simulate health, 1 µg/mL HSA-AGE (and 
99 µl/mL HSA-C to account for protein differences) was added to the artificial saliva, as 
low levels of HSA-AGE are observed in the GCF of patients without hyperglycaemia 
(Kajiura et al., 2014). Pre-conditioned HA pegs were inoculated with the complex 
inoculum and incubated to determine the effects of HSA-AGE on colonisation (pegs 
harvested after 2 days) and mature biofilm composition (pegs harvested after 7 and 14 
days).  
Following incubation of the inoculum with HA pegs under anaerobic conditions for 2 days, 
growth of bacteria on selective media decreased from approximate CFUs of 109 – 1010 
in the inocula to 107 – 108 in the biofilms, with the exception of Lactobacilli where growth 
decreased to below detectable levels (Figure 5.2). This suggests not all the bacteria (in 
the groups investigated) colonised and survived the two-day incubation. This loss of 
diversity is perhaps due to the limitations associated with the available binding sites (for 
colonisation) and changes in environmental conditions (such as nutrient availability and 
pH changes). Comparisons of HA pegs pre-conditioned with different HSA-AGE 
concentrations, indicated no significant differences in the viable counts of early biofilms 
(Figure 5.2). This suggests that pre-conditioning using HSA-AGE has limited effect of the 
colonisation of bacteria to HA pegs as assessed by culture on selective media.    
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Figure 5.1: Proportion of selected genera and groups of bacteria in inoculum used 
for growth of complex biofilm. Colony forming units (CFUs) were determined based 
on viable counts using selective media. The Inoculum was generated using pooled 
saliva, plaque and tongue scrapings from 7 volunteers. Results are presented as 
average counts ± standard deviation and represent the inocula used for 3 experiments. 
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Figure 5.2: Proportion of selected genera and groups of bacteria in early (day 2) biofilms. Colony forming units (CFUs) on selective 
media for biofilms grown anaerobically following incubation of HA pegs with complex inoculum for 2 days. Results are presented as average 
counts ± SD and represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation 
end product, HSA-C: human serum albumin-control.
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5.2.1.2. Bacterial composition of mature (day 7 and day 14) biofilms  
Medium for biofilm growth was supplemented with 100 µg/mL HSA-AGE and 1 µg/mL 
HSA-AGE with 99 µg/mL HSA-C. Serum medium (SM), as described previously (section 
2.1), was growth medium supplemented with serum to reflect increased serum conditions 
associated with periodontitis. This allowed for the representation of periodontitis 
conditions in the absence of diabetes related HSA-AGE concentrations (low HSA-AGE 
pre-conditioning and low HSA-AGE supplemented growth medium –  and Figure 5.4 , 
P). In addition, biofilms were grown to represent periodontitis conditions with the 
hyperglycaemic associated AGE increases observed in diabetes (high HSA-AGE pre-
conditioning and high HSA-AGE supplemented growth media) as well as HSA-C control 
biofilms ( and  Figure 5.4 –HP and C respectively).  
Biofilms were maintained as described previously and pegs harvested at days 7 and 14 
(section 2.13). Following day 7 harvests, biofilms contained Actinomyces, 
Streptococcus, anaerobes, facultative anaerobes and Gram-negative anaerobes under 
all conditions. Lactobacilli were only within detectable ranges under some conditions, 
particularly in biofilms grown following peg pre-conditioning with low HSA-AGE 
concentrations ().  
When comparing the prevalence of each bacterial group in the biofilms as a 
consequence of pre-conditioning, a significant decrease in facultative anaerobe counts 
was observed in pegs pre-conditioned with high HSA-AGE concentrations and grown in 
medium supplemented with 100 µg/mL HSA-AGE or HSA-C compared with 
unsupplemented SM (, row 2). This suggest that the combination of pre-conditioning with 
high HSA-AGE and the presence of HSA-AGE in the growth media decreases facultative 
aerobe growth. When pegs were pre-conditioned with low HSA-AGE concentrations a 
significant decrease in facultative aerobes was observed in biofilms grown with medium 
supplemented with HSA-C compared with low HSA-AGE and SM (, row 1). This suggests 
that when HA pegs are pre-conditioned with health associated HSA-AGE concentrations, 
the addition of HSA-C to the growth media hinders facultative anaerobe growth. 
Contrastingly, pegs pre-conditioned with HSA-C control, showed no difference in biofilm 
bacterial profiles regardless of growth medium conditions (, row 3). This suggests that at 
day 7, the pre-conditioning of HA pegs with HSA-AGE (both at health and 
hyperglycaemia mimicking concentrations) may impact long term biofilm composition 
and in particular alter the abundance of facultative anaerobes and perhaps Lactobacilli.  
To determine the impact growth medium had on day 7 biofilm composition, changes in 
viable counts as a consequence of growth media were compared over different pre-
conditioning (, columns). The only differences observed were in abundances of 
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facultative anaerobes. A dose dependent increase was observed in facultative 
anaerobes of biofilms grown on HA pegs pre-conditioned with HSA-AGE and grown in 
SM (*, , column 1). This suggests pre-conditioning of pegs with HSA-AGE selects for 
facultative anaerobes in day 7 biofilms. However, a significant decrease was observed 
in facultative anaerobe viable counts in biofilms grown on HSA-AGE pre-conditioned 
pegs compared with HSA-C control pre-conditioned pegs grown in media supplemented 
with high concentrations of HSA-AGE (*, , column 3).  
Biofilms harvested at day 14 (Figure 5.4) showed a general increase, across all 
conditions, in viable counts of Actinomyces, anaerobes and facultative anaerobes 
compared with biofilms harvested at day 7 (). In addition, Lactobacilli were observed in 
biofilms grown under more conditions at day 14 compared with day 7 (Figure 5.4 and ). 
When comparing abundances of the different bacterial groups across different 
conditions, significant changes were only observed in facultative anaerobes. Different 
growth media only affected facultative anaerobe growth in biofilms cultivated on low 
HSA-AGE pre-conditioned pegs (Figure 5.4, row 1). Comparisons of day 14 biofilms from 
HA pegs with different pre-conditionings resulted in differences only in facultative 
anaerobes; significantly higher in biofilms grown on pegs pre-conditioned with high HSA-
AGE and grown under high HSA-AGE conditions (*, Figure 5.4). 
Although pre-conditioning of pegs with HSA-AGE (both high HSA-AGE and low HSA-
AGE at day 7, and low HSA-AGE at day 14) appears to impact facultative anaerobe 
growth in biofilms it is difficult to ascertain the role the growth medium has on these 
changes. Particularly when considering comparisons of biofilms representing 
consequences of hyperglycaemia and increased serum levels associated with 
periodontitis (HP) to those representing periodontitis serum levels alone (P) and controls 
(C) at day 7 and day 14 showed no significant differences in any bacterial group. This is 
possibly due to the limited nature of using selective media counts to determine biofilm 
composition.  
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    Figure 5.3: Proportion of selected genera and groups of bacteria in day 7 biofilms. Colony forming units (CFUs) on selective media for biofilms grown 
anaerobically following incubation of HA pegs with pooled saliva, plaque and tongue scrapings inoculum for 7 days. Results are presented as average 
counts ± standard deviation and represent 3 experiments with 6-8 biofilms harvested per experiment. Symbols represent significance in changes associated 
with pre-conditioning, lines represent significance associated with growth media (two-way ANOVA, Tukey, p < 0.05). HSA-AGE: human serum albumin-
advanced glycation end product, HSA-C: human serum albumin-control, C: HSA-C control biofilm, P: biofilm representing increased serum observed in 
periodontitis with health associated HSA-AGE concentrations, HP: biofilm representing periodontitis and diabetes associated HSA-AGE concentrations. 
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Figure 5.4: Proportion of selected genera and groups of bacteria in day 14 biofilms. Colony forming units (CFUs) on selective media for biofilms 
grown anaerobically following incubation of HA pegs with pooled saliva, plaque and tongue scrapings inoculum for 14 days. Results are presented as 
average counts ± SD and represent 3 experiments with 6-8 biofilms harvested per experiment. Symbols represent significance in changes associated 
with pre-conditioning, lines represent significance associated with growth media (two-way ANOVA, Tukey, p < 0.05). HSA-AGE: human serum albumin-
advanced glycation end product, HSA-C: human serum albumin-control, C: HSA-C control biofilm, P: biofilm representing periodontitis, HP: biofilm 
representing periodontitis and hyperglycaemia.    
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5.2.2. Next generation sequencing analysis of complex biofilms  
5.2.2.1. Taxonomical analysis of complex biofilms 
5.2.2.1.1. Sample richness, sample relatedness and biofilm composition at a 
phylum level 
In addition to analysis of biofilm composition using culture methods, a more 
comprehensive analysis of inocula, early (day 2) and mature (day 14) biofilms, was 
carried out using NGS (section 2.5). Results were pre-processed (section 2.6) prior to 
separation of reads into rDNA and DNA. rDNA reads were analysed following the QIIME 
pipeline (section 2.6.1) while short DNA reads were de novo-assembled to form DNA 
contigs and analysed used MEGAN (section 2.6.2). All analysis was limited to bacterial 
reads only. Taxonomic composition of the biofilms was analysed using the operational 
taxonomic unit (OTU) counts based on alignments against the human oral microbiome 
database (HOMD) for rDNA reads and NCBI non-redundant protein databases for DNA 
contigs (section 2.6.1 and 2.6.2).  
As an initial analysis step, alpha diversity of samples was carried out to determine if 
differences in richness (or the number of taxa in each sample) changed over time and 
under different growth conditions (Figure 5.5). Inoculum and early (day 2) biofilms were 
richer in taxa compared with mature biofilms (day 14). This is particularly evident when 
rDNA reads were used for alpha diversity measures (Figure 5.5A). When using DNA 
contigs for calculations, the results indicate a similar trend but with more variation in the 
diversity of mature biofilms (Figure 5.5B). The higher richness in early (day 2) biofilms 
compared with mature (day 14) biofilms is likely to be due to inocula including samples 
from many aspects of the mouth (including hard and soft oral tissues) and as such 
containing a plethora of bacteria, that although initially may colonise the HA pegs or have 
the potential to colonise, do not survive the growth conditions (pH, nutrient availability, 
oxygen levels etc) imposed in this system.  
Alpha diversity measures based on DNA contigs from (day 2) biofilm samples are higher 
using some calculation methods (Shannon, Simpson and Inverse Simpson) for HSA-C 
control biofilms but this did not reach significance (two-way ANOVA, Tukey, p > 0.05) 
(Figure 5.5B). This suggests pre-conditioning of HA pegs did not alter the early 
colonisation. Similar results were observed when using rDNA reads for alpha diversity 
measures (Figure 5.5A). In mature biofilms (day 14) no pre-conditioning/growth medium 
dependent patterns were evident in richness of biofilms.   
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Figure 5.5: Alpha diversity of inoculum for complex biofilms, early biofilms (day 
2) and mature biofilms (day 14). (A) Alpha diversity measures calculated based on 
rDNA alignments. (B) Alpha diversity measures calculated based on DNA contig 
alignments. Results represent 3 experiments with 6-8 biofilms harvested per 
experiment. HSA-AGE: human serum albumin-advanced glycation end product, HSA-
C: human serum albumin-control, C: HSA-C control biofilm, SM: serum medium. 
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Principle coordinate analysis (PCoA) with Bray-Curtis dissimilarity plots were generated 
for comparison of sample relatedness. These results indicate that bacteria colonising 
pegs pre-conditioned with low HSA-AGE concentrations clustered loosely together and 
independently of bacteria colonising pegs pre-conditioned with high HSA-AGE 
concentrations and HSA-C (Figure 5.6). In addition, inoculum, early (day 2) biofilms and 
mature (day 14) biofilms all clustered independently of each other. This clustering was 
observed for both rDNA and DNA contig based analysis. Together these data suggest 
that communities from the inoculum, those able to colonise and those able to survive in 
a mature biofilm are all relatively different to each other.  
Following analysis of sample relatedness, taxonomic composition at a phylum level using 
OTU counts from both rDNA and DNA contigs were analysed. Results are presented as 
percentage relative abundances (abundance of each OTU relative to all OTUs in each 
sample) to allow for a more accurate comparison between samples (Figure 5.7).  
Relative percentage abundances based on rDNA reads indicate inocula consisted 
predominantly of Firmicutes, Bacteroidetes and Proteobacteria with a smaller 
percentage of Actinobacteria and Fusobacteria accounting for a large portion of the 
remainder of the biofilm (Figure 5.7A). Following the two-day incubation of inoculum with 
HA pegs the predominance of Proteobacteria increased with a parallel decrease in 
Bacteroidetes when pegs were pre-conditioned with low HSA-AGE. However, pegs pre-
conditioned with high HSA-AGE or HSA-C resulted in phylum profiles similar to inoculum 
profiles. In mature biofilms (day 14) percentage of Proteobacteria and Fusobacteria 
decreased while percentage of Synergistetes increased. This was regardless of pre-
conditioning and growth media. 
Analysis of OTUs based on DNA contigs had similar trends to that described for rDNA 
(Figure 5.7B). Although similar in patterns of relative abundances, a higher prevalence 
of Actinobacteria and Fusobacteria was observed. Spirochaetes, which were almost 
undetectable when using rDNA were observed at higher percentages when using DNA 
contigs, but only in mature biofilms (day 14). In addition, lower abundances of 
Proteobacteria were observed in analyses of inoculum and early biofilms (day 2) using 
DNA contigs, but higher percentages were seen in mature biofilms (day 14) compared 
with analysis based on rDNA reads. As well as the changes in the most abundant phyla, 
DNA contig based analysis also allowed the detection of less prevalent phyla such as 
Chlamydiae, Cynobacteria, Tenericutes and others.   
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Figure 5.6: Principal component of analysis inoculum for complex biofilms, 
colonisation biofilms (day 2) and mature biofilms (day 14). (A) Plot for taxonomic 
clustering of inoculum/biofilms at a species level based on rDNA reads. (B) Plot for 
taxonomic clustering of inoculum/biofilms at a species level based on DNA contigs. 
Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-
AGE: human serum albumin-advanced glycation end product, HSA-C: human serum 
albumin-control, C: HSA-C control biofilm, SM: serum medium. 
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5.2.2.1.2.  
5.2.2.1.3. Taxonomic composition of early (day 2) biofilms at a genera level 
Figure 5.7: Relative percentage abundance of OTUs in inoculum, colonisation 
and mature biofilms. (A) Taxonomic percentage abundances based on rDNA reads. 
(B) Taxonomic percentage abundances based on DNA contigs. Results represent 3 
experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum 
albumin-advanced glycation end product, HSA-C: human serum albumin-control, C: 
HSA-C control biofilm. 
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Considering comparisons between the various biofilms remained relatively unchanged 
between rDNA and DNA contig based taxonomical analysis, the detection of more phyla 
using the DNA contig method, and increased accuracy in using DNA based alignment 
methods (rather than rDNA/16S alignment methods) for metagenomics, DNA contigs 
were used for a more in-depth analysis of the taxonomy.   
To get a clearer understanding of the changes in biofilm composition associated with 
pre-conditioning, OTU counts for both the inoculum and early (day 2) biofilms were 
analysed at a genera level, limited to the top 50 most abundant and excluding any 
unclassified taxa (Figure 5.8). The results indicated that Streptococcus accounted for the 
majority of the inoculum, followed by Prevotella, Veillonella and Actinomyces (Figure 
5.8A).  
Although Streptococcus was the most prevalent genus found in the inoculum accounting 
for approximately 17% of the genera present, following colonisation and growth on 
control pegs (pre-conditioned with HSA-C) and low HSA-AGE pegs, only between 9.5 
and 11% of the early (day 2) biofilm were composed of Streptococcus (Figure 5.8A and 
Figure 5.8B). While prevalence of Streptococcus decreased in early (day 2) biofilms 
grown on high HSA-AGE pegs compared with the inoculum (decreasing to approximately 
15%), the decrease was less than that seen under low HSA-AGE and control conditions. 
This perhaps suggests that in biofilms cultivated on high HSA-AGE pre-conditioned 
pegs, Streptococcus was able to colonise and grow more efficiently than under low HSA-
AGE and control conditions. Prevotella appeared to follow a similar trend, but with lower 
abundances in all conditions compared with Streptococcus.  
Prevalence of Veillonella decreased from approximately 8% in the inoculum to 
approximately 6% of control and high HSA-AGE early (day 2) biofilms (Figure 5.8A and 
Figure 5.8B). Interestingly, under low HSA-AGE conditions, early (day 2) biofilms had a 
decrease in Veillonella to approximately 3%. This perhaps suggests that while high 
concentrations of HSA-AGE do not impact colonisation compared with the control, low 
concentrations of HSA-AGE hinder Veillonella adherence to pegs pre-conditioned with 
health associated concentration of HSA-AGE (Figure 5.8B). In addition to the potential 
direct effects of HSA-AGE, it is possible that low HSA-AGE concentrations encourage 
the adherence or growth of other bacterial species which in turn hinder the growth of 
Veillonella.  In contrast, Actinomyces appeared to be unaffected by pre-conditioning and 
decreased to approximately the same relative abundance in all three pre-conditioning 
groups compared with the inoculum. Similarly, Fusobacterium was observed at 
comparable percentages in low HSA-AGE early (day 2) biofilms and control early (day 
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2) biofilms to those seen in the inoculum, but growth appeared to be hindered by higher 
concentrations of HSA-AGE.  
While the abundances of some genera decreased in early (day 2) biofilms compared 
with inocula, an increase in abundances was observed with other genera (Figure 5.8B). 
For example, relative percentage abundance of Neisseria increased from approximately 
2.5% seen in the inoculum to approximately 5% in biofilms grown on pegs pre-
conditioned with HSA-AGE and 3.5% in control pegs. This perhaps suggests HSA-AGE 
encourages colonisation of Neisseria in both HSA-AGE concentrations.  
In some cases, genera not observed at all in the top 50 genera of the inoculum were 
detected in early (day 2) biofilms (Figure 5.8B). These include Selenomonas¸ 
Campylobacter, Catonella and Oribacterium. In all four cases, abundances were higher 
in low HSA-AGE early (day 2) biofilms with few differences observed between HSA-C 
and high HSA-AGE early (day 2) biofilms perhaps suggesting low HSA-AGE 
concentrations produced conditions to encourage early colonisers either directly 
(producing binding sites or nutrients) or indirectly (encouraging binding/growth of 
bacteria which in turn produce conditions for binding or growth).  
To determine if changes observed reached significance, differential abundances of 
genera and species were plotted as log2 fold change between groups, with significance 
determined using a Wald test (p < 0.1) and Benjamini-Hochberg adjusted p-value 
(section 2.6). The plots show genera in low HSA-AGE early (day 2) biofilms (Figure 5.9) 
and high HSA-AGE early (day 2) biofilms (Figure 5.9B) which are found at higher or lower 
abundances compared with HSA-C. Differential abundances of genera in high HSA-AGE 
early biofilms compared with low HSA-AGE early (day 2) biofilms were also plotted 
(Figure 5.9C). As described previously, a lower abundance of Streptococcus, Veillonella 
and Prevotella was observed in low HSA-AGE early (day 2) biofilms compared with 
control (Figure 5.8B and Figure 5.9A). Interestingly, despite a lack of obvious difference 
in overall Actinomyces genera percentages (Figure 5.8A), certain species were found to 
have significantly lower abundance in low HSA-AGE early (day 2) biofilms compared 
with HSA-C control biofilms. In addition, a series of lower abundant genera (not in the 
top 50) were shown to be significantly decreased in low HSA-AGE early (day 2) biofilms 
compared with control early (day 2) biofilms. The results also indicated a significant 
increase in species from Neisseria, Catonella, Campylobacter and Fusobacterium 
(Figure 5.9A).  
When looking at genera in high HSA-AGE early (day2) biofilms compared with control 
biofilms fewer significant differences were observed (Figure 5.9B). Interestingly, species 
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from the Treponema genus were shown to be significantly decreased in high HSA-AGE 
early biofilms in comparison to control early biofilms. This decrease was also seen with 
T. denticola; a species generally associated with periodontitis. Contrastingly, P. 
intermedia (also associated with periodontitis) appeared to be increased in prevalence.     
The differences in biofilm composition of low HSA-AGE early (day 2) biofilms to high 
HSA-AGE early (day 2) biofilms were also analysed (Figure 5.9C). There was a 
significant decrease in the abundance of Treponema, Campylobacter, Fusobacterium, 
Haemophilus and Neisseria in biofilms cultivated on pegs pre-conditioned with high HSA-
AGE compared with biofilms grown on pegs pre-conditioned with low HSA-AGE, but a 
significant increase in the abundances of Veillonella, Streptococcus, Prevotella and 
Actinomyces. This was of particular interest given the association of the observed 
decreased species with periodontitis progression (section 1.1.2) and suggests that high 
HSA-AGE concentrations select for genera associated with periodontal health (such as 
Streptococcus and Actinomyces).  
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Figure 5.8: Relative percentage abundance of top 50 genera in inoculum (A) for 
complex biofilms and early (day 2) biofilms (B). Results represent 3 experiments with 
6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced 
glycation end product, HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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Figure 5.9: Differential abundance of genera in early (day 2) biofilms. Results 
represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human 
serum albumin-advanced glycation end product, HSA-C: human serum albumin-control, 
C: HSA-C control biofilm, P: biofilm representing increased serum observed in 
periodontitis with health associated HSA-AGE concentrations, HP: biofilm representing 
periodontitis and diabetes associated HSA-AGE concentrations.    
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Figure 5.9A: Differential abundance of genera in low HSA-AGE early (day 2) biofilms compared with control HSA-C early (day 2) biofilms. 
Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation end product, 
HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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Figure 5.9B: Differential abundance of genera in high HSA-AGE early (day 2) biofilms compared with control HSA-C early (day 2) biofilms. 
Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation end product, 
HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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Figure 5.9C: Differential abundance of genera in high HSA-AGE early (day 2) biofilms compared with low HSA-AGE early (day 2) biofilms. 
Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation end product, 
HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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5.2.2.1.4. Taxonomic composition of mature (day 14) biofilms 
Other biofilms were allowed to reach maturity prior to harvesting at day 14 (mature 
biofilms) and analysis using NGS. As with early (day 2) biofilms, for clarity, analysis was 
limited to the top 50 most abundant genera (Figure 5.10). The results appear to show 
limited differences in mature (day 14) biofilm composition. Differences observed were 
minor with the most obvious being those seen in abundances of Porphyromonadaceae, 
Synergistaceae and Peptostreptococcaceae families.  
Differential abundances were plotted as described previously to determine significant 
differences in mature biofilms (section 2.6). Biofilms representing consequences of 
hyperglycaemia and increased serum levels associated with periodontitis (HP) and 
biofilms representing periodontitis serum levels alone (P) were compared with control 
biofilms (C) (Figure 5.10A and Figure 5.10B). In addition, HP biofilms were compared 
with P mature (day 14) biofilms (Figure 5.10C). Lower concentrations of HSA-AGE 
encouraged the growth of some periodontitis associated genera (including 
Campylobacteria, Treponema, Porphyromonas and Fusobacterium) when compared 
with HSA-C control mature (day 14) biofilms and hindered the growth of Streptococcus 
(Figure 5.10A). On the other hand, HP mature (day 14) biofilms showed significantly 
higher prevalence of Prevotella salivae while other members of the Prevotella genera (P. 
oralis, P. intermedia) were observed at a lower abundance compared with C mature (day 
14) biofilms (Figure 5.10B). In addition, HP biofilms compared with C biofilms indicated 
that a higher concentration of HSA-AGE significantly hindered the growth of T. denticola, 
Porphyromonas catoniae, Porphorymonas endodontalis and Fusobacterium equinum 
while encouraging the growth of various Veillonella species (genera generally associated 
with a healthy periodontium), Campylobacter concisus, Porphyromonas sp oral taxon 
279, F. nucleatum and Haemophilus parainfluenzae (Figure 5.10B).  
29 species (including Fusobacterium periodonticum, Haemophilus influenza, T. 
denticola¸T. forsythia and various Porphyromonas species) were lower in abundance in 
HP biofilms and 24 species (including Veillonella, Prevotella and Streptoccocus species) 
had increased prevalence. As with early (day 2) biofilms, the presence of higher HSA-
AGE concentration in the pre-conditioning of pegs and during biofilms growth selected 
for genera associated with periodontal health (such as Streptococcus and Veillonella), 
while hindering growth of species typically associated with severe periodontitis (T. 
forsythia and T. denticola). 
 Chapter 5 – Complex biofilm model 
 
184 
 
Figure 5.10: Relative percentage abundance of top 50 genera in mature (day 14) biofilms. 
Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: 
human serum albumin-advanced glycation end product, HSA-C: human serum albumin-
control, C: HSA-C control biofilm, P: biofilm representing increased serum observed in 
periodontitis with health associated HSA-AGE concentrations, HP: biofilm representing 
periodontitis and diabetes associated HSA-AGE concentrations.    
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Figure 5.11: Differential abundance of genera in mature biofilms (day 14). 
Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-
AGE: human serum albumin-advanced glycation end product, HSA-C: human serum 
albumin-control, C: HSA-C control biofilm, P: biofilm representing increased serum 
observed in periodontitis with health associated HSA-AGE concentrations, HP: 
biofilm representing periodontitis and diabetes associated HSA-AGE concentrations.    
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Figure 5.11A: Differential abundance of genera in low HSA-AGE mature (day 14) biofilms compared to control HSA-C mature (day 14) 
biofilms. Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation end 
product, HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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Figure 5.11B: Differential abundance of genera in high HSA-AGE mature (day 14) biofilms compared to control HSA-C mature (day 14) 
biofilms. Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation end 
product, HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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Figure 5.11B: Differential abundance of genera in high HSA-AGE mature (day 14) biofilms compared to low HSA-AGE mature (day 14) 
biofilms. Results represent 3 experiments with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced glycation end 
product, HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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5.2.2.2. Metagenomics functional analysis of complex biofilms 
In addition to the above described taxonomic analysis, determination of overall functional 
profile of the microbiota in these environments was also established. Short DNA reads 
were assembled into contigs prior to being aligned against the NCBI non-redundant 
protein database. The resulting protein assignments were then annotated using SEED 
and EggNOG (section 2.6).  
As with taxonomical analysis, a PCoA using the Bray-Curtis distribution was carried out 
for counts based on both SEED and EGGNOG functions. PCoA using both databases 
indicate distinct clustering of inocula, early (day 2) biofilms and mature (day 14) biofilms 
with no discernible patterns between different pre-conditionings and growth media 
(Figure 5.12). Furthermore, no significant differences in functional profiles (Wald test, p 
< 0.1) were observed between the various early (day 2) biofilms and the mature (day 14) 
biofilms (Figure 5.14 and Figure 5.13).  
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Figure 5.12: Principal component of analysis inoculum for complex biofilms, early 
biofilms (day 2) and mature biofilms (day 14) based on functional profiles. (A) Plot 
for functional clustering of inoculum/biofilms based on SEED profiles. (B) Plot for 
functional clustering of inoculum/biofilms based on EggNOG profiles. HSA-AGE: human 
serum albumin-advanced glycation end product, HSA-C: human serum albumin-control, 
HA: hydroxyapatite. 
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Figure 5.13: Functional analysis of inoculum, colonisation (day 2) and mature (day 
14) biofilms using SEED database for annotations. Results represent 3 experiments 
with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced 
glycation end product, HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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Figure 5.14: Functional analysis of inoculum, colonisation (day 2) and mature (day 
14) biofilms using EggNOG database for annotations. Results represent 3 experiments 
with 6-8 biofilms harvested per experiment. HSA-AGE: human serum albumin-advanced 
glycation end product, HSA-C: human serum albumin-control, C: HSA-C control biofilm. 
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5.2.3. Co-culture experiments  
In addition to investigating the impact of HSA-AGE on complex biofilm models, the 
inflammatory response of TIGK cells to complex mature (day 14) biofilms was also 
tested. As a proof of principle study, co-cultures of biofilms with TIGK cells were carried 
out as described previously (section 2.14.1) and TIGK cell ROS and cytokine/chemokine 
release measured. The cytotoxic effect of biofilms on TIGK cells was also analysed 
(section 2.14.2). Biofilms were either suspended above a monolayer of TIGK cells with 
no direct contact between intact biofilms on the HA peg and TIGK cells (no direct contact) 
or placed directly on top of TIGK monolayer cells (direct contact) (Figure 2.13).   
It is important to note that the proof of principle co-cultures described below, utilise 
biofilms cultured using a single inoculum and as such only represent one biological 
replicate. While differences are observed, repeats are required for significance 
calculations.  
5.2.3.1. Analysis of cytokine/chemokine release from TIGK cells in response to 
co-cultures with biofilms  
5.2.3.1.1. Cytokine/chemokine release following uncolonised HA peg-TIGK cell 
co-cultures 
Inocula used to grow biofilms for NGS analysis were used to grow biofilms in parallel to 
determine use of the complex biofilms in co-culture experiments for the analysis of 
cytokine/chemokine release from TIGK cells. Biofilms were cultured with TIGK cells, with 
the addition of either 100 µg/mL HSA-AGE (as a representation of the consequence of 
hyperglycaemia) or 100 µg/mL HSA-C to TIGK culture media. The subsequent release 
of IL-8, IL-6 and IL-1β were analysed (section 2.4).  
To determine TIGK levels of cytokine/chemokine release in response to HA pegs, 
uncolonised pegs were co-cultured with TIGK cells with and without direct contact, in the 
presence of HSA-AGE, HSA-C or unsupplemented culture media (Figure 5.15). IL-8 
concentrations were generally increased when cells were cultured with direct HA peg 
contact compared with cell cultured with no contact (Figure 5.15, row 1). However, no 
obvious differences were observed in concentrations as a consequence of HSA-AGE or 
HSA-C addition to the culture media. Interestingly, concentrations of IL-8 following peg-
TIGK co-culture with HA-peg contact were more comparable to results from previous 
experiments examining TIGK IL-8 release in response to varying concentrations of HSA-
AGE or HSA-C (section 3.2.4). Similarly, IL-6 was also observed at increased 
concentrations with direct TIGK-peg contact compared with no contact (Figure 5.15, row 
2), however, the differences were less evident and no obvious differences were observed 
upon supplementation of the culture medium. Concentrations of IL-6 from TIGK cells in 
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the presence of HA pegs (with or without direct contact) were higher compared with those 
observed previously in TIGK cultures with HSA-AGE or HSA-C alone (section 3.2.4). 
Contrastingly, IL-1β appeared decreased in cells with direct peg contact compared with 
pegs without direct contact (Figure 5.15, row 3). It is important to note that concentrations 
of IL-1β were below 1 pg/mL and therefore below the accurate detection limit of the 
ELISA assay. These low IL-1β concentrations were observed previously following 
exposure of TIGK cells to varying concentrations of HSA-AGE and HSA-C (section 
3.2.4).  
The concentrations of cytokine/chemokines with HA pegs were considered as blank 
controls and show the basal level of cellular cytokine/chemokine releases in response to 
the presence of the pegs (in non-contact conditions) while pegs with direct contact also 
account for the cellular responses associated with cellular damage caused by the 
pressure of the peg.  
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Figure 5.15: Inflammatory response of TIGK cells in response to hydroxyapatite 
coated pegs. Cytokine/chemokine release from TIGK cells cultured with hydroxyapatite 
(HA) pegs either suspended above cell monolayer (no direct contact) or placed directly 
on TIGK monolayer (direct contact). Results are presented as means ± SD and represent 
1 experiment and 3-4 harvested biofilms.  
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5.2.3.1.2. IL-6 release following biofilm-TIGK cell co-cultures 
Biofilms were generated as described previously (section 2.13) under different 
conditions. After 14 days the mature biofilms were co-cultured with TIGK cells in culture 
media supplemented with 100 µg/mL HSA-AGE or HSA-C (section 2.14) and the 
resulting cytokine/chemokine release analysed (section 2.14.1).  
Biofilms suspended above a monolayer of cells (no direct biofilm-TIGK contact) could 
potentially decrease IL-6 production, as indicated by a decrease from 225.65 ± 87.19 – 
298.86 ± 117.65 pg/mL in HA peg controls (Figure 5.15A, row 2) to below 10 pg/mL 
(Figure 5.16A) regardless of peg pre-conditioning and biofilm growth conditions. In all 
biofilm-TIGK co-cultures, concentrations of IL-6 were very low with some co-cultures 
resulting in undetectable levels of IL-6. While IL-6 was detected following co-culture of 
TIGK cells with biofilms cultured on pegs pre-conditioned with HSA-C and low HSA-AGE, 
concentrations were low with large variations (as indicated by SD error bars of technical 
replicates). As such, IL-6 release following no direct biofilm-TIGK contact appeared to 
have little differences between the different biofilm types or upon supplementation of 
culture media with HSA-AGE or HSA-C.  
In contrast, co-cultures with direct biofilm-TIGK contact (Figure 5.16B) resulted in higher 
concentrations of IL-6 than co-cultures without direct biofilm-TIGK contact (Figure 
5.16A). However, the decreases observed following both co-culture methods were 
proportional, owing to the higher basal IL-6 concentrations in co-cultures with direct 
biofilm-TIGK contact (Figure 5.15, row 2). This suggests that a proportion of IL-6 release 
following biofilm-TIGK direct contact co-cultures could be due to the pressure and 
potential cellular damage/stress associated with the contact. Similar to results obtained 
from co-cultures without any direct biofilm-TIGK contact, IL-6 concentrations did not 
appear to be altered in the presence of HSA-AGE or HSA-C supplemented TIGK culture 
media, regardless of the type of biofilm used for biofilm-TIGK co-culture.  
Upon comparison of direct contact biofilm-TIGK co-cultures with biofilms representing 
the consequence of hyperglycaemia and serum condition of periodontitis (HP) to HSA-
C control biofilms (C), lower concentrations of IL-6 were observed (Figure 5.16B). 
Moreover, IL-6 concentration following direct contact biofilm-TIGK co-cultures with 
biofilms representing serum conditions of periodontitis alone (P) appear lower than those 
observed in C co-cultures regardless of culture medium supplementation (Figure 5.16B). 
Comparisons of co-cultures with HP and P biofilms, potentially show higher IL-6 
concentrations in HP. These data suggested that P and HP biofilms are able to supress 
IL-6 release by TIGK cells independently of HSA-AGE or HSA-C in TIGK culture media, 
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when compared with C biofilm co-cultures and HA peg controls. Furthermore, HP 
biofilms seem unable to decrease IL-6 concentrations to the same extent as P biofilms. 
5.2.3.1.3. IL-8 release following biofilm-TIGK cell co-cultures 
Following biofilm-TIGK co-culture without any direct biofilm-TIGK contact, IL-8 release 
was observed at lower concentrations, with ranges from 0 to 42.93 ± 8.73 pg/mL (Figure 
5.17A), in comparison to matched uncolonised HA peg controls (ranging from 100 ± 
67.21 – 125.81 ± 10.74 pg/mL, Figure 5.15). The results suggested biofilm-TIGK no 
contact co-cultures with culture media supplementation have a more pronounced 
reduction in IL-8 concentrations, although no obvious differences are observed between 
HSA-AGE and HSA-C. Furthermore, IL-8 concentrations did not appear to be influenced 
by the different biofilms generated in this system (Figure 5.17A). This suggests that 
although composition of these biofilms did not alter IL-8 concentrations, co-culturing of 
TIGK cells with biofilms did decrease concentrations.  
In contrast, IL-8 concentrations following biofilm-TIGK co-cultures with direct contact 
(Figure 5.17B) resulted in a general decrease in IL-8 concentrations in comparison to 
matched uncolonised HA peg-TIGK co-cultures (Figure 5.15). In addition, no obvious 
trends were observed between different biofilm types or upon addition of HSA-AGE/HSA-
C to the culture media.  
5.2.3.1.4. IL-1β release following biofilm-TIGK cell co-cultures 
Cellular release of IL-1β following no contact biofilm-TIGK co-cultures generally 
appeared to increase, with concentrations ranging from 0 to 15.68 ± 1.76 (Figure 5.18), 
compared with uncolonised HA peg controls (where concentrations ranged from 0 to 
0.50 ± 0.45, Figure 5.15). In addition, IL-1β concentrations also differed when comparing 
concentrations across different culture media supplementation. However, this was also 
only observed in response to biofilm-TIGK co-culture with certain biofilms and there was 
no obvious indication as to the cause of the changes (Figure 5.18A).  
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Figure 5.16: IL-6 concentration following biofilm-TIGK cell co-culture. IL-6 
release following co-culture with complex biofilms without (A) and with (B) direct 
biofilm-TIGK contact and supplementation of culture media with 100 µg/mL HSA-AGE 
or HSA-C. Results are presented as averages ± standard deviation and represent 1 
experiment and 3-4 harvested biofilms. HSA-AGE: human serum albumin-advanced 
glycation end product, HSA-C: human serum albumin-control. C: HSA-C control 
biofilm, P: biofilm representing increased serum observed in periodontitis with health 
associated HSA-AGE concentrations, HP: biofilm representing periodontitis and 
diabetes associated HSA-AGE concentrations.    
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The results also suggested higher concentration of IL-1β in HP biofilms co-cultured with 
TIGK cells in the presence of HSA-AGE compared with matched C biofilms following no 
contact co-cultures (Figure 5.18A), but no obvious differences with HSA-C or 
unsupplemented culture media. Furthermore, no evident differences were observed 
between P and HP biofilms. Despite some of the differences, no discernible pattern could 
be identified. This is perhaps due to the observed concentrations of IL-1β falling at the 
lower end of the detection limit and thus resulting in more variability and less reliability.  
No obvious differences were observed in IL-1β concentrations following biofilm-TIGK co-
cultures with direct biofilm-TIGK contact. This was observed when comparing to 
uncolonised HA peg-TIGK co-cultures, as well as between concentration associated with 
different biofilm types and the addition of HSA-AGE/HSA-C to the culture media (Figure 
5.15 and Figure 5.18B). 
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Figure 5.17: IL-8 concentration following biofilm-TIGK cell co-culture. IL-8 
release following co-culture with complex biofilms without (A) and with (B) direct 
biofilm-TIGK contact and supplementation of culture media with 100 µg/mL HSA-AGE 
or HSA-C. Results are presented as means ± standard deviation and represent 1 
experiment and 3-4 harvested biofilms. HSA-AGE: human serum albumin-advanced 
glycation end product, HSA-C: human serum albumin-control. C: HSA-C control 
biofilm, P: biofilm representing increased serum observed in periodontitis with health 
associated HSA-AGE concentrations, HP: biofilm representing periodontitis and 
diabetes associated HSA-AGE concentrations.    
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Figure 5.18: IL-1β concentration following biofilm-TIGK cell co-culture. IL-β release 
following co-culture with complex biofilms without (A) and with (B) direct biofilm-TIGK 
contact and supplementation of culture media with 100 µg/mL HSA-AGE or HSA-C. Results 
are presented as means ± standard deviation and represent 1 experiment and 3-4 
harvested biofilms. HSA-AGE: human serum albumin-advanced glycation end product, 
HSA-C: human serum albumin-control. C: HSA-C control biofilm, P: biofilm representing 
increased serum observed in periodontitis with health associated HSA-AGE concentrations, 
HP: biofilm representing periodontitis and diabetes associated HSA-AGE concentrations.    
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5.2.3.2. Analysis of cell cytotoxicity and ROS release from TIGK cells in 
response to co-cultures with biofilms  
In addition to changes in cytokine/chemokine profiles in response to TIGK co-culture with 
complex biofilms cultivated under different conditions, ROS release and cytotoxicity were 
also analysed. Biofilms were generated using pooled saliva, tongue scrapings and 
supragingival plaque from three volunteers and grown under conditions representing 
hyperglycaemia associated accumulation of HSA-AGE and the increased GCF serum 
associated periodontitis (100 µg/mL HSA-AGE, high HSA-AGE biofilms), high serum 
levels associated with periodontitis only (1 µg/mL HSA-AGE and 99 µg/mL HSA-C, low 
HSA-AGE biofilms), and HSA-C control biofilms (100 µg/mL HSA-C (section 2.14.2).  
To determine ROS release following introduction of HA pegs to TIGK cells, co-cultures 
were carried out with and without direct contact (Figure 2.13). As with previous co-
cultures, these were grown in culture media supplemented with HSA-AGE or HSA-C. 
Fluorescence readings were taken as a direct measurement of ROS release (section 
2.14.2), with readings corrected using matched unstained cells to eliminate background 
fluorescence associated with TIGK cells or culture media (Figure 5.19). The results 
showed that regardless of HSA-AGE presence, basal levels of ROS released from TIGK 
cells was low, with fluorescence (Ex485/Em535) readings below 5.  
In general, higher levels of ROS were observed in co-cultures with direct uncolonised 
HA peg-TIGK contact. This trend was observed across the different culture media (Figure 
5.19). This increase in ROS in direct contact HA peg-TIGK co-cultures could potentially 
be as a consequence of cell stress associated with the pressure of the peg resting on 
the TIGK monolayer. Given that results indicate differences in ROS levels of TIGK cells 
in response to uncolonised HA pegs under different co-culture condition, fluorescence 
readings following biofilm-TIGK co-cultures were corrected to matched unstained cells 
and fold change in ROS calculated relative to fluorescence readings induced by matched 
uncolonised HA pegs 
No direct biofilm-TIGK contact co-cultures indicated an overall increase in TIGK ROS 
release, with ROS levels of between 4.27 ± 0.70 and 15.81 ± 4.76 fold higher (Figure 
5.20A) than those observed in uncolonised HA peg-TIGK co-cultures (Figure 5.19). This 
is perhaps due to the increased stress the TIGK cells are under when in the presence of 
the biofilm, despite the lack of direct contact between the biofilms and the cells. It is also 
possible that the biofilms shed bacteria during the duration of the co-culture, so that 
although the biofilm is suspended over the TIGK monolayer, there is still bacteria-TIGK 
contact. Indeed, viable bacterial cells were collected from the supernatant following co-
culture (data not shown).  
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The results also suggest high HSA-AGE biofilms had the maximum ROS release when 
culture media was supplemented with HSA-AGE (Figure 5.20A). There also appears to 
be increased ROS release in high HSA-AGE biofilm-TIGK co-cultures in HSA-AGE 
supplemented culture media when compared with all co-cultures in unsupplemented 
culture media. Together the data suggested that the combination of HSA-AGE 
supplemented culture media with biofilms grown under high HSA-AGE and serum 
conditions could increase ROS release.  
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Figure 5.19: ROS release of TIGK cells following incubation with hydroxyapatite 
pegs and co-stimulated with HSA-AGE and HSA-C. Results are presented as means 
± SD and represent 1 experiment and 3-4 harvested biofilms. HSA-AGE: human serum 
albumin-advanced glycation end product, HSA-C: human serum albumin-control, HA: 
hydroxyapatite.  
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Figure 5.20: ROS levels and % cytotoxicity following no direct biofilm-TIGK 
contact co-cultures and % LDH release of biofilms. TIGK cells were co-cultured with 
complex biofilms without any biofilm-TIGK contact in HSA-AGE or HSA-C supplemented 
culture media.  Results are presented as means ± SD and represent 1 experiment and 
3-4 harvested biofilms. HSA-AGE: human serum albumin-advanced glycation end 
product, HSA-C: human serum albumin-control, HA: hydroxyapatite. 
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In parallel to measuring ROS release, the cytotoxic effect of biofilms on TIGK cells was 
also quantified following no contact co-cultures (section 2.14.1). Absorbance readings 
correlating to LDH release were taken as a measurement of cell death, which were 
subsequently corrected to matched culture media control readings. Percentage 
cytotoxicity was calculated relative to matched chemically lysed cell preparations 
representing 100% cell death. In addition to determining percentage cytotoxicity, LDH 
release of biofilms in the absence of TIGK cells were also calculated to determine if 
changes in LDH measurements were associated with biofilms (Figure 5.20B). In general 
there appears to be no differences in % cytotoxicity/LDH release between biofilms 
cultured with cells and biofilms cultured without. This suggests that low levels of LDH are 
potentially released from biofilms. Given the overall low % cytotoxicity/LDH release and 
the lack of obvious differences between different biofilms and different co-culture media, 
it can be concluded that these biofilms did not produce a detectable cytotoxic effect in 
TIGK cells when there was no direct biofilm-TIGK contact during co-culture.  
Similarly, both TIGK ROS release and cytotoxicity were analysed following direct contact 
of biofilm-TIGK co-cultures (Figure 5.21). The results indicated an increase in ROS levels 
of TIGK cells in response to biofilms, with between 2.06 ± 0.45 and 5.48 ± 2.00 fold 
increases (Figure 5.21A) relative to uncolonised HA peg-TIGK control co-cultures 
(Figure 5.19). Interestingly, the increases in ROS levels were lower in TIGK cells co-
cultured with direct biofilm-TIGK contact (Figure 5.21A) compared with those without 
(Figure 5.20A).    
Under the direct contact co-culture conditions, ROS levels were more variable with 
higher ROS observed between co-cultures in HSA-C supplemented culture media 
compared with unsupplemented culture media (Figure 5.21A).  Furthermore, in direct 
biofilm-cell co-cultures, addition of HSA-C to the culture medium increased ROS in a 
manner that appeared to be independent of biofilm type.  
Cytotoxicity analysis of biofilm-TIGK co-cultures with direct contact resulted in increased 
cytotoxicity in HSA-C supplemented culture medium (Figure 5.21B). In particular, HSA-
C control biofilms appeared to be more cytotoxic to TIGK cells compared with low and 
high HSA-AGE biofilm co-cultured in HSA-C supplemented culture media (Figure 5.21B). 
Interestingly, when in HSA-C supplemented culture medium, uncolonised HA pegs 
appeared to be more cytotoxic to TIGK cells than co-cultures with low or high HSA-AGE 
biofilms with HSA-C supplemented culture medium (Figure 5.21B), perhaps suggesting 
in the presence of HSA-C, low and high HSA-AGE biofilms are able to decrease 
cytotoxicity.  
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Figure 5.21: ROS levels and % cytotoxicity following no direct biofilm-TIGK 
contact co-cultures and % LDH release of biofilms. TIGK cells were co-cultured with 
complex biofilms with direct biofilm-TIGK contact in HSA-AGE or HSA-C supplemented 
culture media.  Results are presented as means ± SD and represent 1 experiment and 
3-4 harvested biofilms. HSA-AGE: human serum albumin-advanced glycation end 
product, HSA-C: human serum albumin-control, HA: hydroxyapatite. 
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5.3. Discussion  
The role of AGEs in inflammatory responses of mammalian cells is reasonably well 
established but the impact the presence of AGEs has on bacterial growth is still an area 
of research in its infancy (Ljahdali and Carbonero, 2017). Given that AGEs are found to 
be increased in the GCF of diabetic patients with further increases observed in 
participants with diabetes and periodontitis, it is possible AGEs play a role in the 
progression of periodontitis associated with diabetes (Kajiura et al., 2014). The study 
described in this chapter aimed to determine if the presence of HSA-AGE altered biofilm 
composition and if these cultured biofilms can be used to analyse changes in 
inflammatory responses (cytokine/chemokine release and ROS release) when co-
cultured with oral epithelial cells (TIGK) in the presence of HSA-AGE concentrations 
representative of diabetes.  
5.3.1. Microbial analysis of complex biofilms 
This preliminary study aimed to give an insight into the role of HSA-AGE on the 
composition of the oral microbiota. The compositional analysis of the inoculum indicated 
that the collected and combined oral samples, provided a good representation of the oral 
microbiome. It is well established that Streptococcus accounts for the majority of bacteria 
in most oral habitats (Moon and Lee, 2016). This correlates with the inoculum used for 
the complex biofilm study described here. Furthermore, HMP data analysis of seven oral 
sites (buccal mucosa, hard palate, gingiva, saliva, sub- and supra-gingival plaque and 
tongue scrapings), the predominant phyla in 182-206 healthy individuals were shown to 
be Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria and Actinobacteria (Human 
Microbiome Project, 2012, Zhou et al., 2013b, Moon and Lee, 2016). The inoculum 
isolated for this study was demonstrated to be dominated by these 5 phyla thus indicating 
their appropriateness as a starting point for the growth of model oral biofilms.  
One of the aims of this modelling study was to determine if pre-conditioning of HA pegs 
with HSA-AGE altered the colonisation of bacteria on to the surface of the pegs. We 
showed differences in biofilms harvested after 2 days prior to any media changes. 
Primarily, we demonstrated significant differences in biofilm composition of pegs pre-
conditioned with high HSA-AGE compared with those with low HSA-AGE. Interestingly 
the NGS data for this comparison showed a shift in composition where genera typically 
associated with periodontitis, such as Fusobacterium, Campylobacter, Treponema and 
Haemophilus, were less prevalent while genera generally associated with periodontal 
health (including Actinomyces, Streptococcus and Veillonella) were more prevalent. This 
suggests that diabetes associated GCF HSA-AGE concentrations actually encourage 
heath associated bacteria to colonise HA pegs.  
Chapter 5 – Complex biofilm model 
208 
 
Differential abundances comparing high HSA-AGE and high serum (HP) early (day 2) 
and high serum only early (P) (day 2) biofilms with HSA-C control (C) early biofilms 
indicated higher concentrations of HSA-AGE select for Streptococcus and Prevotella. In 
addition, they reduce colonisation of HA pegs by genera such as Capnocytophaga and 
Campylobacter. Contrastingly, low HSA-AGE concentrations appear to selected for 
Campylobacter and Capnocytophaga and hindered the colonisation by Streptococcus 
and Prevotella. Other bacterial genera (such as Actinomyces and Rothia) appear to be 
less prevalent in early biofilms with both health and diabetes associated HSA-AGE 
concentrations compared with colonisation of pegs with only HSA-C. It is possible this is 
a consequence of HSA-C (in health and control conditions). To determine if HSA-C 
affected biofilm composition, colonisation would need to be tested without any HSA-C 
addition to the sterile saliva during the pre-conditioning step.  
In a similar manner, mature P biofilms, appeared to reflect the colonisation patterns, such 
that a combination of low HSA-AGE (1 µg/mL) with HSA-C (99 µg/mL) in both the pre-
conditioning and the growth media resulted in higher abundances of periodontitis 
associated genera (Fusobacterium and Campylobacter) when compared with HSA-C 
control alone. HP biofilms, on the other hand, appeared to significantly encourage the 
growth of health associated genera and also showed a decrease in the abundance of 
periodontitis associated genera. Again, this suggests a role for HSA-C in the changes 
seen in biofilm composition, particularly when combined with low concentrations of HSA-
AGE. This is perhaps unsurprising when considering serum, which contains high levels 
of HSA, that is, as described previously, beneficial to the growth of bacteria such as P. 
gingivalis during periodontitis.  
Due to the differences in the initial colonisation of pre-conditioned pegs which would 
impact the composition of the mature biofilm, there is the potential that the different 
concentrations of HSA-AGE are adsorbed differently onto the surface of the peg or 
interact differently with proteins originating from the sterile saliva. This in turn could affect 
the ability of bacteria to adhere and grow on the surface of the HA pegs. In addition, the 
protein rich, serum supplemented medium could have selected for species that favour 
the conditions imposed by the model.  
A previous study utilising 16S rRNA sequencing of subgingival plaque from systemically 
healthy and diabetic patients, indicated an increase in prevalence of 
Propionibacteriaceae, Tannerella and Capnocytophaga in diabetes. The study also 
reported a decrease in Prevotella (Zhou et al., 2013a). Our model, using HSA-AGE as a 
representation of hyperglycaemia consequences in diabetes, demonstrated 
contradictory abundances with increases in Prevotella and decreases in Tannerella in 
mature (14 day) biofilms with high HSA-AGE but did show an increase in 
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Propionibacterium. Casarin et al. (2013) demonstrated periodontitis subgingival plaque 
of diabetic patients with poor glycaemic control had higher abundances of some genera 
(such as Neisseria, Actinomyces, Capnocytophaga, Fusobacterium, Veillonella, 
Aggregatibacter, Selenomonas and Streptococcus) and lower abundances of others 
(including Synergistetes, Tannerella, Porphorymonas and Eubacterium). The 
hyperglycaemia consequence models presented here, however, indicates a decrease in 
Fusobacterium and no differences in other genera such as Actinomyces and Neisseria. 
The results do, however, reflect the decrease in Porphyromonas, Tanerella and the 
increase in Veillonella.  
It is difficult to directly compare the results from this model to clinical samples, due to the 
limited nature of the model which does not take into account all the biochemical 
mechanisms involved in both diabetes and periodontitis. The differences in sequencing 
methods utilised by different groups (16S rRNA VS shotgun metagenomics) adds to the 
difficulty in accurately comparing studies. It is also important to note that analysis of 
biofilms grown in a laboratory also risk the loss of bacteria which cannot be cultured 
under these conditions, causing shifts in bacterial composition so that clinical samples 
cannot be accurately compared with model biofilms. The contrasting results, do however 
highlight the limitations of a model which does not take into account the complex 
interactions between bacterial and host cells and varying growth conditions found in the 
oral cavity.  
As well as NGS analysis of biofilms, viable counts were carried out. Although differences 
in facultative anaerobes were observed under different conditions, this method not only 
groups bacteria so that establishing finer changes is difficult (particularly in facultative 
aerobes, anaerobes and gram negative anaerobes) but also causes bias when 
accounting for the broad range of bacteria that cannot be cultured in a laboratory setting 
or indeed grown independently of a biofilm. Despite this, viable counts do provide some 
information. For example, Lactobacilli which were observed in the inoculum, were unable 
to colonise the pegs and only grew in mature biofilms with limited success and in general 
were not observed under high HSA-AGE concentrations. This correlates with previous 
studies which have shown inhibition of colonic Lactobacilli growth when diets were high 
in AGEs (Hernandez et al., 2011, Seiquer et al., 2014, Hellwig et al., 2015).   
5.3.2. Inflammatory responses by TIGK cells in response to complex biofilms 
The results indicated that, despite the general decrease in TIGK IL-8 and IL-6 
concentrations in response to biofilms, limited differences were observed between P and 
HP co-cultures or in response to the addition of HSA-AGE in the culture media. In both 
cases, however, it can be concluded that concentrations of cytokines released were 
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higher when biofilms were in direct contact with the cells compared with biofilms 
suspended over a TIGK monolayer. Given the correction of results for pressure 
associated cytokine/chemokine release (uncolonised HA peg-TIGK co-cultures), this 
suggests direct contact between the biofilm initiates a heightened immune response in 
TIGK cells. The difference in concentrations following with and without contact co-
cultures also suggests bacteria shed from the biofilm cannot initiate the same 
inflammatory response as bacteria of the intact biofilm.  
Although IL-6 concentrations were decreased to the same extent in both co-culture 
methods relative to their respective uncolonised HA peg controls, the extent by which IL-
8 concentrations decreased compared with uncolonised HA peg controls was lower in 
co-cultures with direct contact compared with those without. This suggests when biofilms 
are in direct contact with TIGK cells, they decrease IL-6 concentration but do not 
markedly change IL-8 concentrations compared with uncolonised HA peg controls.  
The study hypothesised that co-culturing of biofilms with TIGK cells in HSA-AGE 
supplemented culture media would lead to altered cytokine concentrations. The results 
for both IL-8 and IL-6, however, showed minimal differences when co-culturing TIGK 
cells with biofilms. A trend was observed in direct biofilm-TIGK contact co-cultures, 
where concentrations of IL-6 were generally higher when HSA-AGE was added to the 
culture media. In addition, concentrations were higher with diabetes and periodontitis 
biofilms compared with periodontitis biofilms alone. Together this indicates a potential 
for higher IL-6 concentrations when the co-culture models high HSA-AGE concentrations 
throughout (HP biofilm-TIGK co-cultures in HSA-AGE supplemented culture media) 
compared with the low HSA-AGE model (P biofilm-TIGK co-culture in unsupplemented 
culture media) with direct biofilm-cell contact. The same trend and observations can be 
made in concentrations of IL-8 in direct biofilm-TIGK contact co-cultures.  
It is important to note, the cytokine analysis was carried out following biofilm growth with 
a single inoculum and without any replicates on separate Calgary devices and although 
biofilms were replicated on multiple pegs no true biological replicates were generated. It 
is possible with more biological replicates differences in cytokine concentrations will be 
more evident. However, the study does indicate the potential use of the model to analyse 
changes in cytokines as a consequence of co-cultures using biofilms cultured on HA 
pegs. In addition, the trends observed highlight the requirement for further analysis.   
Furthermore, the cytokine concentrations observed following HSA-C addition to the 
culture medium and their differences compared with unsupplemented culture media 
implies HSA-C impacts cytokine release by TIGK cells. It is possible that the lack of 
serum in TIGK culture media means TIGK cells are sensitive to the presence of the 
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unmodified HSA. To fully understand if this is the case, cells need to be cultured in serum 
supplemented medium and perhaps conditioned for long term culturing in serum 
supplemented media.  
Interestingly our studies demonstrated higher ROS levels in no contact HP biofilm-TIGK 
co-cultures in HSA-AGE supplemented culture media. This suggested under high HSA-
AGE conditions (for both biofilm growth and cell culture) cells released more ROS 
compared with co-cultures in unsupplemented culture media and indeed compared with 
co-culturing in HSA-AGE culture media but with P or C biofilms. There are, however, no 
differences between HSA-AGE and HSA-C media supplementation, again suggesting 
TIGK cells do respond to the presence of HSA-C. This is further confirmed in direct 
biofilm-TIGK contact co-cultures where cells cultured in the presence of HSA-C release 
higher levels of ROS compared with both HSA-AGE supplementation and no 
supplementation of the culture media.  
Cytotoxicity analysis indicated, in no contact biofilm-TIGK co-cultures, the changes 
observed in cytokine release (over-all decreases in IL-8 and IL-6 in response to biofilm 
presence) and in ROS levels were not due to cell death. In all no contact biofilm-TIGK 
co-cultures, cytotoxicity was below 5%, thus, biofilms co-cultured suspended above the 
TIGK monolayer were not toxic to the cells over the time frame tested. When co-cultured 
with direct biofilm-cell contact there appeared to be higher cellular cytotoxicity suggesting 
that these co-culture conditions caused more damage to the cells. The increase in 
cytotoxicity could go towards explaining the overall decrease in ROS release observed 
in contact co-cultures compared with no contact co-cultures as the ROS assay requires 
intracellular processing for detection. It could also potentially explain the higher IL-8 and 
IL-6 concentrations observed in contact co-cultures.  
5.3.3. Conclusion 
Although differences were observed in biofilm composition in response to HSA-AGE, the 
lack of differences in functional profiles suggests the need for a transcriptomic approach 
to fully comprehend the role of HSA-AGE in shaping the biofilm. Transcriptomics could 
help establish if changes occurring at a protein level in response to HSA-AGE altered 
the way the biofilm as a whole is functioning at the time of sampling.  
In addition, due to cellular inflammatory responses appearing to show limited differences 
between biofilm types and culture media during co-culturing, biological repeats are 
required with multiple inocula. It would also be beneficial to test inflammatory responses 
of immune cells (neutrophils) in biofilm-cell co-cultures particularly when considering 
their crucial role and high prevalence in the oral cavity (as described in detail previously).  
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The model presented here uses increase HSA-AGE to reflect long term effects of 
hyperglycaemia and as such does not fully model diabetes. Despite caveats, the model 
could give an insight into the contribution of hyperglycaemia/HSA-AGE on oral 
microbiota and help in establishing the role of AGEs in linking diabetes to periodontitis. 
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6. Preliminary feasibility study of neutrophils, chemokines/cytokines, MMPs and 
bacterial profiles in clinical samples from healthy and periodontitis 
participants  
6.1. Introduction  
Interactions between the oral microbiota and the host immune responses are in a 
delicate balance and involve complex mechanisms involving interactions between a 
variety of cells and molecules including cytokines/chemokines and adhesion molecules 
(Hajishengallis and Korostoff, 2017). The immune responses central to the maintenance 
of oral health, the dysregulation of these responses involved in the progression of 
periodontitis and the potential roles in linking diabetes to periodontitis have been 
discussed in detail in section 1.1.2.  
Of the cells involved in oral health, neutrophils play a crucial role. As described previously 
(section 1.2.1), neutrophils (a form of terminally differentiated white blood cells) are 
highly prevalent in the gingival crevice, accounting for more than 95% of leukocytes 
present and providing the first line of defence against microbial invasion of gingival tissue 
(Delima and Van Dyke, 2003, Hajishengallis and Hajishengallis, 2014, Dutzan et al., 
2016, Hajishengallis and Korostoff, 2017). Deficiencies decreasing the number of 
neutrophils (chronic or cyclic neutropenia), disorders impacting the movement of 
neutrophils (leukocyte adhesion deficiencies) or disorders compromising antimicrobial 
properties of neutrophils (such as Papillon Lefevre and morbus Kostman) exemplify the 
necessity of neutrophil homeostasis and the critical inflammatory regulation they provide 
as individuals with these conditions are more susceptible to periodontitis (Hajishengallis 
and Hajishengallis, 2014, Moutsopoulos et al., 2014, Hajishengallis and Korostoff, 2017). 
Although decreases in neutrophils in gingival tissues and the consequent impairment of 
immune regulation are associated with increased prevalence of periodontitis, neutrophils 
also play a vital role in periodontal tissue destruction when recruitment to the periodontal 
tissues is increased through improper regulation or inability to clear/control periodontitis 
associated microbial challenge (Hajishengallis and Moutsopoulos, 2014, Hajishengallis 
et al., 2015, Hajishengallis and Korostoff, 2017). Some of the central mechanisms 
involved in neutrophil associated tissue destruction in periodontitis and their potential 
roles in the diabetes-periodontitis relationship have been discussed in detail previously 
(section 1.2).  
It was, therefore, the aim of this preliminary clinical study to determine the feasibility and 
validate the methodology for the determination of systemic neutrophil migration, 
phagocytosis and respiratory burst in systemically healthy participants with and without 
periodontitis. Following this preliminary study, the long-term aim is to evaluate these 
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neutrophil functions in diabetics with and without periodontitis to determine their role in 
diabetes associated periodontitis. 
In addition, this study aimed to create a cytokine/chemokine profile based on a panel of 
nine cytokines/chemokines at both local and systemic levels in these participants. A 
bespoke panel including IL-8, IL-6, IL-1β, macrophage inflammatory protein 1α (MIP-1α), 
TNF-α, monocyte chemoattractant protein 1 (MCP-1), IL-17A, IL-17F and IL-23 was 
designed for this analysis. Some of these chemokines/cytokines (IL-8, IL-6, IL-1β and 
TNF-α) are central to immune regulation in the oral cavity and their roles in health 
maintenance, periodontitis progression and the periodontitis-diabetes relationship have 
been discussed in detail previously (section 1.2.4).   
Others (IL-17A, IL-17F and IL-23) are crucial in Th17 mediated immune responses 
(section 1.2.2) and have been demonstrated to initiate periodontitis associated bone 
resorption (Kotake et al., 1999). A particular interest was paid to IL-17A due to evidence 
demonstrating higher concentrations of IL-17A in serum, saliva and plaque of 
periodontitis patients (Awang et al., 2014). Furthermore, IL-17A+ and IL-17F+ Th17 cells 
were both observed at a higher prevalence in chronic periodontitis participants thus, IL-
17F was also included in the panel (Luo et al., 2014). However, evidence of the role of 
IL-17F in periodontitis progression is not conclusive, with a study demonstrating an IL-
17F-associated protection from periodontitis in both humans and experimental models 
(Moretti et al., 2015). In addition, given the role of these cytokines in the regulation of 
neutrophils and the potential role of neutrophils in the periodontitis-diabetes relationship, 
their inclusion in the panel was crucial for the long-term aim of analysing the 
cytokine/chemokine profiles in diabetics with and without periodontitis.  
The addition of MCP-1 to the cytokine/chemokine panel was based on the production of 
MCP-1 by a variety of cells in response to signals such as TNF-α, IL-1β and IFN-γ. 
Considering the increase in these cytokines associated with periodontitis and diabetes, 
there is a possibility that MCP-1 concentrations also increase in periodontal tissues 
during periodontitis. Indeed, MCP-1 has previously been shown to be increased at a 
gene and protein level in periodontitis (Hanazawa et al., 1993, Yu et al., 1993, Gupta et 
al., 2013). Furthermore, an animal study examining the concentration of MCP-1 in 
diabetic and periodontitis rat models showed a correlation between increased MCP-1 in 
both diabetic and periodontitis rats and increased gingival alveolar bone loss and 
inflammatory cell infiltration (Sakallioglu et al., 2008).  
Similarly, the addition of MIP-1α was based on evidence demonstrating an increase in 
salivary levels in periodontitis with higher levels associated with bone loss (Fine et al., 
2014). Furthermore, MIP1-α concentrations were shown to be higher in the GCF of 
 Chapter 6 – Clinical study 
 
215 
 
periodontitis patients with diabetes compared with those without diabetes regardless of 
site disease state (Duarte et al., 2014).    
Neutrophil activation, in addition to release of cytokines/chemokines also involves the 
release of MMPs which aid in neutrophil migration and microbial clearance. However, if 
MMP release is dysregulated, an increase in MMP associated tissue destruction is 
observed (Silva et al., 2015). The role of MMPs in periodontitis, their impact on tissue 
destruction and their role in linking diabetes to periodontitis has been described in detail 
previously (section 1.2.3). As well as the above-mentioned analysis, this preliminary 
study aims to quantify the concentrations of MMP8 and MMP9 as well as their inhibitor 
(TIMP1) in GCF and saliva collected from the participants.  
Finally, the intention of this preliminary study was  to establish a microbial profile based 
on genetic information recovered directly from the saliva and GCF (metagenomics) 
(Thomas et al., 2012). The metagenomic NGS data were analysed for both taxonomy 
and microbial function. This could potentially provide invaluable information on the role 
of the microbiome in the pathogenesis of periodontitis. This is of particular interest when 
considering established differences in microbial profiles in periodontitis (including 
increases in red complex bacteria) and the advancement of culture independent methods 
for bacterial identification increasing our knowledge of the bacteria involved in 
periodontitis (Hiranmayi et al., 2017). As discussed in detail previously (section 1.4) 
information regarding microbiota profiles in diabetics with and without periodontitis are 
contradictory and more study is required.  
6.2. Results 
6.2.1. Neutrophil analysis 
6.2.1.1. Migration 
Leukocyte rich plasma was isolated from whole blood of five systemically healthy 
participants with periodontitis and five without and neutrophil migration was assessed 
using the Migratest assay (section 2.7.2). Although analysis was carried out on whole 
blood, and neutrophils were not isolated, an attempt was made to gate around 
neutrophils only (cell population with higher SSC due to greater intracellular 
complexity/higher granularity) during acquisition and analysis.  
Data from all samples were acquired and analysed to quantify the number of migrated 
neutrophils, by counting the number of cells which had undergone migration as well as 
the changes in cell shape. The total number of cells that had migrated into the chamber 
was quantified, in addition their expression of L-selectin and cell size was analysed as 
indicators of activation by fMLP.  
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Neutrophils were identified and gated, followed by generation of FITC/L-selectin 
fluorescence histograms for this cell population (section 2.7.2). Thresholds were set on 
FITC histogram/L-selectin expression using non-migrated samples (samples remaining 
within the unstimulated cells inset). As show in Figure 6.1C, cells that failed to migrate 
and remained in the upper insert compartment had a higher FITC fluorescence as a 
consequence of higher L-selectin expression and, thus, more binding of the anti-L-
selectin-FITC antibody. Activated cells (Figure 6.1B), on the other hand, have shed L-
selectin and as such have a lower FITC fluorescence (Hafezi-Moghadam et al., 2001, 
Venturi et al., 2003). Unstimulated neutrophils had a proportion of cells with low L-
selectin and a proportion of cells with higher L-selectin (Figure 6.1A). Furthermore, the 
total number of neutrophils migrating in unstimulated samples was lower than those 
migrating following stimulation (Figure 6.1). 
A total count of migrated neutrophils was carried out (with counts normalised to counting 
beads as described previously) in addition to calculation of percentage of neutrophils 
with low L-selection (Figure 6.3). Changes in neutrophil size were also quantified. A 
decrease in FSC of stimulated neutrophils (Figure 6.2A and Figure 6.3C) compared with 
unstimulated neutrophils (Figure 6.2B and Figure 6.3C) was observed. This correlates 
to a decrease in cell size, a process neutrophils engage to allow more efficient movement 
through blood vessels and into tissues during infection.  
Samples from all donors were analysed for total number of migrated neutrophils, 
percentage of activated cells (as indicated by reduction in L-selectin) and neutrophil size 
(Figure 6.3). Analysis of the data in this manner allowed determination of replicability of 
the methods. When analysing the number of cells that migrated through the membrane, 
there appeared to be varying degrees of replicability in technical repeats. Samples from 
certain participants (for example, participant 2 and participant 10) show large variations 
between technical repeats in both stimulated and unstimulated samples, while samples 
from other participants (e.g. participant 1 and participant 4) show limited differences 
within their technical repeats (Figure 6.3A). When analysing the percentage of cells with 
decreased L-selectin and changes in cell shape these variations were no longer apparent 
and little difference was observed between technical replicates (Figure 6.3B and Figure 
6.3C). 
Samples were also analysed in healthy and periodontitis groups using averages of 
technical repeats. Changes within participant groups were compared for significant 
differences (two-way ANOVA, Tukey, p < 0.05) followed by comparisons of healthy and 
periodontitis participant groups (two-way ANOVA, Bonferroni, p < 0.05). 
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Figure 6.1: Representative flow cytometry data for neutrophil migration analysis. (A) Histogram showing L-selectin associated FITC against the 
number of neutrophils from unstimulated whole blood. (B) FITC histogram shows population shift to the lower L-selectin-FITC region upon neutrophil 
stimulation with fMLP. (C) Histogram for non-migrated cells remaining in the unstimulated insets (negative control).   
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Figure 6.2: Representative flow cytometry data for neutrophil size changes following migration. (A) Contour plot showing FSC/SSC from 
unstimulated whole blood. (B) Contour plot following stimulation with fMLP shows a decrease in neutrophil cell size as indicated by a decrease in FSC 
(C) Population hierarchy.  
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In healthy participants there was no significant difference in the number of cells that had 
migrated from unstimulated samples compared with stimulated samples (Figure 6.4A), 
whereas significantly more neutrophils appeared to have migrated through the insert 
upon stimulation in samples from participants with periodontitis. Interestingly there was 
no significant difference in the number of migrated neutrophils when comparing healthy 
and periodontitis participants regardless of neutrophil stimulation (Figure 6.4A). 
Although not significantly different, there appeared to be a lower number of migrated and 
non-migrated neutrophils in the unstimulated samples of periodontitis participants, 
perhaps indicating a lower total peripheral neutrophil number in periodontitis participants. 
Furthermore, the results suggest potentially more variation in the number of migrated 
neutrophils in patients with periodontitis compared with the healthy participants, 
particularly upon neutrophil stimulation. However, these observations could be a 
consequence of the small sample size and are therefore not conclusive.  
When analysing the percentage of migrated neutrophils with decreased L-selectin, there 
was a significant difference between unstimulated, stimulated and non-migrated 
neutrophils in both periodontitis and healthy participants (Figure 6.4B). As expected, a 
higher percentage of migrated neutrophils had decreased L-selectin when stimulated 
compared with unstimulated and those that remained in the insert for both groups. Upon 
stimulation, 99.54% ± 0.14 (periodontitis) and 99.79% ± 0.083 (healthy) of neutrophils 
that passed through the membrane had decreased L-selectin, thus indicating stimulation 
encouraged migration which was not impacted by periodontitis. Although no difference 
was observed in stimulated migrated neutrophil L-selectin expression between health 
and periodontitis, fewer migrated neutrophils had low L-selectin (indicative of activation) 
in unstimulated samples. This suggests a higher proportion of neutrophils in healthy 
individuals were active despite a lack of stimulation.  
During migration, in samples from healthy participants there was a significant decrease 
in cell size when neutrophils were stimulated (Figure 6.4C). Although no significant 
changes were observed in cell size of stimulated migrated neutrophils in participants with 
periodontitis compared with unstimulated neutrophils, stimulated neutrophils showed a 
decreased size compared with non-migrated neutrophils. In both healthy and 
periodontitis participants, both unstimulated and non-migrated neutrophils showed no 
significant differences in cell size.  
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Figure 6.3: Analysis of neutrophils migration by participant. (A) Total number of neutrophils that migrated through the membrane, normalised to 
the counting beads. (B) Percentage of total migrated cells with low L-selectin-FITC (C) Changes in neutrophil FSC as an indication of changes in cell 
size. 
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Figure 6.4: Migration of leukocyte in samples from healthy and periodontitis participants. (A) Total number of leukocytes that 
migrated through the insert membrane when unstimulated and stimulated with fMLP. All samples were normalised to a set of 2000 counting 
beads. (B) Percentage of migrated cells with decreased L-selectin expression. Symbols (*, **) indicate significant differences between 
groups with matching symbols. (C) Changes in leukocyte cell size as detected by change in FSC. Statistical significance was determined 
by comparing samples within groups and between groups using two-way ANOVA followed by a Tukey/Bonferroni, with significance  
p < 0.05.  
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In addition to no differences being observed in neutrophil L-selectin expression and 
number of migrated cells between healthy and periodontitis patients, there also appeared 
to be no significant differences in cell size changes when comparing the two groups, 
regardless of neutrophil stimulation. Taking both of these indicators of neutrophil 
migration/activation together, we can conclude that in this cohort, the assay provided no 
evidence of changes in neutrophil migration in periodontitis.  
6.2.1.2. Analysis of neutrophil phagocytosis 
Phagocytosis by the peripheral neutrophils from the periodontitis and healthy participants 
was also analysed. Whole blood was processed to generate LRP, and data acquired as 
previously described (section 2.7.3). As with migration analysis, neutrophils were not 
isolated specifically prior to assay but were gated and specified during analysis. 
Determination of neutrophil phagocytosis followed stimulation of neutrophils with various 
FITC labelled E. coli concentrations, so that measurement of FITC correlated with the 
amount of labelled E. coli phagocytosed by neutrophils (described in section 2.7.3). 
Thresholds for FITC were set using unstimulated samples (Figure 6.5A), such that any 
FITC fluorescence seen above the fluorescence of the unstimulated samples 
(background fluorescence), was an indication of neutrophil phagocytosis. Upon 
stimulation, a dose dependent uptake of E. coli was observed (Figure 6.5). 
As with the analysis of neutrophil migration, technical repeats of neutrophil phagocytosis 
were analysed for validation of methodology (Figure 6.6). There was limited variation 
between technical repeats when analysing the percentage of neutrophils phagocytosing 
(Figure 6.6A). This was particularly evident when cells were stimulated with 2 x 107 E. 
coli, perhaps due to the stimulation of maximum phagocytosis. Similarly, when 
measuring the mean fluorescent intensity (MFI) of phagocytosed E. coli (Figure 6.6B) as 
an indication of phagocytic activity, limited variation was observed between technical 
repeats, thus, indicating the replicability of this method.  
Participant data were then analysed according to periodontal health. The results 
indicated a significant increase in the percentage of neutrophils phagocytically active 
upon stimulation, regardless of stimulant concentration (Figure 6.7A), in both healthy and 
periodontitis participant groups. Stimulation with 2 x 107 E. coli induced maximum 
proportions of neutrophils to be phagocytically active; 97.4% ± 1.1 (healthy) and 97.71% 
± 0.83 (periodontitis), with a significant dose dependent decrease in the percentage of 
neutrophils performing phagocytosis (Figure 6.7B).
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Figure 6.5: Representative flow cytometry data for phagocytosis analysis. (A) Histogram of E. coli FITC fluorescence of unstimulated neutrophils. 
Fluorescence observed within the FITC negative region is considered background fluorescence due to lack of E. coli in samples. (B) – (D) histograms 
demonstrating FITC fluorescence associated with stimulation with 2 x 106 E. coli (B), 5 x 106 E. coli (C) and 2 x 107 E. coli  
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Figure 6.6: Analysis of neutrophil phagocytosis by participants. (A) Percentage of 
neutrophils phagocytically active as determined by the percentage of neutrophils which 
have phagocytosed FITC labelled E. coli. (B) Mean fluorescence intensity (MFI) of 
ingested FITC labelled E. coli as an indication of neutrophil phagocytic activity. 
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Figure 6.7: Phagocytosis by neutrophils in samples from healthy and periodontitis 
patients. (A) Percentage of neutrophils which had engulfed FITC labelled E. coli as an 
indication of phagocytically active neutrophils. (B) MFI of FITC labelled E. coli engulfed 
by neutrophils as an indication of neutrophil phagocytic activity. Statistical significance 
was determined by comparing samples within groups (two-way ANOVA, Tukey) and 
between healthy and periodontitis (two-way ANOVA, Bonferroni) with significance  
p < 0.05. Symbols (*, **) indicate significant differences between stimulation groups with 
matching symbols (black * indicate differences in healthy participants, grey * indicate 
differences in periodontitis participants). 
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In healthy participants, stimulation with at least 5 x 106 E. coli was required to induce 
phagocytosis sufficient to significantly increase the fluorescence of the neutrophils. In 
periodontitis participants, stimulation with 2 x 106 E. coli was sufficient to induce 
phagocytosis to significantly increase the fluorescence of the neutrophils. In addition, a 
significant dose dependent decrease in phagocytic activity was observed between the 
stimulated neutrophils.  
Along with analysis within groups, percentage of neutrophils undergoing phagocytosis 
and the phagocytic activity of these neutrophils was compared between healthy and 
periodontitis groups (two-way ANOVA, Bonferroni, p < 0.05) and in both cases no 
significant differences were observed. Similar to migration analysis, we can conclude 
that in this cohort, the assay provided no evidence of changes in neutrophil phagocytosis 
in periodontitis.  
6.2.1.3. Analysis of neutrophil respiratory burst     
Finally, neutrophil respiratory burst from whole blood of these participants was analysed. 
In a similar manner to phagocytosis analysis; LRP was generated, respiratory burst was 
activated using various concentrations of E. coli and fluorescence correlating to ROS 
dependent oxidation of DHR 123 to the fluorogenic R123 was detected at wavelength 
488 nm (section 2.7.4). As with previous assays, neutrophils were identified during 
analysis.  
An initial analysis gate was set using unstimulated samples to distinguish between R123 
negative (background fluorescence – Figure 6.8A) and R123 positive (neutrophils 
undergoing respiratory burst). An E. coli stimulation dose dependent increase was 
observed in R 123 fluorescence (Figure 6.8B-D).  
Methodology for respiratory burst was validated by ensuring replicability between 
technical repeats. Limited variation between samples from the same participant was 
observed for analysis of both the percentage of neutrophils undergoing respiratory burst 
(Figure 6.9A) and the amount of ROS generated by these neutrophils (Figure 6.9B). In 
addition to stimulation of respiratory burst by E. coli, neutrophils were also stimulated by 
PMA (which directly activates protein kinase C for downstream ROS release) and fMLP 
(which binds to its cell surface receptors to activate signalling cascades that result in 
ROS release) (Hu et al., 2011) to activate the respiratory burst independently of 
phagocytosis.  
A significant increase (two-way ANOVA, Tukey, p < 0.05) was observed in the 
percentage of neutrophils undergoing respiratory burst upon stimulation with E. coli 
(regardless of E. coli concentration) and PMA compared with unstimulated samples in 
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both healthy and periodontitis participant groups (Figure 6.10). Furthermore, a significant 
dose dependent increase in the percentage of neutrophils undergoing respiratory burst 
was observed (Figure 6.10A) but no differences were detected in the amount of ROS 
released by these neutrophils, except upon stimulation with PMA (Figure 6.10B). In both 
cases no significant differences between healthy and periodontitis groups was seen. 
In addition, a dose dependent decrease was observed in the percentage of neutrophils 
undergoing respiratory burst upon stimulation with E. coli in both groups. This was 
significant comparing stimulation with 2 x 107 E. coli and 2 x 106 E. coli, but not when 
comparing  stimulation with 2 x 107 E. coli and 5 x 106 E. coli or 5 x 106 E. coli and 2 x 106 
E. coli. This perhaps indicates that the percentage of neutrophils undergoing respiratory 
burst was at its maximum when stimulated by both   2 x 107 E. coli and 2 x 106 E. coli but 
a 10 fold reduction in the stimulant was required to significantly decrease the percentage 
of neutrophils undergoing respiratory burst. Although stimulation by PMA led to 
93.98%±3.5 (healthy) and 96.8%±1.76 (periodontitis) of neutrophils undergoing 
respiratory burst, stimulation by fMLP showed no significant difference compared with 
unstimulated samples. Furthermore, there appeared to be no significant difference when 
comparing responses from healthy participants with those with periodontitis.  
As with previous neutrophil analysis, we can conclude that in this cohort, the assay 
provided no evidence of changes in neutrophil respiratory burst in periodontitis. 
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Figure 6.8: Representative flow cytometry analysis of neutrophil respiratory burst. (A) Histogram of background neutrophil R123 
fluorescence in unstimulated samples. (B) – (D) Histograms of R123 fluorescence in samples stimulated with 2 x 106 E. coli (B), 5 x 106 E. coli 
(C) or 2 x 107 E. coli (E).  
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Figure 6.9: Participant neutrophil respiratory burst analysis. (A) Percentage of 
neutrophils undergoing respiratory burst as determined by the percentage of R123 
positive neutrophils. (B) MFI R123 fluorescence in the R123 positive neutrophils as an 
indication of the amount of ROS released.  
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Figure 6.10: Neutrophil respiratory burst in PMNs of healthy participants and those 
with periodontitis. (A) Percentage of neutrophils undergoing respiratory burst as 
determined by the percentage of PMNs falling into the FITC positive region (Figure 6.8B 
– histogram, boxed region). (B) MFI of FITC fluorescence in the FITC positive region as 
an indication of the amount of PMN respiratory burst. Statistical significance was 
determined by comparing samples within groups (two-way ANOVA, Tukey) and between 
healthy and periodontitis (two-way ANOVA, Bonferroni) with significance p < 0.05. 
Symbols (*, **, ***, •) indicate significant differences between stimulation groups with 
matching symbols and colours (black symbols indicate differences in healthy 
participants, grey symbols indicate differences in periodontitis participants).  
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6.2.2. Cytokine/chemokine profiles of saliva, plasma and GCF 
Saliva, plasma and GCF were collected and processed from five systemically healthy 
participants with periodontitis and five without as described previously (section 2.7.1). 
The samples were analysed to determine the presence and concentration of a panel of 
cytokines/chemokines using a multiplex bead array method (section 2.7.5).  
The multitude of proteins contributing to the complex matrix of saliva has the potential to 
interfere with the detection of the cytokine/chemokines. Taking this into account 
cytokines/chemokines in saliva were quantitated both undiluted and diluted to determine 
the efficiency of the multiplex bead array method with saliva. Dilution methods outlined 
by the manufacturer for plasma analysis was utilised for saliva for a 1:1 dilution with the 
provided diluent (section 2.7.5). Once data were collected, standard curves were 
generated, and cytokine/chemokine concentrations determined using the multiplex bead 
array manufacturer’s analysis software (LegendPlex), with corrections for background 
fluorescence (Figure 6.11).  
There were limited differences between undiluted and diluted samples. However, IL-1β 
and IL-23 were detected in more samples following dilution while detection of IL-17A and 
IL-17F appeared to be lost in some samples following dilution (Figure 6.11). In all cases, 
differences in cytokine/chemokine detection were observed when concentrations were 
low and potentially below the reliable detection limit of the assay. Considering this and 
the potential for interference from salivary proteins, saliva analysis was carried out on 
diluted samples.  
Concentrations of cytokine/chemokines from participant samples were determined using 
the LegendPlex, the results from healthy and periodontitis participants grouped and 
compared for statistically significant differences using two-way ANOVA followed by a 
post-hoc Bonferroni (p < 0.05). The results indicated the presence of eight out of nine 
analysed cytokines/chemokines in saliva to varying degrees in both healthy and 
periodontitis participants (Figure 6.12 and Table 6.1). Of the cytokines/chemokines, IL-
8, IL-1β and MCP-1 were the most prevalent in saliva of both healthy and periodontitis 
groups. In periodontitis IL-1β had the highest concentrations, averaging 12311.63 ± 
1318.28 pg/mL followed by IL-8 (8940.2 ± 7550.71 pg/mL) and MCP-1 (792.02 ± 978.84 
pg/mL), while IL-17 was not detected and IL-17A had the lowest average concentration 
(1.62 ± 3.62 pg/mL). Contrastingly, in healthy participants IL-8 was detected at the 
highest concentrations (1606.75 ± 1331.43 pg/mL) followed by MCP-1 (188.604 ± 80.33 
pg/mL) and IL-1β (122.07 ± 184.94 pg/mL). Both groups, however, exhibited large 
variations in cytokine/chemokine concentrations between participants (Figure 6.12). This 
was particularly evident within the periodontitis group for IL-8, IL-1β and MCP-1 
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concentrations (Figure 6.12 and Table 6.1). It is perhaps for this reason that comparisons 
between healthy and periodontitis groups resulted in no significant differences in any of 
the analysed cytokines/chemokines in saliva.  
In plasma, all nine of the analysed cytokines/chemokines were detected at varying 
concentrations (Figure 6.12 and Table 6.1). In healthy participants MCP-1 had the 
highest average concentration (287.604 ± 27.56 pg/mL) followed by MIP-1α (84.948 ± 
59.37 pg/mL) and IL-23 (72.264 ± 46.4 pg/mL). In plasma of the periodontitis group, 
MCP-1 also had the highest concentration (212.1 ± 53.93 pg/mL) followed by IL-8 
(104.688 ± 139.71 pg/mL) and MIP-1α (74.502 ± 44.71 pg/mL). 
In contrast to saliva, lower concentrations of IL-8, IL-1β and MCP-1 were observed in 
plasma whereas higher concentrations of IL-6, MIP-1α, TNF-α, IL-17A, IL-17F and IL-23 
were seen. However, as with saliva, a large amount of variation was observed in the IL-
8 concentration in periodontitis participants (Figure 6.12A, Figure 6.12B and Table 6.1). 
Although cytokine/chemokine expression appeared to differ comparing the plasma of 
healthy and periodontitis participants these differences were not significant.  
For cytokine/chemokine profiling of GCF, samples from four participants with 
periodontitis and five healthy participants were analysed. GCF strips from one participant 
were contaminated with blood and so data from this sample were not included in the final 
analysis of cytokines/chemokines. Results are presented as concentrations of cytokines 
absorbed at a site onto Perio Paper strips in 30 seconds with samples from five sites 
pooled (section 2.7.1.3 and 2.7.5).  
In GCF, only IL-8 and IL-1β were detectable in both healthy and periodontitis participant 
groups (Figure 6.12C and Table 6.1). This contrasted to saliva and plasma, where 8 out 
of 9 cytokines/chemokines or all cytokines/chemokines respectively were found to be 
present to some degree.  In addition, MCP-1 was also seen in CGF of participants with 
periodontitis. In a similar manner to the trend observed in saliva and plasma, a larger 
variation in concentrations of IL-8 was observed in periodontitis participants compared 
with healthy participants. In the case of GCF, significantly higher concentrations of IL-8 
were observed in periodontitis participants compared with healthy participants. However, 
no difference between health and disease was observed in concentrations of IL-1β and 
MCP-1. Despite the lack of significant difference, on average the concentration of IL-1β 
was higher in periodontitis (10941.52 ± 17932.9 pg/mL) compared with health (687.840 
± 1416.37 pg/mL).  
  
 Chapter 6 – Clinical study 
 
233 
 
 
Figure 6.11: Cytokine/chemokine profiles of saliva from healthy and periodontitis 
participants. (A) Cytokine/chemokine concentrations in undiluted saliva of participants 
detected using a multiplex bead array. (B) Cytokine/chemokine concentrations (with 
dilution factors accounted for) in saliva diluted 1:1 prior to detection using a multiplex 
bead array. 
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Table 6.1: cytokine/chemokine concentrations in saliva, plasma and GCF of 
healthy and periodontitis participants. Results are mean ± SD. 
 Concentration (pg/mL) in samples from: 
Sample matrix Cytokine/chemokine Periodontitis participants Healthy participants 
Saliva 
Interleukin-8 8940.20 ± 7550.71 1606.75 ± 1331.43 
Interleukin-1β 12311.63 ± 1318.28 122.07 ± 184.94 
Interleukin-6 8.55 ± 2.06 9.02 ± 5.90 
Monocyte chemoattractant protein 1 792.02 ± 978.84 188.60 ± 80.33 
Macrophage inflammatory protein 1α 30.42 ± 2.79 33.26 ± 36.27 
Tumour necrosis factor-α 2.60 ± 1.25 9.54 ± 11.96 
Interleukin-17A 1.62 ± 3.62 5.48 ± 7.54 
Interleukin-17F 0 0 
Interleukin-23 7.26 ± 2.76 17.31 ± 19.06 
Plasma 
Interleukin-8 104.69 ± 139.71 28.84 ± 18.06 
Interleukin-1β 30.81 ± 20.76 18.97 ± 13.80 
Interleukin-6 30.54 ± 20.07 30.88 ± 13.60 
Monocyte chemoattractant protein 1 212.10 ± 53.93 287.60 ± 27.56 
Macrophage inflammatory protein 1α 74.50 ± 44.71 84.95 ± 59.37 
Tumour necrosis factor-α 39.82 ± 23.57 19.51 ± 10.90 
Interleukin-17A 35.84 ± 27.46 23.08 ± 9.96 
Interleukin-17F 6.81 ± 9.61 11.25 ± 14.61 
Interleukin-23 65.77 ± 45.09 72.26 ± 46.40 
Gingival 
crevicular fluid 
(GCF) 
Interleukin-8 75997.68 ± 115189.00 151767.08 ± 15613.00 
Interleukin-1β 10941.52 ± 17932.90 687.84 ± 1416.37 
Interleukin-6 0 0 
Monocyte chemoattractant protein 1 75.12 ± 167.97 0 
Macrophage inflammatory protein 1α 0 0 
Tumour necrosis factor-α 0 0 
Interleukin-17A 0 0 
Interleukin-17F 0 0 
Interleukin-23 0 0 
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Figure 6.12: Cytokine/chemokine profiles in samples from healthy and 
periodontitis participants. Saliva (A), plasma (B) and gingival crevicular fluid (C) 
samples were assayed using a multiplex bead array. Significant differences were 
calculated using two-way ANOVA followed by a post-hoc Bonferroni (p < 0.05). 
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6.2.3. MMP8, MMP9 and TIMP1 protein concentrations in saliva and GCF 
Saliva and GCF from healthy and periodontitis participants were processed and analysed 
using ELISAs to determine concentrations of MMP8, MMP9 and TIMP1 as described 
previously (section 2.7.6).  
An increase in the concentration of MMP8 and MMP9 in both saliva and GCF from 
periodontitis participants was observed, however statistical analysis showed no 
significant difference when comparing periodontitis and healthy participants (T-test, 
Mann-Whitney, p > 0.05).  
In both saliva and GCF the MMP8 concentrations in periodontitis participants appeared 
to have a larger range; 445.1 – 1420.3 ng/mL in GCF and 121.53 – 603.42 ng/mL in 
saliva, compared with healthy participants; 118.03 – 1006.46 ng/mL in GCF and 13.382 
– 181.1 ng/mL in saliva (Figure 6.13A and Figure 6.13D). Although not significantly 
different, on average the MMP8 concentration in periodontitis participant saliva (326 ± 
237.9 ng/mL) and GCF (923.6 ± 438.5 ng/mL) appeared to be higher compared with 
health (55.93 ± 70.48 ng/mL in saliva and 519.6 ± 325.8 ng/mL in GCF).  
Results for MMP9, indicated a similar pattern to MMP8 in saliva and GCF. In saliva 
samples from participants with periodontitis, the data indicated a larger variation in 
MMP9 concentration (192 – 1381 ng/mL) compared with healthy (0 – 586.7 ng/mL) 
(Figure 6.13B). This pattern was reflected in GCF but with lower overall concentrations 
compared with saliva (211.9 – 550.2 ng/mL in periodontitis and 41.96 – 404.3 ng/mL) 
(Figure 6.13D). Although, no significant differences were observed in MMP9 
concentrations in saliva and GCF of participants with and without periodontitis, a higher 
average concentration in periodontitis (544.9 ± 480.2 ng/mL in saliva and 433 ± 159 
ng/mL in GCF) was observed compared with health (184.3 ± 237.5 ng/mL in saliva and 
270 ± 152 ng/mL in GCF) (Figure 6.13B and Figure 6.13D) 
In both healthy and periodontitis saliva samples, MMP inhibitor TIMP1, had similar mean 
concentrations (30.02 ± 14.18 ng/mL and 26.02 ± 16 ng/mL respectively) and similar 
concentration ranges (11.84 – 53.21 ng/mL in periodontitis and 14.48 – 41.71 ng/mL in 
health) (Figure 6.13C) with no significant differences between the two groups. In GCF, a 
higher average concentration of TIMP1 was observed in periodontitis (19.1 ± 16.96 
ng/mL) compared with health (2.02 ± 4.52 ng/mL) although the difference did not reach 
significance (Figure 6.13F).   
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Figure 6.13: Matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase 1 (TIMP1) concentrations in healthy and 
periodontitis participants. (A) – (C) Concentrations of MMP8 (A), MMP9 (B) and TIMP1 (C) in saliva determined via ELISAs. (D) – (F) 
Concentrations of MMP8 (D), MMP9 (E) and TIMP1 (F) in gingival crevicular fluid (GCF) determined via ELISAs. 
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6.2.4. Next generation sequencing analysis of clinical samples 
6.2.4.1. Taxonomical analysis of plaque and saliva samples from healthy and 
periodontitis participants  
A Shotgun metagenomic approach was used to process plaque and saliva samples from 
healthy and periodontitis participants. Results were pre-processed (section 2.6) prior to 
separation of reads into rDNA and DNA. rDNA reads were analysed following the QIIME 
pipeline (section 2.6.1) while short DNA reads were de novo-assembled to form DNA 
contigs and analysed used MEGAN (section 2.6.2). All analysis was limited to bacterial 
reads only.  
Taxonomic composition of the microbiota in saliva and plaque was analysed using the 
operational taxonomic unit (OTU) counts based on alignments against the human oral 
microbiome database (HOMD) for rDNA reads and NCBI non-redundant protein 
databases for DNA contigs (section 2.6).  
Alpha diversity plots were used to determine species richness (number of taxa/OTUs) 
within each sample. Multiple calculations of alpha diversity were carried out and analysis 
based on rDNA OTU counts in this cohort demonstrated saliva samples were richer in 
species compared with plaque samples, regardless of calculation method (Figure 
6.14A). Contrastingly, using DNA contig OTU counts for alpha diversity calculations in 
these samples resulted in limited differences in plaque and saliva when using the Chao1, 
ACE and Fisher methods and higher alpha diversity in saliva using the Simpson, inverse 
Simpson and Shannon methods (Figure 6.14B). In both rDNA and DNA contig analysis 
methods and regardless of calculation method, no significant difference was observed 
(unpaired T-test, Mann-Whitney, p > 0.05). 
In alpha diversity measurements of both rDNA and DNA contig counts, the plaque 
samples appeared to have more variation in the alpha diversity measure, indicating more 
variation in richness compared with the saliva samples. Interestingly, in rDNA samples 
no differences were apparent when comparing healthy to periodontitis regardless of 
calculation method. However, when using DNA counts Shannon, Simpson and 
InvSimpson alpha diversity measures were significantly lower in periodontitis than in 
health (unpaired T-test, Mann-Whitney, p > 0.05) (Figure 6.14B). 
Principle coordinate analysis (PCoA) with Bray-Curtis dissimilarity plots indicated saliva 
samples clustered separately from plaque samples in counts from both rDNA and DNA 
contig, with less sample relatedness in plaque samples (Figure 6.15). Additionally, saliva 
and plaque samples from periodontitis and healthy clustered together. There was, 
however, more crossover between health and periodontitis in both saliva and plaque 
when using rDNA counts (Figure 6.15A). Together these data suggest that communities 
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from plaque are relatively different from those found in saliva and communities found in 
health are different compared with those found in periodontitis.  
Following analysis of sample relatedness, taxonomic composition at a phylum level using 
OTU counts from both rDNA and DNA contigs were analysed. Results are presented as 
percentage relative abundances (abundance of each OTU relative to all OTUs in each 
sample) to allow for a more accurate comparison between sample types and sample 
sites (Figure 6.16).  
When looking at the percentage abundance of OTUs based on rDNA data in these oral 
samples it is clear that a difference exists not only between the healthy and periodontitis 
samples, but also between sample sites (Figure 6.16A). In plaque, healthy samples had 
a higher abundance of Proteobacteria compared with periodontitis samples, where 
abundances of Proteobacteria were very low, while abundances of Spirochaetes had the 
opposite trend. In saliva, however, the percentage of Proteobacteria remained 
unchanged and Spirochaetes were undetectable. Furthermore, in both saliva and plaque 
more Firmicutes were observed in health, with abundances higher in saliva compared 
with plaque. Less Bacteroidetes were present in healthy plaque and a similar trend was 
found in saliva. Synergistetes, interestingly, were only detectable in plaque from 
periodontitis participants. Finally, Actinobateria appeared to be more prevalent in health 
and this difference was more evident in plaque than in saliva. 
Analysis of OTUs based on DNA contigs demonstrated similar patterns of prevalence in 
Bacteroidetes, Firmicutes, Fusobacteria and Synergistetes to that of rDNA (Figure 
6.16B). Compared with rDNA based analysis, Fusobacteria appeared to be more 
abundant in plaque and saliva DNA contig OTUs but in both cases little difference was 
observed between health and periodontitis. Proteobacteria percentages based on DNA 
contigs also differed with higher abundances in periodontitis plaque and lower 
abundance in saliva and healthy plaque compared with rDNA based OTU percentages. 
Despite this, Proteobacteria appeared to follow the same trend as described for rDNA 
based abundances. Furthermore, Actinobacteria percentages in DNA contig based OTU 
counts were increased in saliva, unchanged in periodontitis plaque and decreased in 
healthy plaque compared with rDNA but with a similar trend in regard to differences 
between health and periodontitis.  
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Figure 6.14: Alpha diversity measurements of clinical samples. (A) Alpha diversity 
measures calculated using a variety of methods for OTU counts based on rDNA 
alignments. (B)  Alpha diversity measures calculated using a variety of methods for OTU 
counts based on DNA contig alignments. Significant differences between health and 
periodontitis at each site was calculated using an unpaired t-test (*, p < 0.05).    
* * * 
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Figure 6.15: Principal coordinate analysis (PCoA) with Bray-Curtis dissimilarity 
based on taxonomic profiles of samples. (A) Plot for taxonomic clustering of plaque 
and saliva samples at a species level based on rDNA reads. (B) Plot for taxonomic 
clustering of plaque and saliva samples at a species level based on DNA contigs. 
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When using DNA contigs for taxonomy analysis, Spirochaetes abundances were higher 
in plaque than those seen when using rDNA with the increase in periodontitis compared 
with health more prominent (Figure 6.16B). Interestingly, in DNA contig analysis 
Spirochaetes were also detected in periodontitis saliva while in rDNA analysis 
Spirochaetes were not detected. In addition to these changes in the most abundant 
phyla, DNA contig based analysis also allowed the detection of less prevalent phyla such 
as Acidobacteria, Chloroflexi, Chlamydiae, Cynobacteria, Tenericutes and others.   
DNA contigs were then used for a more in-depth analysis of the taxonomy because 
comparisons between health and periodontitis remained unchanged between rDNA and 
DNA contig based taxonomical analysis, more phyla were detected using the DNA contig 
method, and there was increased accuracy using DNA based alignment methods (rather 
than rDNA/16S alignment methods) for metagenomics.   
Analysis of taxonomy at a genus level was limited to the 50 most abundant genera with 
removal of unclassified bacteria to increase clarity (Figure 6.17). Salivary bacterial 
profiles at this genus level were similar in both healthy and periodontitis participants. 
However, of the 50 most abundant genera, higher percentages were observed in 
Porphyromonas, Tannerella, Treponema and Prevotella in saliva samples of 
periodontitis participants. On the other hand, in periodontitis saliva lower abundances of 
Veillonella, Streptococcus, Haemophilus and Actinomyces were seen.  
In plaque, there were higher percentages of Fretibacterium, Treponema, Prevotella, 
Tannerella, Porphyromonas, Fusobacterium, Bacteroides and Anaerolineaceae 
bacterium oral taxon 439 in periodontitis compared with healthy. Contrastingly, lower 
abundances of Streptococcus, Paenibacillus, Mycobacterium, Haemophilus, Rothia, 
Escherichia, Salmonella, Corynebacterium, Chlamydia, Lautropia, Bacillus and 
Actinomyces were observed in periodontitis compared with health. Although the results 
showed changes in the bacterial profiles of both saliva and plaque from periodontitis, 
given the lack of technical replicates and small cohort size it could not be determined 
whether these differences were significant. 
As described above, differences in bacterial composition appeared to be more evident 
in plaque than saliva when comparing health and periodontitis. There were also clear 
differences in the prevalence of certain bacteria between the two sample types. For 
example, Bradyrhizobium was undetectable in saliva but was found at an approximately 
5% abundance in healthy and periodontitis plaque. Similarly, Fretibacterium¸ 
Bacteroides and Anaerolineaceae bacterium oral taxon 439 were observed 
predominantly in periodontitis plaque although detected in small amounts in saliva and 
healthy plaque. On the other hand, Rothia and Bacillus were observed predominantly in 
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healthy plaque with smaller abundances in periodontitis plaque and saliva (periodontitis 
and healthy). There was also an increase in the percentage of Actinomyces, 
Porphyromonas and Treponema in plaque compared with saliva for both healthy and 
periodontitis samples. Conversely, Campylobacter were almost undetectable in plaque 
but was seen in both healthy and periodontitis saliva at similar levels. Similarly, 
Streptococcus, Veillonella, and Haemophilus were found at higher percentages in saliva 
compared with plaque.  
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Figure 6.16: Relative percentage abundances of phyla in clinical samples. (A) 
Taxonomic percentage abundances based on rDNA reads. (B) Taxonomic percentage 
abundances based on DNA contigs.  
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Figure 6.17: Relative percentage abundance of genera in clinical samples. Analyses at a genera level were limited to the top 50 most 
abundant genera.
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6.2.4.2. Metagenomics functional analysis of healthy and periodontitis 
participants’ saliva and plaque samples 
In addition to the above described taxonomic analysis of plaque and saliva samples from 
participants with and without periodontitis, analysis was also carried out to determine 
overall functional profiles of the microbiota in these environments. Short DNA reads were 
assembled into contigs prior to being aligned against the NCBI non-redundant protein 
database. The resulting protein assignments were then aligned using SEED and 
EggNOG for annotation (section 2.6).  
As with taxonomical analysis, a PCoA using the Bray-Curtis distribution was carried out 
for counts based on both SEED and EGGNOG functions. The analysis showed a cluster 
of the majority of the samples with outliers of six or seven samples. No obvious patterns 
were seen in the clustering of samples in both analyses (Figure 6.18).  
The resulting data demonstrated little variation in the SEED functional profiles of saliva 
samples regardless of periodontal health status (Figure 6.19). Indeed, these profiles 
appeared similar to healthy plaque. Differences were observed in periodontitis plaque 
samples, however, with evidently higher counts in genes related to virulence, stress 
response, RNA metabolism, protein metabolism, DNA metabolism, carbohydrates and 
cell wall and capsule proteins.   Interestingly, periodontitis plaque also had higher counts 
for unclassified proteins.  
Using EGGNOG databases for annotations resulted in a similar trend with healthy 
plaque, healthy saliva and periodontitis saliva having no discernible differences in counts 
(Figure 6.20). As with the SEED profiles, periodontitis plaque appeared to have more 
counts for certain protein groups. These included carbohydrate transport and 
metabolism, amino acid transport and metabolism, energy production and conversion, 
defence mechanisms, post translational modification, protein turnover and chaperones, 
cell wall/membrane/envelope biogenesis, cell motility and replication, recombination and 
repair.  On the other hand, lower counts for defence mechanisms, cell cycle control, cell 
division, chromosome partitioning and translation, ribosomal structure and biogenesis 
were observed in healthy plaque compared not only to periodontitis plaque but also 
healthy and periodontitis saliva.  
Although some differences were observed, as with taxonomical analysis, significance 
could not be determined due to lack of technical replicates and limited cohort size in this 
pilot study.  
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Figure 6.18: Principal co-ordinate analysis (PCoA) with Bray-Curtis dissimilarity 
based on functional profiles of samples. (A) Plot for functional clustering of plaque 
and saliva samples based on SEED assignments. (B) Plot for functional clustering of 
plaque and saliva samples at based on EGGNOG assignments. 
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Figure 6.19: Functional analysis of clinical sample microbiota using SEED 
database for annotations   
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Figure 6.20: Functional analysis of clinical sample microbiota using EGGNOG 
database for annotations
 Chapter 6 – Clinical study 
 
250 
 
6.3. Discussion 
A disruption in the balance of immune responses and ineffective clearance of pathogenic 
or excessive bacteria in the oral cavity can be detrimental to the periodontal tissues but 
the exact mechanisms involved in maintaining health are not fully understood 
(Moutsopoulos and Konkel, 2017). In this preliminary study we aimed to establish a 
methodology to examine immune responses in periodontitis participants by determining 
changes in systemic neutrophils, systemic and local cytokines/chemokines and local 
MMPs with the aim to implement these methods in a study including diabetics with and 
without periodontitis. In addition, this preliminary study also analysed the microbiota 
profiles of these participants with the long term aim to correlate microbiota changes to 
changes in immune responses.   
6.3.1. Peripheral blood neutrophils in periodontitis and health  
Although neutrophil analysis (migration, phagocytosis and respiratory burst) in 
systemically healthy participants with and without periodontitis showed that there was no 
significant difference between the two groups, the feasibility of analysing the blood 
samples from participants for all three assays within the appropriate time was confirmed. 
In addition, for both test groups, responses to stimulus in all neutrophil assays were as 
expected, i.e. an increase in neutrophil migration towards the chemoattractant fMLP, a 
dose dependent increase in phagocytosis of increasing E. coli concentrations and a dose 
dependent increase in ROS release when stimulated with increasing concentrations of 
E. coli.  
The study indicated limited variation between participant technical replicates for analysis 
of phagocytosis and respiratory burst regardless of treatment group, indicating that in 
future samples can be analysed without the need for replicates as these flow cytometry 
bases methods analyse the response of 10000 neutrophils per sample. This could 
decrease analysis time and volume of clinical sample used.  
However, during analysis of migration, it was evident that variation in migrated cell counts 
existed between technical replicates, perhaps leading to skewing of final results. This 
indicates that the migration assay requires optimising. Perhaps, calculating migrated 
neutrophils as a percentage of total neutrophils could compensate for any differences 
caused by the number of total cells loaded onto the insert membrane. To accomplish 
this, unmigrated cells would need to be quantified in addition to migrated cells and the 
number of migrated cells calculated as a percentage of the total. Despite this variation, 
it was evident that the neutrophils were migrating in response to the chemoattractant 
fMLP.   
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Although no significant differences in responses were observed between periodontitis 
and healthy participants, previous studies have shown that neutrophil dysfunction plays 
an imperative role in periodontitis. Studies examining the impact of conditions affecting 
neutrophil homeostasis and functions in periodontal health exemplify this. Chediak-
Higashi syndrome, for example, is a condition which is characterised by the fusion of 
cytoplasmic granules leading to a decrease in the number of myeloid precursors. Any 
surviving neutrophils contain giant granules which impacts the process of diapedesis and 
so neutrophil chemotaxis. This links the rapid development of periodontitis and the 
associated bone loss in patients with Chediak-Higashi syndrome to defective chemotaxis 
of neutrophils (Clawson et al., 1978, Kaplan et al., 2008, Hajishengallis and 
Hajishengallis, 2014, Cortes-Vieyra et al., 2016). Furthermore, patients with Chediak-
Higashi syndrome have also been shown to have delayed intracellular killing of 
phagocytosed bacteria due to a reduced content of hydrolytic enzymes in their granules. 
In cases of Chediak-Higashi syndrome, patients often present with periodontitis, thus, 
suggesting the progression of periodontitis is linked to neutrophil function (Delcourt-
Debruyne et al., 2000, Nualart Grollmus et al., 2007). Another example is Papillon-
Lefevre syndrome, which is characterised by defective neutrophil chemotaxis and 
reduced bacterial killing and also show increased susceptibility to periodontitis 
(Hajishengallis and Hajishengallis, 2014, Cortes-Vieyra et al., 2016). 
The disorders discussed above highlight some functions important in oral health 
maintenance, but there is also evidence highlighting changes in neutrophils in 
systemically healthy patients with periodontitis. As discussed in detail previously (section 
1.2.1) neutrophils are the most prevalent leukocytes recruited to the oral cavity and are 
the first line of defence against microorganisms (Dutzan et al., 2016, Nicu and Loos, 
2016). A study examining neutrophils isolated from peripheral blood demonstrated 
decreased speed, velocity and chemotactic accuracy of neutrophils from periodontitis 
patients compared with healthy following stimulation by fMLP and IL-8. Non-surgical 
periodontitis treatment only recovered velocity and chemotactic activity in response to 
IL-8 while no changes were observed in response to fMLP (Roberts et al., 2015). 
Furthermore, comparison of peripheral neutrophils isolated from both chronic and 
aggressive periodontitis indicated a significant decrease in chemotactic activity in both 
forms of periodontitis but no difference between the two (Kumar and Prakash, 2012).   
Despite evidence of decreased chemotaxis of neutrophils in periodontitis patients, an 
increase in neutrophil number has also been demonstrated in periodontitis at both a local 
and systemic level (Loos et al., 2000, Landzberg et al., 2015). Increases in oral neutrophil 
counts have also been shown to be reduced following periodontal treatment (Bender et 
al., 2006). Furthermore, Del-1 (developmental endothelial locus-1) deficient mice have 
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also been shown to spontaneously recruit excessive neutrophils to the gingiva, causing 
a destructive inflammatory response as well as alveolar bone loss. Del-1 has been 
shown to be antagonistic to β2 integrin dependent neutrophil adhesion and, as such, 
loss of Del-1 could disrupt neutrophil homeostasis (Eskan et al., 2012, Hajishengallis 
and Hajishengallis, 2014). Localised aggressive periodontitis (LAP) further exemplifies 
the potential of hyperactive neutrophil migration. Although LAP was previously thought 
to be a consequence of hypofunctional neutrophils, evidence now suggests that in 
combination with dysregulated chemotaxis and phagocytosis, LAP patients also have 
increased secretion of inflammatory mediators and increased oxidative stress (Kantarci 
et al., 2003, Ryder, 2010).   
Similarly, hyper-activity or hyper-reactivity is also observed in isolated peripheral 
neutrophils from patients with periodontitis. For example, a study examining the release 
of ROS in peripheral neutrophils from both chronic and aggressive periodontitis indicated 
higher ROS release in unstimulated neutrophils in periodontitis compared with health 
and showed elevated ROS release in unstimulated neutrophils isolated from periodontitis 
patients (Guentsch et al., 2009). Recruitment of these hyper-active neutrophils to the 
periodontal tissue at the site could contribute to the oxidative tissue damage associated 
with periodontitis in the absence of excessive activation. However, following stimulation 
of these neutrophils with opsonised P. gingivalis and A. actinomycetemcomitans, ROS 
release was increased in chronic periodontitis but decreased in aggressive periodontitis 
compared with health. The same study demonstrated increased phagocytosis of P. 
gingivalis in periodontitis compared with health (Guentsch et al., 2009). Ling et al. (2016), 
also showed increased ROS release in both stimulated (by non-opsonised P. gingivalis 
and F. nucleatum) and unstimulated peripheral neutrophils in periodontitis compared 
with health, with a reduction following periodontitis treatment. Mariano et al. (2012) 
demonstrated elevated LL-37 in neutrophils from periodontitis patients following 
stimulation with P. gingivalis, A. actinomycetemcomitans and E. coli LPS compare with 
health. However, the same study also showed a decrease in NO in neutrophils from 
periodontitis compared with health (Mariano et al., 2012). Although not examined here, 
NET degradation has also been shown to be decreased in periodontitis patients with 
correlating decreased DNase-1 but with no changes in NET production (White et al., 
2016a, White et al., 2016b). Given the importance of NETs as a mechanism employed 
by neutrophils for bacterial trapping and killing and the ability of certain periodontal 
pathogens to degrade NETs, this perhaps indicates a need to examine NETs in addition 
to other functions of neutrophils (Palmer et al., 2012). Together previous studies suggest 
that some neutrophil antimicrobial responses are elevated while others are depressed in 
periodontitis with differences between chronic and aggressive periodontitis in some 
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functions and these patterns of hyper- and hypo- reactivity could contribute to 
periodontitis progression.  
While the results presented above show no significant differences in chemotaxis, 
phagocytosis and ROS release in peripheral neutrophils isolated from periodontitis 
compared with health, previous studies (as described above and previously in section 
1.2.1) generally demonstrate decreased chemotaxis and either increased or decreased 
phagocytosis and increased ROS release. The sample size of the clinical study 
described here could potentially be the reason behind the contradictory results compared 
with previous studies. This small sample size indicates that, although the feasibility of 
the study was confirmed, no concrete conclusions can be made with regards to 
differences observed, or their lack of, comparing healthy participants and those with 
periodontitis.  
Given that both insufficient and excessive numbers of neutrophils, in addition to changes 
in functionality, can contribute to the progression of periodontitis, an assay to analyse 
the total number of neutrophils within the local environment of the oral cavity should also 
be included. This change in total number of cells could potentially go towards explaining, 
at least partially, the progression of periodontitis associated with neutrophils without any 
obvious dysregulation of chemotaxis, phagocytosis or respiratory burst. Moreover, 
considering that the majority of cells recruited to the gingival crevice are neutrophils, 
analysis of local and systemic neutrophils (as studied here) could be beneficial in 
examining their role in periodontitis (Schiott and Loe, 1970, Loos et al., 2000). Indeed, 
apoptosis resistant neutrophils in GCF of periodontitis patients have previously been 
demonstrated (Gamonal et al., 2003). These neutrophils could contribute to increased 
numbers of neutrophils in the oral cavity in periodontitis as well as contribute to the tissue 
degradation associated with excessive neutrophil activation and/or presence.  
A recent study has shown the role of P. gingivalis in altering neutrophil anti-microbial 
responses, whereby P. gingivalis co-activates C5a receptor-1 and TLR2 in human 
neutrophils causing a decrease in myeloid differentiation primary response protein-88 
(MyD88), via ubiquitylation dependent proteasomal destruction, which leads to 
suppression of antimicrobial responses. In addition, this pathway activates 
phosphoinositide 3-kinase leading to the inhibition of RhoA GTPase and actin 
polymerisation, thus, blocking phagocytosis (Hajishengallis and Korostoff, 2017). Not 
only does this highlight the necessity for analysis of local neutrophils, it also suggests a 
potential need to alter the stimulus used for the study carried out above as exposure to 
periodontitis associated bacteria may alter neutrophil responses in a manner not seen 
with E. coli. It is also important to note that local tissues have regulatory roles with regard 
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to neutrophils (as described previously) through the release of cytokine/chemokines, 
thus providing more reason to analyse local neutrophils in addition to systemic 
neutrophils.  
6.3.2. Local and systemic cytokine/chemokine profiles  
In addition to observing no significant differences in the analysed neutrophil functions 
between healthy and periodontitis participant groups, the results indicated no significant 
difference in the concentrations of the panel of cytokines/chemokines at both a local and 
systemic level with the exception of increased IL-8 in GCF of periodontitis participants 
(Figure 6.12). Previous studies are often contradictory with regards to GCF 
concentrations of IL-8, with most studies indicating an increase (Gamonal et al., 2001, 
Giannopoulou et al., 2003, Holzhausen et al., 2010, Konopka et al., 2012, Ertugrul et al., 
2013, Khalaf et al., 2014, Lutfioglu et al., 2016) and a few showing decreases (Jin et al., 
2000, Luo et al., 2011) in periodontitis compared with health.  
In general, there also appeared to be increased salivary and plasma IL-8 in periodontitis 
compared with healthy participants, although this did not reach significance in saliva and 
plasma (Figure 6.12). In contrast to GCF, this correlates with previously described 
salivary concentrations of IL-8 in periodontitis (Cesar-Neto et al., 2007, Michiels et al., 
2009, Venza et al., 2010, Lisa Cheng et al., 2014, Khalaf et al., 2014, Souto et al., 2014). 
The lack of significance in the differences, much like with the neutrophil study, could be 
due to the small cohort of participants used during the study and the participant to 
participant variation observed. It is unsurprising that IL-8 concentrations appeared to be 
higher in participants with periodontitis at a local level considering its role as a 
chemoattractant and consequently its role in recruiting neutrophils (as discussed 
previously).  
In addition to IL-8, the only other cytokine detected in both healthy and periodontitis 
participant GCF was IL-1β which was observed at higher concentrations in periodontitis, 
in agreement with previous studies (Giannopoulou et al., 2003, Holzhausen et al., 2010, 
Tymkiw et al., 2011, Konopka et al., 2012, Ertugrul et al., 2013, Luo et al., 2014). 
Similarly, salivary IL-1β concentrations were higher in periodontitis, correlating with 
previous studies, but did not reach significance (Tobon-Arroyave et al., 2008, Gursoy et 
al., 2009, Mirrielees et al., 2010, Kaushik et al., 2011, Ebersole et al., 2013, Rathnayake 
et al., 2013). 
In GCF, MCP-1 was detected in periodontitis but not in health. An increase in GCF 
concentration of MCP-1 in periodontitis patients has been shown in previous studies (Anil 
et al., 2013, Gupta et al., 2013). Similarly, MCP-1 has also demonstrated to be increased 
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in saliva reflecting the trend observed during this study and highlighting the need for an 
increased sample size for results to reach significance (Gupta et al., 2013).   
Although IL-6, TNF-α, IL-17A, IL-23 and MIP-1α were all detected in saliva, there was 
no significant difference between healthy and periodontitis and average concentrations 
were similar in both groups. As with other cytokines, previous experiments have had 
conflicting results with regards to IL-6 concentrations in saliva and GCF with some 
indicating an increase in periodontitis (Cesar-Neto et al., 2007, Costa et al., 2010, 
Holzhausen et al., 2010, Venza et al., 2010, Tymkiw et al., 2011, Prakasam and 
Srinivasan, 2014) and others demonstrating no significant differences (Gursoy et al., 
2009, Rathnayake et al., 2013). Similarly, local TNF-α concentrations have been 
reported to be signficantly higher (Frodge et al., 2008, Singh et al., 2014) in periodontitis 
as well as having no significant difference (Gumus et al., 2014). On the other hand, 
salivary concentrations of IL-17, IL-23 and MIP-1α, are generally demonstrated to be 
elevated in periodontitis (Fu et al., 2013, Awang et al., 2014, Fine et al., 2014, Luo et al., 
2014, Ebersole et al., 2015, Mitani et al., 2015, Liukkonen et al., 2016). Interestingly, all 
nine cytokines/chemokines were detected in plasma although the profiles of periodontitis 
participants and healthy participants showed no significant difference and similar 
averages. Considering the detection of all cytokines/chemokines in plasma and the 
detection of these in other studies in GCF and saliva but the lack of their detection in the 
samples analysed in this study, there is a possibility that the method utilised (i.e. bead 
array) is inappropriate for analysis of GCF and saliva. Both saliva and GCF are protein 
rich samples, and so there is a potential of masking of cytokines/chemokines especially 
when taking into account the assay was designed for analysis of tissue culture and 
plasma samples. Alternative methods (e.g. ELISAs) are required to ensure results are 
not false negatives. In addition, the general low concentrations of many of the 
cytokines/chemokines in saliva and undetected cytokines/chemokines in GCF could be 
due to the complex nature of the sample matrix.  
The analysis of MMP8, MMP9 and TIMP1 in saliva and GCF, again showed no significant 
differences. As with the analysis of cytokines/chemokines and neutrophils, there did 
appear to be higher concentrations of both MMPs in saliva and GCF of periodontitis 
participants which if significant would draw parallels with previous reports (Marcaccini et 
al., 2010, Leppilahti et al., 2014, Salminen et al., 2014, Ebersole et al., 2015, Gupta et 
al., 2015). For TIMP1, however, there appeared to be no difference in saliva but a higher 
concentration (although not significant) in GCF in periodontitis participants. This could 
perhaps reflect an attempt to control the excessive MMP-associated tissue breakdown 
characteristic of periodontitis. As discussed previously, this increase correlates with 
studies that demonstrate elevated TIMP1 concentrations in GCF of periodontitis patients 
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(Popat et al., 2014, Ghodpage et al., 2014). Interestingly, a previous study has 
demonstrated decreased TIMP-1 concentrations in saliva of periodontits patients 
compared with healthy (Nizam et al., 2014).   
In the analysis of all the immune responses discussed above, it is apparent that variation 
between participants in this study occurs more in participants with periodontitis compared 
with those without. This could perhaps explain the lack of consensus in previous studies 
with regards to changes seen in periodontitis associated immune responses. In addition, 
it is now accepted that periodontitis is a disease with stages of immune activity followed 
by inactivity which could further explain the variations observed. This emphasises the 
necessity to increase the cohort size and potentially include samples taken over a period 
of time in all participants. 
6.3.3. Shotgun metagenomics of saliva and plaque from healthy and periodontitis 
participants 
The analysis of NGS data from periodontitis and healthy plaque and saliva samples 
provides a taxonomic and functional profile of bacteria present. A general decrease in 
microbial alpha diversity in plaque from participants with periodontitis was observed with 
significant differences following analysis of DNA contig counts. Recent studies using 
metagenomic or metatranscriptomic data correlates with these results (Jorth et al., 2014, 
Ai et al., 2017). On the other hand, there is also evidence suggesting a higher alpha 
diversity in periodontitis compared with health (Griffen et al., 2012, Abusleme et al., 2013, 
Dabdoub et al., 2016). As seen previously, no significant differences were seen in saliva 
between health and periodontitis and no trends observed regardless of read counts used 
for the calculations (Belstrom et al., 2017).  
At a phylum level, the decrease in Actinobacteria and Proteobacteria and increases in 
Bacteroides, Synergistetes and Spirocheates in plaque from periodontitis  patients 
described in this study has previously been reported (Griffen et al., 2012, Wang et al., 
2013). Enrichment of the genera Prevotella, Fretibacterium, Porphyromonas, 
Treponema and lower abundances of Streptococcus, Corynebacterium and 
Actinomyces in periodontitis plaque have also been reported previously which is 
reflected in the results presented here (Liu et al., 2012, Wang et al., 2013, Dabdoub et 
al., 2016). 
Metagenomics analysis of saliva from periodontitis subjects is limited, with fewer studies 
reported compared with analysis of plaque. Belstrom et al. (2017) compared healthy and 
periodontitis saliva using both metagenomics and metatranscriptomics and 
demonstrated an increased prevalence of pathogens traditionally associated with 
periodontitis such as P. gingivalis, T. forsythia and Parvimonas. This is reflected in the 
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present study where Porphyromonas and Tannerella were both enriched in saliva from 
periodontitis participants. Furthermore, a previous study also demonstrated distinct 
taxonomic clustering of samples suggesting the plaque microbiota is different to that 
seen in saliva (Yamanaka et al., 2012).  
As with analysis of saliva taxonomy, limited studies have evaluated differences in healthy 
and periodontitis salivary microbiota at a functional level using metagenomics. Evidence 
suggests a downregulation of carbohydrate metabolism in periodontitis compared with 
health using metatranscriptomic data (Belstrom et al., 2017). The metagenomic data 
from this study, however showed similar functional profiles for saliva regardless of health 
status. This could be a consequence of using metagenomic analysis, which evaluates 
the functional capability of the microbiota from each environment but does not indicate 
gene pathways in operation. The metatranscriptomic data, however, allowed the 
evaluation of active gene pathways for growth and survival on microbiota from healthy 
and periodontitis participants.   
A slight downregulation in carbohydrate and amino acid related genes was observed but 
whether these changes are significant requires further analysis. In contrast, evident 
differences were seen in periodontitis plaque compared with healthy plaque with similar 
changes seen in previous NGS studies (Liu et al., 2012, Wang et al., 2013, Jorth et al., 
2014, Dabdoub et al., 2016). Of interest was the upregulation of 
virulence/disease/defence mechanisms, stress, cell motility and chemotaxis, cell 
wall/membrane/envelope biogenesis, transcription and DNA/RNA/carbohydrate/protein 
metabolism. Together this suggests that the microbiota of periodontitis plaque samples 
were more virulent but also suggests a higher bacterial load as indicated by increases in 
various metabolism and transport systems. 
While the data presented above validates the methods and indicates differences in 
composition and function of the microbiota when comparing health to periodontitis, the 
lack of technical sequencing replicates hinders the ability to analyse significance and as 
such limits understanding. It is also important to acknowledge the differences in 
sequencing methods (such as 454/Roche and Illumina/Solexa) and analysis pipelines 
currently used for metagenomic studies and the limitations this imposes on comparing 
between studies. These variations in sequencing and analysis methods, in addition to 
experimental factors (such as sampling sites and participant exclusion criteria) could 
explain conflicting results in previous studies. However, with constantly improving 
bioinformatics tools and increasing genomic data in databases, analysis of NGS data is 
becoming faster, easier and more accurate. Metagenomics provides valuable 
information with regards to functional potential of a microbiome but addition of 
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metatranscriptomic analysis could enhance this and provide a deeper understanding of 
active microbiota gene expression and function.  
6.3.4. Implications for the diabetes-periodontitis link 
Due to time limitations, the scope of this study could not include participants with 
diabetes. The inclusion of this group is imperative to elucidating mechanistic links 
between periodontitis and diabetes as patients with diabetes have previously been 
shown to have impairment in neutrophils, changes in concentrations of 
chemokines/cytokines and increased levels of MMPs (Preshaw et al., 2012). To date, 
studies investigating the relationship between diabetes and neutrophil function have 
been contradictory, with some studies showing up-regulation in total neutrophil counts, 
respiratory burst, migration and apoptosis while other studies have shown a decrease in 
neutrophil counts, adhesion, microbial activities, respiratory burst, migration and 
phagocytosis as discussed in detail in section 1.4.2 (Manouchehr-Pour et al., 1981, Salvi 
et al., 1997a, Salvi et al., 1997b, Alba-Loureiro et al., 2006, Graves et al., 2006, Alba-
Loureiro et al., 2007, Preshaw et al., 2012). In a similar manner, studies on the local and 
systemic cytokine concentrations in diabetic patients with and without periodontitis have 
shown contradictory results (section 1.4.1). With regards to MMPs, studies have mainly 
shown increases in MMP concentrations associated with increased neutrophil activity 
(hyperactivity or increased number) (Kumar et al., 2006, Correa et al., 2008, Costa et al., 
2010, Hardy et al., 2012). Differences in microbial composition in the oral cavity of 
diabetics have also been implicated in the increased prevalence of periodontitis. Indeed, 
previous studies have shown shifts in bacterial composition although reports are 
somewhat contradictory with regards to specific genera/species involved (Thorstensson 
et al., 1995, Lalla et al., 2006, Hintao et al., 2007, Ebersole et al., 2008, Casarin et al., 
2013, Xiao et al., 2017). It is proposed that the methodologies validated in this feasibility 
study for the evaluation of the discussed immune responses alongside bacterial profiles, 
could reasonably be implemented in diabetics with and without periodontitis.  
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7. Conclusions and future directions 
The studies presented in this thesis examine potential links between diabetes and 
periodontitis. The two diseases have complex aetiologies, and while it has long been 
demonstrated that the two are linked (Preshaw et al, 2012), the exact mechanisms are 
unclear. The most promising of these mechanisms has been discussed in detail 
previously (section 1.4). This thesis aimed to evaluate if increased AGEs (associated 
with hyperglycaemia) effected inflammatory responses of gingival keratinocytes, 
bacterial composition of a five species periodontitis biofilm model, and composition and 
functional potential of a complex inoculum biofilm model. In addition, the thesis outlines 
a methodology to evaluate how biofilms grown with concentration of AGEs that are 
commensurate with diabetes and health impact inflammatory responses when co-
cultured with gingival keratinocytes. 
As described previously (section 1.4.3), hyperglycaemia has been linked to the 
accumulation of AGEs and subsequent chronic inflammatory responses. Given the 
central role of inflammatory responses to both diabetes and periodontitis, increased 
periodontitis severity has been correlated to hyperglycaemia (Shlossman et al., 1990, 
Emrich et al., 1991, Taylor et al., 1998, Tsai et al., 2002, Hiroshima et al., 2018).  
Although previous studies have shown that the increase in serum levels of AGEs from 
diabetic patients correlated with an increase in periodontitis-linked attachment loss and 
increased immunoreactivity of AGEs in gingival tissues (Takeda et al., 2006, Zizzi et al., 
2013, Hiroshima et al., 2018), no studies to date have linked increased AGEs to changes 
in oral microbiota. The experiments presented above, demonstrate the potential use of 
a five species biofilm model, cultured to represent a simplistic periodontitis associated 
biofilm, as a way to analyse the effect of increased AGEs on biofilm composition. The 
results from this study demonstrated a change in the composition of the biofilm whereby 
A. naeslundii was the predominant species following introduction of AGE to the growth 
media (Figure 4.2). This was surprising when considering Actinomyces species 
(alongside Streptococcus) are the predominant early colonisers of tooth surfaces (Li et 
al., 2004) and have been long associated with health (Socransky and Haffajee, 2002). 
This was associated with a decrease in pH, potentially as a consequence of AGE 
metabolism. Given the inability of P. gingivalis¸ P. intermedia and F. nucleatum to survive 
in acidic environments, this could go towards explaining the biofilm composition following 
AGE addition (Takahashi et al., 1997).  
While a series of studies have demonstrated AGEs produced by E. coli K12 are 
metabolised intracellularly by metalloproteases and secreted as low-molecular weight 
AGE peptides into the growth media (Katz et al., 2010, Cohen-Or et al., 2011, Cohen-Or 
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et al., 2013), these studies are limited to intracellular bacterial AGEs and did not 
investigate bacterial uptake of extracellular AGEs and subsequent metabolism. 
However, Hellwig et al. (2015), showed the ability of human colonic microbiota to 
metabolise AGEs which were incubated with faecal suspensions, through analysis of the 
resulting metabolites by HPLC. A similar approach could be taken to determine the 
metabolism of AGEs in the five species biofilm model. To fully determine AGE 
metabolism by the five species biofilms future work should also include quantifying the 
AGE levels in the growth media following the incubation period and analysing the 
metabolic pathways activated through transcriptomics.  
The changes observed in the five species biofilm model confirmed the possibility of AGEs 
altering biofilm composition. However, given the complex nature of the oral microbiota, 
the implications of this are limited. As such, the effect of AGEs on a biofilm generated 
with a physiological inoculum to create a more complex biofilm, was evaluated. Using 
NGS, it was concluded that results from the complex biofilm model reflected those 
observed in the five species model. In both models, the addition of AGE encouraged the 
growth of health associated bacteria (section 5.2). In the complex biofilm model, it is 
likely the pre-conditioning of the HA pegs with high HSA-AGE concentrations selects for 
the bacteria that are present in the mature biofilms, as early (day 2) biofilms also favour 
health associated bacteria. Further analysis is required to elucidate the reason the health 
associated bacteria are selected for growth under high HSA-AGE concentrations. It is 
possible the complex biofilm reflect the results seen in the five species model so that 
metabolism of the HSA-AGE alters pH of the media causing the periodontitis associated 
bacteria growth to be halted and as such future studies should include pH monitoring. 
There is also the possibility that changes associated with the biofilms grown with low 
HSA-AGE concentrations are a consequence of the addition of HSA-C (which was added 
to account for protein differences) so that comparisons between low and high HSA-AGE 
are taking into account changes associated with the combination of HSA-AGE and HSA-
C. To account for this biofilms without any supplementation of the media and 
supplementation of the media with low HSA-AGE concentrations alone are needed.   
While these experiments highlight the potential of using HA pegs to generate complex 
biofilms, the study presented above has its limitations. In particular, the cultured biofilms 
were used to model the periodontitis microbiota and the effect of hyperglycaemia on 
these but the inocula used was from healthy volunteers. This is reflected in the 
composition of the inocula which is consistent with HMP data from seven healthy oral 
sites, where the predominant phyla were shown to be Firmicutes, Bacteroidetes, 
Proteobacteria, Fusobacteria and Actinobacteria (Human Microbiome Project, 2012, 
Zhou et al., 2013b, Moon and Lee, 2016). Although the media used for culturing the 
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biofilms was designed to encourage the growth of periodontitis associated bacteria 
(Naginyté, 2017, unpublished), in future studies it would be beneficial to produce inocula 
from periodontitis patients, in an attempt to model periodontitis more closely. This is of 
particular importance when considering the observed shift in composition where genera 
typically associated with periodontitis, such as Fusobacterium, Campylobacter, 
Treponema and Haemophilus, were less prevalent while genera generally associated 
with periodontal health (including Actinomyces, Streptococcus and Veillonella) were 
more prevalent in early (day 2) biofilms compared to the inocula (section 5.2). This could 
perhaps suggest that health associated bacteria are outcompeting the less abundant 
pathogens or opportunistic pathogens found in healthy participants, for colonisation of 
the HA pegs.    
It is also possible that expansion of the AGE concentrations is required. The modelling 
was based on previous evidence from a single study which demonstrated increased 
HSA-AGE concentrations in the GCF of periodontitis patients with diabetes (Kajiura et 
al., 2014). While this study provided a range of HSA-AGE concentrations to use, it is 
likely that analysis of a larger cross section of GCF (and perhaps saliva) of periodontitis 
patients, periodontitis patients with diabetes and healthy volunteers is required for better 
representation of AGE GCF concentrations. In addition, to truly evaluate the validity of 
this method to model the bacterial composition of biofilms in the periodontal pockets of 
diabetics with periodontitis, a direct comparison (using NGS/transcriptomics) of model 
biofilms and patient biofilms is required. As discussed in section 6.3.3 a comparison of 
clinical samples with model biofilms using the same analysis methods is imperative to 
eliminate any method bias.  
The interactions between oral microbiota and the host cells also plays a crucial role in 
the progression of periodontitis and may be exacerbated by the immune dysregulation 
associated with diabetes (Preshaw et al¸ 2012). The methods presented here, attempt 
to model the microbiota-host cell interactions using a co-culture method. Close attention 
was paid to the inflammatory responses of the TIGK cells in response to the biofilms with 
or without AGE in the co-culture media. Biofilms were cultured under varying conditions 
(to reflect health and hyperglycaemia associated AGE concentrations) and introduced to 
TIGK cells, cultured for 8 hours and inflammatory responses analysed.  
Prior to analysis of AGE associated changes in host inflammatory responses in TIGK 
cells, the expression of RAGE was first confirmed in the gingival keratinocytes cell line 
utilised in this study (section 3.2). The results demonstrated RAGE was expressed as 
both the cell surface bound and secreted versions. However, the overall expression of 
RAGE on these cells was not altered as a consequence of increased AGE 
Chapter 7 – Conclusions and future directions 
 
262 
 
concentrations. To ensure the lack of difference is not a consequence of the 
methodologies utilised, further analysis is required. In particular, analysing the ratio of 
cell surface bound RAGE receptor and secreted RAGE receptor at both a protein and 
mRNA level is required. To accomplish this at a protein level an ELISA can be optimised 
to quantitate RAGE concentrations in both WCL and culture supernatant. For the 
analysis of RAGE mRNA, primers specific to the various isoforms of RAGE can be 
designed for use with qRT-PCR methods. Establishing these ratios is important when 
considering the sequestering of AGE by secreted RAGE prevents the activation of 
signalling cascades associated with AGE-RAGE interactions and could prevent the 
feedback required for the upregulation of RAGE expression (Yonekura et al., 2003, 
Hudson et al., 2008, Kalea et al., 2009, Ott et al., 2014, Wautier et al., 2017, Leung et 
al., 2016). In addition to RAGE ratio analysis, quantifying the levels of ADAM10 and 
MMP9 (which have been associated with RAGE cleavage to generate secreted RAGE) 
may prove prudent to determine if changes in these proteolytic proteins are responsible 
for the changes in secreted RAGE (Yonekura et al., 2003, Hudson et al., 2008, Kalea et 
al., 2009).  
While the data presented in this thesis, demonstrated a lack of difference in 
cytokine/chemokine release following AGE addition to culture media (section 3.2), it is 
possible this was due to a lack of interactions between AGE and RAGE. It is possible 
that AGE interacts with various other receptors (including AGE-R1/OST-48, AGE-
R2/80K-H, AGE-R3/galectin-3) which may not result in tested cytokine/chemokine 
changes (Araki et al., 1995, Vlassara et al., 1995, Li et al., 1996, Ohgami et al., 2001a, 
Ohgami et al., 2001b, Ohgami et al., 2001c, Jono et al., 2002, Tamura et al., 2003). To 
ensure AGE interaction with RAGE, investigation into the NFκB, MAPK and other 
signalling pathways would be beneficial, particularly when considering these have been 
linked to downstream signalling cascades for AGE-RAGE interaction (Figure 3.1) 
(Schmidt et al., 2000, Ishihara et al., 2003, Kokkola et al., 2005, Mallidis et al., 2007).  
Although the presence of RAGE on TIGK cells was confirmed, the addition of AGE 
appeared not to alter cytokine/chemokine levels. However, co-stimulation of the TIGK 
cells with biofilms generated under various conditions appeared to dampen IL-6 and IL-
8 responses (section 5.2.3). This could potentially be a consequence of bacterial 
degradation of cytokines/chemokines. This would correlate with other studies which have 
demonstrated P. gingivalis modulation of IL-8 (Darveau et al., 1998, Huang et al., 2001, 
Bainbridge et al., 2010) and IL-6 (Lourbakos et al., 2001, Uehara et al., 2008, O'Brien-
Simpson et al., 2009). Interestingly, concentrations were higher with diabetes and 
periodontitis biofilms compared with periodontitis biofilms alone with changes more 
evident with direct biofilm-cell contact. This suggests the biofilm composition or biofilm 
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functionality is altered to modulate cellular inflammatory responses and perhaps 
highlights the possibility that hyperglycaemia of diabetics activates pathways that lead to 
an increase in inflammation (Preshaw et al., 2012).   
However, as this was a feasibility study and thus limited to one replicate, the results are 
inconclusive and repeats are required for validation. The data do however, indicate a 
potential change in the cytokine/chemokine profile of TIGK cells following co-culture with 
biofilms and as such highlights the necessity for further analysis. Furthermore, this thesis 
demonstrated the feasibility of co-culture and may be applied in the future to analyse the 
effect of oral biofilms on immune cells. This would be of interest, given the high 
predominance of immune cells in the oral cavity and their crucial role in the progression 
of periodontitis and their increase in number during periodontitis (Dutzan et al., 2016). 
Furthermore, high expression of RAGE was shown in gingival epithelial cells and 
circulating leukocytes which contrasted with healthy gingiva, where RAGE expression 
was limited (Abbass et al., 2012). Co-culture of leukocytes under hyperglycaemic AGE 
conditions with complex biofilm, may therefore result in a more exacerbated inflammatory 
response.  
In both TIGK responses to AGE and co-culture experiments, the analysis of MMPs would 
aid in understanding the cytokines/chemokines response. Particularly when considering 
they are targets for MMP cleavage (Franco et al., 2017). Indeed, in previous studies, 
MMP13 has been implicated in activation of other MMPs through a proteolytic cascade 
in gingival cells from periodontitis patients (Hernandez Rios et al., 2009, Franco et al., 
2017). An increase in MMPs in co-culture experiments could account for the decreases 
in cytokines/chemokines observed.  
In addition to the in vitro studies discussed above, the thesis presents a preliminary 
clinical study analysing the immune and inflammatory response of periodontitis and 
healthy participants at both a local and systemic level (section 6.2). Given the limited 
cohort size, no differences in neutrophil phagocytosis, respiratory burst and migration 
were detected and as such an increase in participant number is required. In addition to 
the functions of neutrophils described in this thesis, neutrophil extracellular traps (NETs) 
have recently been indicated as important in neutrophil killing (Brinkmann et al., 2004). 
In chronic periodontitis NETs have been observed in periodontal pockets and GCF 
(Vitkov et al., 2009). Furthermore, P. gingivalis, T. forsythia, F. nucleatum and Prevotella 
intermedia, have been shown to have DNAse activity and can degrade NETs under 
certain growth conditions, thus, avoiding NET-associated killing (Palmer et al., 2012). 
Together these studies suggest the addition of NET analysis would be beneficial to 
elucidating the links between diabetes and periodontitis. As described previously, an 
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increase in local and systemic neutrophil number has been observed in periodontitis and 
P. gingivalis has been shown to increase migration and retention of neutrophils into 
tissues (Wingrove et al., 1992, Meyle and Chapple, 2015, Dutzan et al., 2016), perhaps 
suggesting a need to evaluate the number of systemic and local neutrophils in 
periodontitis patients with and without diabetes.  
Similar to neutrophil data, the panel of cytokines/chemokines analysed indicated limited 
significant differences between healthy and periodontitis patients at both a systemic and 
local level. However, IL-8 (GCF, saliva and plasma), IL-1β (GCF, saliva), MCP-1 (GCF, 
saliva) all appeared to have increased concentrations in periodontitis. Likewise, the 
MMPs analysed appeared to be present at increased concentrations in the GCF and 
saliva of periodontitis participants. Although the differences didn’t always reach 
significance, the data suggest that periodontitis participants had an increased 
inflammatory response. To confirm these results an increase in cohort size is required. 
The clinical study also indicates differences in composition and function of the microbiota 
when comparing health to periodontitis. It is proposed that the methodologies validated 
in this clinical feasibility study for the evaluation of cytokine/chemokine concentrations, 
neutrophil functions and bacteral profiles, can be implemented in diabetics with and 
without periodontitis.  
The data described in this thesis presents a framework for future investigation. Alongside 
expanding the clinical study to include diabetic patients and increasing the cohort size, 
future work includes optimizing the complex biofilm model to better represent long term 
consequence of hyperglycaemia on periodontitis biofilms and co-culture experiments to 
analyse the effects of biofilms on oral cells.  
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